Freedom of Information (FOI)

The Freedom of Information Act 2000 (FOI) came fully into force in January 2005. All bodies must have in place a Publication Scheme (a list of classes of information available to the public).

The act also gave individuals and corporate bodies the right of access to all types of recorded information held by public sector bodies, with the exception of certain specified exemptions (for instance, personal information and commercially sensitive information). For more information about the act please visit the Information Commissioner’s website: www.ico.org.uk/for-the-public/official-information

Before making a formal request to the Trust, please check our website to make sure that the information isn’t already available.Our Publication Scheme has most of the information frequently asked for by members of the public. Alternatively, you can search this site below for information disclosed by the Trust following requests made under the Freedom of Information Act 2000 since 1 April 2015.

If the information you require is not held on our website, you can contact us either by emailing us at: mtw-tr.foiadmin@nhs.net or writing to us at Freedom of Information Officer, Trust Headquarters, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone ME16 9QQ.

Once we have received your request, we will send you an acknowledgement letter. We are required to give you a response within 20 working days of our acknowledgement letter. We will try to respond as quickly as possible. Sometimes, some or all of the information cannot be provided. If this is the case, we will explain the reasons why.

We are able to charge fees for requests, outlined in the Freedom of Information Guide. We will generally only charge you for hard copies or copying onto media eg CD. The charges will vary according to how information is made available. Legally, if the cost of obtaining and sending you the information is more than £450, we do not have to provide you with the information you requested. This amount is based on the DCA’s (Department of Constitutional Affairs) regulations of a national cost of 18 hours work at £25 per hour.

In the first instance you should appeal to us directly, in line with our FOI appeal process. Download a copy of the appeals process document, or email us at mtw-tr.foiadmin@nhs.net for a copy to be sent to you. If you are still dissatisfied after the appeals process, you have the right, under section 50 of the Act, to apply to the Information Commissioner to seek resolution to the matter.

Search our FOI database

Choose a category:

Agency staff

Agency Staff

1) Total spend on agency staff split by each of the following staffing groups:
2) Total spend on internal bank staff (split by the following categories)
3) Total number of staff employed on the bank, and of which, the number that also hold substantive contracts with the trust.
4) Does the trust outsource bank staff to NHSP? If so, how much was spent on outsourced bank staff?
5) Does the trust use rostering software, if so which provider (Allocate, SMART, DRS, SMI etc.)?
6) Does the trust directly engage locum staff? If so, how much of the trust’s medical locum spend was put through direct engagement in the last financial year?

Download response Agency Staff 170815

A&E agency staff 2016. 290317

1. The amount spent on employing agency/temporary/locum doctors in A&E departments in each month in 2016.
2. The number of FTE roles covered by agency/temporary/locum doctors in each month in 2016
3. The total number of FTE doctors working in the A&E department in each month in 2016.

Download response A&E agency staff 2016. 290317

Agency costs 2014/2015

1. Staff Numbers (Average over the whole year or the count on Tuesday, March 31st 2015)
2. Staff Cost
3. Agency Hours
4. Agency Spend
I would greatly appreciate it if you could supply this information for the year 2014/15 (April ’14 to March ‘15).

Download response Agency costs 2014/2015 040216

Agency doctors and nurses 2016-2017. 231117

• The total amount you spend on Agency Doctors & Nurses for the financial year 16/17 (April – March)

• For the above information to be broken down by Banding / Grade and also specialty

Download response Agency doctors and nurses 2016-2017. 231117

Agency expenditure 2016-2017. 050717

1. The trust’s completed ‘Detailed agency collection” for month 12 of 2016-17, showing the year to date figures. (Example attached)
If for any reason the trust is minded not to provide this document, please list the five specialties for which the trust had the highest agency staff costs – as a % of total pay costs for the specialty – in 2016-17 in the table below. Please also fill in the cells detailing expenditure. If the trust’s accounts have not yet been audited, please use the unaudited figures.
2. Please state the total number of shifts for which the trust breached the national pay cap for medical agency staff in 2016-17 (55% above basic rates), and break this total down for each specialty where the breach occurred (its fine to only detail the top five specialties).
3. Please state the total number of shifts for the trust breached the national pay cap for agency nursing staff in 2016-17 (55% above basic rates), and break this total down for each specialty where the breach occurred. (It’s fine to only detail the top five specialties).
4. Please state the total number of shifts which required CEO sign off, and break these down for each specialty.
5. Please state the ten shifts for agency medical staff for which the highest hourly rate was paid. Please state the rate paid and the specialty.
6. For individual medical locums who have incurred the greatest total expenditure for the trust in 2016-17, please state the total amounts paid by the trust in the year in relation to these individuals’ work. Please also state their specialty. E.g. Medical locum 1, emergency medicine, total expenditure by the trust in 2016-17; £196,000

Download response Agency expenditure 2016-2017. 050717

Agency Locum Doctor spend for 2015-2016.

• The total amount you spend on Agency Locum Doctors for the financial year 15/16 (April – March)
• For the above information to be broken down by grade and specialty (example provided below)

Download response Agency Locum Doctor spend for 2015-2016 270616

Agency locum doctors and consultants spend for 2015-2016.

Please can you let us know what the Trust as a whole (including hospitals that are run by you) spent on employing agency locum Doctors and Consultants last year.

Download response Agency locum doctors and consultants spend for 2015-2016 010716

Agency locum spend. 010818

How much did the trust spend on agency locums last year? Broken down into SHO, Middle Grade and Consultants

If I could please have this information on the following specialities: A&E, Acute Medicine, General Medicine, Radiology and Paediatrics I would be appreciative.

Download response Agency locum spend. 010818

Agency locum spend 2015-2016.

Please could you send me the agency locum spend for the trust for the last financial year. I would like the spend for doctors only.

Please include the agency spend in each specialty breaking it down into the different grades (SHO, Middle Grade, Consultant).

Please could you also provide the spend on introductory fees for doctors for each specialty based on Doctors taken onto NHS contracts.

Download response Agency locum spend 2015-2016 050816

Agency locum spend in Cardiology. 040717

Could you please let me know the locum agency spend from May 2016 – Present? This refers directly to the cardiology department only; the staff will be Cardiographers, Cardiac Physiologists, Echo cardiographers, please note this is not referring to locum doctors or specialists.

These staff will fall under AHP/HSS or healthcare.

Download response Agency locum spend in Cardiology. 040717

Agency midwives and pay 2015.

1. What was the total cost for your trust, including fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?

2. What was the cost for your trust for the fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?

3. What was the total number of hours worked by midwives supplied by an agency, broken down by the months in the table below?

4. What was the total cost for your trust for midwives working overtime, broken down by the months in the table below?

5. What was the total number of hours worked by midwives working overtime, broken down by the months in the table below?

6. What was the total cost for your trust, for midwives supplied by the bank, broken down by the months in the table below?

7. What was the total number of hours worked by midwives supplied by the bank, broken down by the months in the table below?

8. Does your trust pay bank rates at the individual’s actual pay point or higher or lower than their pay point?

Download response Agency midwives and pay 2015 140316

Agency Midwives and pay 2016. 300117

1. What was the total cost for your trust, including fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?
2. What was the total number of hours worked by midwives supplied by an agency, broken down by the months in the table below?
3. What was the total cost for your trust for midwives working overtime, broken down by the months in the table below?
4. What was the total number of hours worked by midwives working overtime, broken down by the months in the table below?
5. What was the total cost for your trust, for midwives supplied by the bank, broken down by the months in the table below?
6. What was the total number of hours worked by midwives supplied by the bank, broken down by the months in the table below?

Download response Agency Midwives and pay 2016. 300117

Agency nurse cover November 2015 – April 2016. 061216

1. Are off frame work agencies used to cover nurse shifts?
2. On a month by month basis, what was your spend on agencies supplying off frame work nurses from 1st November 2015 to date? Please break down this information by RGN, ITU, CRITICAL, ODP’S, SCRUBS, PAEDS, HDU, A&E, AMU, ADVANCED NURSE PRACTITIONER, HCA’S ETC. If this is not possible then please break down by nurse bands.
3. Which agencies supply off frame work nurses?
4. On a month by month basis, how many times was the break glass clause used from 1st November 2015 to date?
5. Please pick 10 random shifts which were filled via off frame work agencies between 1st November 2015 to date and provide the following for each of the 10 shifts picked at random (it is not essential to name the specific agencies which relate to the chosen shifts):
• Amount that was paid to the agency to fill each shift or the hourly rate paid to the agency
• Number of hours in the shift
• Date shift filled
• The type of nurse used to fill the shift e.g. RGN, ITU, HDU, CRITICAL, A&E, PAEDS etc.
• The type of shift or shift start time e.g. Long Day or Long Night or alternatively shift start time e.g. 08:00 etc.

Download response Agency nurse cover November 2015 – April 2016. 061216

Agency nurse expenditure for 2015-2016.

• The total amount you spend on Agency Nurses for the financial year 15/16 (April – March)
• For the above information to be broken down by banding and specialty (example provided below)

Download response Agency nurse expenditure for 2015-2016 010716

Agency nursing costs – January and February and July to December 2015?

Please could you tell me what the cost was in wages to the trust for agency nursing during the months of January and February and July to December 2015? (Could the cost per month be separated, please?)

Please include the wage bill for the two sites, and, if at all possible, please can you break them down into departments and sites?

However, if this is not possible, please still provide me with the overall cost.

Please could you tell me what the cost was in wages to the trust for all agency staff during the months of January to December 2015? (Could the cost per month be separated, please?)

Please include the wage bill for the two sites, and, if at all possible, please can you break them down into departments and sites?

However, if this is not possible, please still provide me with the overall cost.

Download response Agency nursing costs – January and February and July to December 2015 080116

Agency nursing spending rules from October 01 2015

Questions on the trust’s ceiling for agency nurse spend, as per the rules introduced from October 1, 2015:

1) How many applications has your trust made to increase its ceiling for agency nurse spend?
2) How many of these applications were successful?
Questions on the agency pay caps – specifically regarding nurses – as per the rules introduced on November 23, 2015:
3) On how many shifts has your trust overridden the rules for hourly rate agency caps – specifically for nurses – since the rules were introduced?
4) Across how many weeks have these breaches (in question 3 above) occurred? .
5) How many band five nurses has your trust overridden the rules for?
6) How many band six nurses has your trust overridden the rules for?
7) How many band seven nurses has your trust overridden the rules for?
8) How many band eight nurses has your trust overridden the rules for?

Download response Agency nursing spending rules from October 01 2015 150216

Agency Shift Cost

1. What was the highest amount you paid (including any agency commission/charges) for a single shift filled by each of the following a. a doctor b. a GP (if employed) c. a registered nurse and d. a non-registered support worker/healthcare assistant in the period March 28th to April 19th 2015? Please include date and length of shift and grade of doctor/nurse involved, the department they were needed for (e.g. A&E) and the agency which supplied the doctor/nurse in each case.
2. What percentage of shifts covered by agency staff during this time period were paid in accordance with either an NHS wide or a local framework, and what proportion were off framework?
3. What was your total spend on temporary (locum, agency and bank) clinical staff for 2014-15? Please include doctors, nurses and healthcare assistants/support workers in your answer. What were the comparable figures for 2013-14 and 2012-13?

Download response Agency Shift Cost 050515

Agency shifts. 250817

I am making a Freedom of Information Request to gain information on the volume of shifts that have been filled by agencies within nursing and medical locums (Doctors) at your organisation.

Further to this what is the percentage of shifts filled for Medical and for Nursing above the NHSi Cap.

Download response Agency shifts. 250817

Agency spend for Radiology locum doctors December 2015 to May 2016.

Can you please assist me with retrieving the total Agency spend for Locum Doctors only within Radiology over the following months, within your Trust or Health Board?

Download response Agency spend for Radiology locum doctors December 2015 to May 2016 060916

Agency spend in Radiology August 2016 – January 2017. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Radiology over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend in Radiology August 2016 – January 2017. 240317

Agency spend and substantive vacancies. 091117

1. The total amount of agency spend on medical locums in the 2016/2017 tax year
2. The total amount of spend on agency nurses in the 2016/2017 tax year
3. The total amount of spend on agency AHPs in the 2016/2017 tax year
4. The percentage of substantive Doctor positions that are currently unfilled
5. The percentage of substantive Nurse positions that are currently unfilled
6. Do you have a managed service or master vendor arrangement, or an outsourced staff bank for any clinical staff groups and if so, who is/are the supplier(s)?
7. Do you have a Direct Engagement supplier and if so, who?

Download response Agency spend and substantive vacancies. 091117

Agency spend within Gastroenterology.

Can you please assist me with retrieving the total Agency spend within Gastroenterology over the following months, within your Trust or Health Board?

Download response Agency spend within Gastroenterology

Agency staff. 010818

1. Since January 2018, have you allowed an Agency to fill a shift or booking above the April Cap (implemented in 2016) via the CPP Framework (otherwise known as the National Clinical Staffing Framework Agreement (Reference CPP2015/01))? For reference the term ‘shift’ can include any general nursing or critical nursing role.

2. If the answer is yes to the above question, please inform us of how many such shifts have been filled above cap via the CPP Framework.

3. What was the total value of charges paid under all of the call-off agreements identified in response to request 1 (above)?

4. Any information relating to the decision(s) of the Trust to enter into call-off agreements that include pay rates that exceed the maximum pay rates allowed under the Framework Agreement.

Download response Agency staff. 010818

Agency Staff. 210917

I am looking at the other positions supplied, starting with AHP and HSS staff.
Namely:
Allied Health Professionals Health Science Services
Dieticians Biomedical Scientists
Occupational Therapists Cytologists
Orthoptists Dental Service Staff (excluding dental nurses)
Physiotherapists Genetic Counsellors
Podiatrists Healthcare Scientists
Psychologists Medical Technologists
Radiographers Optometrists
Speech and Language Therapists Pathologists
Pharmacy Services Staff

Please could you provide me with the following information:
1. Names of Agencies used to provide AHP or HSS staff over the last 12 months
2. Monthly spend, on Agency Staff, per job role over the last 12 months
3. Hours, per job role, filled each month by Agency over the last 12 months
4. Number of shifts offered to Agencies for each role, monthly for the last 12 months.
5. Number of shifts filled by Agency for each role, monthly for the last 12 months.

Download response letter Agency Staff. 210917

Agency Staff Cost

Under the freedom of information act 2000, I am writing to formally request the following information:
1. Staff Numbers
2. Staff Cost
3. Agency Hours
4. Agency Spend
I would greatly appreciate it if you could supply this information for the year 2013/14 (April ’13 to March ‘14).

Download response Agency Staff Cost 040815

Agency staff spend 2013-2016. 221116

Please can you confirm your monthly Hospital and/or Trust spend on agency staff during the last three financial years (FYE Mar-14, Mar-15, & Mar-16). Ideally, this should be broken down into spend by Hospitals/Trusts, the agency supplying the staff and by month.

Download response letter Agency staff spend 2013-2016. 221116

Agency Staffing. 050718

1. Agency spend on Medical Locums/Doctors
2. Agency spend on AHP’s (Allied Health Professionals) and HSS (Health and Social Sciences)
3. Agency spend on Nursing
4. Agency spend on NMNC (Non-Medical, Non Clinical)
5. Do you use a Direct Engagement model to engage locum staff?
6. If so, please state the name of the company used
7. What is the expiry date for this contract?

Download response Agency Staffing. 050718

Agency usage. 240418

1. How many agencies do you engage with for your recruitment of temporary nurses and health care assistants and can you please list them?
2. How many agencies do you engage with for your recruitment of permanent nurses and can you please list them?
3. What has your spend been on temporary nurses?
4. What has your spend been on permanent nurses in 2017?
5. How many temporary shifts have been released to agencies for mental health nurses?
6. How many temporary shifts have been released to agencies for general nurses?
7. How many temporary shifts have been released to agencies for theaters nurses?
8. How many temporary shifts have been released to agencies for A&E nurses?
9. How many temporary shifts have been released to agencies for Community nurses?
10. How many temporary shifts that have been released to agencies for mental health nurses go unfilled?
11. How many temporary shifts that have been released to agencies for general nurses go unfilled?
12. How many temporary shifts that have been released to agencies for theaters nurses go unfilled?
13. How many temporary shifts that have been released to agencies for A&E nurses go unfilled?
14. How many temporary shifts that have been released to agencies for Community nurses go unfilled?
15. Are all temporary shifts released to all agencies at the same time or is there a tiering system?
16. Do you have any off framework spend for temporary agency staff?

Download response Agency usage. 240418

Agency use. 010818

1) Which Frameworks do you use for the supply of;
a) Locum Doctors
b) Locum Nurses
2) Do you operate a master vend arrangement or preferred supplier list?
3) Please list the agencies on your preferred supplier list for a and b. Please provide the supply list in tearing order or PSL if applicable.
a) Locum Doctors
b) Locum Nurses
4) Please provide contact details for the member of staff in charge of this process.

Download response Agency use. 010818

AHP agency staff spend 2015-2016

Question 1
Please can you confirm what your total spend on Allied Health Professional (AHP) agency staff was during the financial year April 2015-January 2016?
Can you please break this financial information down by AHP specialism:
• Arts Therapists,
• Chiropodist/Podiatrist,
• Dietician,
• Occupational Therapist,
• Physiotherapist,
• Prosthetist / Orthotist,
• Imaging Professionals,
• Speech / Language Professionals.
Question 2
Please can you confirm the names of the organisation/s you procure temporary Allied Health Professionals (AHP) from and the total spend for each organisation/s. To provide additional clarity on my request, ‘temporary Allied Health Professionals’ is to mean all persons who are AHPs and are not on permanent contracts of employment with the Board, but are supplied via employment agencies.

Download response AHP agency staff spend 2015-2016 150316

Amount spent on employing agency/temporary/locum doctors in A&E departments 2014 and 2015

Under the Freedom of Information Act, please can you provide me with the amount spent on employing agency/temporary/locum doctors in A&E departments, and the number of FTE roles covered by agency doctors, if possible for each month in 2014 and 2015, or for 2014 and for 2015 as whole years.

Please can you provide me with the number of FTE doctors working in the A&E department, if possible for each month in 2014 and 2015, or for 2014 and for 2015 as whole years?

If possible, please provide a breakdown between junior doctors and consultants.

Download response Amount spent on employing agency/temporary/locum doctors in A&E departments 2014 and 2015 140316

Annual spend on agency nursing staff. 070417

1) What is your annual spend on Agency Nurses?
2) How is this spend on agency Nurses broken down by individual supplier and what status are they? (i.e. PSL, Tier 1, Tier 2, Master Vendor, or Managed Service Provider?
3) What is the end / renewal date of the current contract you have in place for agency nursing?
4) Which framework do you currently use? (CCS, HTE, LPP, other)
5) Who is your senior procurement contact?
6) Who is your senior medical staffing/ nurse bank contact?

Download response Annual spend on agency nursing staff. 070417

Bank and Agency spend 2016. 070417

1. The number of hours filled by agency for all categories of Allied Health Professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

2. The number of hours filled by bank for all categories of Allied Health Professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

3. The Trusts total spend on agency staff for all categories of Allied Health professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

4. The Trusts total spend on bank staff for all categories of Allied Health professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

5. The number of hours filled by agency for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

6. The number of hours filled by bank for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

7. The Trusts total spend on agency staff for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band
8. The Trusts total spend on bank staff for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

Download response Bank and Agency spend 2016. 070417

Bank and Agency Staff 221116

Staff Bank
1. Do you use a nurse bank?
2. Is it outsourced?
a. If yes, who is the provider?
b. Is your outsourced bank used via a framework, e.g., CCS, HTE, LPP?
c. Do you use the bank for other staff groups?
d. What was the spend on your staff bank in 2015/2016?
3. Do you use Agency Nurses?
a. What was your spend on agency nurses during 2015/2016?
b. Which framework do you use for agency nursing staff? E.g.: CCS, HTE, LPP, NOECPP
4. Are you meeting the NHS Improvement price caps on?
a. Band 5 general nurses
b. Band 5 specialist nurses
c. HCAs

Download response letter Bank and Agency Staff 221116

Bank Staff (Medical Locums) Maidstone Hospital

Please complete the attached table with the relevant information regarding Bank Staff (Medical Locums) at your Trust.

Grade Core Hours Pay rate Unsocial Pay Rates
FY1
+FY2
Sp1-2
Sp3+
Dental Core Training
Specialty Doctor/staff grade
Associate Specialist
Consultant

Download response Bank Staff (Medical Locums) Maidstone Hospital 010216

Bank Staff (Medical Locums) Tunbridge Wells Hospital

Please complete the attached table with the relevant information regarding Bank Staff (Medical Locums) at your Trust.

Grade Core Hours Pay rate Unsocial Pay Rates
FY1
FY2
Sp1-2
Sp3+
Dental Core Training
Specialty Doctor/staff grade
Associate Specialist
Consultant

Download response Bank Staff (Medical Locums) Tunbridge Wells Hospital 010216

Community Nursing. 010618

1. What was your trust spend for temporary community agency nursing in 2017?
2. How many rgn shifts are released to temporary agencies?
3. How many rgn shifts released to agency go unfilled?
4. How many hca shifts are released to temporary agencies?
5. How many hca shifts released to agency go unfilled?
6. How many agencies are on your proffered suppliers list for these requirements?

Download response Community Nursing. 010618

Dermatology locum doctors 060317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Dermatology over the following months, within your Trust or Health Board?

Download response Dermatology locum doctors 060317

Engagement of locum staff using third parties. 181718

1. Does your organization use a Direct Engagement scheme?
2. If so, who provides it? And when did you start using it?
3. Did you take external legal advice before entering into it and, if so, from whom did you take external legal advice?
4. What has your total locum/temporary staffing spend since you started using the scheme? If you started using the scheme before April 2017 please also state the total locum/temporary staffing spend since April 2017.
5. How does the third party direct engagement facilitator save you money on the agency spend? Please answer in short point form
6. How much has been paid to the third party direct engagement facilitator thus far?
7. Was this payment calculated as a percentage of the savings generated by employing the services of the third party direct engagement facilitator? If so, what percentage is this?

Download response Engagement of locum staff using third parties. 181718

Flexible staffing 071216

1. Does your Trust currently utilise a Direct Engagement (DE) model? – YES / NO
2. If Yes, who currently provides the service;
a. Brookson
b. Liaison/ PWC (StafFlow)
c. Liaison (TEMPre)
d. 24/7 Time
e. Other (please specify here)………………………..
3. What proportion (in percentage) of your agency workers for the following staff groups are directly engaged:
a. Medical Locums/Doctors (e.g. Acute, Emergency, General Surgery, Paediatrics, Gynaecology, Neurosurgery, Dermatology, Cardiology)
b. Allied Health Professionals/Health Science Staff (e.g. Biomedical Science, Clinical Physiology (Cardiology), Dietician, Occupational Therapy, Pharmacy, Physiotherapy, Radiography, Talking Therapy, Speech & Language Therapy, Psychology, Anatomical Pathology)
4. What percentage are you charged for the management of these services?
5. When was the DE contract awarded?
6. What is the contract duration?
7. What was the motivation with engaging with these services?

Download response Flexible staffing 071216

Framework and non-framework locum agencies

What framework and non-framework locum agencies you use for:
Doctors
Nursing staff
Doctors and nursing staff

I also want to know do you have a staff bank. Do you with any particular agencies as a rule and others when simply in need?

Download response Framework and non-framework locum agencies 260116

Full contact details for the HR staff member responsible for locum appointments

Please can you give me the contact details for the HR person that deals with Locum appointments?

Please can I have their full name, job title, email address and direct dial telephone number.

Download response Full contact details for the HR staff member responsible for locum appointments 180516

locum agency ahp and hss staff.

Please provide the spend on locum agency ahp and hss staff broken down by the below disciplines and, if applicable whether the spend is in an acute or community setting for the period 1st October 2014 – 30th September 2015.

Occupational Therapists

Physiotherapists

Speech & Language Therapists

Dietitians

Pharmacists

Radiography to include Diagnostic, CT, MRI, Nuc Med

Radiotherapists

Sonographers

Download response locum agency ahp and hss staff 161215

Locum-agency spend. 300518

1) The total amount the trust spent on agency/locum doctors for the following years: 2012/13, 2013/14, 2014/15, 2015/16, 2016/17 – breaking this information down by speciality and grade.
2) What is the highest hourly/shift rate paid to an agency or locum doctor at any point in the following years: 2012/13, 2013/14, 2014/15, 2015/16, 2016/17 – please include job title and date.

Download response Locum-agency spend. 300518

Locum agency spend within Dermatology.

Can you please assist me with retrieving the total Locum Agency spend for Locum Doctors only within Dermatology over the following months, within your Trust or Health Board?

Download response Locum agency spend within Dermatology 060916

Locum Audiologists. 210917

1. Are the Locum Audiologists that are selected by the trust registered with a regulatory body? If not, why not and when will this become a mandatory trust requirement?
2. Does the trust believe in regulated professionals raising the quality of care given to patients as per other trusts where mandatory registration with the RCCP is a precursor?
3. When does the trust envision the newly recruited Audiologists taking up their posts? Will the locum cover cease or continue after this date?
4. Has the trust sought to recruit band 5 locum’s? When was the last time this was attempted to reduce costs? Is this something the trust would consider now to save taxpayer’s money?
5. What is the present weekly spend on locum’s excluding agency fees per full time (2) and part time locum?
6. What is the process in place for the trust in “increasing hourly rates” as per previous FOI – who makes the final decision on the rate given to a locum Audiologist and how is this audited?
7. Within the trust recruitment checks are immediate prior employers (locum) sought for a reference or does MTW NHS trust allow for references from any sources? How does the trust ensure competency with the locums used?

Download response Locum Audiologists. 210917

Locum doctor costs 2015

1. How many permanent positions for doctors did the trust undertake recruitment to fill in 2015?
2. What was the trust’s total spend on recruiting doctors in 2015?
3. What was the average length of time taken to fill vacant doctor posts in 2015?
4. What was the trust’s total spend on employing locum doctors in 2015?
5. What was the trust’s total spend on employing locum doctors to cover unfilled permanent posts in 2015?
6. What was the trust’s total spend on locum agency fees, for the recruitment of doctors, in 2015?

In your response, please confirm the official name of the trust or trusts that the information relates to.

Download response Locum doctor costs 2015 110316

Locum doctors in Radiology. 201117

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Radiology over the following months, within your Trust or Health Board?

Download response Locum doctors in Radiology. 201117

Locum doctors in Stroke Medicine. 061217

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Stroke Medicine over the following months, within your Trust or Health Board?

Download response Locum doctors in Stroke Medicine. 061217

Locum doctors within Gastroenterology. 011217

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Gastroenterology over the following months, within your Trust or Health Board?

Download response Locum doctors within Gastroenterology. 011217

Locum doctors within Haematology.

Can you please assist me with retrieving the total Agency spend on Locum Doctors within Haematology over the following months, within your Trust or Health Board?

December 2015
January 2016
February 2016
March 2016
April 2016
May 2016

Download response Locum doctors within Haematology 060916

locum staff.010318

1. What was the total spend on locum Physiotherapists in the last financial year 01/04/2016 to 01/04/2017?
2. What was the spend on locum Occupational Therapists in the last financial year 01/04/2016 to 01/04/2017?
3. What was the spend on locum Podiatrists in the last financial year 01/04/2016 to 01/04/2017?
4. What was the spend on locum Radiographers in the last financial year 01/04/2016 to 01/04/2017?
5. What job roles have the Trust broken glass (Paid outside the framework rates) for in the last financial year within the Allied Health Professionals area 01/04/2016 to 01/04/2017?

Download response Locum staff.010318

locum staff 2013 – 2015 161116

Please could you provide me with the information mentioned below for 2013, 2014 and 2015?
1. Doctors: Annually how many posts are covered by locum staff in your Trust?
2. Nurses: Annually how many posts are covered by locum staff in your Trust?
3. How many posts as a percentage was covered by locum agency staff in your Trust (doctors and nurses separately for the years mentioned above)?

Download response locum staff 2013 – 2015 161116

Locum staff and job vacancies 2010/2011 & 2014/2015

1. (a) In the Financial Year 2014/15, how many hours in total were worked by locum staff for the Trust?

(b) In the Financial Year 2014/15, how many days in total were permanent job positions left vacant for? (I.e. the number of days that positions were left unfilled by permanent staff)

2. (a) In the Financial Year 2010/11, how many hours in total were worked by locum staff for the Trust?

(b) In the Financial Year 2010/11, how many days in total were permanent job positions left vacant for? (I.e. the number of days that positions were left unfilled by permanent staff)

NB: I would prefer the figures to be for financial years, as stated. However, if it is only possible to supply the figures in terms of calendar years, please supply them for 2014 (in Q1), and 2010 (in Q2).

Download response Locum staff and job vacancies 2010/2011 & 2014/2015 260116

Medical locum agencies. 070417

1. A list of all agencies the trust uses for temporary workers (Med Locums).

2. A breakdown of monetary spend per agency for the last 12 months.

Download response Medical locum agencies. 070417

Medical Locum doctors and Agency Nurses. 221116

Please clarify for the supply of both medical locum doctors and agency nurses:
1. What was your total spend for the last financial year (2015/16) for agency medical locums?
2. What was that spend broken by specialty, for example Accident and Emergency, Anaesthetics, Medicine, Mental Health, Obstetrics and Gynaecology, and Surgery?
3. What was that spend broken down by agency?
4. What was your total spend for the last financial year (2015/16) for agency nurses?
5. What was that spend broken by specialty, for example Accident and Emergency, Community, Critical, General, Mental Health, Midwifery, and Theatres?
6. What was that spend broken down by agency?

Download response Medical Locum doctors and Agency Nurses. 221116

Medical locum spend 2016. 130417

I would like to request the Trusts Medical Agency Locum Spend for the year 2016.

Can you please break these figures down accordingly?
1. Agency Locum spend for A&E Doctors in 2016
2. Agency Locum spend for General and Acute medicine Doctors in 2016
3. Agency Locum spend for Radiology Doctors in 2016
4. Agency Locum spend for Paediatric Doctors in 2016
5. Agency Locum spend for Obs and Gynae Doctors in 2016
6. Total Medical Agency Locum Spend in 2016

Please also break them down into the grade accordingly (SHO, Middle and Consultant).

Download response Medical locum spend 2016. 130417

Medical locums. 070318

1. Please confirm the Trust’s total annual spend on agency Medical Locums
2. Please confirm what delivery model the Trust currently uses to engage agency Medical Locums:
a. Managed Service
b. PSL
3. If the Trust uses a managed service, please can you confirm the name of the provider and when this contract is due to expire
4. If the Trust uses a PSL, is this a third party PSL i.e. CCS framework, H T E Framework etc. or the Trusts own PSL?
5. Please confirm whether the Trust currently uses any form of e-rostering platform in relation to engaging Medical Locums. Yes / No, if Yes please can you confirm the name of this technology.
6. Does the Trust operate a Medical Locum staff bank Yes / No?
7. In relation to the above, does the Trust currently utilise any technology for running this staff bank – if yes, what is the name of this technology?
8. Is the trust participating in the DHSC / NHSI 2018 Bank Pilots?
9. Who is / are the person(s) responsible at trust level for leading the DHSC / NHSI Bank Pilots project? Please provide name(s) and job title(s).

Download response Medical locums. 070318  

NHS Improvement Agency Rules (20 November 2015). 040117

1. Since the introduction of NHS improvement Agency Rules (20 November 2015) how many times have you reported service closure of elective pathway?
2. Since the introduction of NHS Improvement Agency Rules (20 November 2015) how many times have you reported an effect on the patient experience?
3. Since the introduction of NHS Improvement Agency Rules (20 November 2015) how many times has there been occurrence of serious harm due to staffing levels?
4. How many times have you fallen below your safer staffing target since the introduction of the NHS Improvement Agency rules (20 November 2015)?
5. How many of the below have been reported due to insufficient staffing numbers since the introduction of NHSI Agency Rules in November 2015?
a). Patient falls
b). Pressure Ulcers

Download response NHS Improvement Agency Rules (20 November 2015). 040117

Nursing agency information. 210417

1. A list of all agencies the trust uses to fill Nursing requirements in tearing order (If the trust uses any tearing systems).
2. A breakdown of spend per agency the trust uses for nursing in the last 12 months.
3. A breakdown of hours filled per agency for nurses in the last 12 months.
4. The highest charge rate agreed to pay an agency nurse per hour for each speciality.
5. The highest margin an agency has declared per hour, for each speciality for nursing.
6. Any agency which has been blacklisted from supplying nurses to the trust.
7. If the trust uses any 3rd party payment systems and/or master venders in place who cascade shifts out to agencies, if so what are they called?

Download response Nursing agency information. 210417

Permanently employed and supplemental nurses. 241016

1. The number of nurses permanently employed and the number of supplemental nurses:
By each of those two categories, supplemental vs. permanently employed, we would like to know:
a. The average experience, measured in number of years as registered nurse.
b. The average age.
c. How many of them are i) British ii) EU-citizen (with exclusion of the UK) iii) Extra-EU citizen.
d. How many of them are certified.
e. How many of them are male.

Download response Permanently employed and supplemental nurses. 241016

Physiotherapy Services. 280917

VACANCIES
Request 1
a) Please confirm how many whole time equivalent physiotherapist and physiotherapy support worker vacancies were held in Maidstone and Tunbridge Wells NHS Trust as at 31 March 2017.
b) Please confirm how many of the posts in Request 1a had been vacant for 3 months or more as at 31 March 2017.

POSTS
Request 2:
Please confirm how many whole time equivalent (WTE) physiotherapists and physiotherapy support workers were employed by Maidstone and Tunbridge Wells NHS Trust on the 31 March 2017. (This should include any generic assistant or technical instructor posts that support physiotherapy service provision).

PATIENT DEMAND
Request 3:
Please confirm the number of new referrals (including patient self-referral) to physiotherapy services in Maidstone and Tunbridge Wells NHS Trust, in the following financial years:
• 1 April 2016 to end of 31 March 2017
• 1 April 2015 to end of 31 March 2016
• 1 April 2014 to end of 31 March 2015

SPENDING
Request 4:
Please confirm how much was spent on physiotherapy agency/locum/temp staff in Maidstone and Tunbridge Wells NHS Trust, in the following financial years:
• 1 April 2016 to end of 31 March 2017
• 1 April 2015 to end of 31 March 2016
• 1 April 2014 to end of 31 March 2015

PRACTICE BASED LEARNING
Request 5:
Please identify the clinical areas within your physiotherapy services that provide placements for physiotherapy undergraduates in the last financial year (1 April 2016 to end of 31 March 2017).

MUSCULOSKELETAL (MSK) PATHWAY
Request 6:
a) Please confirm/deny whether Maidstone and Tunbridge Wells NHS Trust provides MSK services that include first contact physiotherapists in General Practice
b) Please confirm/deny whether patients can self-refer to physiotherapy services within the MSK services provided by Maidstone and Tunbridge Wells NHS Trust

Download response Physiotherapy Services. 280917

Public sector spending on contingent staff. 221217

Questions
Is the organisation part of any regional Workforce networks, forums or collaborations? If so please provide name(s) and description(s)
Is there a named person responsible for leading HR / workforce / agency for the STP region that you are a part of?
Named individual
Organisation
Job title
Please state the organisation’s total expenditure on agency (non-contract) staff (16/17)
TOTAL
Nursing & HCAs
Medical & Dental
AHPs
Admin & Clerical
Estates & Facilities
Scientific
Other
Please state the organisation’s total expenditure on internal bank staff (16/17)
TOTAL
Nursing & HCAs
Medical & Dental
AHPs
Admin & Clerical
Estates & Facilities
Scientific
Other
Does the organisation use a third party to provide a Direct Engagement / Outsourced Employment Solution to recover VAT?
Please state the name of the Direct Engagement / Outsourced Employment supplier (e.g. Liaison, 247 Time, Brookson, Retinue etc.)
Contract start date
Contract end date
How much did the organisation spend on these services in total? (16/17)
Please state the organisation’s expenditure on staff directly engaged via these employment solutions (16/17) Please note this figure should be the proportion of your agency expenditure engaged directly
Medical & Dental
AHPs
Please state what rostering systems have been successfully implemented at the organisation, split by the following staffing types:
Nursing & HCAs
Medical & Dental
AHPs
Admin & Clerical
Estates & Facilities
Scientific
Other
Does the organisation use a third party systems to assist with job planning, appraisals or revalidation for medical staff? Please provide the following information:
Supplier name
Service description
Staffing types
Contract start date
Contract end date
Name of framwork used to procure services
How much did the organisation spend on these services in total? (16/17)
Does the trust use any third party systems / services to manage the supply of temporary staff? Please provide the following information for each supplier. Please copy cells down for each supplier as necessary:
Supplier name
Service description
Staffing types
Contract start date
Contract end date
Name of framework used to procure services
How much did the organisation spend on these services in total? (16/17)

Download response Public sector spending on contingent staff. 221217

Shifts covered by any doctor level for which the Trust has paid in excess of £150 per hour. 170517

1) In the past 6 months, have many shifts covered by any doctor level have you paid in excess of £150 per hour

2) In the past 3 months, have many shifts covered by any doctor level have you paid in excess of £150 per hour

3) In the past 1 months, have many shifts covered by any doctor level have you paid in excess of £150 per hour

Download response Shifts covered by any doctor level for which the Trust has paid in excess of £150 per hour. 170517

Staff and agency information

1. Staff Numbers – Average headcount of permanent and non-permanent staff over the entire 2015/16 financial year or just the headcount as at Thursday, March 31st 2016. Can you please split this into the major speciality/grades used by the trust?
2. Staff Cost – Total staff cost during the 2015/16 financial year split into permanent and non-permanent staff.
3. Agency Hours – Hours worked by agency staff in the 2015/16 financial year split by speciality/grade depending on how you report this within your trust.
4. Agency Spend – Total amount spent on agency staff in the 2015/16 financial year split into the categories or speciality/grade used by the trust.
5. Do you use a direct engagement model within your trust? Direct engagement model means the Trust pays agency staff directly and then pays the agency commission separately. The alternative to this is to pay the agency a lump sum for any work done by agency staff and the Agency in turn pays their own staff.

Download response Staff and agency information 060916

Staff recruitment and agency spend. 300518

1. Spend on agency recruitment fees for permanent staff (not including salaries) – medical staff
2. Spend on agency recruitment fees for permanent staff (not including salaries) – nursing staff
3. Spend on agency recruitment fees for permanent staff (not including salaries) – allied health professionals (AHPs) and health science services (HSS) staff
4. Spend on agency recruitment fees for permanent staff (not including salaries) – non medical, non-clinical (NMNC) staff
5. Internal spend bank staff management
6. Outsourced spend on bank staff management
7. Please provide your spend on recruitment process outsourcing in the last available full financial year (please note the year in your response).

Download response Staff recruitment and agency spend. 300518

Staffing and locum data 2013 – 2016. 250417

Rota Data: (Please complete separate tables for each month for which data exists, for the last three years).
Consultant
Trainee (Specialist Registrar)
Trainee (Core Trainee)
Trainee (Foundation Year 2 Trainee)
Trainee (Foundation Year 1 Trainee)
Band 5 and 6 Registered Nursing Staff
Other Registered nurses
Nursing assistant
Phlebotomists
Occupational Therapists
Physiotherapists
Other allied Healthcare Professionals (please specify)
Ward Clerks
Other staff (please specify)

Locum Data: (Please provide separate tables for each year, for the last three years, that there is data available from).
Consultant
Non-training grades (excluding consultants)
Trainee (Specialist Registrar)
Trainee (Core Trainee)
Trainee (Foundation Year 2 Trainee)
Trainee (Foundation Year 1 Trainee)
Band 5 and 6 Registered Nursing Staff
Other Registered nurses
Nursing assistant
Phlebotomists
Occupational Therapists
Physiotherapists
Other allied Healthcare Professionals (please specify)
Ward Clerks
Other staff (please specify)

Download response Staffing and locum data 2013 – 2016. 250417

Temporary agency workers 211116

1. Please advise the total staff headcount that are employed directly by Maidstone and Tunbridge Wells NHS Trust, with each part-time employee counted as one employee. Please exclude all temporary agency workers from this figure.
2. Please identify each supplier that Maidstone and Tunbridge Wells NHS Trust has a contract with to supply temporary agency workers.
3. Please identify: a. the type of contract that Maidstone and Tunbridge Wells NHS Trust has with each of these suppliers (preferred supplier list/ framework/ etc. If framework, please indicate b. which – e.g. MSTAR/ YPO/ Panel London/ Pan London/ NPS All Wales/ Crown Commercial Services/ etc; and c. whether this is on a neutral/ master/ hybrid vender model, or the lot number.
4. Please advise for each contract identified within (2) above of: a. the current end date of the contract; b. the date(s) that any break clause(s) can be enabled; and c. the length of time of any extension that can be enabled.
5. Please advise of the full name of the main contact at Maidstone and Tunbridge Wells NHS Trust who is responsible for the main (or majority of the) contract(s) identified within (2) above, together with their:
a. job title;
b. group (either team, division or department, whichever is the smallest identifiable group);
c. telephone number;
d. email; and
e. full postal address, inc postcode.
6. Please identify all suppliers that Maidstone and Tunbridge Wells NHS Trust has sourced a temporary agency worker from – but does not have a contract with – from 1 April 2015 to 31 March 2016.
7. For each temporary agency supplier (either a. contracted as identified within (2) above; b. non-contracted as identified within (6) above; and c. all workers Maidstone and Tunbridge Wells NHS Trust has sourced directly), how much has been spent on each supplier (or directly), from 1 April 2015 to 31 March 2016?

Download response Temporary agency workers 211116

Temporary Nursing staff – Internal Bank and External Agency suppliers

1) Do you use temporary nurses? If yes, can we have a breakdown of how many have been used in the last three years?

2) What is the cost if using these nurses? Can we have a breakdown of how much one nurse costs and the total of cost in the last three years?

Download response Temporary Nursing staff – Internal Bank and External Agency suppliers 010216

Temporary staff provisions 2015-2016 221116

Medical Locums
1. What was your agency spend on medical locums during 2015/2016?
2. Do you source your locums via:
o Mastervend
o Managed service
o Preferred supplier list
o Other (please state)
3. Which framework do you use to source your medical locums?
4. Are you working to the NHS Improvement rate caps?
5. Do you use direct engagement (VAT mitigation)?
AHP/HSS Staff Groups
6. What was your spend on agency AHP and HSS during 2015/2016?
7. Which framework do you use to source your agency workers in this area?
8. Are you working to the NHS Improvement rate caps?
Other staff groups
9. What was your agency spend on non clinical staff (not doctors, nurses, HSS or AHP staff) during 2015/2016?
10. Which framework do you use to source these staff?
11. Which staff groups do you use (eg, admin and clerical, ancillary, IT staff, senior manager interim staff, VSM interims)
12. Are you working to the NHS Improvement rate caps?

Download response Temporary staff provisions 2015-2016 221116

Temporary staffing processes

1) Do you have a master vendor (MV) arrangement in place for the supply of medical locums? If so please state the name of the provider used (Medacs, Holt, A&E Agency etc.)
2) Please state the utilisation rate that has been achieved through the master vendor in the last 12 months. This is the total value of locum spend supplied by the master vendor itself in the last 12 months as a percentage of total locum spend in the same period.
3) Does the trust use a direct engagement model to engage locum staff? If so please state the name of the company used (Liaison PwC, 247 Time, Brookson, HB Retinue, Medacs etc.)?
4) Do you run a weekly payroll for medical bank?
5) Does the trust use rostering software (Allocate, Smart etc.)? If so please state the name of the company used, and the total amount that the trust has spent on rostering in 2014/15.
Please provide all subsequent information split by the following staffing categories. Please include all spend outside of the specified categories as “other”.
– Nursing & HCA’s
– Medical & Dental
– AHP’s
– Other
6) Please state the trusts expenditure on agency staff in 2014/15 split by the above staff categories.
7) Please state the total spent on internal bank staff in 2014/15, split by the above staff categories. This is the total paid to workers completing shifts via the trust bank, excluding any costs to 3rd parties. Please do not include any spend on outsourced bank staff
8) Please state the total number of staff signed up to the trust’s internal bank, split by the above categories.
9)Of the above figure, please state the total number of staff signed up to the bank who also work as substantive staff at the trust. I.e. Staff that hold substantive contracts but have also completed shifts via the internal bank.
10) Does the trust outsource the supply of any bank staff to third parties such as NHS Professionals, Bank Partners, etc.? If so please specify the name of the company used and the staffing categories supplied by the 3rd party. 11)Does the trust use any third party tech solutions to manage internal bank staff (de Poel, HB Retinue, Liaison, Holt, 247 Time etc.)? If so please specify the name of the company used and the staffing categories managed through the tech solution.
12)Do you use any suppliers or systems to manage the release of vacancies to agencies and bank workers? If so please state the name of the company used and the staffing categories managed. If you use different suppliers/systems for different staffing categories, please specify.

Download response Temporary staffing processes 150416

Trust’s expenditure on Interim Managers 2014/2015

By interim managers we mean any manager who is referred to as “interim” or “temporary” in the trust Annual Reports for the five previous financial years up to 2014/2015.

For each individual interim manager, please provide:
1. The name, position within the trust, and the recruitment firm associated with the interim manager.
2. The total amount paid for the services of the interim manager, and for how many months’ work.
3. Out of the money paid for the individual’s services, how much of that money went to the recruitment firm (i.e. was not part of the interim manager’s salary).
4. Please could you provide the information from the five previous financial years up to 2014/2015 in Excel Format?
5. In a separate data set, please could you provide how much has been spent this year up to the present date (4/2/16) in Excel format?

Download response Trust’s expenditure on Interim Managers 2014/2015 290316

Utilisation of nursing recruitment agencies. 030518

Shifts filled a week via Nursing Recruitment Agencies
How many Nursing Recruitment Agencies you source from
For the following departments that you have within your Hospital:
Paediatrics
Oncology
NICU
Cath Labs
HDU
Interventional Radiology

Download response Utilisation of nursing recruitment agencies. 030518

 

Cancelled operations

Cancelled children’s operations – 01.07.16. 050517

1. How many children’s operations have been cancelled each month since 1st July 2016? Please give additional details as to what the main reasons for the cancellations were, how many were urgent operations or elective operations, and what type of illness did they involve, e.g. cancer, breathing problems, broken limbs etc.

2. How many children’s operations have been cancelled over the last four financial years to date?

Kindly note a child is anyone up to the age of 18.

Download response Cancelled children’s operations – 01.07.16. 050517

Cancelled elective admissions and outpatient attendances. 150118

1) In the months of October, November and December, how many elective admissions and outpatient attendances had to be cancelled due to non-clinical reasons?
2) How many of these were able to be rescheduled within 28 days (please give actual figure)?
3) And how many were not able to be rescheduled within 28 days?

Download response Cancelled elective admissions and outpatient attendances. 150118

Cancelled elective operations 2010-2016. 200417

1. Since 1st April 2010 what has been the maximum cost to the Trust of an elective operation being cancelled last-minute for non-clinical reasons? Please give additional detail as to what the operation was and how many members of staff were supposed to be working on the operation.
2. Please provide the total number of elective operations cancelled last-minute for non-clinical reasons for each quarter going back to 2010.
3. Please provide the total quarterly cost of elective operations being cancelled last-minute for non-clinical reasons for each quarter going back to 2010.

Download response Cancelled elective operations 2010-2016. 200417

Cancelled elective operations for December 2015 and January 2016.

I would like to ask for each day over the past two months how many elective operations have had to be cancelled and what reasons were given?

And for each of those days, how many elective operations had been originally planned?

Download response Cancelled elective operations for December 2015 and January 2016 190416

Cancelled operations 2011 – 2016. 141216

1. Over the past five financial years (2011-12, 2012-13, 2013-14, 2014-15, 2015-16) please state the number of last minute elective surgery cancellations there have been for non-clinical reasons for the following branches of surgery: trauma and orthopaedics, neurology, cancer, and ophthalmology. Please break down by year and surgery type.
2. Over the past five financial years (2011-12, 2012-13, 2013-14, 2014-15, 2015-16) please state how many patients were not treated within 28 days of last minute elective cancellation of an operation for the following branches of surgery: trauma and orthopaedics, neurology, cancer, and ophthalmology. Please break down by year and surgery type.

Download response Cancelled operations 2011 – 2016. 141216

Cancelled operations 2012-2017. 200917

1. The number of elective operations carried out by the Trust in the following financial years:
2012/13
2013/14
2014/15
2015/16
2016/17

2. The number of elective operations cancelled at the last minute* due to non-clinical reasons, in the following financial years:
2012/13
2013/14
2014/15
2015/16
2016/17
NOTE: Please use NHS England’s standard definition of last minute cancellations, “Last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.” See: https://www.england.nhs.uk/statistics/statistical-work-areas/cancelled-elective-operations/

3. The number of elective operations cancelled at the last minute due to non-clinical reasons per financial year (2012/13 to 2016/17 inclusive), split into the following categories:
– Staff unavailable or sick (either anaesthetist, surgeon, theatre staff or other)
– Lack of available bed (either general or HDU, critical, or intensive care)
– Theatre list over-ran or no space on it (e.g. due to emergency case(s) coming in)
– Equipment missing / failure
– Any other reason

Download response Cancelled operations 2012-2017. 200917

Cancelled operations 2013 to 2016.

1. In relation to (i) 2013/14, (ii) 2014/15 and (iii) 2015/16 financial year please provide me with the number of operations cancelled at your Trust on the day of operation or admission where the reason is recorded as there being no post-operative bed available for the patient.
2. For each year please state if possible how many of these cancellations were due to the fact that there was no critical care bed or intensive care bed available rather than the unavailability of a general ward bed?

Download response Cancelled operations 2013 to 2016 250716

Cancelled operations 2014 – April 2017. 050517

How many operations have been cancelled for non-clinical reasons IN THE 3 DAYS BEFORE a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within 1 month?
How many operations have been cancelled for non-clinical reasons ON THE DAY a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within the statutory time limit – e.g. 28 days?
Please provide this data by month for 2014, 2015, 2016 and 2017 – up to and including April 2017.
The following should be included in the figures for ‘operations’:
All planned or elective operations and day surgery
For ‘non-clinical reasons’ please include a break-down of the following:
· Bed-ward not available
· Staff unavailable
· Emergency operations taking priority
· Maintenance needed on equipment
· Patient unavailable
· Admin error

Download response Cancelled operations 2014 – April 2017. 050517

Cancelled operations and appointments. 210218

The National Emergency Preparedness Panel warned on 22 December that non-urgent operations should be cancelled, with a further update on 2 January advising that “day case and outpatient procedures” should also be put on hold to preserve emergency care.

Could the trust please provide the following details about cancellations for non-clinical reasons, and last minute (on the scheduled day of arrival at hospital or later) non-clinical cancellations.

Download response Cancelled operations and appointments. 210218

Cancelled operations for non-clinical reasons 2013 to March 2016. 170516

How many operations have been cancelled for non-clinical reasons IN THE 3 DAY BEFORE a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within 1 month?
How many operations have been cancelled for non-clinical reasons ON THE DAY a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within the statutory time limit – e.g. 28 days?
Please provide this data by month for 2013, 2014, 2015 and 2016 – up to and including March 2016.
The following should be included in the figures for ‘operations’:
• All planned or elective operations and day surgery
For ‘non-clinical reasons’ please include a break-down of the following:
Bed-ward not available
Staff unavailable
Emergency operations taking priority
Maintenance needed on equipment
Patient unavailable
Admin error

Download response Cancelled operations for non-clinical reasons 2013 to March 2016. 170516

Cancelled planned operations. 210318

How many planned operations were cancelled in January 2018 due to winter pressures? If possible, please provide a specific reason for each case.

Download response Cancelled planned operations. 210318

Missing medical records 2013-2016.100217

• Over the last four years how many medical records went missing? Can I have that data broken down by year?
• How many incidents was this? Can I have that data broken down by year?
• As a result of these lost records how many procedures were a) delayed/postponed b) cancelled. Can I have that data broken down by year?
• What procedures were a) delayed/postponed b) cancelled. Can I have that data broken down by year?
I would like all this data by calendar years please.

Download response Missing medical records 2013-2016.100217

Theatre cancellation 2015-2017. 070317

1. Total number of theatre cancellations at your Trust on the day of surgery by month, site and surgical specialty from the 1st January 2015 to 31st January 2017 (inclusive).

2. Total number of theatre cancellations at your Trust within three (<3) days of surgery by month, site, surgical specialty and cancellation reason from the 1st January 2015 to 31st January 2017 (inclusive).

3. Total number of theatre cancellations at your Trust whether on or before the day of surgery due to no ward beds or no HDU / ITU beds being available by month, site and surgical specialty from the 1st January 2015 to 31st January 2017 (inclusive).

4. Total number of operations actually performed at your Trust by month, site, admission type (elective or non-elective) and surgical specialty from the 1st January 2015 to 31st January 2017 (inclusive).

Download response Theatre cancellation 2015-2017. 070317

 

Cancer and Haematology & Radiology

Active surveillance for prostate cancer. 260717

Please outline details of the active surveillance protocol below (or attach the protocol document when replying to our request email):

Download response Active surveillance for prostate cancer. 260717

Advanced Prostate Cancer 070317

1. Within your trust how many unique patients with Advanced Prostate Cancer have been treated in the past 12 months?

2. How many patients with Advanced Prostate Cancer have received:
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
Bicalutamide (Casodex)

Download response Advanced Prostate Cancer 070317

Advanced prostate cancer June 2016 to May 2017. 090617

Within your trust how many unique patients with Advanced Prostate Cancer have been treated in the past 12 months?

How many patients with Advanced Prostate Cancer have received;
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
Bicalutamide (Casodex)
Advanced prostate cancer is cancer that has spread outside the prostate to other parts of the body such as the bones

Download response Advanced prostate cancer June 2016 to May 2017. 090617

Average and longest waiting times for cancer treatment. 141217

Firstly, in days what is the a) average and b) longest a single patient has waited to receive a First Consultant Appointment following a GP Urgent Referral (two week target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.
Secondly, in days what is the a) average and b) longest a single patient has waited for a First Treatment for Cancer following a Decision to Treat (31 days target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.
Thirdly, in days what is the a) average and b) longest a single patient has waited for a First Treatment for Cancer following a GP Urgent Referral (62 days target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.

Download response Average and longest waiting times for cancer treatment. 141217

Breast Biopsy. 280317

Under the Freedom of Information Act, please could you provide the following information for your Trust?
1. How many benign breast lesions has your Trust diagnosed per annum in the last three years?
2. How many benign breast lesions have been removed surgically per annum within your Trust in the last three years?
a. Of this total number, how many of these are classified as B2?
b. Of this total number, how many of these are classified as B3?
3. How many benign breast lesions have not been removed per annum in the last three years?
4. How many benign breast lesions have been removed by vacuum assisted excision (VEA) per annum in the last three years?
a. Of this total number, how many of these are classified as B2 (definition below)?
b. Of this total number, how many of these are classified as B3 (definition below)?
5. Is the Trust aware of NICE guidance promoting the use of VAE for removal of benign lesions?
6. Does the Trust have a referral pathway in place for vacuum assisted percutaneous excision of benign breast lesions?

With regards to this request, please note the following:

B3 Breast Lesion – Lesion of Uncertain Malignant Potential
Findings typical of this category include:
1. Clusters of tiny calcifications – round or oval
2. Non-calcified solid nodules (no size limitation but non palpable on physical examination), round, ovoid and well-defined.
3. Selected focal asymmetrical areas of fibroglandular densities (not palpable): This might include concave-outward defined margins, interspersed with fat and without central increased fibular density on two projections.
4. Miscellaneous focal findings, such as a dilated duct or post biopsy architectural distortion without central density
5. Generalized distribution in both breasts. For example, multiple similar lesions with tiny calcifications or nodules distributed randomly

B2 Breast Lesion – Benign Lesion
A definitive benign finding indicating something abnormal on a mammogram but not something that is breast cancer or malignant in any way. Findings often include:
1. Round opacities with macrocalcifications (typical calcified fibroadenoma or cyst)
2. Round opacities corresponding to a typical cyst at ultrasonography
3. Oval opacities with a radiolucent center
4. Fatty densities or partially fatty images (lipoma, galactocele, oil cyst, hamartoma )
5. Surgical scar
6. Scattered macrocalcifications (fibroadenoma, cyst, cytosteatonecrosis, secretory ductal ectasia);
7. Vascular calcifications
8. Breast implants, silicone granuloma

Download response Breast Biopsy. 280317

Breast Cancer Services. 070417

Can you please tell me how many women were diagnosed and received treatment between the years 2014 – 2015 and 2015 – 2016. How many women in each year were treated by breast conserving surgery (lumpectomy) and how many by mastectomy. Of the women who underwent mastectomy how many received an immediate reconstruction.

Download response Breast Cancer Services. 070417

Breast Cancer Surgery. 051017

Do you have data showing the outcome of breast cancer surgery at your trust in relation to?

1. Survival rates for patients five years after surgery?
1a. Can you tell me what the figure is?
1b. Do you have results for individual surgeons?

2. Survival rates for patients ten years after surgery?
2a. Can you tell me what the figure is?
2b. Do you have results for individual surgeons?

Do you have data showing the outcome of breast cancer surgery at your trust in relation to:

3. Local Recurrence rates for patients five years after mastectomy and breast conserving surgery.
3a. Can you tell me what the figures are.
3b. Do you have figures for individual surgeons?

Download response Breast Cancer Surgery. 051017

Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

Cancer operations – Annual cancellations. 310117

In the years 2015, 2016 & 2017 from January 1st until the current date could you please provide me with the total number per month of cancer operations cancelled by Hospitals under the umbrella of your Acute NHS Trust?

Download response Cancer operations – Annual cancellations. 310117

Cancer treatment. 040817

Please provide the following information:

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment privately at your trust (including directly and through private patient units located on trust premises), providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the total value of treatments received, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the five cancer treatments that were most commonly provided privately, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, please include a breakdown of patient numbers and value of treatment by type of cancer.

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment from any private provider, providing an annual total for each of the last five financial years.

Download response Cancer treatment. 040817

Cancer treatment. 081117

Please provide the following information:

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment privately at your trust (including directly and through private patient units located on trust premises), providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the total value of treatments received, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the five cancer treatments that were most commonly provided privately, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, please include a breakdown of patient numbers and value of treatment by type of cancer.

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment from any private provider, providing an annual total for each of the last five financial years.

Download response Cancer treatment. 081117

Cancer treatment 2010 – 2016. 250917

How many patients were treated for cancer by your trust each year since 2010?

How many of these patients in each year were ‘self-funders’ or paid the trust for their treatment, either personally or through an insurer and other third party?

What was the total amount of money raised in this way for each year?

How many patients for each year were ordinary NHS patients, ie patients whose care was free at the point of delivery?

How many designated cancer wards does your trust have for each year since 2010?

How many wards, if any, were for ‘self-funders’ and how many were for ordinary NHS patients for each year since 2010?

Download response Cancer treatment 2010 – 2016. 250917

Cancers. 050718

1. How many individuals diagnosed in the last 5 years with prostate cancer?
2. How many deaths attributable to prostate cancer in the last 5 years?
3. How many individuals diagnosed in the last 5 years with breast cancer?
4. How many deaths attributable to breast cancer in the last 5 years?
5. How many individuals diagnosed with brain cancer in the last 5 years?
6. Of those diagnosed with brain cancer how many with GBM4?
7. How many deaths attributable to brain cancer in the last 5 years?
8. Of those deaths how many due to GBM4?
9. How many children diagnosed with brain cancer in the last 5 years?
10. How many child deaths attributable to brain cancer in the last 5 years?
Download response Cancers. 050718

Carcinoma and melanoma

1. The number of patients with NON SMALL CELL LUNG CARCINOMA (Stage IIIB/Stage IV) treated in the last 6 months with the following:
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Pemetrexed (Alimta)
Nivolumab (Opdivo)
Nintedanib (Vargatef)

2. The number of patients with METASTATIC MELANOMA Stage IV (advanced or metastatic), treated in the last 6 months with the following:
Ipilimumab (Yervoy)
Nivolumab (Opdivo)
Ipilimumab AND Nivolumab
Pembrolizumab (Keytruda)
Vemurafenib (Zelboraf)
Vemurafenib AND Cobimetinib
Dabrafenib (Taflinar)
Trametinib (Mekinist)
Dabrafenib AND trametinib
Dacarbazine (DTIC)
For the period 1/1/2016-30/06/2016

Download response Carcinoma and melanoma 230916

Chronic Myeloid Leukaemia (CML) 2015.

1. In your organisation, how many patients diagnosed with Chronic Myeloid Leukaemia (CML) have been treated in calendar year 2015?

2. Of these patients, how many are currently being treated with each of the following tyrosine kinase inhibitors (TKIs)?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)

3. If possible, of these patients on a TKI, how many have had treatment with a previous TKI?

4. In your organisation, how many patients diagnosed with Philadelphia positive (Ph+) Acute Lymphoblastic Leukaemia (ALL) have been treated in calendar year 2015?

5. Of these patients how many are currently being treated with each of the following TKIs?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)
· Other (i.e. not on a TKI)

Download response Chronic Myeloid Leukaemia (CML) 2015 190416

Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

1. Please tell us which Trust, Health Board or Health and Social Care Trust you are responding on behalf of?
2. What percentage of men receive mpMRI before biopsy as part of the initial diagnostic process using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences?
3. What are your eligibility criteria/exclusion criteria for men to receive pre-biopsy mpMRI?
4. Are you using mpMRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process?
5. What mpMRI scores and/or other clinical factors are used to rule men out of biopsy?
6. Do you intend to use mpMRI to rule men out of biopsy in the future?
7. How many men annually are referred?
8. If you are unable to provide numbers for question 6, please estimate the percentage of all men referred for b, c and d.
9. Do you carry out targeted biopsies in men with mpMRI lesions in addition to systematic biopsies?
(Please indicate with a X below)
If No, what are the reasons for not carrying this out? (e.g. expertise, equipment, don’t believe it makes a difference)
10. If you do not currently carry out targeted biopsies, but wish to in the future, what are the current barriers to doing so?
(Please indicate with a X below)
11. Please indicate the number of uroradiologists undertaking prostate MRI
12. How many scanners do you have available for mpMRI before biopsy?
Has this increased in the last 12 months?
13. What percentage of scanner time is dedicated to mpMRI before biopsy?

Download response Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

EMB Biopsy 060317

Do any hospitals in the trust perform Endomyocardial Biopsy?
– Yes
– No
a) If so how many were performed in 2014-15 financial year?
b) How many were performed for investigation of Myocarditis?
2) How many patients in 2014-15 were diagnosed with Myocarditis in the trust?
3) Does the Trust refer patients to other centres or trusts for Endomyocardial Biopsy?
4) If so which centres or trusts do you refer to?
5) Does your trust receive referrals from other centres or trusts for Endomyocardial biopsy?

Download response EMB Biopsy 060317

Extravasation Incidents. 310118

Name of person completing request:
Hospital Trust/Health Board:
Telephone No:
E-mail Address:
1. Does your organisation provide a chemotherapy service – this may include inpatient, outpatient or a community service? 0 Yes 0 No
2. In the past financial year, how many doses of chemotherapy did you deliver? (April 2016 – March 2017)
3. In the past financial year, how many doses of anthracyclines did you administer? (April 2016 – March 2017)
4. In the past financial year, how many anthracycline extravasations have been reported due to chemotherapy? (April 2016 – March 2017)
5. In the past 3 financial years, how many patients have submitted a claim for medical negligence and/or damages against the Trust/Health Board due to an anthracycline extravasation injury?
6. In the past 3 financial years, how much compensation has the Trust/Health Board had to pay to those claimants who have suffered an anthracycline extravasation injury and have been successful in their medical negligence and/or damages case?
7. Does your Trust/Health Board have in place guidelines as to how to recognise and manage an extravasation injury? If not, is this available via your Cancer Alliance/Network or another source? If other, please state source ………………………………………………….
Trust/Health Board Guidelines 0 Yes 0 No If yes, when were they last updated?…………………………………………
8. Does your Trust/Health Board stock or have readily available any of the following extravasation treatments for chemotherapy?
a. Sodium Thiosulfate 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
b. Hyaluronidase 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
c. DMSO 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
d. Dexrazoxane (Savene) 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
9. In the past 3 financial years, how many annual reconstruction operations have been carried out by the Trust/Health Board due to an extravasation injury?
10. Does your Trust/Health Board’s plastics and/or nursing team have the expertise/core competency to undertake the wash-out/flush-out technique if an extravasation occurs?
0 Yes 0 No
11. If you answered yes to question 10, in the past 3 financial years, how many wash-out/flush-out procedures have been carried out by the Trust/Health Board due to an extravasation incident?

Download response Extravasation Incidents. 310118

Gonadorelin (GnRH) Analogues.

1 Within your organisation, which healthcare professional (role) clinically recommends the LHRH that is prescribed?
2 Which healthcare professional (role) within your organisation usually administers the first injection?
3 Where is the first injection usually given (hospital or primary care)?
4 Which healthcare professional (role) within your organisation usually administers subsequent injections?
5 Where are subsequent injections usually given (hospital or primary care)?
6 For subsequent injections, does the patient still remain under the care of the hospital (e.g. attends hospital clinics although injections are given in primary care), and if so, for how long?
7 If injections are administered in primary care, what recommendation/advice comes from the hospital?

Download response Gonadorelin (GnRH) Analogues 300316

Head and Neck Cancer

Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
April to September 2015 – 26 patients
Of these how many are treated with the following therapies;
Carboplatin
Cetuximab
Cisplatin
Docetaxel
5-Fluorouracil (5FU)
Radiotherapy Only
Please see the table below:
If your health trust has a protocol or pathway for the treatment of head and neck cancer patients [including referral pathway to other trusts], please could you provide details?
Please see the attached document.
Within your health trust how many patients are currently [within the past 6 months] being treated for Colorectal Cancer?
April to September 2015 – 136 patients
Of these how many are treated with the following therapies;
Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)

Download response letter Head and Neck Cancer 201115

Head and Neck Cancer (Squamous cell carcinoma).

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of the these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
3. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so please could you provide details?
4. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;

Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous cell carcinoma) 270616

Head and Neck Cancer (Squamous Cell Carcinoma). 081116

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
2. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;
Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous Cell Carcinoma). 081116

Head and Neck Cancer (Squamous cell carcinoma). 260418

1. Within your health trust how many patients are currently [within the past 6 months available] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
a. Locally advanced
b. Recurrent metastatic
3. Of the locally advanced/ recurrent or metastatic head and neck cancer patients how many are currently [within the past 6 months available]
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab (Erbitux) with/without chemotherapy
Cetuximab (Erbitux) with radiotherapy
Docetaxel (Taxotere) -only or in combination with 5-FU
Fluorouracil (5FU)
Radiotherapy only
Other
4. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials?
5. Within your health trust how many patients are currently [within the past 6 months available] being drug treated for metastatic colorectal cancer?
Of those patients please split by their drug treatment;
Cetuximab (Erbitux) with/without chemotherapy
Panitumumab (Vectibix) with/without chemotherapy
Nivolumab (Opdivo) with/without chemotherapy
Chemotherapy + other mAb
Chemotherapy alone
Other
6. Does your health trust participate in any ongoing clinical trials for the treatment of colorectal cancer patients, if so how many patients are currently taking part in clinical trials?
Download response Head and Neck Cancer (Squamous cell carcinoma). 260418

HER2 Breast Cancer. 080517

In your trust, how many patients with HER2 breast cancer are currently being treated (in the past 3 months available) with the following products;

Herceptin IV (trastuzumab IV) only
Herceptin SC (trastuzumab SC) only
Perjeta (pertuzumab) combined with Herceptin/Docatexel
Kadcyla (trastuzumab emtansine)
Tyverb (lapatinib)

Download response HER2 Breast Cancer. 080517

Intravenous cancer drug therapies 081116

On average how many patients receive intravenous cancer drug therapies (includes monoclonal antibodies (mAbs)) on a daily basis across all hospital chemotherapy day units in your organisation/Trust?

Download response Intravenous cancer drug therapies 081116

Leukaemia care. 111217

1. What haematological (blood) cancers are treated at the trust?
2. In May 2015 how many blood cancer patients were under the care of your trust?
3. In May 2015 how many leukaemia patients were under the care of your trust?
• How many of these are chronic lymphocytic leukaemia (CLL) patients?
• How many of these are chronic myeloid leukaemia (CML) patients?
• How many of these are Acute Lymphoblastic leukaemia (ALL) patients?
• How many of these are Acute Myeloid leukaemia (AML) patients?
4. As of September 2017 how many blood cancer patients are under the care of your trust?
5. As of September 2017 how many leukaemia patients are under the care of your trust?
• How many of these are chronic lymphocytic leukaemia (CLL) patients?
• How many of these are chronic myeloid leukaemia (CML) patients?
• How many of these are Acute Lymphoblastic leukaemia (ALL) patients?
• How many of these are Acute Myeloid leukaemia (AML) patients?
6. The total number of haematology clinical nurse specialists in your trust in May 2015.
7. The total number of haematology clinical nurse specialists in your trust in September 2017.
8. The total number of blood cancer specific clinical nurse specialists in your trust in May 2015.
9. The total number of blood cancer specific clinical nurse specialists in your trust in September 2017.
10. The total number of leukaemia specific clinical nurse specialists in your trust in May 2015.
11. The total number of leukaemia specific clinical nurse specialists in your trust in September 2017.
12. Are haematology/blood cancer clinical nurse specialists at your trust required to undertake normal ward duties?
13. Have you measured patient access to a clinical nurse specialist within your trust? If so what was the outcome of this.
14. Have you measured the cost value or savings relating to haematology/blood cancer clinical nurse specialists in the trust? If so what were your findings?
15. Do you have or plan to have any funding in place for training more haematology or blood cancer specific clinical nurse specialists?
If you do not have any specialised leukaemia clinical nurse specialists please answer:
16. As of September 2017 how many patients are there per haematology clinical nurse specialist in your trust?
17. As of September 2017 how many blood cancer patients are there per haematology clinical nurse specialist in your trust?
18. As of September 2017 how many leukaemia patients are there per haematology clinical nurse specialist in your trust?
If you have specialised leukaemia clinical nurse specialists please answer:
19. As of September 2017 how many leukaemia patients are there per leukaemia clinical nurse specialist in your trust?

Download response Leukaemia care. 111217

Locum doctors in Oncology. 111217

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Oncology over the following months, within your Trust or Health Board?

Month Total Agency Spend in Oncology
April 2017
May 2017
June 2017
July 2017
August 2017
September 2017

Download response Locum doctors in Oncology. 111217

Lynch Syndrome testing. 111018

1. Do you test newly diagnosed bowel cancer patients in your trust (either contracted or referred) for molecular features of Lynch syndrome using either immunohistochemistry or microsatellite instability testing?
2. If yes, at what stage does this testing take place?
3. Is this test carried out as a reflex test i.e. automatically or upon referral?
4. In their published adoption support resource NICE suggest identifying a named ‘clinical champion’ within each colorectal multidisciplinary team to effectively implement testing people for molecular features for Lynch syndrome. Is this established in your trust?
5. Do you audit diagnostic outcomes within your trust to ensure that every patient is tested for molecular features for Lynch syndrome?
6. Have you had to submit a business case for funding in order to effectively implement this new guidance?
7. If no such testing is in place, do you have information on whether there are any plans to introduce molecular testing for Lynch syndrome as per NICE guidance?
8. What are the main barriers you have faced if no molecular testing or only selected testing is performed? Please specify.

Download response Lynch Syndrome testing. 111018

Melanoma patients and treatments. 240317

1. Within your health trust how many patients are currently [within the past 6 months] being treated for Melanoma?

2. Of these Melanoma patients how many are being treated for stage IV (advanced or metastatic) melanoma?

3. Of these how many are being treated for (advanced or metastatic) melanoma with the following;
Ipilimumab (Yervoy) single agent
Ipilimumab (Yervoy) in combination
Nivolumab (Opdivo)
Pembrolizumab (Keytruda)
vemurafenib (Zelboraf) single agent
vemurafenib (Zelboraf) in combination
dabrafenib (Taflinar)
trametinib (Mekinist)
dabrafenib AND trametinib
dacarbazine (DTIC)

4. How many patients are currently [within the past 6 months] being treated for Non Squamous Cell Lung Cancer with the following;
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Pemetrexed (Alimta)
Nivolumab (Opdivo)
Pembrolizumab (Keytruda)

5. How many patients are currently [within the past 6 months] being treated for Renal Cell Carcinoma (RCC) with the following;
Interferon (Intron A)
Bevacizumab (Avastin)
Sunitinib (Sutent)
Pazopanib (Votrient)
Aldesleukin (IL-2, Proleukin or interleukin 2)
Sorafenib (Nexavar)
Everolimus (Afinitor)
Temsirolimus (Torisel)
Cabozantinib (Cometriq)

Download response Melanoma patients and treatments. 240317

Metastatic hepatocellular carcinoma patients. 260418

1 – In the past three months, how many metastatic hepatocellular carcinoma patients were treated with?
Sorafenib (Nexavar)
Other active systemic anti-cancer therapy
Other including palliative care
2 – In the past three months, how many metastatic renal cell carcinoma patients were treated with?
Sunitinib (Sutent)
Pazopanib (Votrient)
Everolimus (Afinitor)
Temsirolimus (Torisel)
Cabozantinib (Cometriq)
Nivolumab (Opdivo)
Axinitib (Inlyta)
Nivolumab + Ipilimumab (Opdivo + Yervoy)
Levantinib (Lenvima) + Everolimus (Afinitor)
Tivozanib (Fotivda)
Other active systemic anti-cancer therapy
Other including palliative care
3 – In the past 3 months, how many metastatic melanoma patients were treated with?
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Ipilumumb (Yervoy)
Nivolumab + Ipilumumb (Opdivo + Yervoy)
Dabrafenib + Trametinib (Tafinlar + Mekinist)
Dabrafenib (Tafinlar)
Vemurafenib (Zelboraf)
Vemurafenib + cobimetinib (Zelboraf _ Cotellic)
Other active systemic anti-cancer therapy
Other including palliative care

Download response Metastatic hepatocellular carcinoma patients. 260418

Metastatic Squamous Cell Non-Small cell lung cancer. 070618

Metastatic Squamous Cell Non-small cell lung cancer (NSCLC):
1. In the past 3 months, how many patients were treated with?
Atezolizumab (Tecentriq)
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Other active systemic anti-cancer therapy
Palliative care only

Metastatic Non Squamous Cell Non-small cell lung cancer (NSCLC):
2. In the past 3 months, how many patients were treated with?
Atezolizumab (Tecentriq)
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Other active systemic anti-cancer therapy
Palliative care only

Adjuvant Melanoma
3. In the past three months how many patients were seen who had stage III resectable melanoma?
4. Of all stage III patients seen, how many received a complete resection?
5. Of all stage III patients seen, how many were stage III a?

Download response Metastatic Squamous Cell Non-Small cell lung cancer. 070618

Molecular testing for mismatch repair (MMR) deficiency.

1. Do all patients, who are diagnosed with bowel cancer under the age of 50 years in your trust, have a molecular screening test for Lynch Syndrome, such as immunohistochemistry or microsatellite instability testing, carried out on tumour tissue?
2. If yes, at what stage does this testing take place? Does it take place:
3. Is this test carried out as a reflex test i.e. automatically or upon referral?
4. Which of the following molecular tests does your trust use to identify people who could have Lynch syndrome:
5. Are the results of this reflex test communicated to the patient?
6. If no such reflex test is in place, do you have information on whether there are any plans to introduce molecular testing for Lynch syndrome?

Download response Molecular testing for mismatch repair (MMR) deficiency 100616

Mouthwash product for oral mucositis treatment or prevention. 270317

1. Please advise the estimated number of beds at your hospital(s)
2. Please advise the estimated number of patients treated annually at your hospital(s)
3. Please advise the estimated number of patients receiving chemotherapy at your hospital(s) each year
4. What is the preferred mouthwash product prescribed to patients for oral mucositis treatment or prevention?
5. What is the estimated annual spend on mouthwash?
6. What is the estimated annual number units of mouthwash prescribed?

Download response Mouthwash product for oral mucositis treatment or prevention. 270317

Multiple Myeloma

Section 1 – Treatment and Management
1. How many patients has your Trust diagnosed with multiple myeloma in the calendar year 2014?
2. How many multiple myeloma patients in your Trust received systemic anti-cancer treatment in the calendar year 2014?
3. How many patients aged 75 years and over has your Trust diagnosed with multiple myeloma in the calendar year 2014?
4. How many multiple myeloma patients aged 75 years and over in your Trust received systemic anti-cancer treatment in the calendar year 2014?
5. Does your Trust produce local guidelines to support the management of elderly cancer patients?
6. Does your Trust produce local guidelines to support the management of elderly multiple myeloma patients?
(Note: Multiple Myeloma is defined by the ICD-10 code as C90.0 – C90.3)
Section 2 – Specialist Geriatric Input
7. Does your Trust’s multiple myeloma multidisciplinary team (MM MDT) include input from a geriatrician?
a. If so, does a geriatrician routinely attend all MM MDT meetings?
b. How often does the MM MDT meet?
8. Do multiple myeloma patients aged 75 and over at diagnosis routinely receive a consultation with a geriatrician?
a. If so, does this happen prior to making a decision as to whether a patient is suitable for systemic anticancer therapy?
b. If, so does information from this consultation feed into clinical decision making?
9. How frequently do all multiple myeloma patients aged 75 years and over receive a consultation with a geriatrician?
a. How is this information used in these consultations fed into clinical management and decision making?
Section 3 – Specific Tools and Metrics
10. Does your Trust use Comprehensive Geriatric Assessment to assess if a patient with cancer is suitable for treatment?
a. If so, what proportion of multiple myeloma patients aged 75 and over received the assessment in 2014?
b. Who routinely carries out this assessment (i.e. a nurse or a consultant – and what type of consultant (haematologist or geriatric))?
11. Does your Trust routinely assess patients over the age of 75 according to a Comorbidity Score (either a standardised score such as the Charlson index or a local ‘in house’ score, please specify)?
a. If so, what proportion of multiple myeloma patients aged 75 and over received the assessment in 2014?
b. Who routinely carries out this assessment (i.e. a nurse or a consultant – and what type of consultant (haematologist or geriatric))?
12. Does your Trust routinely assess patients over the age of 75 according to a Clinical Frailty Scale (either a standardised scale or a local ‘in house’ scale, please specify)?
a. If so, what proportion of multiple myeloma patients aged 75 and over received the assessment in 2014?
b. Who routinely carries out this assessment (i.e. a nurse or a consultant – and what type of consultant (haematologist or geriatric))?

Download response Multiple Myeloma 201115

Neuroendocrine Tumours. 070717

1. In your trust, please provide the number of patients treated in the last 12 months who have been diagnosed [any diagnosis position] with neuroendocrine tumours
2. Of these how many have carcinoid syndrome (E34.0)?
3. Of the patients with neuroendocrine tumours (NETs), how many received with the following treatments:
• Somatuline Autogel (lanreotide)
• Somatuline LA (lanreotide)
• Sandostatin LAR (octreotide LAR)
• Octreotide
• Afinitor (everolimus)
• Sutent (sunitinib)
4. Please provide the number of patients treated in the last 12 months who have been diagnosed [any diagnosis position] with acromegaly (ICD10 code E220 or ICD10 code D352), with the following treatments:
• Somatuline Autogel (lanreotide)
• Somatuline LA (lanreotide)
• Sandostatin LAR (octreotide LAR)
• Octreotide
• Somavert (pegvisomant)
• Signifor (pasireotide pamoate)

*To assist in sourcing the answer to my question specifically in respect of NETs, the below information may be of use.
In relation to patients with neuroendocrine tumours, these tumours are typically identified from pathology analysis, but may be coded using various ICD10 codes. The following may be commonly used:
• C787 – Secondary malignant neoplasm of liver
• C786 – Secondary malignant neoplasm of retroperitoneum and peritoneum
• C772 – Secondary and unspecified malignant neoplasm of Intra-abdominal lymph nodes
• C780 – Secondary malignant neoplasm of the lung
• Z850 – Personal history of malignant neoplasm of digestive organs
In any event, I am requesting information only in respect of those patients with neuroendocrine tumours who are being treated with the above treatments.

Download response Neuroendocrine Tumours. 070717

Non-Small Cell Lung Cancer. 300317

1. Within your health trust how many patients are currently [within the past 6 months] being treated with a chemotherapy agent [not including surgery/radiotherapy only];

a. All Non-Small Cell Lung Cancer patients
b. Patients with Non-Small Cell Lung Cancer (NSCLC) Stage IIIB**/IV** (Stage 3b/4)

c. Of the NSCLC patients, please state the number of patients currently [within the past 6 months] being treated with the following therapies;
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Nitendaninb + docetaxel
Nivolumab (Opdivo)
Pemetrexed (Alimta) mono or in combination with carboplatin / cisplatin
Pembrolizumab (Keytruda)
Gemcitabine mono or in combination with carboplatin / cisplatin
Paclitaxel mono or in combination with carboplatin / cisplatin
Doxetaxel mono or in combination with carboplatin / cisplatin
Vinorelbine [or other Vinka alkaloid] mono or in combination with carboplatin / Cisplatin

Download response Non-Small Cell Lung Cancer. 300317

Non-small Cell Lung Cancer. 301117

1. How many of the following patients (excluding clinical trial patients) are currently being managed by your Health Trust:
All Non-Small Cell Lung Cancer (NSCLC) patients
Patients with NSCLC Stage IIIB**/IV** (Stage 3b/4)
2. Of the Stage IIIB/IV NSCLC patients, please state the number of patients currently being treated with the following therapies:
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Nintedanib + docetaxel
Pemetrexed (Alimta) mono or in combination with carboplatin / cisplatin
Gemcitabine mono or in combination with carboplatin / cisplatin
Atezolizumab (Tecentriq)
Nivolumab (Opdivo)
Pembrolizumab (Keytruda)
Paclitaxel mono or in combination with carboplatin / cisplatin
Doxetaxel mono or in combination with carboplatin / cisplatin
Vinorelbine [or other Vinka alkaloid] mono or in combination with carboplatin / Cisplatin
3. If your trust does not treat Stage IIIB/IV NSCLC patients and you refer your patients to another trust, please state to which trust patients are referred

Download response Non-small Cell Lung Cancer. 301117

Non-small cell lung carcinoma (NSCLC) pathology testing 111016

1) What is the volume of NSCLC pathology samples tested in house?
2) Does your laboratory process EGFR samples in house? (Yes/No)
• If yes, what is the number of samples being tested per year/month?
3) Does your laboratory process ALK samples in house? (Yes/No)
• If yes, what is the number of samples being tested per year/month?

Download response Non-small cell lung carcinoma (NSCLC) pathology testing 111016

Oral mucositis and barrier mouthwashes. 190717

1) Please advise the estimated number of patients receiving chemotherapy and radiotherapy at your hospital(s) each year.
2) What is the preferred ‘barrier’ mouthwash product prescribed to patients for oral mucositis treatment and/or prevention?
3) Which of the following ‘barrier’ mouthwash brands, if any, have previously been prescribed in your hospital(s):
– Caphosol
– Gelclair
– Mucodis
4) What is the estimated annual spend on mouthwash?
5) What is the estimated annual number of units of mouthwash prescribed annually?
6) How much Saline and Difflam mouthwash are prescribed for OM?
7) What are your current prescribing pathways for oral mucositis care?
8) Do you currently prescribe anything for the prevention and/or treatment of the following conditions:
– Vaginal mucositis (Vulvovaginitis)
– Rectal mucositis
– Radiation dermatitis

Download response Oral mucositis and barrier mouthwashes. 190717

Ovarian cancer. 040118

Does your Trust manage/treat patients with Ovarian Cancer?
Number of patients diagnosed with Ovarian Cancer
Please indicate the number of unique NHS Ovarian Cancer patients managed by your Trust treated at initial diagnosis with the following:
• Avastin (Bevacizumab) +/- chemotherapy
• Chemotherapy alone
Does your Trust refer Ovarian Cancer patients to other Trusts or Centres for the treatment of ovarian cancer?

Download response Ovarian cancer. 040118

Ovarian and Prostate treatments. 010318

1 – How many Ovarian Carcinoma patients (any stage) have been diagnosed in the last 12 months?
2 – How many stage III or IV Ovarian Carcinoma patients have received Chemotherapy for the first time in the last 12 months?
Of these how many patients are on Platinum based therapy (Monotherapy or combination therapy)?
3 – How many stage III or IV Ovarian Carcinoma patients have been diagnosed as Platinum refractory (i.e. progression of disease whilst receiving Platinum therapy) or resistant (i.e. progression of disease within 6 months of last Platinum dose) in the last 12 months?
4 – How many patients with Stage III or IV Ovarian Carcinoma have been treated with the following treatments in the last 12 months?
5 – Within your Trust how many patients with Advanced Prostate Cancer have been treated in the past 12 months with the following treatments?
6 – How many patients being treated with Abiraterone or Enzalutamide and have been on this treatment for more than 1 year?

Download response Ovarian and Prostate treatments. 010318

PDL1 testing. 070417

1. Do you currently offer a clinical testing service for PD-L1 in non-small cell lung carcinoma (NSCLC) as off the beginning of 2017?
2. How is PD-L1 testing in NSCLC normally requested by the clinician? (please select all that apply)
3. If requested as part of a NSCLC panel of tests, how is PD-L1 testing performed in the lab
4. What sample types are processed by the lab for NSCLC testing (EGFR/ALK/PD-L1)? (please select all that apply)
5. What is the number of NSCLC samples being tested (or sent-out) are tested for:?
6. What proportion of PD-L1 NSCLC samples tested are cytology/ cytological cell block samples? (per month or per year or as a percentage of PD-L1 samples tested, whichever is easier to determine)
7. What proportion of PD-L1 NSCLC samples are NOT tested because the samples are EBUS/cytology samples? (per month or per year or as a percentage of PD-L1 samples tested, whichever is easier to determine)
8. What methods are used for PD-L1 testing in NSCLC and their associated clinical cut-off? (please select all that apply)
9. What is the clinical cut offs are used in relation to the antibodies selected above?
10. What IHC staining platform(s) are used in the laboratory that performs the PD-L1 testing e.g. Ventana, Dako, Leica, Menarini, Shandon, Labvision, etc? (If possible, please supply the model of the platform)
11. What percentage of samples tested have ≥1% PD-L1 expression?
12. What percentage of samples tested have ≥50% PD-L1 expression?
13. What is the average turnaround time from sample receipt to report being issued?
14. Are there bottlenecks that prevent this turnaround time from being quicker?
15. Who pays for DLBCL testing?

Download response PDL1 testing. 070417

Post-treatment support for breast cancer patients. 160518

1) Does your Trust offer a Health and Wellbeing event accessible to all breast cancer patients at the end of hospital-based treatment?
(A Health and Wellbeing event is defined as a group education and support event which helps people to manage their physical and psychological health after a cancer diagnosis.)

2) If the Trust does offer a Health and Wellbeing event for breast cancer patients, are these events:
A. solely for people with breast cancer
or
B. for people with all types of cancer

3) For breast cancer patients who have completed their hospital-based treatment, do the nurses in the breast care unit routinely make direct referrals, where appropriate, to the following?
(By ‘direct referral’ we mean gaining consent from a patient to pass on their details to a support service or arranging for someone from the service to contact the patient)

Services provided by charities

a. Support services provided by charities that support people with cancer (yes/no)
b. Support services provided by charities that support people with breast cancer only (yes/no)

NHS Services

c. Counselling / psychology services within the NHS (yes/no)
d. Physiotherapy services within the NHS (yes/no)
e. Fertility services within the NHS (yes/no)
f. Lymphoedema services within the NHS (yes/no)
g. Other support services – please specify below (yes/no)

4) If you do not refer to some/any of the services in question 3, is this due to any of the reasons below? Please indicate all that apply.
a. Support services provided by charities that support people with cancer
• Service not available (yes/no)
• Unaware of service (yes/no)
• Service is oversubscribed (yes/no)
• Service is unsuitable for breast cancer patients (yes/no)
• Patient is informed of the service but a direct referral is not made (yes/no)
• Workload capacity does not allow time for referrals (yes/no)
• Other (please give details)
b. Support services provided by charities that support people with breast cancer only
• Service not available (yes/no)
• Unaware of service (yes/no)
• Service is oversubscribed (yes/no)
• Patient is informed of the service but a direct referral is not made (yes/no)
• Workload capacity does not allow time for referrals (yes/no)
• Other (please give details)
c. Counselling / psychology services within the NHS
• Service not available (yes/no)
• Unaware of service (yes/no)
• Service is oversubscribed (yes/no)
• Patient is informed of the service but a direct referral is not made (yes/no)
• Workload capacity does not allow time for referrals (yes/no)
• Other (please give details)
d. Physiotherapy services within the NHS
• Service not available (yes/no)
• Unaware of service (yes/no)
• Service is oversubscribed (yes/no)
• Patient is informed of the service but a direct referral is not made (yes/no)
• Workload capacity does not allow time for referrals (yes/no)
• Other (please give details)
e. Fertility services within the NHS
• Service not available (yes/no)
• Unaware of service (yes/no)
• Service is oversubscribed (yes/no)
• Patient is informed of the service but a direct referral is not made (yes/no)
• Workload capacity does not allow time for referrals (yes/no)
• Other (please give details)
f. Lymphoedema services within the NHS
• Service not available (yes/no)
• Unaware of service (yes/no)
• Service is oversubscribed (yes/no)
• Patient is informed of the service but a direct referral is not made (yes/no)
• Workload capacity does not allow time for referrals (yes/no)
• Other (please give details)

Download response Post-treatment support for breast cancer patients. 160518

Prescribing data in Oncology 01.11.2015- 31.10.2016. 090617

I am writing to request hospital prescribing data for the attached list of chemical substances being used in Oncology.

The data is required for all generic and branded prescriptions of these and I would request to provide this in the attached format.

Download response Prescribing data in Oncology 01.11.2015- 31.10.2016. 090617

Prostate Cancer 160916

1. We understand the Trust has a Local Urology MDT and has representation on the Specialist Urological MDT for West Kent. Please can you confirm if these MDTs are still operational?
2. If yes, please confirm if the following individuals/roles are still members of the MDTs?
3. Please can you confirm whether the Trust still references the following document(s) in relation to the treatment of patients with Prostate Cancer:
Local Management of Urological Cancers 2015 – Review date June 2016 (Dartford and Gravesham NHS Trust, Medway NHS Foundation Trust, Maidstone and Tunbridge Wells NHS Trust)
4. Does the Trust reference any other Referral Pathways / Care Pathways in relation to the treatment of Prostate Cancer? If so, please provide a copy or website link.
5. If yes, when is/are the document(s) expected to be reviewed?
6. Please can you confirm whether we are permitted to reuse the above information under the Open Government Licence?
We (IMS Health) request permission to re-use as a part of an independent analysis into the treatment of patients with Prostate Cancer, which has been commissioned by one of our clients. The contents of the report will not be made available publically, but may be used by other IMS Health Group entities and service suppliers. The information in the report will be presented in a factual manner with all publication details staying true to the publisher.

We acknowledge that information provided may be protected by copyright and will include a copyright statement to this effect at the end of any information we publish if requested by you.

Download response Prostate Cancer 160916

Radiographer posts and vacancies. 030518

1. From the latest data, how many FTE radiographer posts in your trust are vacant?
2. How many FTE radiographer posts do you currently have funded?
3. How does this compare to the situation on 1st April 2013? For the sake of clarity: please can you provide answers on the same questions in Q1 and Q2 but for 1st April 2013 if possible.
4. How are you currently filling the shifts that should be covered by the vacant posts?
5. Have you had to offer fewer radiography services in any way as a result of this?

Download response Radiographer posts and vacancies. 030518

Renal cell carcinoma specialist nurses

Please provide the number of a.) Renal cell carcinoma clinical nurse specialist b.) Uro-oncology clinical nurse specialists and c.) Urology clinical nurse specialists currently employed by your Trust

Download response Renal cell carcinoma specialist nurses 040116

Renal Multidisciplinary team (MDT)

1. Does your Trust employ one or more renal Multidisciplinary team (MDT)?
2. If yes, does this team include an Interventional Radiologist (IR)?
3. Does your Trust employ a Specialist to look into access problems with AV fistulas?

Download response Renal Multidisciplinary team (MDT) 270516

Secondary breast cancer

1. Is Maidstone and Tunbridge Wells NHS Trust (MTW) routinely collecting data on secondary breast cancer?

2. If so, how many people were diagnosed with the disease within the Trust in the last twelve months (or for the latest period available)? These should include (a) those who were diagnosed with secondary breast cancer at their first presentation; and (b) those for whom their primary breast cancer has progressed and spread to other parts of the body. Please also include the time period this data refers to.

Download response Secondary breast cancer 100516

Sickle cell and thalassaemia specialist nurses. 220118

1. How many sickle cell and thalassaemia specialist nurses are employed at your trust in the financial years 2013/14, 2014/2015 and 2015/2016?

2. How many sickle cell related deaths have there been in the years 2013/14, 2014/2015 and 2015/2016?

3. What is the age of deceased and cause of death?

Download response Sickle cell and thalassaemia specialist nurses. 220118

Surface contamination wipe tests. 161216

• Does your Trust conduct regular environmental monitoring, risk assessment and/or staff surveillance within cancer day units to detect possible chemical contamination from hazardous drugs being administered? E.g. Surface contamination wipes tests.
• If so, what assessments/tests are conducted and how often are they carried out?

Download response Surface contamination wipe tests. 161216

TARGeted Intraoperative Radiotherapy

For Maidstone and Tunbridge Wells NHS Trust (and any previous iterations of it) the number of early breast cancer cases treated at the Trust with TARGeted Intraoperative Radiotherapy (also known as Intrabeam or TARGIT IORT) for each year from January 2000 to the date of this request. Please identify the number of cases in each year which were delivered as part of a clinical trial and the number which were delivered as treatment which was not part of a clinical trial.

For the Trust, the date at which the Trust or Clinical Commissioning Group purchased equipment able to deliver TARGeted Intraoperative Radiotherapy, the price paid for that equipment and the name of the organisation from whom it was purchased.

Download response TARGeted Intraoperative Radiotherapy 220216

Tele-Radiology Reporting services. 270618

If your trust uses Tele-radiology services, please kindly outline which suppliers you utilise and the total number of images outsourced during the months of November 2017 – March 2018:

Download response Tele-Radiology Reporting services. 270618

Testing services for cancer indications and therapies.

Do you currently offer a companion diagnostic (stratified medicine) testing services for the following cancer indications and therapies? If so I would be grateful if you could please indicate which tests are offered, the charge per patient test (ideally a comment on what the overhead/kit breakdown of the test cost) and the number performed per year January-December (or month if easier – please specify in comments). The brand name of the test used or any information regarding commercial partnerships would also be appreciated to be included in the comments.

Test Types: IHC = Immunohistochemistry, FISH = Fluorescent In-Situ Hybridization, PCR = Polymerase Chain Reaction, Pyro= Pyrosequencing, NGS = Next Generation Sequencing. If the lab performs another test type or the test is linked to another oncological therapy not listed please check “Other” and include it in the comments section.

Download response Testing services for cancer indications and therapies 270616

Urgent cancer referrals

How many urgent cancer referrals did the Trust receive from GPs each year in 2011, 2012, 2013, 2014 and 2015?
How many of these referrals each year were deemed, by the consultant or referral management panel, to not meet the criteria for an urgent cancer referral?

Download response Urgent cancer referrals 090916

Urgent suspected cancer (USC) MRI. 090617

1. What is the trust target time for an urgent suspected cancer (USC) referral for an MRI scan?
2. If question 1 does not apply, what is the trust target time for a USC referral to have a diagnostic test/report?
3. How many of the referrals from questions 1 and 2 have failed to meet these targets in the year 1/4/16 – 1/4/17? If the data is available please may I have the amount who have not met the MRI waiting time? If that data is unavailable may I have the amount that have failed to meet the target time for a USC referral to a diagnostic test/report?
4. Is there a financial penalty if either above target is not met? If so what is this penalty?

Download response Urgent suspected cancer (USC) MRI. 090617

Urothelial Cell Cancer. 301117

1. How many of the following patients (excluding clinical trial patients) are currently being managed by your Health Trust:
All Urothelial cancer (UCC, transitional carcinoma, TCC) patients
Metastatic* or locally advanced* Urothelial cancer (UCC, transitional carcinoma, TCC) patients
2. Of the metastatic* or locally advanced* Urothelial cancer (UCC, transitional carcinoma, TCC) patients, please state the number of patients currently being treated with the following therapies:
Cisplatinum single agent
Cisplatinum in combination with another agent
Carboplatinum single agent
Carboplatinum in combination with another agent
Any other chemo regimen without cisplatinum or carboplatinum
Pembrolizumab (Keytruda)
Atezolizumab (Tecentriq)
3. If your trust does not treat these cancers and you refer your patients to another trust, please state to which trust patients are referred:

Download response Urothelial Cell Cancer. 301117

Venous Thromboembolism in cancer patients. 241016

Please find attached a set of questions relating to venous thromboembolism in cancer patients.

Venous thromboembolism (VTE) in cancer patients

Part 1: Incidence
Question 1: How many patients has your Trust treated for cancer (of all types) in each of the past four years?
Question 2: Of the patients treated for cancer, how many also had a diagnosis of venous thromboembolism (VTE) {VTE is defined by the following ICD 10 codes: I80.0-I80.3, I80.8-I80.9, I82.9, O22.2 – O22.3, O87.0 – O87.1, I26.0, and I26.9} in each of the past four years?
Question 3: Of the patients treated for cancer who also had a diagnosis of VTE in each of the past four years, how many:
Were receiving chemotherapy?
Had metastatic disease?
Had localised disease?
Were treated for brain cancer?
Were treated for lung cancer?
Were treated for uterine cancer?
Were treated for bladder cancer?
Were treated for pancreatic cancer?
Were treated for stomach cancer?
Were treated for kidney cancer?

Part 2: Mortality
Question 4: In how many patient deaths within your Trust was cancer (of any type) listed as the primary cause of death in each of the past four years:
Question 5: Of the patients who died within your Trust, in how many was VTE as well as cancer listed as a cause of death in each of the past four years:
Question 6: Of the patients who died in your Trust who had both VTE and cancer listed as a cause of death, how many:
Were receiving chemotherapy?
Were treated for brain cancer?
Were treated for lung cancer?
Were treated for uterine cancer?
Were treated for bladder cancer?
Were treated for pancreatic cancer?
Were treated for stomach cancer?
Were treated for kidney cancer?

Part 3: Advice given to patients
Question 7: Are patients who receive chemotherapy provided with written and verbal information about the risk of developing VTE during chemotherapy? Is this information provided to chemotherapy inpatients only, chemotherapy outpatients only, or both in and outpatients?
Question 8: Are patients who receive chemotherapy provided with written and verbal information which outlines the symptoms suggestive of VTE? Is this information provided to chemotherapy inpatients only, chemotherapy outpatients only, or both in and outpatients?
Question 9: Are patients who receive chemotherapy provided with written and verbal information regarding what action they should take if they suspect a Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE)? Is this information provided to chemotherapy inpatients only, chemotherapy outpatients only, or both in and outpatients?
Question 10: Does your Trust have a policy or pathway for the management of suspected VTE in patients receiving chemotherapy?

Download response Venous Thromboembolism in cancer patients. 241016

Venous thromboembolism (VTE) in cancer patients 2012,2013 & 2014

Question 1: How many patients has your Trust treated for cancer (of all types) in each of the past three years?

Question 2: Of the patients treated for cancer, how many also had a diagnosis of venous thromboembolism (VTE) {VTE is defined by the following ICD 10 codes: I80.0-I80.3, I80.8-I80.9, I82.9, O22.2 – O22.3, O87.0 – O87.1, I26.0, and I26.9} in each of the past three years?

Question 3: Of the patients treated for cancer who also had a diagnosis of VTE in each of the past three years, how many:
2014 2013 2012
Were receiving chemotherapy?
Had metastatic disease?
Had localised disease?
Were treated for brain cancer?
Were treated for lung cancer?
Were treated for uterine cancer?
Were treated for bladder cancer?
Were treated for pancreatic cancer?
Were treated for stomach cancer?
Were treated for kidney cancer?

Part 2: Mortality
Question 4: In how many patient deaths within your Trust was cancer (of any type) listed as the primary cause of death in each of the past three years:
a) 2014
b) 2013
c) 2012

Question 5: Of the patients who died within your Trust, in how many was VTE as well as cancer listed as a cause of death in each of the past three years:

Question 6: Of the patients who died in your Trust who had both VTE and cancer listed as a cause of death, how many:
2014 2013 2012
Were receiving chemotherapy?
Were treated for brain cancer?
Were treated for lung cancer?
Were treated for uterine cancer?
Were treated for bladder cancer?
Were treated for pancreatic cancer?
Were treated for stomach cancer?
Were treated for kidney cancer?

Part 3: Advice given to patients
Question 7: Are patients who receive chemotherapy provided with written and verbal information about the risk of developing VTE during chemotherapy?

Question 8: Are patients who receive chemotherapy provided with written and verbal information which outlines the symptoms suggestive of VTE?

Question 9: Are patients who receive chemotherapy provided with written and verbal information regarding what action they should take if they suspect a Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE)?

Question 10: Does your Trust have a policy or pathway for the management of suspected VTE in patients receiving chemotherapy?

Download response Venous thromboembolism (VTE) in cancer patients 2012,2013 & 2014 311215

 

Car parking

Car Parking Charges

How much money did the trust raise from car parking charges in each of the last four years (state the amount and the years for which figures are available)?
Do you charge for disabled parking? If so, how much of the total amount raised by the trust from car parking charges came from disabled parking?
Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?
Please provide a breakdown of your car park charges – per hour/per day/per week.
Do you provide concessions for long-term visitors? What are these?

Download response Car Parking Charges 181115

Hospital Parking Charges

How much money was generated by your hospital trust through parking charges in the hospital car parks during 2013-14 and 2014-15?
How many parking fines were issued for parking infringements in your car parks during 2013-14 and 2014-15?
How many parking fines were written off during 2013-14 and 2014-15?

Download response Hospital Parking Charges 200515

Abandoned motor vehicles

1) How many instances of abandoned motor vehicles were recorded between 2004-15? If the data doesn’t stretch back to 2004, please use the earliest you have.

2) If a 3rd party was called to recover, what was the average cost involved?

Download response Abandoned motor vehicles 181215

Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

Car park management 070317

1. Please could you confirm when your contract for Car Park Management will expire and also when the contract will be re-tendered?

2. Do you currently manage your own car parks or use a Car Park Management company?

3. Which Portal does the trust use when they tender the Car Park Management out?

Download response Car park management 070317

Car parking

1. Please state what the income was to the Trust from parking income in patient car parks in (i) the (14/15) financial year and (ii) the (15/16) financial year?
2. What is the highest hourly rate for parking charged to patients in any of your car parks?

Download response Car parking 090916

Car parking 071116

1. How much revenue did the Trust receive from car parking fees between 1st October 2015 and 1st October 2016?
2. What are the Trusts rates per hour and per day (can you indicate if this varies between hospitals in the Trust)? Is there any way to get a reduction in this rate?
3. Has the Trust increased the parking charge in the last two years and if so by how much?
4. If the Trust car parks are run by an outside firm and can you please say who that is?

Download response letter Car parking 071116

Car parking 071116

1. How much revenue did the Trust receive from car parking fees between 1st October 2015 and 1st October 2016?
2. What are the Trusts rates per hour and per day (can you indicate if this varies between hospitals in the Trust)? Is there any way to get a reduction in this rate?
3. Has the Trust increased the parking charge in the last two years and if so by how much?
4. If the Trust car parks are run by an outside firm and can you please say who that is?

Download response Car parking 071116

Car parking. 190717

1. Hourly Car Parking Charges
2. Daily Car Parking Charges
3. Weekly Car Parking Charges
4. Car Parking Charges for Blue Badge Holders
5. Car Parking Charges for Staff

Download response Car parking. 190717

Car parking 2015-2016 221216

1. Are your carparks managed by a private contractor? If yes, please provide the name of the contractor.
2. How many parking enforcement tickets were issued in your carparks between 1st April 2015 and 31st March 2016?
3. What is the cost of a parking enforcement fine in your carparks?
4. How many parking enforcement ticket appeals did you receive between 1st April 2015 and 31st March 2016?
5. How many parking enforcement ticket appeals were successful between 1st April 2015 and 31st March 2016?

Download response Car parking 2015-2016 221216

Car parking. 210318

1. The income earned from hospital car parking charges for the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017
2. The money spent on maintenance for car parking facilities in the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017
3. Where the income earned from hospital car parking facilities was spent in the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017

Download response Car parking. 210318

Car parking at the Trust sites 261015

Under the Freedom of Information Act 2000, I am seeking the following pieces of information in relation to parking at the hospitals covered under your trust.
1. The parking ticket costs at the hospitals under your trust.
2. How much does your trust – or a third party contracted by the trust – charge in fines and/or penalty notices if people are deemed to have breached parking rules?
3. What is the revenue from visitors paying for parking tickets? I would like this broken down for each hospital. I would like this information annually for 2012-2013, 2013-2014, and 2014-2015.
4. What is the revenue received from the payment of fines and/or penalty notices? I would like this broken down for each hospital. I would like this information annually for 2012-2013, 2013-2014, and 2014-2015.

Car parking at the Trust sites 261015

Car parking charges 041116

How much money did the trust raise from car parking charges in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient parking if possible.

How much money was raised from parking fines in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient fines if possible.

Do you charge for disabled parking?

Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?

Download response Car parking charges 041116

Car parking charges. 111217

1. How much money did the trust raise from car parking charges in each of the last four financial years – up to and including 2016/17 (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient parking if possible.

2. How much money was raised from parking fines in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient fines if possible.

3. Do you charge for disabled parking?

4. Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?

Download response Car parking charges. 111217

Car parking charges 2015/2016 to date.

1. How much money has the trust raised from car parking charges so far this year?
2. How many parking fines were issued for parking infringements in your car parks so far this year?
3. How many parking fines were written off so far this year?

Download response Car parking charges 2015/2016 to date 100516

Car parking charges 2016. 140317

1. Name of your organisation
2. Does your Trust use a private contractor to oversee the car park?
Yes (if yes please provide name of contractor)
No
Parking Charges
3. Parking charges made to general public (patients, visitors, etc.)
4. Parking charges made to staff
5. Agreed exemptions from charges
6. How income from charges is used
Parking Fines (fines issued from 1 January 2016 to date)
7. Number of fines issued to the general public
8. Income from those fines
9. Number of fines issued to staff
Income from those fines
10. How income from fines is used
11. Does the policy for fining staff differ from the fines policy for the general public?
Yes (if yes, please advise how the policy differs) No
12. Please provide details of any policy or agreements covering car parking charges (e.g. collective agreement with NHS Trade Unions)

Download response Car parking charges 2016. 140317

Car parking charges and fines. 070618

1) How much revenue was made by Maidstone and Tunbridge Wells NHS Trust on all car parking charges and fines in 2015, 2016 and 2017. Please break this down by charges and fines.

2) How much profit was made by Maidstone and Tunbridge Wells NHS Trust on all car parking charges and fines in 2015, 2016 and 2017. Please break this down by charges and fines.

Download response Car parking charges and fines. 070618

Car parking contractor

Could you please advise me if you manage the Car Parking facilities on your own or do you employ a contractor to manage the facilities for you? I.e. ANPR, POF’s and PCN’s etc.  If you use a contractor can you please advise me who they are and when their existing contract with yourselves expire?

Download response Car parking contractor 080515

Car parking revenue. 241017

How much revenue the hospital trust made through the charging of hospital car parking in 2016?

Download response Car parking revenue. 241017

Cost and revenue of car parking 2010 – 2016

1. The total amount of revenue generated by in each of the last 5 years by car parking.
2. What was the cost for an hour of car parking in 2010 and 2016?

Download response Cost and revenue of car parking 2010 – 2016 060916

Disclosure and Barring checks and staff parking. 221116

1) How many nurses and midwives (from Band 5 upwards) waiting to take up employment with your trust are awaiting completion of Disclosure and Barring Service (DBS) checks?
2) How long is the average wait for DBS approval for new starters at your organisation?
3) How many parking spaces at your hospitals are exclusively for staff use and how much do they pay to use them?
4) What is your FTE nursing and midwifery staff establishment (from Band 5 upwards)?

Download response Disclosure and Barring checks and staff parking. 221116

Electric Vehicle charging points.

1) Does your organisation already offer charging facilities (Electric Vehicle Charging Points EVCP) for electric vehicles and if so, how many charge points?
2) If there is currently no charging provision, what plans do you have to install EVCP and when?
3) Will the charge points be for fleet usage or public charging?
4) Within your organisation, which department is responsible for the selection and installation of EVCP?

Download response Electric Vehicle charging points 060916

Hospital parking 2013-2017. 060617

1. How much money was generated by your hospital trust through parking charges in the hospital car parks during 2013-14, 2014-15, 2015-16 and 2016-17?
2. How many parking fines were issued for parking infringements in your car parks during the years stated above?
3. How many parking fines were written off during the years stated above?

Download response Hospital parking 2013-2017. 060617

Management of car parking facilities

Q: Could you please advise me if you manage the car parking facilties on your own, or do you employ a contractor to manage the facilities for you ie ANPR, POFs and PCNs etc? If you use a contractor can you please advise me who they are and when their existing contract with yourselves expires? Download response car parking contractor 080515

Ownership of the land the Trust Hospitals stand on and the contractual terms of First Parking LLP’s contract

Details of who owns the land on which both Maidstone and Pembury hospitals are located.
Full details of the contractual terms that allow First Parking LLP to initiate legal action on behalf of the Trust.

Download response Ownership of the land the Trust Hospitals stand on and the contractual terms of First Parking LLP’s contract 021215

Parking. 060717

1. How many car parking sites fall under the remit of the Maidstone and Tunbridge Wells NHS Trust?
2. Roughly how many spaces do they provide in total across all sites?
3. Does the organisation manage their Car Parks directly (go to Q5) or via a Third Party (go to Q4)?
4. If managed by a Third Party:
a. Who is the provider?
b. Dates of the contract duration (from/to)?
c. What is the basis of the contract (build/operate; land lease; management only etc.)?
d. Any pros/cons of this arrangement?
5. How is parking currently controlled, e.g. POF, P&D, Permit, parking officers, barrier control, in/out global counting, bay occupancy?
6. Are you currently able to readily identify any patterns of use of particular zones/bay types/long or short term stays etc. and collate this data to address specific problems areas on certain days/time periods?
7. What existing customer service focused measures are in place, e.g. information provided at entry points, visual guidance to zones/bays with available spaces, on-site support staff?
8. What are the key challenges that the Maidstone and Tunbridge Wells NHS Trust face in regards to the provision of parking for patients/carers/visitors?
9. What are the key challenges that the Maidstone and Tunbridge Wells NHS Trust face in regards to the provision of parking for staff?
10. Do you attend any conferences/events that focus on best practice in the management of parking/land use which you would recommend as good networking opportunities?
11. Who is the person responsible for Car Parks in your organisation (Name, Title, telephone and direct email?)

Download response Parking. 060717

Parking and Security

  1. Who is/are the contractor(s) managing parking at both/either site(s)
  2. How long have they had the contract and when does it/they expire?
  3. What revenue arrangements are in place?I.e where does the money from parking go?
  4. What arrangements are in place for the sharing of parking charge notice revenue?
  5. What input did the trust have in setting the parking charge notice levels and the hourly charges for parking?
  6. Does the parking contract allow for the contractor to initiate and take forward legal action on behalf of the trust in cases where parking charge notices remain unpaid?
  7. I should like to see a full unredacted version of the contract between the trust and any contractor for parking management.
  8. What is the trusts policy regarding intervention at the request of service users after parking charge notices have been issued?
  9. How many times have the trust intervened at the request of a customer and what was the outcome on each occasion?

Download response Parking and Security 111115

Parking charge notices

How much money was generated by your hospital Trust through parking charges in the hospital car parks during 2013/14 and 2014/15? How many parking fines were issued for parking infringements in your car parks during 2013/14 and 2014/15? How many parking fines were written off during 2013/14 and 2014/15? Download response Parking charge notices 200515

Parking charges at Trust controlled or owned car parks 2013 to 2016.

1. What is the hourly parking rate at Trust-controlled or owned car parks?
2. How many spaces are available in Trust-controlled or owned car parks?
3. Who operates the car parks?
4. Please provide details of any discounts/exemptions offered to patients.
5. How much money was raised in each of the last three financial years from parking revenue? Please provide a breakdown for 2013/14, 2014/15, 2015/16.
6. How many parking fines were issued in each of the last three financial years? Please provide a breakdown for 2013/14, 2014/15, 2015/16.
7. How much money was raised from parking fines in each of the last three financial years? Please provide a breakdown for 2013/14, 2014/15, 2015/16.
8. What percentage (if any) of the parking revenue is diverted to the car park operator?
9. What is the remaining money raised from parking and received by the Trust used for?

Download response Parking charges at Trust controlled or owned car parks 2013 to 2016 180516

Parking permits issued between 30 August 2015 to 30 March 2016.

Can you tell me how many NHS staff have applied for a parking permit and issued with a permit between 30th of August last year and 30th of March 2016 and how many Interserve security staff have applied for a parking permit and issued with a permit between 30th of August last year and 30th of March 2016?

Download response Parking permits issued between 30 August 2015 to 30 March 2016 230516

Parking services July 2016

1. How many car parks out of the total number designated for hospital patients/visitors offer free parking, as of your most up-to-date statistics? (Please state how many and out of the total)
2. If you charge fees for hospital patients/visitor designated parking, do you have the same pricing structure at all your parking sites? (Yes/No)
3. What is your most commonly charged minimum rate for patient/visitor parking (excluding any free parking), and for how long does this allow somebody to park?
4. What is your most commonly charged maximum rate for patient/visitor parking (excluding any free parking), and for how long does this allow somebody to park?
5. What percentage of car parks designated for hospital patients/visitors allow payment by debit or credit card? Please approximate if necessary, and state if you do so.
6. What percentage of car parks designated for hospital patients/visitors allow payment on exit? Please approximate if necessary, and state if you do so

Download response Parking services July 2016 010816

Staff car parking spaces and cost 2011-2015.

1) How many staff work at the trust?
2) How many car parking spaces are there?
3) How many staff members use car parking facilities each day?
4) Do staff pay to park?
5) If so, how much to they currently pay if they pay by
a) salary sacrifice
b) daily
(please state if staff on different bands or pay grades pay different amounts to park. Please state what these amounts are)
6) Please state what the charges were for both salary sacrifice and daily parking in 2014/5
7) Please state what the charges were for both salary sacrifice and daily parking in 2013/4
8) Please state what the charges were for both salary sacrifice and daily parking in 2012/3
9) Please state what the charges were for both salary sacrifice and daily parking in 2011/2
10) What is the total amount paid by staff for parking at the trust in 2014/5
11) What is the total amount paid by staff for parking at the trust in 2013/4
12) What is the total amount paid by staff for parking at the trust in 2012/3
13) What is the total amount paid by staff for parking at the trust in 2011/2

Download response Staff car parking spaces and cost 2011-2015 180416

Staff parking. 070618

1. Please can you let me know if you charge your staff for parking at Tunbridge Wells hospital and if so how much?

2. If you have a policy on staff parking at Tunbridge Wells hospital may I please have a copy?

3. Finally can you let me know what ward shift patterns you have for staff nurses. What time do they start the day shift and what time do they finish.
Download response Staff parking. 070618

Staff parking. 160418

How many parking spaces are available for Staff who work for your trust at both hospital sites, and how many parking permits are issued to staff across both sites.

Download response Staff parking. 160418

 

Children's Services

6-in-1 vaccine. 170718

a) The number of 6-in-1 vaccines offered to be given to babies in the financial years 2017/18, 2016/17, and 2015/16.

b)The number of 6-in-1 vaccines that were refused by parents or guardians of the baby in the financial year 2017/18, 2016/17, and 2015/16.

c) The number of children diagnosed with any of the following in 2017/18 alone, who had not received the 6-in-1 vaccine when they were a baby because their parent or guardian had refused it. If a child was diagnosed with more than one of the below, please provide that information: diphtheria, hepatitis B, Hib, polio, tetanus, or whooping cough

Download response 6-in-1 vaccine. 170718

Anorexia and bulimia in under 14 year olds.

The number of children under the age of 14 your trust has treated for anorexia and bulimia from 1 January 2010 up until the date this request was received.
Please provide the information in yearly breakdowns;
Please break the numbers down by age and, if possible, by gender;
Please keep the data for anorexia and bulimia separate;

Download response Anorexia and bulimia in under 14 year olds 060916

Audiology services for children and young people.150317

1. Thinking about the 2015/16 financial year, did your service experience longer waiting times for?
2. Were there any changes in policy or practice in what your audiology service provided in 2015/16?
3. If you have ticked yes to any of the above, please tell us what has changed and the reasons for the
Change
4. At what age does your service transfer deaf young people to adult services?
5. Were there any changes to how your audiology service for deaf children is commissioned in 2015/16?
6. Were there any changes in the number and skill-mix of full time equivalent (FTE) staff in your team, including administrative staff, in 2015/16?
7. If you have ticked yes to any of the above, please describe in more detail what has changed (including the number of staff reductions, if any) and the reasons for the change.
8. Was there a training programme in place for audiologists in your service in 2015/16?
9. If yes, were there any changes to the availability of training in 2015/16?
10. Looking ahead to the 2016/17 financial year, are you aware of any planned changes to any of the below?
11. Did your service provide informal family support services such as parent coffee mornings, playgroups, use of voluntary sector, etc. in 2015/16?
12. If yes, were there any reductions in informal family support services in 2015/16?
13. Is anyone from the audiology team involved in the development of Education Health and Care plans?
14. Have you faced any barriers to being involved in developing Education Health and Care plans?
15. If yes, what were the barriers?
16. Did your service provide any assistive listening devices or take any action to ensure they work effectively with the child’s personal amplification in 2015/16?
17. If you have ticked any of the above, were there any reductions in the provision of assistive learning devices or services to ensure they work effectively with the child’s personal amplification in 2015/16
18. Has your service gained accreditation with (Improving Quality in Physiological Diagnostic Services) IQIPS?
19. Has your service registered for the IQIPS process?
20. Has your service started using the Self-Assessment and Improvement Tool (SAIT)?
21. Has your service applied to UKAS to begin the accreditation peer review process?
22. Has your service booked or completed its onsite assessment with UKAS?
23. If you have not registered with the SAIT for IQIPS, what are your reasons for not doing so?
24. What are the most successful aspects of your audiology service at the moment?
25. What are main challenges or problems facing your audiology service at the moment?
26. Is there anything else you would like to tell us about the audiology service and any future plans?
* 27. Your name:
* 28. Your role:
* 29. Name of audiology service (please don’t use abbreviations):
* 30. Name of Trust that provides the paediatric audiology service (please don’t use abbreviations):
* 31. Sites where paediatric audiology is delivered by your service (please don’t use abbreviations):

Download response Audiology services for children and young people.150317

Babies born in 2015 whose birth-weight was 12lbs or 5443g or more.

In the 2015 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birth-weights were.

Download response Babies born in 2015 whose birth-weight was 12lbs or 5443g or more 280416

Babies born with neonatal abstinence syndrome 2016-2017. 150517

How many babies were born with neonatal abstinence syndrome (showing signs of drug addiction because of their mother taking drugs during pregnancy) at hospitals run by your trust in the past financial year, April 2016 to April 2017? Please break the figures down by hospital.

Download response letter Babies born with neonatal abstinence syndrome 2016-2017. 150517

Babies injured during assisted delivery. 280317

1) Please state the number of babies that were injured during delivery when tools to assist in delivery were used, for example a vacuum extractor or forceps.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date
2) Of these babies injured, please provide a breakdown of injuries that they suffered. Please provide a summary of each incident, including the cause of the injury.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date
3) Please state the number of babies injured during delivery due to hospital error.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date

Download response Babies injured during assisted delivery. 280317

Babies weighing 12lbs (5443g) or more at birth 2016. 250417

In the 2016 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Babies weighing 12lbs (5443g) or more at birth 2016. 250417

Baby weights 2015-2016

I would like to know the following regarding live births:
1. The weights of the five heaviest babies that were born in the Trust last year – financial (2015-16) or calendar (2015) year, whichever is easiest.
2. The weights of the five lightest babies that were born in the Trust last year for pregnancies that reached around full term (i.e. that weren’t born prematurely).

Download response Baby weights 2015-2016 090916

Bed shortages and overcrowding. 310117

1. Do you have any strategy or informal policy that allows adults to be treated in beds/wards that are usually used for paediatric care to help with overcrowding?
2. What is that wording of that strategy?
3. When as it first drawn up?
4. How many times since January 2016 year has this been implemented? If applicable, how many times was it implemented between Jan 2015 and Jan 2016?
5. How many individual adult patients since January 2016 have been treated on child wards/bed -with dates if possible? And the same figure Jan 2015-16.
6. Were there any occasions when adults and children were treated on the same ward?
7. How many times has the hospital been on a) black alert and b) red alert for capacity since January 2016? How many times was it put on a and b from January 2015 – 2016?

Download response Bed shortages and overcrowding. 310117

Bereavement of babies

(a) Does your trust have a bereavement suite available for use by parents in the event of limited life expectancy of an anticipated birth of a child?

(b) If the answer to (a) is no, what alternative arrangements are available?

(c) If the answer to (a) is yes, would parents of a baby who turn up at hospital with a sudden infant death be allowed to use the bereavement suite?

(d) If the answer is yes to (a) where in relation to the Labour ward is the suite located?

(e) Do you have bereavement trained midwives? If yes, how many?

(f) Do you have a trained bereavement councillor at the hospital? If yes, what is the average waiting time to be able access support from that councillor?

(g) Do you provide any written information to parents following the loss of a baby? If yes, please name the third sector organisation information is provided from.

(h) Can you list the guidelines around infant death which are implemented by the hospital?

(i) Does the hospital provide support around funeral arrangements for infants or babies who have died at the hospital?

Download response Bereavement of babies 030216

Brain cooling in babies. 011217

1. Please provide the number full term babies at 36 weeks or later who , because of HIE, were transferred for consideration of brain cooling to a tertiary centre for the following calendar years 2014,2015, 2016 and 2017 to date. ( if you are already one of those tertiary centres then please let me know how many babies were considered for brain cooling because of HIE.)
2. For those same babies, and years, please let me know how many were subject to a serious incident report relating to childbirth?

Download response Brain cooling in babies. 011217

CAMHS. 270618

How many referrals were made to CAMHS from any possible referrer for the last three financial years (April 1 2015 – March 31 2016, April 1 2016 – March 31 2017, April 1 2017 – March 31 2018)?
How many were accepted for each of the years above?
Of those accepted, how many had any of the below factors known or believed to be evident (if information is available), for each of the years above?
– Previous contact with CAMHS
– Recurrent threats or acts of self-harm
– High levels of risk
– Eating disorders
How many accepted were from each type of referrer (e.g. GP, A&E etc.) for each of the years above?
What was the mean and median waiting time between referral and treatment for each of the years above?
How many were declined for each of the years above?
Of those rejected, how many had any of the below factors known or believed to be evident (if information is available), for each of the years above?
– Previous contact with CAMHS
– Recurrent threats or acts of self-harm
– High levels of risk
– Eating disorders
How many rejected were from each type of referrer (e.g. GP, A&E etc.) for each of the years above?

Download response CAMHS. 270618

Cancelled children’s operations – 01.07.16. 050517

1. How many children’s operations have been cancelled each month since 1st July 2016? Please give additional details as to what the main reasons for the cancellations were, how many were urgent operations or elective operations, and what type of illness did they involve, e.g. cancer, breathing problems, broken limbs etc.

2. How many children’s operations have been cancelled over the last four financial years to date?

Kindly note a child is anyone up to the age of 18.

Download response Cancelled children’s operations – 01.07.16. 050517

Cerebral Palsy (CP). 270618

1. What is the total number of children and young people diagnosed with Cerebral Palsy by your Trust/Health Board in the last five years? (N.B.: this should be recorded as a total figure rather than figures for each year individually.)
2. What is the care pathway for children and young people with cerebral palsy in your Trust/Health Board? Please provide a copy of this if possible.
3. Is there a specific timescale set out in your care pathway for referral to a child development service for diagnosis of cerebral palsy from the point when symptoms are initially identified? If so, please provide this data.
4. What is the total number of:
a. Health visitors employed by your Trust/Health Board?
b. Specialist health visitors for children with special needs employed by your Trust/Health Board?
5. What training is given to healthcare professionals, including health visitors and GP’s, to recognise the risk factors and possible symptoms for Cerebral Palsy?
6. What is the total number of specialist staff employed by your Trust/Health Board, who are trained to work with children and young people with Cerebral Palsy, from the following disciplines:
a. Paediatric speech and language therapy
b. Paediatric physiotherapy
c. Paediatric occupational therapy
7. How many children and young people with Cerebral Palsy are currently on a waiting list to access any of the above services within your Trust/Health Board?

Download response Cerebral Palsy (CP). 270618

Child and Adult Mental Health Services. 260218

How many people under specialist Child and Adolescent Mental Health Services were issued with the ICD-10 code F12. – ‘mental and behavioural disorders due to use of cannabinoids’, during the 2016/17, 2015/2016, 2014/2015, 2013/2014, 2012/2013, 2011/2012, 2010/ 2011, 2009/ 2010, 2008/ 2009, 2007/ 2008, 2006/ 2007 periods?

Download response Child and Adult Mental Health Services. 260218

Child and Adolescent Mental Health Services (CAMHS).

For the purposes of this request we define children and young adults as being between the ages of 0 and 25 years.
1. The information request:
Please can you provide us with the following information?
• The (a) budget and (b) expenditure for all mental health services.
• The (a) budget and (b) expenditure for Child and Adolescent Mental Health (CAMHS) services (total spend) – if you attribute to a CAMHs Tier 1-4 please specify.
• The (a) budget and (b) expenditure for mental health urgent and emergency care (including mental health crisis care) for children and young people – if only total spend is available please approximate proportion that is spent on children and young adults.
• Any additional, discretionary monies (a) budgeted for and (b) spent on child, adolescent or young adult mental health – please specify source.
We are requesting information for the financial years: 2010/11, 2011/12, 2012/13, 2014/15, 2015/16, 2016/17.
And if available – we are also requesting the projected budget (or settlement) for the financial years covering the remainder of Future in Mind and the Five Year Forward View for Mental Health, which includes: 2017/18, 2018/19, 2019/2020, 2020/21.
2. Clarifications:
If the requested information does not relate to your activity, please answer ‘not applicable’ (N/A).
If you share a budget with another organisation, please specify:
a. The name of the other organisation(s) (for example a Clinical Commissioning Group, Local Authority or NHS Trust).
b. Whether the expenditure / budget reported is the total amount of the shared budget, or your organisation’s contribution to the shared budget.

Download response Child and Adolescent Mental Health Services (CAMHS) 270616

Child drug and alcohol related admissions. 241016

This request relates to drug and alcohol related admissions of children. Please include cases where the relevant diagnoses were recorded as both the primary and secondary condition.

I) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged under 13 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

II) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged 13-16 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

III) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged 16-17 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

Download response Child drug and alcohol related admissions. 241016

Child and Mental Health Services. 170817

What was the average waiting time for patients referred to the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?
What was the average waiting time for patients referred to the Child and Mental Health Services at at your trust between May 31st 2015 and May 30th 2016?
What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?
What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust between May 31st 2015 and May 30th 2016?
How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services between May 31st 2016 and May 30th 2017?
How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services between May 31st 2015 and May 30th 2016?
What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services between May 31st 2016 and May 30th 2017, having been turned away due to a lack of resources?
What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services between May 31st 2015 and May 30th 2016, having been turned away due to a lack of resources?
What age was the youngest patient dealt with by the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?

Download response Child and Mental Health Services. 170817

Child and Mental Health Services. 200418

1.a. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2017-2018, and what was their age and gender?
1.b. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2016-2017, and what was their age and gender?
1.c. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2015-2016, and what was their age and gender?
2.a. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2017-2018, and what was their age and gender?
2.b. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2016-2017, and what was their age and gender?
2.c. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2015-2016, and what was their age and gender?
3.a. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2017-2018?
3.b. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2016-2017?
3.c. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2015-2016?
4.a. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2017-2018, having been turned away due to a lack of resources, and what was their age and gender?
4.b. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2016-2017, having been turned away due to a lack of resources, and what was their age and gender?
4.c. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2015-2016, having been turned away due to a lack of resources, and what was their age and gender?
5.a. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2017-2018?
5.b. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2016-2017?
5.c. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2015-2016?

Download response Child and Mental Health Services. 200418

Children’s Dental Hospital. 250417

1. As of March 31st, 2017, can you tell me how many children were on the waiting list to visit the Trust’s children’s dental hospital?
2. How long is the present waiting list, in terms of months/weeks to be seen?
3. How long is the wait for teeth extractions?
4. How many children are affected by the wait for teeth extractions?
5. Is there a wait for youngsters to be added to the waiting list? if, so how many children are waiting to be placed on to the waiting list?
6. How many dental nurses does the Trust employ at the children’s dental hospital?
7. How many vacancies does it have at present?
8. How many children were on the waiting list to visit the Trust’s children’s dental hospital on?
a) March 31st, 2016?
b) March 31st 2015?
c) March 31st 2014?
d) March 31st 2013?
9. How many children received treatment at the children’s dental hospital between January 1, 2016 and December 31, 2016?

Download response Children’s Dental Hospital. 250417

Cow’s milk protein Allergy (CMPA) 090916

1) Does your organisation use any guidelines when prescribing specialised infant formula for cow’s milk protein allergy (CMPA)?

2) If yes, please provide a link to, or a copy of the guidelines referenced by your organisation.

3) Please can you confirm whether we are permitted to reuse any information provided under the Open Government Licence?

Download response Cow’s milk protein Allergy (CMPA) 090916

Disorders of Sex Development in the UK. 070818

1. Who provides expert evaluation of gender assignment in newborns with Disorders of Sex Development?

2. Does the trust use a multidisciplinary team that deals with the evaluation and long-term management and needs of patients with Disorders of Sex Development?

3. If yes to question 2, can you provide contact details for the team?

4. What specialties are represented on the multidisciplinary team (e.g. paediatric subspecialists in endocrinology, surgery, and/or urology, psychology/psychiatry, gynaecology, genetics, neonatology, and, if available, social work, nursing, and medical ethics)? Please list them.

5. When dealing with Disorders of Sex Development, what guidelines, if any, do decision makers follow?

6. How many people are referred to this team per year (please give numbers for the last five years)?

Download response Disorders of Sex Development in the UK. 070818

Drug and alcoholism in children aged under 15 2013-2017. 280417

Can I ask for the following information: for each of the last four financial years (including the current one) I request disclosure of data relating to children aged 15 and under who have been diagnosed with alcoholism or drug related conditions.
1. For each year I would like a table containing patients’ ages, from 0 to 15 years old accompanied by a figure for the number of children of that age who were diagnosed as alcoholic, alcohol poisoning, treated for alcoholism or excessive alcohol consumption (for example 2016/17: Age 15– 33 Age 14 – 3). Can you outline the figures for each?
2. For each financial year I would also like a table set out in the same way detailing the numbers of children aged 15 or below who were admitted to A&E suffering alcohol-related illness.
3. For each year I would like a table containing patients’ ages, from 0 to 15 years old accompanied by a figure for the number of children of that age who were diagnosed for drug related illnesses or over-consumption (for example 2016/17: Age 15– 33 Age 14 – 3).
4. For each financial year I would also like a table set out in the same way detailing the numbers of children aged 15 or below who were admitted to A&E suffering drug-related illness. Can you outline the figures for each?
5. For each admission in Q1 and Q3, please tell me a) the sex of the child c) a brief summary of the problem, e.g. child was drunk

Download response Drug and alcoholism in children aged under 15 2013-2017. 280417

Eating disorders in paediatric patients 2014-2016.

The number of paediatric patients you have seen between January 1st 2014 and December 31st 2014 for the treatment of eating disorders
The number of paediatric patients you have seen between January 1st 2015 and December 31st 2015 for the treatment of eating disorders
The number of paediatric patients you have seen between January 1st 2016 and December 31st 2016 for the treatment of eating disorders
How many of the paediatric patients were aged 10 and under between January 1st 2014 and December 31st 2014
How many of the paediatric patients were aged 10 and under between January 1st 2015 and December 31st 2015
How many of the paediatric patients were aged 10 and under between January 1st 2016 and December 31st 2016
How many of the paediatric patients were aged 11-16 between January 1st 2014 and December 31st 2014
How many of the paediatric patients were aged 11 -16 between January 1st 2015 and December 31st 2015
How many of the paediatric patients were aged 11 -16 between January 1st 2016 and December 31st 2016

Download response Eating disorders in paediatric patients 2014-2016.

Electronic Patient Records systems in Mental Health, Community Health or Child Health.

1. What are the main Electronic Patient Records systems you operate in Mental Health, Community Health or Child Health?
2. Can you provide a name for these systems?
3. How much are you currently spending on these systems annually for licensing and support fees?
4. What is the date of contract expiry for the systems?
5. How many users? (An estimation if unsure)
6. How are the systems hosted?
7. Who is responsible for your local implementation of the objectives set out by the NHS in the Five Year Forward View?

Download response Electronic Patient Records systems in Mental Health, Community Health or Child Health 270616

FGM C 2013-2016

1) How many females have you treated in connection to/relating to/as a result of FGM/C (female genital mutilation or cutting) practices?
2) Please can you break your answer down by financial years:
– 2015/16
– 2014/15
– 2013/14
3) Can you also break down and categorise the numbers by “reason for treatment”? So for example, i. bleeding ii. infection
4) Can you break down and categorise the numbers by what the treatment was? So for example, i. amputation ii. cosmetic surgery
5) Can you break down and categorise the numbers by the females’ ages? Ideally in these age brackets: i. 0 – 9 ii. 10 – 18 iii. 19 – 27 (and continue by nine-year age brackets)

Download response FGM C 2013-2016

Foetal Alcohol Syndrome 2014-2016. 070417

1. For 2016,
a) How many people were diagnosed as being on the Foetal Alcohol Spectrum. With a breakdown of ages and hospitals.

2. and 3. Same for 2015/2014

Download response Foetal Alcohol Syndrome 2014-2016. 070417

Foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016). 011216

Please supply information for all of the questions below relevant to – foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016).

1. Are you holding organs or tissue samples or bodies of foetuses that were miscarried, stillborn, aborted or of children up to one year old, pending disposal?

2. If yes to Q1, please report how many organs, tissue samples, body parts or bodies of foetuses that were miscarried, stillborn, aborted or of children up to one year old you have retained and still have?

3. In how many of these cases of foetuses that were miscarried, stillborn or aborted or of children up to one year old which have been retained and you still have was consent given by the nearest relatives to take, use and dispose of organs or tissue samples or body parts or bodies?

4. In how many of these cases of foetuses that were miscarried, stillborn or aborted or of children up to one year old which were retained but have since been disposed of was consent given by the nearest relatives to take, use and dispose of organs or tissue samples or body parts or bodies?

Download response Foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016). 011216

Intersex Babies 2012-2017. 170817

• How many intersex babies have you operated on (up until the age of 2) between 2012 and 2017?

• How many of those babies were not operated on (up until the age of 2) between 2012 and 2017?

Download response Intersex Babies 2012-2017. 170817

Kent birth rates. 301117

For the financial years 2017-18 to date, 2016-17, 2015-16, 2014-15, 2013-14, 2012-13

1. What age was the youngest mother to give birth at your trust – and what age was the oldest?

2. What percentage of births were to foreign national or non-British mothers?

Or if that’s not possible – can you please break down the births by the ethnicity of the baby?

Download response Kent birth rates. 301117

Live births and Downs Syndrome. 010618

1. Please could you tell me the total number of live births and separate out the number of live births with Down syndrome in your Trust in the past 7 years?
2010 2011 2012 2013 2014 2015 2016 2017
Number of live births
Number of live births with Down syndrome
2. Also could you tell me if it has, when your hospital started to recommend NIPT (Non Invasive Prenatal Testing) to mothers?
Dates: From – to
a. NIPT offered for free within Trust (also interested to know to what chance level this would be offered i.e. 1:150 or other)
b. NIPT mentioned as an option, but only available outside of Trust, i.e. by private providers not connected with the hospital/Trust
c. NIPT mentioned as an option and available within the Trust if patient willing to pay

Download response Live births and Downs Syndrome. 010618

Neonatal abstinence syndrome. 200617

Q1) How many babies were born with neonatal abstinence syndrome (showing signs of drug addiction because of their mother taking drugs during pregnancy) at hospitals run by your trust in each of the past five financial years?
Q2) Please breakdown the figure from Q1. giving the age of each mother and the substance she was addicted to?
Q3) Please tell me how much it cost to care for these babies as well as the mothers with addictions to illegal drugs in a hospital/other facility your NHS Trust runs in each of the past five financial years?

Download response Neonatal abstinence syndrome. 200617

Neonatal abstinence syndrome 2011-2016.

Can you provide answers for 2011-2012, 2012-2013, 2013-2014, 2014-2015 and 2015-2016 please?

How many babies were born with neonatal abstinence syndrome (showing signs of drug addiction because of their mother taking drugs during pregnancy) at hospitals run by your trust during each financial year?
If you run more than one hospital please breakdown the figures for each hospital.

Download response Neonatal abstinence syndrome 2011-2016 290416

Neonatal drug addiction 2014 – 2016. 070417

1. For 2016,
a) How many babies were born with drug addiction/ drug dependency? With a breakdown of which drugs they were addicted to.

2. and 3. Same for 2015/2014

Download response Neonatal drug addiction 2014 – 2016. 070417

Neonatal Unit 161216

1. The type of neonatal unit you have (NICU, Local Neonatal Unit or SCBU). If you have more than one site, please provide the highest level.
2. The region your hospital is in from this list (trusts will only be identified by region in the analysis):
a. South East
b. London
c. North West
d. East of England
e. West Midlands
f. South West
g. Yorkshire and Humber
h. East Midlands
i. North East
3. Activity (in bed days) for the following Healthcare Resource Groups (HRGs):
a. XA01Z
b. XA02Z
c. XA03Z
d. XA05Z
4. Your 2015/16 and 2016/17 Tariff for the above HRGs. Please provide your full tariff including any MFF enhancements.
5. Current neonatal nursing vacancy rate (% of expected) at
a. Band 5
b. Band 6
c. Band 7

Download response Neonatal Unit 161216

Neonatal withdrawal 2010-2015

Could you let me know how many babies were born to mothers who had abused/ taken drugs during pregnancy each year for the past 5 years including 2014-2015?

How many babies were born showing neo-natal withdrawal symptoms each year for the past five years?

Could you also let me know from the mothers who had taken drugs what was the breakdown for each type of drugs e.g. heroin, cocaine

Download response Neonatal withdrawal 2010-2015 140415

NHS Children’s Workforce 030117

1. How many registered children’s nurses (Whole Time Equivalent) are employed at your organisation? Please list by clinical area.
2. How many support workers (Whole Time Equivalent, bands 1-4) are working in your children’s service? Please list by clinical area.
3. How many nurses (Whole Time Equivalent) deliver your community children’s nursing service? Please list by clinical area.
4. How many clinical specialist children’s nurses do you have in your service? Please list their clinical specialisms, e.g. 1x haematology; 2x epilepsy.
5. How many advanced neonatal nurse practitioners do you have in your service?
6. How many advanced paediatric nurse practitioners do you have in your service?
7. Do you have transition (children’s to adults’ services) nursing roles? If yes, how many? Do any have clinical specialisms? If so, please list their clinical specialisms, e.g. 1x haematology; 2x epilepsy.
8. Do you employ a play specialist?
9. How many inpatient beds are there designated for children and young people? Please provide a number against the following and list by clinical area:
a. Neonates
b. Children’s
c. Adolescents
10. What were the key gaps in knowledge and skills within the children’s nursing workforce identified by your most recent Training Needs Analysis or courses commissioned through Non-Medical Education and Training (NMET)?

Download response NHS Children’s Workforce 030117

Nitrofurantoin antibiotic oral suspension. 070318

1. Nitrofurantoin is the antibiotic 25mg/5ml Oral suspension. Why is it Maidstone hospital pharmacy are not permitted to dispense?
2. On what basis was this decision/policy made?
3. Is there any way in particular clinical cases policy decisions can be challenged or changed?

Download response Nitrofurantoin antibiotic oral suspension. 070318

Paediatric Cerebral Palsy

1. The total number of children and young people diagnosed with cerebral palsy by Maidstone and Tunbridge Wells NHS Trust within each of the last five years.

2. The total working-time equivalent (WTE) number of specialist staff employed by Maidstone and Tunbridge Wells NHS Trust from the following disciplines, trained to work with children and young people with cerebral palsy:

a. Paediatric speech and language therapists
b. Paediatric physiotherapists
c. Paediatric occupational therapists

3. The total working-time equivalent (WTE) number of:

a. Health visitors
b. Specialist health visitors for children with special needs employed by Maidstone and Tunbridge Wells NHS Trust.

4. A copy of your care pathway for children and young people with cerebral palsy.

5. A copy of your service framework for children and young people with cerebral palsy.

6. Whether there is a specific timescale set out in your care pathway for referral for diagnosis of cerebral palsy, from the point of the formal identification of symptoms.

7. An overview of training and advice provided by Maidstone and Tunbridge Wells NHS Trust for health professionals on identifying and referring children with cerebral palsy.

Download response Paediatric Cerebral Palsy 250516

Paediatric policies and procedures. 260218

I wondered if you could please send me copies of your paediatric day case surgery policies and procedures?
I am doing some research into this field. I am a nurse.

Polices such as:
Starvation times
Transfer policy
Medications

Download response Paediatric policies and procedures. 260218

Premature birth survival 2012-2016. 280317

For each of the last five calendar years, could you please provide information on the following births at your trust?
How many babies were born live at 21 weeks gestation and how many survived to discharge
How many babies were born live at 22 weeks gestation and how many survived to discharge
How many babies were born live at 23 weeks gestation and how many survived to discharge
How many babies were born live at 24 weeks gestation and how many survived to discharge
How many babies were born live at 25 weeks gestation and how many survived to discharge

Download response Premature birth survival 2012-2016. 280317

Provision of services for Attention Deficit Hyperactivity Disorder (ADHD) 101116

  • What proportion of children and young people with symptoms of ADHD have been referred to an ADHD specialist for assessment in the past 12 months (Quality Statement 1)
  • What proportion of adults with symptoms of ADHD without a childhood diagnosis of ADHD have been referred to an ADHD specialist for assessment in the past 12 months (Quality Statement 2)
  • What proportion of adults who were diagnosed with ADHD as children or young people and present with symptoms of continuing ADHD have been referred to general adult psychiatric services in the past 12 months (Quality Statement 3)
  • What proportion of parents or carers of children with symptoms of ADHD who meet the NICE eligibility criteria have been offered a referral to a parent training programme in the past 12 months (Quality Statement 4)
  • What proportion of children and young people with moderate ADHD have been offered a referral to a psychological group treatment programme in the past 12 months (Quality Statement 5)
  • In the past 24 months, what proportion of eligible patients with ADHD who are starting drug treatment go on to have their initial drug dose adjusted and response assessed by an ADHD specialist (Quality Statement 6)
  • In the past 24 months, what proportion of eligible patients with ADHD who are taking drug treatment have a specialist review at least annually to assess their need for continued treatment (Quality Statement 7)

In addition, can you please provide information on?

  • The number of people with symptoms of ADHD who have come into contact with your service in the past 12 months:

O Children and young people

O adults

  • The number of people referred with symptoms of ADHD who are currently waiting for their first outpatients’ appointment:

O Children and young people

O adults

  • The average waiting time from referral to first outpatients’ appointment in the past 12 months for

O Children and young people presenting with symptoms of ADHD

O Adults presenting for the first time with symptoms of ADHD

  • The range of waiting times (i.e. shortest to longest) for patients from referral to first outpatient appointment in the past 12 months for

O Children and young people presenting with symptoms of ADHD

O Adults presenting for the first time with symptoms of ADHD

  • What specialist services are available for referral for adults presenting with symptoms of ADHD
  • Does your organisation provide a transition to an adult service for adolescents with ADHD?
  • The age at which your organisation transitions a young person diagnosed with ADHD to general adult psychiatric services
  • Does your organisation receive out of area referrals for specialist ADHD services?

Download response letter Provision of services for Attention Deficit Hyperactivity Disorder (ADHD) 101116

Reported extravasation injury within the Neonatal Unit (NNU).

I would like to be provided with the following information.

1. The latest total annual figures for reported extravasation injury within your NNU/NICU/SCBU

2. Model of the large volume infusion pump used on the unit

3. Model of the syringe pump used on the unit

Download response Reported extravasation injury within the Neonatal Unit (NNU) 060416

Self-harming. 260218

1. How many children aged under-18 were admitted to hospital through each of your accident and emergency departments between 1 April 2016 and 31 March 2017 due to self-harming?

2. Can you provide an age breakdown of admittance’s for this period?

Download response Self-harming. 260218

Self-harming in under 18 year olds.

1. How many children aged under 18 were admitted to each of your accident & emergency departments in the below years due to self-harming?
• 2015-16
• 2014-15
• 2013-14

2. Can you provide an age breakdown of admittances for each of these years?

3. Can you provide an injury breakdown for each of these years?

Download response Self-harming in under 18 year olds 060916

Sexually transmitted diseases in the under 16 year olds 2012-2016. 250417

1.) How many children (aged 15 and under) have attended services at your trust to get tested for sexually transmitted diseases? Please provide the total number for each year – and in addition, break down by age (age band is adequate if the numbers are small).
2.) Please provide the total number of STD tests that came back positive in children under 16 over the last five years – and again, please break down by year, age, – as well as the type of STDs that were diagnosed.
3.) If this has not been made clear in the above response – what is the specific age of the youngest child to be diagnosed with an STD over the last five years – and what was the STD?
4.) Within these figures, please also include the numbers of children who were found to have an STD when using hospital services for other services.
5.) Please separately provide the total number of children under 16 who were a) tested b) diagnosed with HIV over the last five years – with a breakdown of people and ages for each year. This includes children who were found to have HIV when attending hospital for another matter.
If you believe any of the questions this to be exempt information in line with Section 40 (2)(a)(b)(3)(a)(i) Can you please, then, instead, provide an age bracket and the total number for the 5 years as a total.

Download response Sexually transmitted diseases in the under 16 year olds 2012-2016. 250417

Self-harm and suicidality in 14-25 year olds.

How many people aged 14-25 have presented to your services with self-harm and suicidality (ICD-10 term/code: ‘Intentional Self-Harm’ (X60-X84))? I would like the figures for the past 5 years (either calendar of financial).

Download response Self-harm and suicidality in 14-25 year olds 060916

Under 16’s and sexually transmitted diseases (STD).

Q1.) How many children (aged 15 and under) have attended services at your trust to get tested for sexually transmitted diseases?

Please provide the total number for each year – and in addition, break down by age (age band is adequate if the numbers are small).

Q2.) Please provide the total number of STD tests that came back positive in children under 16 over the last five years – and again, please break down by year, age, – as well as the type of STDs that were diagnosed.

Q3.) If this has not been made clear in the above response – what is the specific age of the youngest child to be diagnosed with an STD over the last five years – and what was the STD?

Q4.) Please separately provide the total number of children under 16 who were diagnosed with HIV over the last five years – with a breakdown of ages for each year. This includes children who were found to have HIV when attending hospital for another matter.

Q5.) Within these figures, please also include the numbers of children who were found to have an STD when using hospital services for other services.

Download response Under 16’s and sexually transmitted diseases (STD) 060416

Weight of new born babies. 140618

In the 2017 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Weight of new born babies. 140618

 

Complaints, PALS and Legal Services

Allegations of misconduct. 081117

For each of the past five financial years (12/13 – 16/17) please tell me the following:

The total number of allegations of misconduct made by employees of your trust against another employee, broken down by:
• The job category of the complainant, for example doctor, nurse, porter, receptionist.
• The nature of the alleged misconduct. For example sexual harassment, sexual assault, physical assault, theft, bullying, racism.
• The outcome of the complaint. For example, unsubstantiated, written warning, dismissed, training requirement, police informed.

Download response Allegations of misconduct. 081117

Allegations of sexual assault or sexual harassment. 081117

1- How many allegations of a) sexual assault and b) sexual harassment has your trust received against staff members in each of the past four years?
2- In how many of the cases were any of the alleged victims aged 18 or under at the time of the alleged offence?
3- In how many of the cases were any of the alleged victims current or former patients?
4- For each case, did it lead to i) internal disciplinary proceedings, ii) external disciplinary proceedings (i.e. through a regulator) and/or iii) a financial settlement.
5- For each case, please provide a broad description of the allegations involved, including the number of alleged victims / alleged perpetrators; their age (within a 10-year band); the date of the alleged offence and whether the alleged perpetrator occupied a managerial position.
6- For each case, please list the gender of the alleged perpetrator and the alleged victim. Alternatively, provide totals for the genders of the alleged perpetrators and alleged victims across all of your cases.
7- For each case which was dealt with by disciplinary proceedings, how many alleged offenders were i) fired; ii) suspended, iii) received written or verbal warnings.
8- Please provide the value of any financial settlement in each case.
9- Did any settlements (financial or otherwise) include clauses placing any restriction on the ability of the alleged victim to discuss the events involved or the institution? If so, how many?

Download response Allegations of sexual assault or sexual harassment. 081117

Breaches of the Data Protection Act.

1a.Approximately how many members of staff do you have?
1b.Approximately how many contractors have routine access to your information?

2a.Do you have an information security incident/event reporting policy/guidance/management document(s) that includes categorisation/classification of such incidents?
2b.Can you provide me with the information or document(s) referred to in 2a? (This can be an email attachment of the document(s), a link to the document(s) on your publicly facing web site or a ‘cut and paste’ of the relevant section of these document(s))

3a.Do you know how many data protection incidents your organisation has had since April 2011? (Incidents reported to the Information Commissioners Office (ICO) as a Data Protection Act (DPA) breach)
Answer: Yes, No, Only since (date):
3b.How many breaches occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

4a.Do you know how many other information security incidents your organisation has had since April 2011? (A breach resulting in the loss of organisational information other than an incident reported to the ICO, eg compromise of sensitive contracts or encryption by malware. )
Answer: Yes, No, Only since (date):
4b.How many incidents occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

5a.Do you know how many information security events/anomaly your organisation has had since April 2011? (Events where information loss did not occur but resources were assigned to investigate or recover, eg nuisance malware or locating misfiled documents.)
Answer: Yes, No, Only since (date):
5b.How many events occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

6a.Do you know how many information security near misses your organisation has had since April 2011? (Problems reported to the information security teams that indicate a possible technical, administrative or procedural issue.)
Answer: Yes, No, Only since (date):
6b.How many near-misses occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

Download response Breaches of the Data Protection Act 230516

Communication and consent. 031117

1. In the past 5 years how many complaints have you had regarding communication with or supplying information to patients (written and oral)?
2. In the past 5 years how many complaints have you had regarding the inappropriate or incorrect taking of consent?
3. If the level of detail in questions 1 and 2 is unknown then please say how many complaints have you had in the past 5 years categorised as communication complaints?
4. In the past 5 years how many claims for compensation have you had involving the inappropriate or incorrect taking of consent?
5. If the level of detail in question 4 is unknown please say how many claims for compensation have you had categorised as communication claims?
6. How much did you pay the NHSLA for insurance last year?
7. Can I have a copy of your Consent to Examination or Treatment Policy?
8. If no Consent to Examination or Treatment Policy exists then can you supply me with your approved documented process for obtaining consent, as specified in the NHSLA Risk Management Standards 2013-14?
9. Can you tell me how information is provided to patients to support their decision making, including risks, benefits and alternatives where appropriate?
10. Can you tell me how the discussion and provision of information to patients is recorded?
11. Can you tell me the process for recording that consent has been given?
12. Can you tell me how your organisation monitors compliance with points 9 to 11?
13. Who has overall responsibility for your Consent to Examination or Treatment Policy? (There name would helpful)?

Download response Communication and consent. 031117

Compensation claims by staff. 070417

I would like information on the number and nature of compensation claims brought against your organisation by members of staff who have sustained an injury or contracted a disease while employed your organisation in the past five years.
I would like a year by year breakdown, preferably on an excel document via email, detailing:
Details of the injury (i.e. moving and handling injury, slips/trips/falls and so on)
Staff role if known (i.e. staff nurse, doctor)
Whether compensation was paid
The total amount of compensation paid
If information available, any action taking following the incident (i.e. additional training, non-slip flooring and so on)

Download response Compensation claims by staff. 070417

Complaints about noise for 2013 – 2016.

How many noise-related complaints the organisation has received in the past three years? For each year, I would like to know:
The department/ward the noise-related complaint refers to
Who made the complaint (patient/relative/staff member etc.)
The nature of the complaint – i.e. if it is noise from staff, noise from another patient, equipment, building work etc.
I would also to know if your organisation has a noise policy or any noise-reduction measures in place – for example soft-closing doors, not transferring patients at night, ‘sleep kits’ for patients and so on.

Download response Complaints about noise for 2013 – 2016 270616

Complaints or concerns raised by staff members

1) Name of:
a) Your trust
b) The hospitals in your trust
2) Between April and October 2015, how many complaints/concerns were raised by Trust staff members regarding?
a) Staffing levels/staffing shortages
b) Shifts being filled by under-qualified staff/staff “acting up”/agency staff/locums
c) Staff overwork/unpaid overtime
d) Staff not being able to take breaks
3) What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) from September 2014 to September 2015?
4) What was the age of the patient (from question 3) and the reason for delay?
5) What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) from September 2013 to September 2015?
6) What was the age of the patient (from question 5) and the reason for delay?

Download response Complaints or concerns raised by staff members 270516

Delayed discharge and court action. 070317

1. Since 1.1.15 how many times have you taken court action to evict a patient from a hospital in your trust because you believe they are fit for discharge but they have failed to leave their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge?
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharge and court action. 070317

Employees who have left the Trust as a result of judicial mediation 2011 – 2016

1. For each of the past five financial years, what was the total number of employees that left your trust through judicial mediation?
2. For each of the last five financial years how much was paid to departing employees through judicial mediation? Again, I am looking for annual breakdowns of the data.
The annual breakdown should include the following three elements;
A – The statutory amount the employee received (i.e. the sum to which they were legally entitled for redundancy).
B – The amount paid in special severance payments.
C – The overall total of statutory and special severance payments.
3. For each of the past five financial years, how many of the employees who left through judicial mediation signed a settlement agreement (formerly known as a compromise agreement)?
4. For each of the past five financial years, how many employees who left through judicial mediation agreed a confidentiality clause?
5. Taking the definition of confidentiality clauses used in Question 4, for each of the past five financial years, how many fell under the definition 1? 2? 3? Other?
6. For each of the past five financial years, how many staff who left via judicial mediation received an agreed reference?
7. For each of the past five financial years, how many of the judicial mediation cases were referred to the Department for Health/Treasury for sign off?

Download response Employees who have left the Trust as a result of judicial mediation 2011 – 2016

Enforced DNR. 300317

The number of patients who have been taken to the Royal Courts of Justice Court of Protection, to have a DNR placed upon their lives by your hospital. I would like to know if the patient had a Lasting Power of Attorney and the sex, age, ethnicity of the patients and the length of time each case took & outcomes of each case. From when the hospital opened to the present day.

Download response Enforced DNR. 300317

External legal advice

1. How many members of staff are directly employed at the Trust at present as of 24 August 2015?
2. What was your external legal advice expenditure from 01/04/2014 to 31/03/2015?
3. What is your budget for external legal advice for the current financial year?
4. Please provide the list of the solicitors instructed for external legal advice from 01/04/2014 to 31/03/2015.
5. Please provide the full structure of your legal services team (titles of the positions- no names are required).
6. Please provide your Trust’s policy which relates to the process of provision of internal legal advice to the members of staff within your Trust.
7. Please provide the name of the software or system which you use for the claims management.
8. Please provide the annual cost of your claims management system.
9. Please provide the name of the software or system which you use for the complaints management.
10. Please provide the annual cost of your claims management system.
11. How many active Coroner’s Inquest cases are you managing at your Trust as of 24 August 2015?
12. How many active clinical negligence claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
13. How many active clinical negligence claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
14. How many active Employer’s Liability claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
15. How many active Employer’s Liability claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
16. How many active Public Liability claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
17. How many active Public Liability claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
18. Please attach a relevant policy and a flowchart which describe the process of how your legal services team communicates the lessons learned from the claims and coroner’s inquests to the relevant teams across the Trust, to ensure the effective risk management and prevention of similar incidents and to improve care provided.
19. Please provide two, most recent, monthly claims management/ legal services reports. If you do not have monthly reports please provide two most recent quarterly reports.

Download response External legal advice 280716

External legal spend

1. What does your organisation spend on legal fees e.g. external legal advice and what is the breakdown of fees and expenses.
2. What is the breakdown of spend e.g. what percentage of work is completed on an hourly rate basis, capped fee, fixed fee etc. We do not break it down in these terms.
3. Who in your organisation is responsible for managing external legal spend-
4. What controls do you have in place to manage external legal counsel spend?
5. Do you use any of the eBilling (also known as Enterprise Legal Management or Legal Spend Management) tools (e.g. Serengetti, Mitratech, CT Tymetrix, Datacert etc.) available in the market to manage your legal spend – if yes what are you currently paying for this system and does the vendor charge your firms to use the same
6. Do you use a matter management system and if yes how much do you pay for the system.
7. How do you decide if work is completed internally or by external counsel?
8. What performance management do you complete with your external legal counsel to ensure you are receiving value for money?
9. What is the breakdown of spend e.g. % of time billed by partner, by senior associate, junior associate, trainee and paralegals etc.
10. What is the breakdown of your legal spend by location e.g. how much work is performed in London, Manchester, Birmingham, Edinburgh, Glasgow, Cardiff, Belfast etc.
11. How do you measure what value added services law firms provide to you (e.g. free advice, free training, free secondees etc.)
12. Do you use external consultants to advice on how to manage your legal spend more effectively. If yes, who and what have you spent with them in the last 12 months

Download response External legal spend 180216

Grievance complaints in the last five years.

1. The number of all the Grievance complaint cases dealt with by MTW Trust in the last five years?
2. The outcome of these cases:
a. Numbers and percentage of Grievance cases accepted
b. Numbers and percentage of Grievance cases upheld
c. Number of staff members suspended, demoted or sacked within a year of making a grievance complaint.
3. Numbers and percentage of cases made by BME members of staff.
4. Outcome of BME grievance complaints in numbers and percentage as successful or upheld
5. Number of BME staff members suspended, demoted or sacked within a year of making a grievance complaint.

Download response Grievance complaints in the last five years 270616

Legal proceedings issued to patients refusing to leave the Trust hospitals.

1. The number of letters issued by your Trust threatening legal proceedings if a patient does not leave. Please include specific details of any laws referred to in each.

2. How many letters has your Trust issued threatening legal proceedings if a patient does not vacate a hospital bed/ward on 2013/14, 2014/15, 2015/16. Please include specific details of any laws referred to in each if different from Question 1.

3. Number of cases an eviction notice or court order for possession of a bed been served by your trust in 2013/14, 2014/15, 2015/16. Please include specific details of any laws referred to in each if different from Questions 1 and 2.

Download response Legal proceedings issued to patients refusing to leave the Trust hospitals 060916

Legal spend in Government

1. How much did your organisation spend on legal fees in the financial year 2015?
2. Do you have a panel of preferred legal providers? If yes, what year was this panel appointed?

Download response Legal spend in Government 270616

Letters of complaint 2013. 310517

We request the first 25 type-written letters of complaint that your Trust received after 1st October 2013. If your Trust contains more than one unit, we request that the letters are from across the units.

Anonymity of patient letters: The letters will contain personally identifying information, and we request that all personally identifying information be redacted from the letters (i.e., information about addresses, dates, units attended, sexuality, religion, ethnicity, age etc.). We only request information about the patient’s experience of the NHS. We understand that the resultant letters may be heavily redacted.

Why we have selected your Trust: Your trust has been randomly selected. We want a national sample of letters of complaint received by NHS Acute Trusts, and your Trust is an Acute Trust.

Anonymity of your Trust: The name of your trust will not appear in any of our research. The letters which you provide will be aggregated with letters from other Trusts, and will in no way be traceable back to your trust. We are not interested in the identity of any particular Trust.

Download response Letters of complaint 2013. 310517

Litigation cases bought against the Trust since 2010.

1. How many litigation cases have been brought against the trust since 2010? (Please provide a breakdown per year)
2. For each litigation case brought against the trust, please provide a brief outline of the nature of the case
3. For each litigation case brought against the trust, how many did the trust admit liability for?
4. For each litigation case brought against the trust, how much money did the trust pay out to the other party?
5. For each litigation case brought against the trust, how much money was spent on legal fees?

Download response Litigation cases bought against the Trust since 2010 070416

Losses and special payments 2014-2015

In your financial accounts for the financial year 2014/15 did you have a section for “losses and special payments?
1. If so how much money was accounted for in the 2014/2015 financial year as being “losses and special payments”? (Please note l am aware that the loss may have occurred many years earlier but I am interested in items which were accounted for in the last financial year, irrespective or when the loss took place.)
Please detail the three largest single amounts within this total, giving a cost for each loss and a detailed description of the claim and the reason for the loss.
2. What was the total paid on claims for property lost by patients and how much related to (i) Dentures, (ii) Spectacles, (iii) jewellery and (iv) hearing aids?

Download response Losses and special payments 2014-2015 080216

Managing personal injury claims. 280917

1. What policies does the Trust have in place to identify, investigate and report potential cases of clinical negligence?
2. In the financial year 2015/16, how much did the Trust spend in-house on managing clinical negligence claims?
3. In the financial year 2015/16, how much did the Trust spend in-house on managing all personal injury claims (e.g. clinical, employer’s /public liability etc.)?
4. How many full-time equivalent staff within the Trust’s employment are responsible for managing clinical negligence claims? What is the total annual pay bill for these members of staff?
5. How many full-time equivalent staff within the Trust’s employment are responsible for managing all types of personal injury claim? What is the total annual pay bill for these members of staff?
6. In total, how much did the Trust spend in 2015/16 on contracting outside providers (e.g. solicitors), other than the NHS LA, to deal with clinical negligence claims.

Download response Managing personal injury claims. 280917

Medication errors 2014 and 2015.

I would be grateful if you could let me have the following information, for two separate years: 2014 and 2015.
1) The number of medication errors recorded by the Trust for each of these two years.
2) The number of these incidents for each of these two years that were recorded as causing:
– no harm
– low harm
– moderate harm
– severe harm
– death
3) The number of errors for each of these two years attributed to:
– prescribing error
– dispensing error or
– any other cause
4) The number of errors for each of these two years attributed to:
– the prescribing or dispensing of the wrong dose, or
– the prescribing or dispensing of the wrong medicine.

5) The number of incidents for each of these two years in which the Trust has paid financial compensation to patients or relatives of patients in respect of medication errors, and the total paid in compensation for each of these two years in respect of medication errors.
6) Finally, does the Trust have a named medication safety officer, and when was this post established and filled?

Download response Medication errors 2014 and 2015 030516

NHS Injury Costs Recovery Scheme 2015-2016 171016

Please can you provide me with information about the total amounts collected by the Trust/Hospital in relation to the NHS Injury Costs Recovery Scheme (was RTA) for the year 2015/16.

Download response NHS Injury Costs Recovery Scheme 2015-2016 171016

Number and costs of court cases launched to prevent patients being identified in media reports.

1) How much money has your Trust spent in total during the three financial years between April 2012 and April 2015 to prevent patients being identified in media reports? Please enter the answer into the supplied MS Excel template file in the cells under the column labelled “Q1”.

2) How much money has your Trust spent in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q2 – 12/13”; “Q2 – 13/14”; “Q2 – 14/15”.

3) How many separate court cases has your Trust launched in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q3 – 12/13”; “Q3 – 13/14”; “Q3 – 14/15”.

4) How many Reporting Restriction Orders has your Trust obtained in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q4 – 12/13”; “Q3 – 13/14”; “Q3 – 14/15”.

5) How many other privacy injunctions has your Trust obtained in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q5 – 12/13”; “Q3 – 13/14”; “Q3 – 14/15”.

6) How many separate court cases has your trust launched in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports where the mental capacity of the patient was an issue? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q6 – 12/13”; “Q4 – 13/14”; “Q4 – 14/15”.

7) How many separate cases has your trust launched in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports where the Trust acted with the family of the patient? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q7 – 12/13”; “Q4 – 13/14”; “Q4 – 14/15”.

8) How many separate cases has your Trust launched in each financial year between April 2012 and April 2015 to prevent patients being identified in media reports where the Trust acted without the family of the patient? Please enter the answer into the supplied MS Excel template file in the cells under the columns labelled: “Q8 – 12/13”; “Q4 – 13/14”; “Q4 – 14/15”.

9) Please enter any additional notes, caveats or general points into the supplied MS Excel template file in the cell under the column labelled “Additional notes”.

Download response Number and costs of court cases launched to prevent patients being identified in media reports 250216

Penalties and fines 2014-2015.

1) Name of a) your trust b) the hospitals in your trust
2) Does the hospital trust have a Major A&E Unit?
3) We would like to request the income retained by the commissioner (the CCG) as a result of funds withheld or ‘defunded’ from your Trust under the application of the 30% marginal emergency tariff in the following financial year of 2014/15?
4) How much money has the Trust been fined or had withdrawn/withheld for not meeting the percentage target for referral to treatment time of 18 weeks for patients in the following financial year of 2014/15?
5) How much money has the Trust been fined or had withdrawn/withheld for not meeting the percentage target for A&E waiting time (4 hours) in the following financial year of 2014/15?
6) How much money has the Trust been fined or had withdrawn/withheld for emergency readmissions of patients within 30 days of discharge in the following financial year of 2014/15?

Download response Penalties and fines 2014-2015 181115

Physical attacks on Trust premises 2011 to 2016. 040118

1) How many physical attacks have there been on premises owned by your Trust in each of the last five financial years by patients on
a) patients
b) staff
c) visitors?
2) How many physical attacks have there been on premises owned by your Trust in each of the last five financial years by staff on
a) patients
b) staff
c) visitors?
3) How many physical attacks have there been on premises owned by your Trust in each of the last five financial years by visitors on
a) patients
b) staff
c) visitors?
By ‘physical attacks’ I mean any physical attack by one person on another person reported to or collected by your trust, or reported by your trust to the police or any other law enforcement agency.

Download response Physical attacks on Trust premises 2011 to 2016. 040118

Sexual assaults. 040118

Please clarify whether you hold data on the number of patient-on-patient sexual assaults in your Accident and Emergency department, as well as patient-on-staff sexual assaults?

If so, could you please release the number of reported assaults to me, divided by year and by category (patient-on-patient and patient-on-staff) in an Excel spreadsheet to send to this email, along with the number of resulting arrests or convictions (if you have this information), for the past five years.

Download response Sexual assaults. 040118

Violent incidents. 081117

1. Following the changes to NHS Protect in April 2017 do you still have access to an accredited local security management specialist? Yes / No
a. If yes, are they directly employed or support accessed as part of a contract?
b. If no, how is your board assured of maintaining security standards?

2. Please provide in the table below information about aggression and violence incidents for the financial years April 2014 – March 2015, April 2015 – March 2016, April 2016 – March 2017. Please note all non-physical assaults would include all incidents of aggression and violence that did not result in physical contact i.e. verbal, racial abuse etc.

3. For the physical assault numbers above please break down by the actual impact recorded for each incident in the table below. If your grading of actual impact is different to that defined below, please match to the nearest descriptor from your risk management system.

4. For the physical assaults number above, please indicate in the table below how many incidents were classified as serious and investigated in line with the NHS England Serious Incident Framework.

5. For the physical assaults numbers detailed in table 2, please break down the number in the table below by the staff group.

Download response Violent incidents. 081117

 

Critical Care

Agency spend for locum doctors in Acute Medicine. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Acute medicine over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend for locum doctors in Acute Medicine. 240317

Anchors. 050418

Name of your Trust
Hospitals within Trust (select multiples as needed)
The number of anchors used between Jan 2017-Dec 2017
The supplier name(s) of knotless anchors (select multiple suppliers as needed)
The supplier name(s) of knot tying anchors (select multiple suppliers as needed)
Procurement Route
Procurement agreement end date (DD/MM/YY)
Estimated annual value, Jan 2017-Dec 2017 (£s)
Number of Rotator Cuff repairs completed between Jan 2017-Dec 2017
Number of instability/stability repairs completed between Jan 2017-Dec 2017

Download response Anchors. 050418

Complaints regarding end of life care.

1. How many complaints in the following years has the Trust received relating to the end of life care/palliative care of a patient? Please answer each year by breaking down month by month e.g. January: 9, February 10…
a) In 2015
b) So far in 2016 (up to 16/5/2016)
2. Of the number of complaints above what numbers were related to:
a) Communication that the patient is actually dying
b) The patient or relatives was unaware that lifesaving drugs had been withdrawn
c) Care, including dignity, respect and privacy
d) Lack of pain relief
e) Access to specialised support and information
f) Lack of access to care through the night, at weekends and over holiday’s periods

Download response Complaints regarding end of life care 060616

Continuous renal replacement therapy (CRRT). 010217

1. How many machines do you have for continual renal replacement (CRRT) in the intensive care unit/critical care unit?
1. a. Can you split these by manufacturer and age of machine please?
2. Are you in a contract for your machines, if so when does the contract expire?
3. How many CRRT treatments were carried out in 2016 (or the latest 12 month period you have data for)?
4. How many bags of fluid did you use for CRRT in 2016 (or the latest 12 month period you have data for)?
5. Who is your current manufacturer of fluids for CRRT? And for Vascular access? (Double Lumen catheters)
6. Are you in a contract for fluids, if so, when does this expire and is it linked in with the machine contract?
7. What was your total spend on CRRT fluids in 2016 (or the latest 12 month period you have data for)?
8. What was your total spend on CRRT consumables (e.g. consumable sets for the machines) in 2016 (or the latest 12 month period you have data for)?
9. What is the typical renal dose you prescribe to the patients? (In ml/kg/h)
10. Are your units using Citrate Anticoagulation? If yes how frequent (in % vs. Heparin).

Download response Continuous renal replacement therapy (CRRT). 010217

Covered stents. 030118

What is the total number of Covered stents deployed in Arterio venous (AV) fistula/graft access procedures in 2016-17?

Download response Covered stents. 030118

Critical care. 200718

The hospitals under your trust?
Number and types of operating theatres.
Number of beds within the critical/intensive care unit(s).
Number of endoscopy treatment rooms/theatres.
If possible I would like to know the make, model and age of the following equipment if applicable:
1.0 Ultra clean ventilation systems
2.0 General Theatres
3.0 Ceiling mounted medical service pendants
4.0 Operating lights
5.0 Theatre control panels
6.0 AHU Units
7.0 Class 1,2 & 3 Cabinets

Download response Critical care. 200718

Critical care bed capacity. 090617

Question 1: What is the total number of critical care beds (Level 2 and Level 3) per 100,000 of the population your trust serves?
1. If you cover both secondary and tertiary care, please provide your TOTAL bed:population ratio for the whole trust, AND a figure for both types of service
Question 2: How many critically ill patients were transferred from your hospital to another hospital’s critical care unit for non-clinical reasons in 2016-17?
Question 3: How many days in 2016-17 was the occupancy of your critical care beds over 85% at least one point during those 24 hours?
Question 4: How many patients had an elective operation cancelled due to lack of a critical care bed capacity in 2016-17?
Question 5: How many days in 2016-17 was at least one critical care bed closed due to lack of staff for at least part of the day?

Download response Critical care bed capacity. 090617

Domiciliary services for medicines review and palliative care. 281116

I am currently setting up (1) domiciliary visiting medicines review (focussing on both medicines optimisation and medicines adherence) and (2) palliative care services (to ensure the timely and appropriate availability of end of life medicines) within Norfolk using the community pharmacy network and GP practice based pharmacy network, working in conjunction with our NHS community services teams.  I am therefore writing to ask if you could send me any reports (service specifications, audit reports, service evaluations etc.) which you may have relating to any services of a similar nature delivered in your area.

Download response Domiciliary services for medicines review and palliative care. 281116

Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

1. For the last 4 quarters from January 2016 – December 2016, please provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
2. For the last 4 quarters from January 2016 – December 2016, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
3. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
4. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
5. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.

6. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2?

Download response Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

Escalation procedures for ITU/ICU/HDU.

This is FOI request, please tell me what happens if you get patients for ITU / ICU / HDU but they are full with other patients, what do you do?

Download response Escalation procedures for ITU/ICU/HDU 190416

Follow-up of Critical Care patients.

Please could you send me any policies relating to intensive care/ critical care follow up of patients?

Download response Follow-up of Critical Care patients 130116

No Resus Orders (DNR) in 2011 – 2016. 200417

1. How many No Resus Orders were issued by your hospital in last 5 years?
2. How many of these patients survived and were thus discharged from your hospital in same above period?
3. Have you a pro forma No Resus Order checklist which you use to see whether patient should be given No Resus Order, please send me a copy?
4. What percentage of your SpR or Specialist Registrars are on the General Medical Council’s Specialist Register?

Download response No Resus Orders (DNR) in 2011 – 2016. 200417

Operating theatre fire incidents. 020518

1) What is the number of operating theatre fire incidents reported in Maidstone and Tunbridge Wells NHS Trust for the period 2010-2018? Please provide a breakdown for each year.
2) Can you please include a breakdown of the type of operating theatre fire incidents for the period 2010-2018, broken down by each year and characterised as follows:
a. chemical ignition
b. chemical related
c. diathermy related
d. equipment related
e. other reported in Maidstone and Tunbridge Wells NHS Trust? Please provide a breakdown for each year.
3) What is the number of operating theatre fire incidents related to alcoholic skin preparation agents specifically reported in Maidstone and Tunbridge Wells NHS Trust’s for the period 2010-2018? Please provide a breakdown for each year.
4) Can you please include additional details on the number of operating theatre fire incidents that resulted in an injury for the patient, i.e. burn reported in Maidstone and Tunbridge Wells NHS Trust for the period 2010-2018? Please provide a breakdown for each year.
5) Can you please describe what prevention protocols are in place to avoid operating theatre fire accidents in Maidstone and Tunbridge Wells NHS Trust? Please attach a copy of any protocols.
6) Does Maidstone and Tunbridge Wells NHS Trust provide any prevention training courses for operating theatre healthcare professionals on operating theatre fire incidents? If so please provide details.

Download response Operating theatre fire incidents. 020518

Operating theatres and intensive care units.

1. How many operating theatres do you have per hospital?
2. How many intensive care units (ICU) do you have per hospital for each of the following?
a. Neonatal
b. Pediatrics
c. Adults

Download response Operating theatres and intensive care units 060916

Service suspensions. 300317

1) In the past 12 months, have you suspended any acute services because of a shortage of doctors or nurses to staff the service?
If yes:
a) Which services were suspended?
b) How many suspensions have there been?
c) What was the longest period a service was suspended for?
2.) Intensive care services: Are any ITU beds closed?
If yes:
a) How many times in the past 12 months have ITU beds had to be closed?

Download response Service suspensions. 300317

Uscomm BP+. 270917

Please tell me if you have bought, stock it and use this product:

It is called Uscomm BP+, previously it was called Pulsecor.

It is used by cardiologists or doctors and consultants who have interest in heart related things.

Download response Uscomm BP+. 270917

 

Delayed transfer of care

12 hour trolley waits. 141217

a) How many patients spent longer than 12 hours from decision to admit to admission at your Trust between October 2016 and October 2017?
b) Of those patients waiting longer than 12 hours from decision to admit to admission, what was the longest wait over 12 hours between October 2016 and October 2017?
c) If possible, please provide a reason for the delay.

Download response 12 hour trolley waits. 141217

Delayed discharge 2013-2017 150217

What is the longest continual stretch of days that have been lost to delayed discharge by one patient in?
a) 2013/14
b) 2014/15
c) 2015/16
d) 2016/17 (YTD)

Download response Delayed discharge 2013-2017 150217

Delayed discharge and court action. 070317

1. Since 1.1.15 how many times have you taken court action to evict a patient from a hospital in your trust because you believe they are fit for discharge but they have failed to leave their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge?
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharge and court action. 070317

Delayed discharge from the stroke rehabilitation unit at Tunbridge Wells Hospital at Pembury. 011216

1. Please could you provide details of the current number of patients whose discharge from the stroke rehabilitation unit at Pembury Hospital is being delayed while social services arrange personal care packages?
2. Please could you provide details of the number of patients whose discharge has been delayed for more than 7, 14, 21 and 28 days for the same reasons for each month of 2016?
3. Please state the longest number of days for which an individual patient had to wait for a discharge from the stroke rehabilitation unit at Pembury hospital due to a lack of social services capacity to provide personal care 2016?

Download response Delayed discharge from the stroke rehabilitation unit at Tunbridge Wells Hospital at Pembury. 011216

Delayed discharges. 080517

1 – Number of adult patients who are medically fit to leave hospital but are currently unable to be safely discharged. Most recent figures are preferential however the latest on record would also be of use.

2 – Please provide the number of packages of care that are currently delayed due to lack of staffing resources within the community.

3 – Data on agency spend between March 2016 to present date for nursing services within the community.

Download response Delayed discharges. 080517

Delayed discharges. 091117

For the financial year 16/17 how many people were classed as bed-blocking; who was responsible for delayed discharges and over the length of time they were bed blocking by weeks. A simple table showing councils/relevant body holding up the discharge down the side and weeks along the top and number of patients in the data will suffice.

Download response Delayed discharges. 091117

Delayed discharges 2014-2017 111116

In two of the questions we ask for information collected on 28th September, 2016. This date has been chosen because it is the most recent data collection day for NHS England.

When giving reasons for the delay in discharging a patient, please chose one of the ten categories used by NHS England – awaiting completion of assessment, awaiting public funding, awaiting further non-acute NHS care, awaiting residential home placement or availability, awaiting care package in own home, awaiting community equipment and adaptations, patient or family choice, disputes or housing.
If you record it differently please supply information using the official categories for your nation.

1) Please state the five longest delays (in days) which patients who were ready for discharge, have had before they were able to leave the hospital during the period 1st April 2014 to 31st September 2016.
For each of these delayed discharges, please state:
i) The age of the person concerned.
ii) The original reason for admission to hospital.
iii) The reason for the delayed discharge.
iv) The date on which the patient was ready for discharge.
v) The date on which they were in fact discharged.
2) Please state how many patients, who were ready for discharge, had to wait 28 days or more to leave the hospital.
Please break these figures down by the cause of the delay.
Please provide this information for the following financial years:
i) 2014/15
ii) 2015/16
iii) 2016/17 to date
3) On the day of the 28th September 2016, please state:
i) The five longest waits in days that patients ready for discharge had had as of this date.
ii) For each of these waits, please state the age of the person concerned and the reason for their admission.
iii) For each of these waits, please state the reason for the delay.
4) Please state how much your trust spent on delayed discharges in each of the following financial years.
i) 2011/12
ii) 2012/13
iii) 2013/14
iv) 2014/15
v) 2015/16
vi) 2016/17 to date.
5)
i) On the 28th September 2016, how many of your acute beds were occupied by people who were ready for discharge?
ii) What proportion of your overall number of acute beds were being used by people who were ready for discharge?
iii) Have you had to open extra transitional, reablement or similar beds to meet the additional demand caused by delayed discharges?
iv) If yes, please state how many beds and the cost of providing these.

Download response Delayed discharges 2014-2017 111116

Delayed discharges. 210218

1. Between 1.2.16 and 31.1.17 how many times have you written to a patient, or the family members of a patient, or the legal guardians of a patient, stating that in the Trust’s view they are fit for discharge and should vacate their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge prior to the date of the letter being sent to them or their representatives? For the most recent occasion that a letter was sent please provide me with a copy of the letter accepting that any details that might identify the patient will be redacted to comply with S.40.
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharges. 210218

Delayed transfer of care 2013-2016. 070317

1. Over the last 3 years (2013-2016) how many patients have been involved in long-term delayed transfer of care (broken down into a delay of over six months; over one year; over two years etc.)
2. Over the last three years (2013-2016) what is the longest someone has been medically fit to be discharged but is still in the hospital?
3. Currently, what is the longest duration a patient has occupied a hospital bed because they are refusing to leave/disputing/family or patient not accepting the care package available?
4. How many times has the Trust applied for court orders to evict a patient over the last three years?
5. (If this figure is available) How much a year does delayed transfer for care cost the Trust?

Download response Delayed transfer of care 2013-2016. 070317

Delayed transfers of care 060317

1. The number of patients who have died in hospital while experiencing a delayed transfer of care. Please could I have these figures for the years 2014, 2015 and 2016, broken down by year?

Download response Delayed transfers of care 060317

Delayed transfers of care 2016-2017. 150517

What is the longest amount of time in days a patient had been kept in hospital due to delayed transfer in the past 12 months?

Could you give me details for the three longest delayed transfer stays, the name of the hospital concerned and if possible the age and gender of the patients concerned and the department they were in (i.e. elderly care/general surgery, paediatrics etc.)?

Are you also able to give a brief reason for the delay in each instance (i.e. lack of beds in care facility/delay equipping home etc.)?

Download response Delayed transfers of care 2016-2017. 150517

Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16.

1. What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16;

2. In each case, please provide the age of the patient and reason for delay.

Download response Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16.

Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16. 190417

1. What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16;

2. In each case, please provide the age of the patient and reason for delay.

Download response Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16. 190417

Delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16.190416

1. What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16;

2. In each case, please provide the age of the patient and reason for delay.

Download response Delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16.190416

DTOC and self-funding patients. 240817

DTOC and Self-Funding Patients
1. How many self-funding adult social care patients waiting for placements causing DTOCs in 2015-16, 2016-17 and 2017 to date?
2. Are there currently any care home placements and / or care package brokerage services being offered to the self-funders at the moment?
MH / Alcohol Related A&E Admissions
3. How many Alcohol and Mental Health A&E admissions and related occupied bed days? And total cost for this?
4. Is there an Alcohol Nurse Liaison service available at the hospital?
Acute Bed Days DTOCs
5. What is the average cost of an acute hospital bed in your NHS Trust
6. The gross cost to the Trust due to delayed transfers of care (DTOC) (before taking into account reimbursements from local authorities).
7. The gross cost to the Trust due to delayed transfers of care where Social Care was responsible for the delay (before taking into account reimbursements from local authorities).
8. The total sum received from local authorities in reimbursements for delayed transfers of care.
9. How many bed days were lost as a result of delayed transfers of care in your NHS Trust for the years 2014/2015 , 2015/2016 & 2016 /2017
10. What is the longest time (in days) one patient has been a delayed transfer of care (DTOC) in your NHS Trust for the years 2014/2015 2015/2016 2016/2017
11. In each case, please provide the age of the patient and reason for the delay and responsible CCG/local authority.
12. What is the longest time in (in days) one patient has been a delayed transfer of care awaiting further assessment in your NHS Trust for the years 2014/2015 2015/2016 2016/2017.
13. In each case, please provide the age of the patient and responsible CCG/ Local authority
14. Has the Trust ever taken legal action to remove a patient whose transfer of care was delayed? a) If so please provide details of when and the reason for delay in transfer of care and responsible CCG/local authority
Contact Details
15. Discharge and DTOC lead within the Trust
16. Alcohol Liaison Service

Download response DTOC and self-funding patients. 240817

Elderly patients delayed transfer of care (DTOC). 040117

I would like some information on the number of elderly patients who have been kept in hospital when they are well enough to be discharged due to a lack of suitable social care provision in the last 5 years.

Download response Elderly patients delayed transfer of care (DTOC). 040117

Patient discharges 2011 – 2016. 081116

(a) Total number of patients discharged by the Trust between 11pm and 6am in each of the last six financial years
(b) Total number of patients discharged by the Trust in each of the last six years

Download response Patient discharges 2011 – 2016. 081116

Patients who have died in hospital while waiting for the start of a social care package 2016

Q1: How many people in all the hospitals within your Trust have died in hospital awaiting the start of a package of local authority social care?
Q2: How many people in all the hospitals within your Trust have died in hospital awaiting the start of a package of continuing healthcare broken down by:

· Those that have been identified as meeting the fast track criteria
· Those that have not been identified as meeting the fast track criteria

Q3: What is the average time period in your Trust in hours/days from the point at which a fast-track CHC application is made to the care package being provided for the 12 month period to the end of September 2016?

What is the average time period in hours/days from the point at which a fast-track CHC application is approved to the care package being provided for the 12 month period to the end of September 2016?

Download response Patients who have died in hospital while waiting for the start of a social care package 2016

Section 5 under the Community Care (Delayed Discharges) Act in the year to March 31 2015

Please could you provide the number of patients whose discharge has
delayed by 28 days or more after the serving of a Section 5 under
the Community Care (Delayed Discharges) Act in the year to March 31
2015, with any available monthly breakdowns?

Please including the longest number of days for which an individual
patient had to wait for a discharge after a Section 5 was served, and any available breakdown by length of wait for a discharge after a Section 5 was served.

Would you please state on November 15 2015, how many beds were occupied in your trust by patients who had been served a Section 5 at least 24
hours previously?

Download response Section 5 under the Community Care (Delayed Discharges) Act in the year to March 31 2015 010216

 

Diagnostics, Therapies, Pathology & Pharmacy

Pain relief prescriptions 031016

For each of the questions, please can you provide answers for each of the financial years 2013/14, 2014/15 and 2015/16:

1. PARACETAMOL

a. Which suppliers did you buy paracetamol from?
b. How many packets of paracetamol did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of paracetamol did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for paracetamol?
e. How much did you spend on paracetamol in total?
f. How many prescriptions in total did you make for paracetamol?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for paracetamol?

2. IBRUPROFEN

a. Which suppliers did you buy ibuprofen from?
b. How many packets of ibuprofen did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of ibuprofen did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for ibuprofen?
e. How much did you spend on ibuprofen in total?
f. How many prescriptions in total did you make for ibuprofen?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for ibuprofen?

3. ASPIRIN

a. Which suppliers did you buy aspirin from?
b. How many packets of aspirin did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of aspirin did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for aspirin?
e. How much did you spend on aspirin in total?
f. How many prescriptions in total did you make for aspirin?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for aspirin?

4. CODEINE PHOSPHATE

a. Which suppliers did you buy codeine phosphate from?
b. How many packets of codeine phosphate did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of codeine phosphate did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for codeine phosphate?
e. How much did you spend on codeine phosphate in total?
f. How many prescriptions in total did you make for codeine phosphate?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for codeine phosphate?

Download response Pain relief prescriptions 031016

Acupuncture treatments 2010 to 2015

Please provide the following for the years 2010 to 2015 inclusive:
1. The names of the hospitals, clinics or other settings in which you provided acupuncture treatments.
2. The number of acupuncture treatments provided and the number of patients treated at each of these locations.
3. The types of clinicians who provided these treatments, e.g. physiotherapists, doctors, acupuncturists.
4. The total cost of providing acupuncture treatments at each of these locations.
5. The cost of acupuncture needles purchased included in the total cost.

Download response Acupuncture treatments 2010 to 2015 241016

Adult formulary

We would like to request the following information regarding the prescribing of growth hormones within Maidstone and Tunbridge Wells NHS Trust

1. We have the following formularies listed as used by your organisation. Please confirm if they are correct and if not, please provide a link/copy of relevant formularies.

West Kent Interface Adult Formulary

2. Please provide a copy or link to any supporting guidelines containing growth hormone product prescribing recommendations that are in addition to the published formulary. If none are available, please confirm if they are currently being developed/drafted.

3. Where guidelines are held in addition to the published formulary, please confirm which has dominance when prescribing growth hormones.

Download response Adult formulary 170815

AeroChamber with and without mask January – December 2015. 290617

I am writing to request the prescribed annual units (for the period January 2015 – December 2015) of the below:

• AeroChamber with Mask
• AeroChamber without Mask

Download response AeroChamber with and without mask January – December 2015. 290617

Agency spend in Radiology August 2016 – January 2017. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Radiology over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend in Radiology August 2016 – January 2017. 240317

Alternative medicine

1. Do you offer complementary therapies within the trust?
2. If yes, do you offer Reiki therapy?
3. Which types of services or departments offer Reiki therapy?
4. Have you conducted a formal evaluation of the Reiki service? If so, please provide brief details.

Download response Alternative medicine 060916

Anaemia and blood transfusions. 290118

1. Number of RBC units utilised by ward and/ or department in a) 2015 and b) 2016
2. Number of elective surgical procedures cancelled in 2016 due to the patient being identified as anaemic
3. Number of elective surgical procedures occurring for patients who were anaemic on the day of surgery
4. Of the above, the number of these procedures that required a blood transfusion
5. Following the NICE Quality Standards published in December 2016 on blood transfusion, is able to meet Quality Standard 1? Please see Quality Standard Review form attached. We are partially compliant with Standard 1. The Pre-Assessment Teams are referring patients for IV iron if they are found to be anaemic at Clinic, if there is time pre-operatively. Post-op iron therapy does not appear to be standard practice as yet.

Download response Anaemia and blood transfusions. 290118

Anti-microbial resistance. 230817

Please could you provide me with the number of cases between 2010-2017?

– In which patients were unable to be treated with anti-biotics due to anti-microbial resistance.
– In which patients had to undergo an operation to remove the site of resistance due to anti-microbial resistance.
– In which patients had amputations due to anti-microbial resistance.

Download response Anti-microbial resistance. 230817

Antibiotic guidelines. 040117

1) Please provide, in full, the antibiotic guidelines used by your trust.
2) Is antibiotic prophylaxis routinely given for urinary catheter removal after any joint replacement? : yes/no
3) If yes, which is given and how?
4) If yes, what proportion of patients with urinary catheters receive it?

Download response Antibiotic guidelines. 040117

Antibiotic prescribing. 220118

Could you please supply me with the number of each antibiotic prescribed in hospital for the past 10 years?
Could you please break this information down by the name of the drug (eg vancomycin) for each year in the past 10 years? For 2016 could you please give the number of each antibiotic prescribed so far?
Could you also provide me with the cost of each drug for each year?
Please note I am not seeking antibiotics dispensed in the community, but antibiotics prescribed in hospitals.
Download response Antibiotic prescribing. 220118

Antibiotic resistant NDM 2014-2016. 280217

Can you please send details of any cases of antibiotic resistant NDM (New Delhi metallo-ß-lactamase) “superbugs” you have reported to Public Health England in 2014, 2015 and 2016.

We are particularly interested in NDM-1, but would appreciate details of any other NDM incidents if available.

Please break the information down into the three years listed.

Download response Antibiotic resistant NDM 2014-2016. 280217

Antibiotics. 270617

Please could you provide me with a list of all companies currently supplying antibiotics – or that have supplied antibiotics in the last three years – to Maidstone & Tunbridge Wells NHS Trust.

Plus:

– The details, where possible, of the antibiotic products these companies supply or have supplied.

Download response Antibiotics. 270617

Aseptic drug compounding or preparation. 290617

1. How much does your aseptic unit cost to run annually?
2. How many aseptically prepared doses does your unit produce per annum?
3. What types of aseptically prepared products does your aseptic unit produce? E.g Parenteral nutrition, antibiotics, cancer chemotherapy?
4. What IT systems does your Aseptic unit currently use to manage the compounding process or help with your prescribing?
5. How many staff do you employ in your aseptic department?
6. How many members of staff are full time equivalents?
7. How many clean rooms do you have in your department?
8. How many isolators do you have in your department?
9. Do you do any outsourcing? Or is all of your compounding carried out in house?
10. Are you a licensed unit? If so, do you compound for any other customers? If yes, who and for how long?
11. What is your unit’s annual drug spend?

Download response Aseptic drug compounding or preparation. 290617

Benzodiazepines. 270617

Prescription of Benzodiazepines (class of psychoactive drugs)
How many patients were given any form of benzodiazepines during treatment in hospital?
Please provide broken-down figures (if possible) for up to the past five years and at least for the past 3 years

Download response Benzodiazepines. 270617

Biological and Biosimilar medicines. 070818

1 – In your Trust, how much did you spend on Biological and biosimilar medicines, in the past financial year ending April 2018?
2 – Have you developed a policy on how prescribers can switch their patients to biosimilars and support them in making informed choices to save resources?
If yes, please provide details
3 – Do you have any specific plans in place for the launch of biosimilar Adalimumab later in 2018?
4 – Are there any agreements in place between you the Provider and CCG that would enable savings in drug costs to be made? (For example, Gainshare agreements where the benefits associated with more efficient use of medicines not reimbursed through national prices is shared between the Provider and the Clinical Commissioning Group party to the agreement. This included agreements for the switch to biosimilar products)
If “Yes”, then please provide the following details:
5 – Are there any other agreements with a CCG, not included in the above, for the following services?
If “Yes”, then please provide the following details:

Download response Biological and Biosimilar medicines. 070818

Biologics 101016

We would like to request from Maidstone and Tunbridge Wells NHS Trust (MTW) the numbers of patients treated in the last 12 months with the following drugs for the conditions listed below:

Download response Biologics 101016

Biologics and Biosimilar

1. Does your trust run a dedicated Gastroenterology infusion clinic for the treatment of patients with Infliximab [or Vedolizumab] If Yes, how frequently are they run?
2. Could you please provide me with the following numbers of patients treated in the last six months with the following drugs for the conditions listed below?

Rheumatology [Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis] Dermatology [Psoriasis] Hidradenitis suppurativa (sometimes known as acne inversa) L73.2 Gastroenterology
[Crohns / Ulcerative Colitis]
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Tocilizumab (RoActemra)
Tofacitinib [Xeljanz]
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar 120116

Biologics and biosimilar prescribing 01.06.2015 – 31.05.2016

Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs for the conditions listed below?

• Psoriasis
• Hidradenitis Suppurativa
• Crohn’s disease
• Ulcerative Colitis

Download response Biologics and biosimilar prescribing 01.06.2015 – 31.05.2016 250716

Biologics and Biosimilar prescribing. 050718

Could you please provide me with the following numbers of patients treated in the last 12 months (latest 12 months possible) with the following drugs for either Rheumatology, Dermatology or Gastroenterology departments.

Download response Biologics and Biosimilar prescribing. 050718

Biologics and Biosimilar prescribing. 210917

Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs for the conditions listed below?

• Psoriasis
• Hidradenitis Suppurativa
• Crohn’s disease
• Ulcerative Colitis

Download response Biologics and Biosimilar prescribing. 210917

Biologics and Biosimilar prescribing. 250517

Could you please provide me with the following numbers of patients treated in the last six months (to date) with the following drugs for the conditions listed below?

Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Etanercept biosimilar (Benepali)
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Ixekizumab (Taltz)
Tocilizumab (RoActemra)
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar prescribing. 250517

Biologics and biosimilar prescribing. 290617

Could you please provide me with the numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs within the dermatology or gastroenterology departments?
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Etanercept biosimilar (Benepali)
Fumaric Acid Esters N/A
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Ixekizumab (Taltz)
Tocilizumab (RoActemra)
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and biosimilar prescribing. 290617

Biologics and Homecare. 290118

1. What is the Trust’s annual spend on anti-TNF drugs (most recent year available)?
2. How many patients has the Trust treated with anti-TNF drugs in the last 12 months?
3. What is the % split of anti-TNF patients by the following channels?
4. How many patients has the Trust treated with the following conditions in last 12 months?
5. Are there any gain share agreements in place between the Trust and CCGs for anti-TNF biosimilars?
If yes, please provide:

Biologics and Homecare. 290118

Biomarker testing. 270318

1. Do you currently offer a biomarker testing for the following, as of the beginning of 2018?
PD-L1 in NSCLC
ALK in NSCLC
BRAF in Melanoma
2. Is predictive biomarker testing conducted at the same lab (or similar location such as in same building) as the initial cytological and histological (H&E stain) assessment, or is this done at a different site?
IHC
FISH /ISH/ NGS / PCR
3. Is biomarker testing performed reflexively or upon request for the following biomarkers?
PD-L1 in NSCLC
ALK for NSCLC
BRAF in Melanoma
4. Which of the following biomarkers are assessed in lung cancer patients in your laboratory? (please select all that apply)
5. Which of the following testing platforms are used at this this laboratory?
6. What IHC staining platform(s) are used in the laboratory for biomarker testing? (please select all that apply)
7. What type of test does the institution prefer to use for biomarker-predictive IHCs?
What is the main factor in this decision?
8. Does your lab / trust seek separate reimbursement from NHS under the “high-cost medicines and tests” provision for biomarker tests that have been excluded from tariff?
9. What is the number of samples being tested (or sent-out) are tested for the following biomarkers?
ALK
EGFR
PD-L1
BRAF
10. Where are archived tissues from lung cancer patients stored?
11. If on-site; how long are tissues stored on site until transferred to other storage facility?
12. What is the typical turn-around time from tissue/specimen extraction to the report of biomarker testing results in lung cancer patients?
13. How are the following biomarker testing funded at your lab?

Download response Biomarker testing. 270318

Blood cultures. 090617

1. Who is the policy or clinical lead for blood culture best practice at your trust? Please provide a name, job title, postal address, email address and phone number.
2. Does your Trust follow the Public Health England SMI guidelines for blood cultures?
3. How many blood culture sets are taken for each suspected case of (a) sepsis and (b) other bacterial infection, and where there is more than one blood culture set taken are these taken from different sites – please provide an answer for both (a) and (b).
4. How many individual blood cultures were taken at your trust in the following years: (a) 2012/13 (b) 2013/14 (c) 2014/15 (d) 2015/16 (e) 2016/17?
5. How many individual blood cultures were identified as being contaminated in the following years: (a) 2012/13 (b) 2013/14 (c) 2014/15 (d) 2015/16 (e) 2016/17?

Download response Blood cultures. 090617

Blood pressure monitors

1. Total number of all types of blood pressure monitors in your institution (e.g. 1000 blood pressure monitors overall)
2. Can you please list all the types of blood pressure monitors and its quantities (e.g. NIBP – x20, SpO2 – x20), its brands (e.g. Omron – x20, Criticare – x20, Datascope – x20), and models (e.g. Criticare 506DXN – x10, Criticare 507DXN – x10, Datascope Accutorr + x20). We would like to ask you kindly if you can state this information in a separate spreadsheet document.
3. In which departments do you use blood pressure monitors? (e.g. 20 Omron in wards, 20 Criticare in ITU, 20 Datascope in outpatient surgery).
4. Types of devices acquired in period of 2014 – 2016 (e.g. 100 Omron monitors in 2014, 150 Criticare monitors in 2015.) if none please state when was the last purchase.
5. Minimum and maximum price of blood pressure monitors. If you can not provide this information, please give us an average price of a single blood pressure monitor
6. Please provide a full contract with supplier of blood pressure equipment
7. Which quality tests or quality standards a blood pressure device must pass in order for you to consider it as a good quality blood pressure monitor (e.g. CE Marked)
8. Can you please provide regulations and guidelines that your institution follow (we would like to know about national, local and your own guidelines + regulations (if it also possible can you please attach medical device management action card + medical equipment pre-registration form))
9. What creates extra costs for the usage of monitors on a yearly basis? Please break it down and relate the expenditure associated to it (e.g. cuffs = £2.000, hoses = £3.000, maintenance = £5.500)
10. Do you provide maintenance in-house or out?
11. How do you provide training to medical staff when a new blood pressure monitor is introduced in your hospital? (e.g. manual handbook, training sessions from suppliers)
12. How the supply chain is established in your organisation when you order new blood pressure monitors? (e.g. supplier delivers the products, currier or take out?)
13. Do you provide feedback to your suppliers? If “yes” how? (e.g. emailing, calling, submitting a form)
14. What is the average useful life of a single blood pressure monitor?

Download response Blood pressure monitors 090916

Bronchial challenge testing 040117

Can you please advise if the trust performs Bronchial challenge testing? If the trust does perform these tests could you also advise?
1) The number of tests performed in the last 12 months?
2) Which products are used to perform the test?
3) Contact details for the sites performing the test?

Download response Bronchial challenge testing 040117

Candida Auris. 250817

I am attempting to discover whether the fungus ‘Candida Auris’ has been found in the Tunbridge Wells hospital.

Is it possible for you to give me any information regarding this matter?

Download response Candida Auris. 250817

Carboxyhaemoglobin levels

Under the Freedom of Information Act 2000 I request that the NHS Trust provides me with the following information:

• What methods of measuring carboxyhaemoglobin levels do each hospital covered by the Trust use
• Whether or not each hospital covered by the Trust has a Masimo Rad-57 Oximeter in its accident and emergency department.

Download response Carboxyhaemoglobin levels 181215

Caspofungin (Generic) and Cancidas (May 2016-April 2017). 070917

I am writing to request details of the quantity of vials prescribed for below products by your Trust.

The period for which data is being requested is May 2016 – April 2017.

Data Requested for below products:
• Caspofungin 50mg powder for concentrate for solution for infusion
• Cancidas 50mg powder for concentrate for solution for infusion
• Caspofungin 70mg powder for concentrate for solution for infusion
• Cancidas 70mg powder for concentrate for solution for infusion

Download response Caspofungin (Generic) and Cancidas (May 2016-April 2017). 070917

Charges for ultrasound baby scan pictures for 2011, 2012, 2013, 2014 and 2015. 160617

1) The charges for ultrasound baby scan pictures for the years 2011, 2012, 2013, 2014 and 2015 until now (how much you charge expectant mums/dads).
2) The figures for how much profit has been made from the ultrasound charges for each year from 2011 to now.
3) An explanation for why the charges increased (if they did so).

Download response Charges for ultrasound baby scan pictures for 2011, 2012, 2013, 2014 and 2015. 160617

Chronic Myeloid Leukaemia (CML) 2015 (follow up)

Following your reply, please could you provide the information requested in sections 2, 3 and 5 regardless of indication.

1. In your organisation, how many patients diagnosed with Chronic Myeloid Leukaemia (CML) have been treated in calendar year 2015?

2. Of these patients, how many are currently being treated with each of the following tyrosine kinase inhibitors (TKIs)?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)

3. If possible, of these patients on a TKI, how many have had treatment with a previous TKI?

4. In your organisation, how many patients diagnosed with Philadelphia positive (Ph+) Acute Lymphoblastic Leukaemia (ALL) have been treated in calendar year 2015?

5. Of these patients how many are currently being treated with each of the following TKIs?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)
· Other (i.e. not on a TKI)

Download response Chronic Myeloid Leukaemia (CML) 2015 (follow up) 230516

Chronic pain service 031016

1. The definition of calculation used for new to follow up ratios for chronic pain referrals.
2. The data for new to follow up for chronic pain referrals for your trust for the years April 2010 to April 2015
3. Is the calculation used for new and follow-up in Chronic Pain a local or national definition?
4. Can you provide the wording of the definition used?
5. Does the New to follow up ratio calculation that is used by your organisation for Chronic Pain also apply to other specialties?
6. If no – please explain the differences in the calculations.

Download response Chronic pain service 031016

Complementary therapy. 240418

1. Do you have a staff Health and Wellbeing Strategy for the Trust? If yes, can you supply an electronic copy?
2. As part of your strategy or through Occupational Health Department, do you or have you considered using Complementary Therapies to support staff? For example, holistic therapeutic massage for staff mental wellbeing and workplace stress, reflexology, sports massage for rehab and recovery or any others
3. If you do use complementary therapy – do you find it useful in reducing sickness absence, reducing stress related absences and expediting return to work?
4. If you don’t currently use complementary therapy, would you consider using them if they could help reduce sickness absence days, help manage workplace stress and help rehab/recovery from MSK related sickness?
5. Would you consider offering complementary therapy as a staff benefit at discounted rates or donations towards your hospital charity?
6. Would you consider employing a Complementary Therapist as part of your Occupational Health Team? If no, would you reconsider this if their qualification was gained via the NHS natural health school which is supported by NHS England?

Download response Complementary therapy. 240418

Continence Product Formulary 011216

1) Does the Trust have a Continence Product Formulary?
2) If yes to Q1, please provide a copy
3) How often is the Continence Product Formulary reviewed?
4) What date was the Continence Product Formulary last reviewed?
5) What date will Continence Product Formulary be next reviewed?

Download response Continence Product Formulary 011216

CRE infections. 181116

1. How many patients have been?
-colonised
-infected
With CRE infections for each of the past 10 years in your trust?
2. Does your trust have universal screening of patients for CRE when they are admitted, screening of patients with high risk factors or no formal screening policy?
3. How many patients were screened for CRE when they were admitted and deemed high risk for a CRE infection?
4. How many isolation rooms does your hospital have for isolating CRE patients?
5. How many isolation rooms have en suite bathrooms?
6. What is your policy if there is no side room available for isolating patients with CRE?

Download response CRE infections. 181116

CT scanner. 301117

Q1. Does your trust have a 64-slice (or above) CT scanner?
Q2. Does your trust perform Coronary CT angiography?
Q3. How many Coronary CT Angiography scans have you performed in the past financial year? (2016-2017)
Q4. Does your Trust have access to Coronary CT Angiography with non-invasive FFR analysis or HeartFlow technology?
Q5. If so how many CT FFR scans have been performed in total in the past financial year (2016-2017)?

Download response  CT scanner. 301117

CT scanner information – June 2016

• How many CT scanners are in your hospitals?

• Who is the manufacturer of them and what is their model?

• Who has the service maintenance contract for the scanners – is it the supplier or an external service company?

Download response CT scanner information – June 2016 060616

Cyanide antidotes, Levothyroxine and Primidone. 210218

1) Does your trust hold stocks of the following Cyanide poisoning antidotes: Cyanokit (hydroxocobalamin), Sodium Nitrite, Sodium Thiosulfate and Dicobalt Edetate?
• If yes, what is your stock volume and total expenditure by financial year from FY11-12 to present day for each individual medication?
• If yes, what is the price paid per unit for each medication type?

2) Does your trust hold stocks of Levothyroxine in the following forms: Tablets (25mcg, 50mcg & 100mcg), Oral solution (25mcg/5ml, 50mcg/5ml, 100mcg/5ml) and Levothyroxine solution for injection (IV or IM)
• If yes, what is your stock volume and total expenditure by financial year from FY11-12 to present day for each individual medication?
• If yes, what is the price paid per unit for each medication type?

3) Does your trust hold stocks of Primidone in the following forms: tablets (50mg & 250mg?)
• If yes, what is your stock volume and total expenditure by financial year from FY11-12 to present day for each individual medication?
• If yes, what is the price paid per unit for each medication type?

Download response Cyanide antidotes, Levothyroxine and Primidone. 210218

Cyclotron 221116

This FOI is about the use of Cyclotrons, used for the manufacture of radiopharmaceuticals in PET-CT scanning
Pertains to four main radiopharmaceuticals isotopes (radio-isotopes) used for PET-CT scanning:
18F-Fluorodeoxyglucose = FDG
18F-Choline = FEC for the diagnosis of prostate cancer
18F-Sodium Fluoride = NAF for the diagnosis of skeletal cancers
18F-Florbetaben = FBB for the diagnosis of Alzheimer’s

Download response Cyclotron 221116

Dermatology and Atopic Dermatitis. 010917

Funding pre-NICE;
For the attention of (FAO): Pharmacy / Dermatology Department Clinical Director
1. Is it your Trust/CCG policy to wait until 90 days post NICE guidance to fund new drugs or do they fund earlier?
2. What is your Trust/CCG policy re use of Zero Risk (ZR)/Early Use Schemes (EUS), i.e. where a medicine is made available free of charge or at a reduced price to the NHS whilst awaiting NICE/SMC approval, in lieu of NICE?
3. What is the process for getting such ZR/EUS schemes implemented/approved/signed off within your Trust/hospital? Who needs to sign the contracts for such schemes?
IFR/Cohort Funding;
FOA: Dermatology Lead Pharmacist / Dermatology Department Clinical Director
4. What is your Trust’s policy re Individual Funding Request and/or Cohort Funding policy? Ref: IFR/Cohort Funding
https://www.engage.england.nhs.uk/consultation/af642939/supporting_documents/genericcommissioningpolicies.pdf
5. Do you have a pathway/preferential prescribing list, illustrating sequential use of Biologics in Dermatology? What does this recommend?
6. How many lines/trials of biologics are allowed/funded for the management of psoriasis within your trust/CCG? What happens if a clinician needs to exceed this?
7. If there is a biologics psoriasis pathway – how often is it updated to reflect changes to NICE status of new therapies?
8. If there is no formulary/pathway – what do the Trust/CCG utilise in order to guide use of biologics in the management of psoriasis?
Atopic Dermatitis
FAO: Dermatology Service Manager
9. How many patients attended for a new outpatient appointment in dermatology Utilising ICD-10 classification – L20 Atopic Dermatitis (Eczema) – from April 2015 – March 2016?
10. The number of paediatric attendances of patients utilising ICD-10 classification – L20 for Atopic Dermatitis (Eczema) – from April 2015 – March 2016?
11. Does your Trust have a paediatric dermatologist? Does your Trust have a paediatrician with a dermatology interest/specialism?

Download response Dermatology and Atopic Dermatitis. 010917

Diabetes. 091117

1. The number of patients with Type 1 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
2. The number of patients with Type 2 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
3. The number of patients with Type 1 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
4. The number of patients with Type 2 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
5. The number of Diabetes Specialist Nurses that are employed in Maidstone and Tunbridge Wells NHS Trust as of the 1st October 2017. Please break down the response to this question by pay band e.g. band 6, band 7.
6. Is structured education for patients with Type 1 diabetes offered within Maidstone and Tunbridge Wells NHS Trust?
7. The number of patients with Type 1 diabetes that have received structured education within Maidstone and Tunbridge Wells NHS Trust between the period October 1st 2016 to October 1st 2017.

Download response Diabetes. 091117

Diagnosis of heart failure in 2015.

1. What was the size of the patient population covered by your Trust in 2015?
2. How many patients were diagnosed with heart failure by your Trust in 2015?
3. Does your Trust follow NICE guidelines to support the diagnosis of suspected heart failure? If not, what guidance does your Trust follow? Please provide a copy
4. Please provide the details – including the manufacturer and brand name – of those tests used to support the diagnosis of heart failure
5. Does your Trust follow NICE guidelines to support the management of chronic heart failure? If not, what guidance does your Trust follow? Please provide a copy
6. Please provide the details – including the manufacturer and brand name – of those tests used to support the management of chronic heart failure
7. Does your Trust use NTproBNP or BNP testing to support the diagnosis of heart failure in patients presenting through A&E?
8. How many NTproBNP tests were performed by your Trust in 2015? Please provide the manufacturer and brand name of the test used
9. Are there any restrictions for using NTproBNP or BNP tests? If yes, please explain
10. How many echocardiographs were performed at your Trust in 2015?
11. What was the average waiting time for an echocardiogram at your Trust in 2015?

Download response Diagnosis of heart failure in 2015 290416

Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

1. Please tell us which Trust, Health Board or Health and Social Care Trust you are responding on behalf of?
2. What percentage of men receive mpMRI before biopsy as part of the initial diagnostic process using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences?
3. What are your eligibility criteria/exclusion criteria for men to receive pre-biopsy mpMRI?
4. Are you using mpMRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process?
5. What mpMRI scores and/or other clinical factors are used to rule men out of biopsy?
6. Do you intend to use mpMRI to rule men out of biopsy in the future?
7. How many men annually are referred?
8. If you are unable to provide numbers for question 6, please estimate the percentage of all men referred for b, c and d.
9. Do you carry out targeted biopsies in men with mpMRI lesions in addition to systematic biopsies?
(Please indicate with a X below)
If No, what are the reasons for not carrying this out? (e.g. expertise, equipment, don’t believe it makes a difference)
10. If you do not currently carry out targeted biopsies, but wish to in the future, what are the current barriers to doing so?
(Please indicate with a X below)
11. Please indicate the number of uroradiologists undertaking prostate MRI
12. How many scanners do you have available for mpMRI before biopsy?
Has this increased in the last 12 months?
13. What percentage of scanner time is dedicated to mpMRI before biopsy?

Download response Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

Diagnostic imaging 150217

1. What is the approximate local population catchment your hospital trust provides services for?
2. For each MRI, CT, and PET-CT, please set out the location for each scanner located on Trust property using one line per machine:
3. For each scanner listed in Question 2 as per index, please set out the type of ownership and both the year of manufacture and the year of installation in your trust for each machine:
4. For each scanner listed in Question 3 that is not owned by the trust and as per index, please list the name of the company providing the service:
5. For each scanner listed in Question 2 as per index, please set out the current ‘normal opening hours’ of the service per week and indicate whether this includes a non-emergency weekend service or not:
6. Please set out the total number of MRI, CT, and PET/CT scans that were carried out on scanners within your trust in the financial years (April to March) 2012/13, 2013/14, 2014/15, and 2015/16:
7. Please set out the total number of MRI, CT, and PET/CT scans referred by clinicians from your trust, regardless of whether they were carried out at your trust or at another trust or provider, in the financial years (April to March) 2012/13, 2013/14, 2014/15, and 2015/16:
8. Please list the providers outside your trust below that carried out MRI, CT, and PET/CT scans on your trust’s patients trust during the financial year 2015/16:
9. For each of the hospital providers listed in Question 8 as per index, please set out the total number of MRI, CT, or PET/CT scans that were carried there on your behalf in the financial years (April to March) 2012/13, 2013/14, 2014/15, 2015/16:
10. Does your trust currently hold plans to extend its MRI, CT, or PET/CT capacity (e.g. increase number of scanners)?
11. If yes, what is the likely procurement method your trust is likely to take?
12. Does your trust currently hold plans to invest into high value (>£500k) capital diagnostic equipment (both radiological and non-radiological) over the next five years?
13. If your trust has done any assessment/forecasting of the evolution of demand for MRI, CT, and/or PET-CT scanning, either historic or future, please provide a copy.

Download response Diagnostic imaging 150217

Diagnostic Imaging (DI) for 2014/2015.

Please provide the information set out below in respect of Diagnostic Imaging (DI) at your Trust for the FY 2014/15:

For each of the key Points of Delivery categories (just EL, SSEL, NEL, SSNEL, DC and OP), the numbers and types (e.g. CT/MR/PET-CT/endoscopy) of DIs performed per Primary Diagnosis (ICD) and the number of patients so investigated in that ICD category.

We would only need the first three characters of the Primary Diagnosis code (e.g. C00 to D49 for Neoplasms).

Download response Diagnostic Imaging (DI) for 2014/2015 270516

Diagnostic and procedure codes. 160518

1) Any diagnosis from the category Z38 (i.e. Z38.0 – Z38.8, I believe obtained by searching for Z38.X, but local procedures may vary). This diagnosis could be in any position, principle or secondary.
Explanation: This is looking at the number of live births in the time period in your trust.

2) The number of episodes from the results of part 1) that has also given the diagnosis code P39.9. This diagnosis could be in any position, principle or secondary.
Explanation: This is looking at the number of the above patients who were screened and treated for sepsis, without diagnosed bacteraemia.

3) The number of episodes from the results of part 1) that has also given a diagnosis from the category P36 (i.e. P36.0 – P36.9, I believe this is searched for by P36.X). This diagnosis could be in any position, principle or secondary.
Explanation: This is looking at the number of patients from part 1) that had a bacterial sepsis.

4) The number of episodes from the results of part 1), which also has the procedure code A55.8 or A55.9
Explanation: This is looking at the number of patients from parts 1) that have had a lumbar puncture, an investigation for meningitis.

5) The number of episodes from the results of part 1), which also has any diagnosis from the category G00, G01, G02, or G03. These diagnoses could be in any position, principle or secondary
Explanation: This is looking at the number of patients from parts 1) that actually were diagnosed with meningitis.

Notes to help complete request:

For each of 1) 2) 3) 4) and 5), you only need to provide one number for the number of episodes for each; they do not need to be broken down in to subcategories. If any of the answers is zero, please state as such (or state you do not hold any information on it). Kindly note this information is not publicly available from other sources, including NHS Digital.

Download response Diagnostic and procedure codes. 160518

Diagnostic services provided by external providers outside the UK. 260717

Does your trust have any diagnostic services provided by external providers outside the UK (e.g. radiology)?

If yes –

– What services?
– Which provider(s) have been chosen to provide these services?
– How much is each contract worth?
– For what time period will the contract run?
– When did you first enter into these arrangements?

Download response Diagnostic services provided by external providers outside the UK. 260717

Disposal of drugs. 070818

1. Please can you provide me information on the quantity of prescription medications, drugs and any other dispensed medical substances (“Drugs”) disposed of during the summer heat wave (from the start of June 2018 until the most recent possible date when the search is made.
2. If you have a register of Drugs being disposed of including dates of the disposal, type and name of Drug, quantities involved, and value of each batch to be disposed of, please provide me with such a register for the given period.
3. Otherwise, please provide information as to the overall quantity and value of Drugs to be disposed, and provide as much of a breakdown into the fields given previously as is possible.
4. Please can you tell me whether (i) all, (ii) some, or (iii) which of the hospitals or medical centres that come under the Trust, have the appropriate facilities to refrigerate Drugs.

Download response Disposal of drugs. 070818

Drug spend 2014-15 and 2015-16. 081117

a) Total drug spend for financial years 2014-15, and 2015-16
b) Total Off-tariff drug spend for financial years 2014-15, and 2015-16
c) Total Homecare drug spend for financial years 2014-15, and 2015-16

Download response Drug spend 2014-15 and 2015-16. 081117

Drug stock. 300518

1. Has your trust accepted or is it currently accepting manufacturer provision of free of charge drug stock between licensing and NICE funding? [Yes/No]
2. Has your trust accepted or is it currently accepting the following list of drugs in psoriasis:
Brodalumab [Kyntheum] [Yes/No]
Guselkumab [Tremfya] [Yes/No]
Ixekizumab [Taltz] [Yes/No]
Secukinumab [Cosentyx] [Yes/No]
3. Has your trust accepted or is it currently accepting the following list of drugs in Rheumatoid Arthritis:
Tofacitinib [Xeljanz] [Yes/No]
Baricitinib [Olumiant] [Yes/No]
Golimumab [Simponi] [Yes/No]
Certolizumab [Cimzia] [Yes/No]
Apremilast [Otezla] [Yes/No]
Tocilizumab [Ro Actemra] [Yes/No]
4. Has your trust accepted or is it currently accepting the following list of drugs in Ankylosing Spondylitis or Psoriatic Arthritis:
Secukinumab [Cosentyx] [Yes/No]
5. Has your trust accepted or is it currently accepting the following list of drugs in Ulcerative Colitis:
Golimumab [Simponi] [Yes/No]
6. If your trust has not accepted manufacturer provision of free of charge drug stock, what have been the reasons for this?
7. In future, will your trust be able to accept manufacturer provision of free of charge drug stock? [Yes/No]
8. What is the preferred distribution channel for the provision of free of charge drug stock?
Homecare [Yes/No]
Delivered directly to hospital/Trust [Yes/No]
Other (please provide details)
9. For how long is free of charge drug stock typically provided for each patient?
First dose [Yes/No]
First month [Yes/No]
First 3 months [Yes/No]
Other

Download response Drug stock. 300518

Drugs usage. 070318

This is a Freedom of Information request regarding usage of certain products in all NHS Trusts, these products are:
• Iloprost 0.5mg/0.5ml Ampoules
• Melatonin 1mg/ml oral solution,
• Melatonin 2mg Capsules,
• Melatonin 3mg Capsules,
• Melatonin 5mg Capsules,
• Melatonin 3mg Tablets
• Mexiletine 200mg capsules
• Diazoxide 50mg/ml oral suspension
1. How many packs of these products were dispensed quarterly in 2015?
2. How many packs of these products were dispensed quarterly in 2016?
3. How many packs of these products were dispensed quarterly in 2017?
4. What was the annual spend for each product between 2015 and 2017?
5. What was the cost per unit of each product between 2015 and 2017 to your organisation?

Download response Drugs usage. 070318

Drugs usage. 210218

This is a Freedom of Information request regarding usage of certain products in all NHS Trusts, these products are:
Iloprost 0.5mg/0.5ml Ampoules
Melatonin 1mg/ml oral solution,
Melatonin 2mg Capsules,
Melatonin 3mg Capsules,
Melatonin 5mg Capsules,
Melatonin 3mg Tablets
Mexiletine 200mg capsules
Diazoxide 50mg/ml oral suspension

1. How many packs of these products were dispensed quarterly in 2015?
2. How many packs of these products were dispensed quarterly in 2016?
3. How many packs of these products were dispensed quarterly in 2017?
4. What was the annual spend for each product between 2015 and 2017?
5. What was the cost per unit of each product between 2015 and 2017 to your organisation?

Download response Drugs usage. 210218

ECG equipment. 260418

1. The name or your current ECG equipment manufacturer and product name, the year of purchase and installation date?
Do you have plans and timescales to replace?

2. The name of your current Stress Exercise ECG equipment manufacturer and product name, the year of purchase and installation date?
Do you have plans and timescales to replace?

Download response ECG equipment. 260418

Electrophysiology equipment. 300317

1. Does your Trust have an Electrophysiology Lab or perform Electrophysiology Procedures?
2. How many 3D Mapping Systems are installed in your Trust?
3. How many Electrophysiology Recording Systems are installed in your Trust?
On average, what is the lifespan of these EP Recording systems?
What brands are they?
Were there any EP Recording systems purchased in the last 12 months?
If yes, how many?
Were these to replace old machines or new purchases?
4. How many Intracardiac Echocardiography (ICE) Systems are installed in your Trust?
5. How many Radiofrequency (RF) Ablation Generators are installed in your Trust?
6. How many cardiac stimulators are installed in your Trust?
7. How many Remote Navigation Systems (from Stereotaxis) are installed in your Trust?

Download response Electrophysiology equipment. 300317

ESBL and CPE infections. 181116

Can you please tell me how many people in your hospital trust:

1. Were admitted to hospital with an ESBL infection
2. Acquired an ESBL infection while in hospital
3. Were admitted to hospital with a CPE infection
4. Acquired a CPE infection while in hospital

Please provide the information for the past 10 years.

Download response ESBL and CPE infections. 181116

Foot protection team. 020617

1. Does your trust operate a foot protection service, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

2. If the answer to Q1 is yes, please state the number of podiatrists and orthotists employed within this service.

3. If the answer to Q1 is yes, is this service led by a podiatrist with specialist training in diabetic foot problems, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

4. If the answer to Q1 is no, please provide a reason for this.

Download response Foot protection team. 020617

Formaldehyde and Formalin

1. How many reported incidents involving formaldehyde and/or Formalin have occurred in the last 3 years at your trust? Please provide numbers of staff and patients involved in such incidents
2. How many reported illnesses or injury due to formaldehyde and/or formalin has your trust had?
3. Has your trust ever been subject to legal proceedings due to exposure to formaldehyde and and/or formalin? Please supply numbers of incidents
4. Does your trust have a policy or procedure in place to reduce exposure to formaldehyde and/or formalin in the treatment room setting whilst harvesting biopsy samples? If so please supply
5. Does your trust have a policy to purchase the safest practicable solution to reduce harmful exposure to Formaldehyde and/or formalin? If so please supply details

Download response Formaldehyde and Formalin 260216

Haemochromatosis. 261016

A. the number of patients treated with Haemochromatosis in 2015 who are in maintenance phase of the treatment (*)
B. the number of patients treated with Haemochromatosis in 2015 who are in PRE-maintenance phase of the treatment (+)
C. a copy of the clinical protocol(s) used to treat haemochromatosis
D. a copy of the clinical protocol(s) for therapeutic venesection

(*) “Maintenance phase” relates to patients whose ferritin is <=50 ug/L
(+) “PRE-maintenance phase” relates to patients whose ferritin is in excess of 50 ug/L

Download response Haemochromatosis. 261016

HCV testing 151216

1. Do you currently offer a clinical testing service for HCV?
o Yes, In-house service
o Yes, Send-out to another laboratory
o No
If you have selected send-out testing above, to which laboratory do you send samples for HCV testing?
2. What type of clinical HCV testing do you offer?
o HCV Antibody testing
o HCV RNA testing
o HCV Genotyping
o HCV Drug resistance testing
o Other. Please Specify:
3. If you are offering HCV antibody testing as well as HCV RNA testing, what is the laboratory algorithm used for testing?
o RNA testing is automatically performed as a reflex test dependant on the Antibody result
o The HCV antibody result is reported to the clinician and RNA testing is only performed when specifically requested by the clinician
4. HCV antibody testing details:
Is HCV antibody testing performed using a kit or laboratory developed technique?
If appropriate, please specify kit details:
What platform is used for HCV antibody testing?
What is the laboratory turnaround time for HCV antibody testing?
How frequently is HCV antibody testing performed
(on sample receipt, daily, twice a week, monthly)?
5. HCV RNA testing details:
Is HCV RNA testing performed using a kit or laboratory developed technique?
If appropriate, please specify kit details:
What platform is used for HCV RNA testing?
What is the laboratory turnaround time for HCV RNA testing?
How frequently is HCV RNA testing performed
(on sample receipt, daily, twice a week, monthly)?
6. HCV sample volume:
Annual Sample Volume
1st Nov 2015- 1st Nov 2016 Positivity Rate
1st Nov 2015- 1st Nov 2016
HCV
Antibody testing
HCV
RNA testing
HCV
Genotyping
(If applicable)
HCV
Drug resistance testing
(If applicable)

Download response HCV testing 151216

Hepatitis C. 151217

Please could you supply the following information, for patients with hepatitis C, for the latest month available? Please use the tables to enter by genotype if possible thank you.

Treatment Regimens in last month by Genotype

Download response Hepatitis C. 151217

Hepatitis C. 280417

1. Does your trust treat Hepatitis C? [Yes/No]
2. How many patients with Hepatitis C are registered, or recorded as under you care? [Number]
3. Please could you supply the following information, for patients with hepatitis C, for the last month if possible? Please use the tables to enter by genotype as possible thank you.
By genotype as follows
Interferon Free Treatment
Epclusa
Harvoni
Sovaldi
Sovaldi/Olysio
Sovaldi/Daklinza
Viekirax
Viekirax/Exviera
Zepatier
If your systems do not support the ability to split by treatment, please supply total treated by the genotype split. Similarly, if you are unable to split by genotype, please just split by treatment type.

Download response Hepatitis C. 280417

Hepatitis C Patients 221216

For Hepatitis C patients:
1. How many patients in total are under the institution’s care, but not under any treatment (i.e. no drugs being given for this virus)?
If possible please split by Genotype.

2. For Hepatitis C patients, how many were treated in the month (last month’s available data) with interferon containing therapy and interferon free therapy as listed below. Please use the tables to enter by genotype if possible, thank you.

Download response Hepatitis C Patients 221216

Heroin and cocaine prescriptions. 250117

Under the FOI Act, can you please tell me how many times your trust has prescribed either heroin/diamorphine and/or cocaine to patients in the 2015 and 2016 calendar years.

Download response Heroin and cocaine prescriptions. 250117

Hidradenitis Suppurativa 230117

In your trust, how many patients with a diagnosis of Hidradenitis Suppurativa* (HS) have been treated in the last 12 months [latest available]?

Of these patients how many have been treated with the following;
Adalimumab
Etanercept
Infliximab
Infliximab Biosimilar
Ustekinumab

Download response Hidradenitis Suppurativa 230117

Histology Reporting. 240817

For the financial year 2016/17 please provide information relating to histology slides/ cases reported for patients of the trust.

1. How many histology slides and or cases (please state whether the number given is slides or cases or both) were reported by consultant histopathologists for patients treated by the trust. If exact numbers are not available, an estimate to within 5% is acceptable, but please state whether exact numbers or estimates are given. (Cytology should be excluded)

2.Of these slides/ cases how many were reported by: a.Consultants employed by the trust working in their normal NHS programmed activity sessions b.Consultants employed by the trust being paid for additional sessions c.Consultants employed by the trust being paid an amount per slide or case for activity outside their contracted programmed activities d.Consultants employed by other trusts, where the trust contracts with these consultants or their trust e.Backlogs Limited f.Unilabs g.Source Bioscience h.Cellular Pathology Services Limited i.Other private histology providers (please specify which)

3.How much was spent in 2016/17 with each of the following in relation to the reporting of histology slides/ cases a.Consultants employed by the trust being paid for additional sessions b.Consultants employed by the trust being paid an amount per slide or case for activity outside their contracted programmed activities c.Consultants employed by other trusts, where the trust contracts with these consultants or their trust d. Backlogs Limited e.Unilabs f.Source Bioscience g.Cellular Pathology Services Limited h. Other private histology providers (please specify which)

Download response Histology Reporting. 240817

Histopathology Speciality Registrars July 2015

Under the Freedom of Information Act I am requesting the following

Monitoring results for the full time Histopathology Specialty Registrars who undertook a monitoring exercise July 2015
Monitoring results for the Less Than Full Time Histopathology Speciality Registrars who undertook monitoring July 2015

Download response Histopathology Speciality Registrars July 2015 211215

HIV patients treated with antiretroviral therapy (ART). 170817

1. Within your Trust for HIV patients treated between August 2016 – May 2017’ and August 2016 – July 2017, the total numbers treated with antiretroviral therapy (ART)

2. For HIV patients treated between August 2016 – May 2017 and August 2016 – July 2017, the total numbers treated with the following drugs.

Download response HIV patients treated with antiretroviral therapy (ART). 170817 

Hospital pharmacy provision. 220817

1. Please can you inform me whether your inpatient pharmacy (Discharge Medication not ward-level dispensing) is:
a. A department of the hospital?
b. A wholly owned outsourced subsidiary of the hospital?
c. Contracted-out to a private provider?

2. Please can you inform me whether your out-patient pharmacy is:
a. A department of the hospital?
b. A wholly owned outsourced subsidiary of the hospital?
c. Contracted-out to a private provider?

3. Please can you inform me whether your home care dispensing service is:
a. Provided by the pharmacy as a department of the hospital?
b. Provided by the pharmacy as a wholly owned outsourced subsidiary of the hospital?
c. Contracted-out to a private provider?

Download response Hospital pharmacy provision. 220817

Hydrotherapy pools. 011217

– What was the total cost of maintaining the hydrotherapy pools in your NHS trust between October 2016 and October 2017 and how many pools do you have? [Can you specify which hospitals these are at?]
– If possible, can I also have a breakdown of the maintenance cost per pool during the same time period?
– If this total cost include staff costs could you give the total amount relating to staff costs separately for this period?
– How much revenue did you raise between October 2016 and October 2017 from charging people to use the hydrotherapy pools in the hospitals within your NHS trust?
– Have any hydrotherapy pools been closed down in your NHS trust in the time period October 2014- October 2017? If yes, which hospitals had their hydrotherapy pools closed down?
– What were the reasons for the hydrotherapy pool closures at hospitals within your NHS trust?

Download response Hydrotherapy pools. 011217

Imaging services. 070317

1. Total number of and the manufacturer and model number(s) of each individual:
o MRI scanner
o CT scanner
o PET scanner
o SPECT scanner
o Ultrasound scanner
o Flexible Endoscope [An estimate of the number and predominant manufacturer brand will suffice]
o Catheter Lab X-ray machines
2. The year each individual scanner was purchased, the purchase method**, cost and the scheduled replacement year for each individual:
o MRI scanner
o CT scanner
o PET scanner
o SPECT scanner
Please state the total cost for trust purchases and annual payments if lease or MES.
Please indicate if equipment was purchased through a group purchasing organisation
3. How each of the following equipment has been purchased (e.g. contract with OEM, NHS Supply Chain catalogue) and how often they are replaced on average:
o Ultrasound scanner
o Sets of Flexible Endoscopes
o Catheter Lab CT machines
An estimate of how often the trust aims to replace the listed equipment would be useful (e.g. once every 2 years).
4. The maintenance provider (e.g. the OEM or a third party) and the annual maintenance cost (if applicable) for each individual:
o MRI scanner
o CT scanner
o PET scanner
o SPECT scanner
o Ultrasound scanner
o Catheter Lab CT machines
Might be done by the Original Equipment Manufacturer (OEM) (e.g. Siemens maintenance for a Siemens MRI machine) or a third party. If so, please state the provider name.
If no listed maintenance provider, please state – possibly the case for ultrasound.
5. Staffed hours for each individual: (Please note which of the individual scanners are available 24/7 for A&E purposes.)
o MRI scanner
o CT scanner
o PET scanner
o SPECT scanner
Please state hours each scanner is manned. (e.g. 9am – 6pm, Mon-Fri). Scanners used by A&E departments presumably must be 24/7, so please indicate these where relevant.
6. Number of scans/procedures performed annually in period financial year 2005/06 – 2015/16 for the following: [See the attachment for the relevant OPCS and modality ID codes].
o MRI scans*
o CT scans*
o PET scans*
o SPECT scans*
o Ultrasound scans
o Endoscopy procedures (Upper GI, Lower GI and Urological)
o Cardiac Angiography and Angioplasty procedures
o Cardiac Electrophysiology procedures
*For MRI, CT, PET and SPECT these may be covered by submissions to HSICIC for the Diagnostic Imaging Dataset (DID) (http://www.hscic.gov.uk/did), but we are looking for more granular data by individual machine if possible.
7. Number of scans/procedures performed by external providers on behalf of the trust in this same period. How much was paid per scan/procedures on average? Please list by external provider name. For the following:
o MRI scans
o CT scans
o PET scans
o SPECT scans
o Ultrasound scans
o Endoscopy procedures (Upper GI, Lower GI and Urological)
o Cardiac Angiography and Angioplasty procedures
o Cardiac Electrophysiology procedures
Number of activities performed by an external provider (NHS or Non-NHS), data may be collected by CCGs.
8. Average cost per scan from by year for the period 2005/06 – 2015/16 for the following:
o MRI scans
o CT scans
o PET scans
o SPECT scans
9. The provider of tracers for PET (e.g. FDG) and annual spend on tracers.

Download response Imaging services. 070317

Instrument sterilisation service February 2016

1, Is the core instrument sterilisation service
A) Run in house
B) Onsite
C) Out sourced to a separate trust
D) Outsourced to a private company

2, How many instruments have been processed by the sterile services facility mentioned in question one.
A) In 2014 (or that financial year)
B) In 2015 (or that financial year)
C) How many surgical instruments are anticipated to require sterilising in 2016?

3, How much has the trust spent annually on sterilising surgical instruments for the following years?
A) Financial year 2013/14
B) Financial year 2014/15
C) How much has been budgeted or anticipated to be spent for the Financial year 2015/2016

4, How many staff are employed by the sterile service facility mention in question on, for the purposes of instrument sterilisation only, (i.e. exclude porters)
A) Management/admin
B) Team Leaders, supervisors, technicians

5, Does the trust provide decontamination and sterilisation services for re-usable surgical instruments to other customers who are not part of the trust? If so who?

6, In relation to surgical cancellations due to sterilisation failures.
A) How many operations were cancelled in 2014 due to issues with sterilisation of the equipment?
B) How many operations have been cancelled in 2015 due to issues with sterilisation of the equipment?

7, What where the costs associated with these cancellations
A) 2014
B) 2015

8, Of the instruments sterilised, approximately how many would be from dental/oral departments?
A) In 2014 (or that financial year)
B) In 2015 (or that financial year)

9, What Would the costs be for these instruments to dental/oral departments (Please state if approximate costs or not)
A) In 2014 (or that financial year)
B) In 2015 (or that financial year)

10, Does the trust use single use instruments?

Download response Instrument sterilisation service February 2016 250216

Insulin pump and UFE NICE compliance. 070318

1. Please enter the name of your Trust.
2. Does your Trust have a policy to ensure that all staff fully and objectively inform all patients of all their treatment options and offer them a choice of treatment? Please tick the appropriate box below
Yes
No
Don’t know
3. How do your monitor your staff to ensure that all patients are properly and objectively informed? [Please tick all answers that apply]
Carry out patient surveys to ensure they have been given all the information about all their treatment options?
We have patient information leaflets available all treatments on our web site
We send patient information leaflets about all treatments options before their outpatient clinic so they can discuss them with their doctor
We include questions on patient information and treatment options in all patient surveys
We have a policy and expect all staff to comply
We do not have a policy and do not think this important
It is up to the individual clinician
Other (please specify)
4. How many complaints has your Trust received in the last 2 years about lack of patient information and choice of treatment?
5. NICE Clinical and Diagnostic Guidelines set minimum standards that patients would expect for the quality of their healthcare. Does your Trust have a policy to ensure that all your staff comply with all NICE Clinical and Diagnostic Guidelines? Please tick appropriate box
Please provide us with a copy of your Trust’s policy on NICE Guideline compliance.
6. How do you monitor each of your clinical departments and clinicians to ensure their compliance with all NICE Guidelines? [Please tick all that apply]
Each department is required to update all care pathways to include the latest NICE Guidelines and this is reviewed by a Director
Every care pathway is reviewed by their clinical lead to ensure compliance with all NICE Guidelines
Audits are carried out in each clinical department to ensure NICE Guideline compliance and reported to the Board
Audit and patient surveys are carried out to ensure compliance
We trust our clinicians to comply with NICE Guidelines but do not monitor this
7. How many complaints has your Trust received in the past 2 years about lack of compliance with NICE Guidelines?
8. NICE Technology Appraisal Guidance 151 (TAG 151 Jul 08) states that continuous subcutaneous insulin infusion (CSII or insulin pump) therapy is a treatment option for adults and children with type 1 diabetes who meet certain criteria. How does your Trust ensure that all patients who meet the criteria are given the option of insulin pump therapy? [Please tick all that apply]
9. Which brands of insulin pump are offered at your Trust? [Please tick the appropriate box below]
10. What is the number of people with Type 1 diabetes registered with this Trust?
11. What is the number of patients using insulin pumps attending clinic at this Trust?
12. NICE Clinical Guidelines on Heavy Menstrual Bleeding (CG44 Jan ’07), which includes uterine fibroids, states that all women with fibroids >3cm requiring hospital treatment must be offered hysterectomy, uterine artery embolisation and myomectomy. How does your Trust ensure that all women are given the choice of all 3 treatments and that there is no age discrimination in treatment choices given to women? [Please tick all that apply]
13. NICE Guidelines on Heavy Menstrual Bleeding state that “1.3.1 A woman with HMB referred to specialist care should be given information before her outpatient appointment.” How does the Trust ensure compliance? [Please tick all that apply]
14. NICE Interventional Procedures Guidance on Uterine Artery Embolisation (IPG 367 Nov ‘10) states that – 1.3 Patient selection should be carried out by a multidisciplinary team, including a gynaecologist and an interventional radiologist.
How does your Trust ensure multidisciplinary team working between gynaecologists and interventional radiologists to ensure women have access to all fibroid treatment recommended by NICE? [Please tick all that apply]
15. NICE Guidelines on Heavy Menstrual Bleeding (HMB) states that –
1.10.1 All those involved in undertaking surgical or radiological procedures to diagnose and treat HMB should demonstrate competence (including both technical and consultation skills) either during their training or in their subsequent practice.
How does the Trust ensure all gynaecologists receive adequate training on UAE?
16. How is the training of gynaecologists about UAE monitored and recorded?
17. How many patients referred to your Trust in the last 2 years had a primary main diagnosis of heavy menstrual bleeding – Diagnostic Code N92?
18. How many patients referred to your Trust in the last 2 years in total (i.e. both primary and secondary main diagnosis) had a diagnosis of heavy menstrual bleeding Diagnostic Code N92?
19. How many patients had a primary main diagnosis of uterine leiomyoma/fibroids in the last two years Diagnostic Code D25.0 – 25.02 and D25.9?
20. How many patients in total (i.e. both primary and secondary main diagnosis) had a diagnosis of uterine leiomyoma/fibroids in the last two years Diagnostic Code D25.0 – 25.02 and 25.9?
21. How many patients with a diagnosis of heavy menstrual bleeding or fibroids (N92 and D25.0- 25.02 and 25.9) had a hysterectomy in the last 2 years Code Q07.1- Q08.9?
22. What were the ages of these women who had hysterectomy in the last 2 years Code Q07.1- Q08.9? (Please indicate the numbers for each age range below)
23. Does your Trust provide myomectomy – surgical removal of the fibroid(s) alone?
24. If ‘Yes’ how many myomectomies did your Trust perform in the last 2 years – open myomectomy code Q09.2, a endoscopic myomectomy in the last 2 years Code Q17.1?
25. What were the ages of the women who underwent myomectomy in the last 2 years (codes Q09.2 -9.3 + Q16.1 + Q17.1 and 17.4)? [Please indicate the numbers in each age range below]
26. Does your Trust provide uterine artery/fibroid embolisation? [Please tick the appropriate box below]
27. If ‘No’ where are patients wanting UAE referred?
28. If ‘Yes’ had uterine artery/fibroid embolisation in the last 2 years Code RC41Z?
29. Does your Trust provide beds for UAE patients on a regular basis – say once a week, as are provided for hysterectomy patients?
30. Do your interventional radiologists have admitting rights and named consultant status?
31. What were the age ranges of the women who had uterine artery/fibroid embolisation in the last 2 years Code RC41Z?

Download response Insulin pump and UFE NICE compliance. 070318

Intra-vitreal injections and implants. 070618

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January to April 2018
If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

Download response Intra-vitreal injections and implants. 070618

Intra-vitreal vials or implants. 210917

Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between May and August 2017?
Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

Download response Intra-vitreal vials or implants. 210917

Intra-vitreal vials or implants September – December 2016.100217

1. Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between September and December 2016
Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

2. Does your trust record the time taken from referral of a patient for treatment to the time for an injection or implant to be complete?
If so what is the average waiting time for treatment with an injection of implant?

Download response Intra-vitreal vials or implants September – December 2016.100217

Intra-vitreal vials/implants January 2016 – April 2016.

Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between January to April 2016
Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

Download response Intra-vitreal vials/implants January 2016 – April 2016 270616

Intra-vitreal vials/implants May – August 2016.

Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between May and August 2016

Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

Download response Intra-vitreal vials/implants May – August 2016 101016

Klebsiella Pneumoniae 090617

In the 12 months ending 31 October 2016, what was:
1. The number of patients who had a blood culture positive for Klebsiella pneumoniae (Group A)
2. In Group A, the number of patients who had a blood culture positive for Klebsiella pneumoniae, with the organism found to be resistant to meropenem, resistant to ertapenem, OR reported positive for a carbapenemase (Group “CRKPb”).
3. In Group A, the number of patients who had a blood culture positive for Klebsiella pneumoniae, with the organism NEITHER found to be resistant to meropenem, NOR resistant to ertapenem, NOR reported positive for a carbapenemase (Group “CSKPb”).
4. Within Group CRKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae found to be resistant to meropenem, resistant to ertapenem, OR reported positive for a carbapenemase, and 6 days after the specimen date.
5. Within Group CRKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae found to be resistant to meropenem, resistant to ertapenem, OR reported positive for a carbapenemase, and 30 days after the specimen date.
6. Within Group CSKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae NEITHER found to be resistant to meropenem, NOR resistant to ertapenem, NOR reported positive for a carbapenemase, and 6 days after the specimen date.
7. Within Group CSKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae NEITHER found to be resistant to meropenem, NOR resistant to ertapenem, NOR reported positive for a carbapenemase, and 30 days after the specimen date.”
Please provide answers on the same questions for the 12 months period ending 31 October 2015.

Download response Klebsiella Pneumoniae 090617

Laboratory medicine services. 210318

I would like to request the following information applicable for year 2016-2017:
1. Regarding the following diagnostic procedures/tests:
a. Complete (Full) blood cell count (FBC)
b. C-Reactive Protein (CRP)
c. Procalcitonin (PCT)
d. Chemistry panel/Serum electrolytes
e. Blood gas
f. Blood culture
g. Urine culture
h. Sputum culture
i. Stool (faeces) culture
j. Multiplexed PCR panels for pathogen identification
k. Viral serology (Antibody ID panel)
l. Lumbar puncture (Cerebro Spinal Fluid cytology)
m. Urine stick/Rapid urine test (Urine dipstix)
n. Chest x-ray
o. Rapid viral (RSV/FLU) diagnostic test
2. The total number of diagnostic procedures/tests performed in Maidstone and Tunbridge Wells NHS Trust as given in the table below.
3. The unit cost for said diagnostic procedures/tests for the requested year.
4. The total cost for said diagnostic procedures/tests for the requested year.

Download response Laboratory medicine services. 210318

Lord Carters Pathology Report

Following on from Lord Carters Pathology Report and in turn Efficiency report, please can you provide information on the following questions?
1. Does your pathology service currently meet the 1.6% cost of service to Trust operating expenditure target as set out by the 2016 report?
2. Do you currently have a managed service arrangement within Pathology (entire disciplines or pan pathology, not individual analysers)?
3. If yes, please can you provide the Suppliers name, expiry date, and average annual cost?
4. Are you planning on collaborating with another NHS entity to provide pathology services?

Download response Lord Carters Pathology Report 100616

Lymphoma Subtyping. 051017

1. Do you provide a lymphoma testing service?
2. Do you participate in an EQA program for lymphoma testing?
3. Approximately how many lymphoma cases are tested? (per month or per year, whichever is easier to determine)?
4. Approximately how many of these samples are B-cell lymphomas? (per month or per year or as a percentage of lymphoma samples above, whichever is easier to determine)?
5. Do you perform DLBCL subtyping?
6. Approximately how many samples are DLBCL positive? (per month or per year, whichever is easier to determine)?
7. Which DLBCL algorithm do you use to classify subtypes?
8. Which IHC antibodies are used for DLBCL subtyping?
9. Which IHC platform/autostainer do you use for DLBCL subtyping?
10. Is Gene Expression Profiling (GEP) used for DLBCL subtyping?
11. Approximately how many DLBCL samples are tested using GEP? (per month or per year, whichever is easier to determine)?
12. If GEP is used to test for DLBCL which platform is used in your lab?
13. What is the laboratory turnaround time for DLBCL subtyping using IHC?
14. What is the laboratory turnaround time for DLBCL subtyping using GEP?
15. Are any additional tests performed to help confirm a diagnosis of DLBCL?
16. If multiple tests are performed to confirm DLBCL, how are the reports issued?
17. Who pays for DLBCL testing?

Download response Lymphoma Subtyping. 051017

Managed Service agreements. 070318

1. Do you currently have Managed Service agreement in place, either in Cardiology, Radiology, Ultrasound or for Patient Monitoring?
2. If any such agreements are in place, who is your existing provider?
3. What is the scope of the agreement by department and by services offered?
4. When was the contract start date? When is the contract end date?
5. Have there been any measurable financial or operational benefits from the agreement and what are they?
By Managed Service we understand any contract with a private provider which:
– Spans multiple years
– Includes provision of technology and services
– Includes Service Level Agreements and KPIs
– Has an element of risk transfer for pricing and service delivery
– There is an element of performance risk transfer to the contracting party

Download response Managed Service agreements. 070318

Medicines Formulary

Does the Trust have its own formulary? If so could you please provide me with a copy or a link to the most recent version?

Download response Medicines Formulary 280716

Micafungin (Generic) and Mycamine Vials (May 2016-April 2017). 070917

I am writing to request details of the quantity of vials prescribed for below products by your Trust.

The period for which data is being requested is May 2016 – April 2017.

Data Requested for below products:
Micafungin 50mg vials
Mycamine 50mg vials
Micafungin 100mg vials
Mycamine 100mg vials

Download response Micafungin (Generic) and Mycamine Vials (May 2016-April 2017). 070917

Microbiological techniques 281116

1. Clostridium difficile
2. Penicillin resistant Streptococcus pneumonia
3. Macrolide-resistant Group A Streptococcus
4. Clindamycin-resistant Group B Streptococcus
5. Meticillin resistant Staphylococcus aureus (MRSA
6. Vancomycin resistant / intermediate Staphyloccocus aureus
7. Glycopeptide-resistant
8. Multi-drug resistant Pseudomonas aeruginosa
9. Multi-drug resistant Acinetobacter
10. Drug resistant campylobacter
11. Fluconazole-resistant Candida albicans
12. Carbapenemase-Producing Enterobacteriaceae (CPE
13. ESBL-Producing Enterobacteriaceae
14. AmpC-Producing Enterobacteriaceae
15. Drug resistant non-typhoidal Salmonella
16. Drug resistant Salmonella typhi / paratyphi
17. Drug resistant Shigella
18. Drug resistant TB (MRDTB, XDRTB, Pan-DRTB)

Download response Microbiological techniques 281116

Missing or unaccounted for drugs. 301117

1/ Please state the quantity of controlled drugs that has gone missing or unaccounted for from Trust hospitals in each of the last three calendar years, 2014-15, 2015-16, 2016-17?
• Please include a breakdown of types of drugs and locations from which they have gone missing
2/ Please state the quantity of prescription drugs that has gone missing or unaccounted for from Trust hospitals in each of the last three calendar years, 2014-15, 2015-16, 2016-17?
• Please include a breakdown of types of drugs and locations from which they have gone missing
3/ Please state the monetary value of the missing or unaccounted for drugs, broken down by each of the last three calendar years 2014-15, 2015-16, 2016-17?
4/ Please state the number of cases referred to police and relevant professional regulators
5/ Please describe auditing procedures that take place relating to controlled and non-controlled medicines

Download response Missing or unaccounted for drugs. 301117

Mobility related products. 110917

Formally request a breakdown of your suppliers of mobility-related products (wheelchairs, hoists etc.), including names, goods/services supplied and funds paid out to each supplier.

Download response Mobility related products. 110917

Modalities computed radiography. 050418

This is in relation to the computed radiography portfolio within your trust.

Please answer the ‘Computed Radiography Questions FOI’ and submit the responses in the ‘Modalities Computed Radiography FOI Form’.
Download response Modalities computed radiography. 050418

Molecular pathology BRAF testing

1. Do you currently offer a clinical testing service for BRAF mutation in solid tissue, specifically melanoma? (Yes, No, currently in development)

2. Which methodology(ies) do you use for BRAF testing in melanoma? e.g. Real time PCR (QPCR), High resolution melting curve analysis (HRMCA), Sanger sequencing, Next Generation Sequencing (NGS), Pyrosequencing, Immunohistochemistry (IHC), Fluorescence In Situ Hybridisation (FISH), Other (please specify). If you use a specific kit I would be grateful if you could provide the name of the kit you use.

3. Which BRAF mutations does your methodology(ies) cover? E.g. V600E, V600K, V600D, V600R etc.

4. What is your current laboratory turnaround time for BRAF testing in melanoma?

5. What is the level of sensitivity of your BRAF methodology(ies)?

6. I understand that molecular testing in FFPE tissue can be difficult due to tissue quality and/or quantity. What would you estimate is your current failure rate for BRAF testing for melanoma?

7. Approximately how many BRAF tests for melanoma would you conduct per month or year (whichever time period is most convenient for you to estimate)?

8. Of the BRAF tests performed for melanoma, please estimate how many (or what percentage) are found to be positive for a mutation?

9. Of the positive tests, please estimate how many (or what percentage of the positives) are V600E? How many (or what percentage of the positives) are V600K? How many (or what percentage of the positives) are V600 all other mutations?

Download response Molecular pathology BRAF testing 250216

Mortuary numbers. 270618

1. How many deceased bodies do you have at today’s date 14.06.2018 in your mortuary?
2. In any of your hospitals of that number how many are unidentified?
3. Or identified but no one has stepped forward to arrange a funeral service?
4. Or identified or unidentified but are being stored for some other reason?
5. Please provide details of how long they have been in the mortuary and the sex male or female.

Download response Mortuary numbers. 270618

Mortuary storage

1. How many fridge spaces does the trust/council have for deceased on each site?
2. How many freezer spaces does the trust/council have for deceased on each site?
3. How many deceased are sent out to external overflow storage per year for normal refrigeration (2016, 2015 + 2014)?
4. How many deceased are sent out to external overflow storage per year for deep freeze refrigeration (2016, 2015 + 2014)?
5. How much does the trust/council pay for transfer of deceased to external overflow storage?
6. How much does the trust/council pay per day for external overflow storage of deceased per day?
7. How many deceased per year do the trust/council transfer between sites (non-coroner cases e.g. hospital post-mortems?
8. How much does the trust/council pay to transfer deceased between sites (non-coroner cases) e.g. hospital post-mortems?
9. If the hospital does not have any mortuary storage what is the procedure for dealing with deceased?

Download response Mortuary storage 060916

Mouthwash product for oral mucositis treatment or prevention. 270317

1. Please advise the estimated number of beds at your hospital(s)
2. Please advise the estimated number of patients treated annually at your hospital(s)
3. Please advise the estimated number of patients receiving chemotherapy at your hospital(s) each year
4. What is the preferred mouthwash product prescribed to patients for oral mucositis treatment or prevention?
5. What is the estimated annual spend on mouthwash?
6. What is the estimated annual number units of mouthwash prescribed?

Download response Mouthwash product for oral mucositis treatment or prevention. 270317

MRI equipment and activity 070317

Please provide the total number of, the manufacturer, the model number(s), and the emplacement type of each individual MRI scanner used in the last year by your trust.
For each of the individual MRI scanner above, in which year was it purchased (or contracted), what was the purchase method, and the scheduled replacement year.
For each of the individual MRI scanner above, please provide the maintenance provider (if applicable).
Please provide the total number of MRI scanners in your trust (static sites only, excluding any mobile scanners), as well as the total number of days during which a MRI Mobile Scanner was used / contracted in your trust annually, for the period from financial year 2005/06 until 2015/16.
Where the number of static MRI scanners changed during a financial year, please list the number of static scanners in operation on 31st March for the year in question.
Please provide the number of MRI scans/procedures performed by external providers (3rd party providers, such as Alliance Medical, InHealth, etc.) on behalf of the trust over the same period.
How much was paid per scan/procedures on average, every year over the same period? Please list by external provider name.
Please detail the normal staffed hours of operation for each individual MRI scanner. In addition, please note which (if any) of the MRI scanners is available for emergency and urgent scanner (e.g. referrals from A&E or medical assessment unit).
Please provide the number of staff employed in your Imaging Department (FTEs = Full Time Equivalent), for each site you may operate, and whether the operation of the scanner(s) and the reporting are done in-house, partly outsourced to a third party provider (supplementing in-house staff) or fully outsourced to a third party provider.
Please describe the availability of free space you currently have within the radiology / imaging sites of your trust, and whether it would be sufficient to add an additional MRI scanner (assuming an increase in demand would require one additional scanner).
Please provide the list of activities (clinical and non-clinical areas) for which your trust (partly) relies on the use of third party providers, and whether those activities have been outsourced to a third party provider outside the hospital ground or within the existing premises.

Download response MRI equipment and activity 070317

MRI scanners. 200417

1. What make/model are your existing MRI scanners?
2. When were they installed?
3. When are they due for renewal?

Download response MRI scanners. 200417

MRI scanners. 310118

For each scanner operated anywhere by your Trust
1. Manufacturer?
2. Model?
3. Software version?
4. Do your scanners have fast T1 mapping capacity?
5. Located in which hospital within Trust?
6. Acquisition year?
7. How it was financed (owned by Trust, leased or held under Managed Equipment Service (‘MES’) arrangements)?
8. If MES, which provider do you use?
9. What year will the equipment be replaced?
10. Is maintenance done by the Trust, by the Manufacturer or by 3rd party provider?
11. If 3rd party provider which provider do you use?
12. What are the operational hours of the equipment?

Download response MRI scanners. 310118

MRI scans 111116

1. What is the current waiting time (in weeks) for a routine MRI scan? What is the current trust waiting time (in weeks) targets for a routine MRI scan?

2. Does the trust hire in any private mobile MRI scanners to meet the existing workload? Or do they send any NHS patients to private centres for their scans?

Download response MRI scans 111116

MRI scans 2016. 070417

A- What is the total number of MRI scans performed by your trust between 1st Jan 2016 and 31st Dec 2016?

B- Of these scans please can I have a breakdown on how many are scans of the brain, IAMS, Cervical spine, Lumbar spine, Hip, Knee, Ankle, Foot, Shoulder, Wrist, Elbow, Hand, Thumb and Finger.

Download response MRI scans 2016. 070417

MRI scans under general anaesthetic. 070417

1. How many patients each year have required an MRI under general anaesthetic in the following years?
a. 2016/17
b. 2015/16
c. 2014/15

2. What is the total approximate cost of these scans in each of the above years?

download response MRI scans under general anaesthetic. 070417

Multiparametric MRI. 070317

Please find attached a copy of your letter in response to a “freedom of information” request. Please can you explain the answer at point 1 in your letter which, at best seems factually incorrect and at worse, deliberately misleading.

Your letter clearly states at point 1 that the Trust does provide multi-parametric MRI scans prior to biopsies but, I have been told by the consultant at Maidstone Hospital that only larger tumours will be detected thereby. I have been advised that there are no machines suitable for mpMRI scans at either Maidstone or Tunbridge Wells hospitals.

The web-site here seems to be clearly relying on the information provided in your letter – https://public.tableau.com/profile/ali.cooper#!/vizhome/mpMRIFOIpublicdashboard-ProstateCancerUK_0/FullresultsStory as shown by the map excerpt below.

Download response Multiparametric MRI. 070317

Multiparametric MRI usage data.

1. Do you conduct multi-parametric MRI (mpMRI) scans (using T2-weighted, diffusion-weighted and dynamically enhanced sequences) before prostate biopsies?
If no, it would be helpful to know what the main reasons are:
If yes, it would be helpful if you can you provide an estimate of the percentage of men who receive an mpMRI scan before prostate biopsy:
2. How many scanners do you have available to use for mpMRI scans before prostate biopsy?
3. For each individual scanner used for mpMRI scans before prostate biopsy, please provide the following:
• Make
• Model
• Magnetic field strength
• Age
• When the scanner is due to be replaced
4. How many mpMRI scans before prostate biopsy do you estimate you carry out per year?
• 0
• Up to 50
• 50 -100
• 100 – 250
• 250 – 500
• 500 – 750
• 750 – 1000
• More than 1000
5. i. Do you intend to increase the number of mpMRI scans before prostate biopsy following the first results from the large clinical trial PROMIS?
The ASCO 2016 abstract has shown mpMRI as a triage test can identify one quarter of men (27%) who might safely avoid unnecessary biopsy, without impairing the detection of clinically significant cancer (http://abstract.asco.org/176/AbstView_17…).
5. ii If yes, do you currently have sufficient resources and capacity to cope with this increase?

Download response Multiparametric MRI usage data 270616

Multiple Sclerosis 031016

In your trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months, latest 6 months that you can provide?
Please provide the number of patients by treatment for the following disease modifying drugs.
Aubagio (Teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (Glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (Fingolimod)
Lemtrada (Alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (Natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a (Plegridy)
Daclizumab (Zinbryta)
Others

Download response Multiple Sclerosis 031016

Multiple Sclerosis and MRI

Number of patients with an annual review in the last 12 months and number of patients with an MRI in the last 12 months being treated with the following products:
· Tysabri
· Gilenya
· Interferon beta 1a
· Interferon beta 1b
· Copaxone
· Lemtrada
· Tecfidera
· Aubagio
· Plegridy
I would also like to request the following information on patient numbers:
· Number of new MS diagnoses
· Number of patients who have had a relapse in the above month
· Number of relapse events in the above month
I would like this information for the period March 2015 to February 2016, broken down by month

Download response Multiple Sclerosis and MRI 270516

Multiple Sclerosis patients 160916

Please see attached for form to fill in to respond to an FOI request regarding the number of patients treated in your trust for the names drugs. I am also interested in knowing the number of new MS diagnoses, MRI scans and the total catchment population of the trust.

Download response Multiple Sclerosis patients 160916

NHS Imaging Infrastructure

For each scanner operated anywhere by your Trust
Q1. Equipment type (CT or MRI)?
Q2. Manufacturer?
Q3. Model?
Q4. Located in which hospital within Trust?
Q5. Acquisition year?
Q6. How was it financed (owned by Trust, leased or held under Managed Equipment Service (‘MES’) arrangements)?
Q7. If MES, which provider do you use?
Q8. What year will the equipment be replaced?
Q9. Is maintenance done by the Trust, by the Manufacturer or by 3rd party provider?
Q10. If 3rd party provider which provider do you use?
Q11. What is the annual maintenance cost for the relevant scanner?
Q12. What are the operational hours of the equipment?

Download response NHS Imaging Infrastructure 230516

Occupational Therapists 2011-2017. 310317

1. How many occupational therapists were/are employed within your Trust in each of the following financial years, in working time equivalent format: 1) 2011/12; 2) 2012/13; 3) 2013/14; 4) 2014/15; and 5) 2016/17 budgeted?

2. What was the total amount spent on occupational therapy services within your Trust in each of the following financial years: 1) 2011/12; 2) 2012/13; 3) 2013/14; 4) 2014/15; and 5) 2016/17 budgeted?

3. Of these, how many occupational therapists were/are working on acute medical wards in each of the following financial years, in working time equivalent format: 1) 2011/12; 2) 2012/13; 3) 2013/14; 4) 2014/15; and 5) 2016/17 budgeted?

4. Of these, how many occupational therapists were/are working in Accident & Emergency departments in each of the following financial years, in working time equivalent format: 1) 2011/12; 2) 2012/13; 3) 2013/14; 4) 2014/15; and 5) 2016/17 budgeted?

Download response Occupational Therapists 2011-2017. 310317

Occupational Therapy Lead 150217

Do you have an occupational therapy lead for the Trust? If so, please provide their name, job title and contact information (including email address, postal address and contact phone number).

Download response Occupational Therapy Lead 150217

Ocriplasmin (Jetrea) treatment. 110717

We are trying to understand the cost effectiveness of Ocriplasmin (Jetrea) treatment for vitreo-macular traction.

We would like to obtain data regarding the number of injections performed, and possibly cost, of this treatment in your Trust, should you have ever provided it.

The time frame would be 01/01/2016 to 31/05/2017, if possible divided by month, otherwise just a total number will suffice.

Download response Ocriplasmin (Jetrea) treatment. 110717

Omnicell Medicine Cabinet. 270618

1. Can you please tell me if your hospital/trust uses Omnicell Medicine cabinets?
2. Have you taken disciplinary measures against any staff (or agency staff) resulting from the use, or the reports generated, of the Omnicell System.

Download response Omnicell Medicine Cabinet. 270618

Outbreaks of resistant organisms 2012-2016. 280217

In the last five years, please list each outbreak the trust has declared due to the following organisms:
– Vancomycin-resistant enterococci
– Methicillin-Resistant Staphylococcus aureus (MRSA)
– Extended-spectrum β-lactamase (ESBLs) producing Gram-negative bacteria
-Carbapenem resistant enterobacteriaceae
-Carbapenemase producing organism
-Drug resistant Acinetobacter
-Drug resistant pseudomonas

For each case please specify
-The organism causing the outbreak (eg for carbapenemase producing organisms specify Klebsiella pneumoniae carbapenemase)
-Date the outbreak was declared and date it was declared over
-Number of confirmed cases and number of probable cases
-Description of control measures, eg whether wards were closed, patients put in isolation rooms, hydrogen peroxide vapour used to clean rooms etc. For ward closures please give details of ward type and size (eg 30-bed renal ward)
-Whether the outbreak was reported to Public Health England, and if so, the date it was reported
-Date audit report, outbreak investigation, infection control committee report (or equivalent report) was published
-Number of bed days lost
-Number of patient deaths

Download response Outbreaks of resistant organisms 2012-2016. 280217

Ozudex (Dexamethasone) Implants. 040917

In relation to Ozudex (Dexamethasone) Implants, in your response you indicate that you cannot break their use down by indication. As such I was wondering if the total used for any indication could be given instead for this implant.

Download response Ozudex (Dexamethasone) Implants. 040917

PACS and medical monitors. 301117

1. Which company is the current PACS system provider for the trust?
2. When will the current PACS contract end?
3. Roughly how many reporting workstations the X-Ray department currently have?
4. When the current medical monitors are due to refresh?
5. The contact details of the PACS manager.

Download response PACS and medical monitors. 301117

Pathology. 300518

1. The name and email address of your Clinical Director of Pathology
2. The name and email address of your Service manager of Pathology
3. The name and email address of your Lead Pathologist

Download response Pathology. 300518

Pathology integration projects. 300518

1. Can you please tell us whether your Pathology department is currently working on any integrated care projects, such as:
a) Creating a single, integrated pathology service with partnering organisations, or;
b) Creating bi-directional interfaces between systems e.g. sharing Pathology data with A&E or GP systems
2. If you answer yes to any of the above, please can you provide the name of the contact who is leading on this project and their contact email address?
3. If you answered yes to Q1, will your Organisation be procuring for external integration services to assist with these projects?

Download response Pathology integration projects. 300518

Pathology Services

We are carrying out a short survey to understand the impact of Lord Carter’s reviews and the HSCA 2012 on pathology services across England and the potential role of private providers.
For pathology services, we are considering the following laboratory diagnostic specialties: Chemical pathology/Clinical biochemistry, Haematology, Medical Microbiology and Virology, Histopathology.
Under the Freedom of Information Act 2000 we seek the following information within your NHS Trust/NHS Foundation Trust:

Download response Pathology Services 040216

Pathology Services – Follow up request

6. What is your current total budget for pathology services (in GBP) including laboratory staff?
________________________________________
7. In the year 2010, what was your total budget for pathology services (in GBP) including laboratory staff?

Download response Pathology Services – Follow up request 270516

PD-L1 testing

I would like to access information with regard to PD-L1 testing offered by your institution as detailed in the document attached; this testing will likely be performed in pathology/histopathology laboratories. If your institution does not currently offer PD-L1 testing in-house then I would please ask that the request is still sent to the relevant laboratory as there are questions included regarding whether they send samples for this testing to be conducted in other laboratories and also whether they have any plans to introduce this testing in-house in the future. If your institution does not in fact have any testing laboratories then do please let me know.

Download response PD-L1 testing 290616

PDL1 testing. 070417

1. Do you currently offer a clinical testing service for PD-L1 in non-small cell lung carcinoma (NSCLC) as off the beginning of 2017?
2. How is PD-L1 testing in NSCLC normally requested by the clinician? (please select all that apply)
3. If requested as part of a NSCLC panel of tests, how is PD-L1 testing performed in the lab
4. What sample types are processed by the lab for NSCLC testing (EGFR/ALK/PD-L1)? (please select all that apply)
5. What is the number of NSCLC samples being tested (or sent-out) are tested for:?
6. What proportion of PD-L1 NSCLC samples tested are cytology/ cytological cell block samples? (per month or per year or as a percentage of PD-L1 samples tested, whichever is easier to determine)
7. What proportion of PD-L1 NSCLC samples are NOT tested because the samples are EBUS/cytology samples? (per month or per year or as a percentage of PD-L1 samples tested, whichever is easier to determine)
8. What methods are used for PD-L1 testing in NSCLC and their associated clinical cut-off? (please select all that apply)
9. What is the clinical cut offs are used in relation to the antibodies selected above?
10. What IHC staining platform(s) are used in the laboratory that performs the PD-L1 testing e.g. Ventana, Dako, Leica, Menarini, Shandon, Labvision, etc? (If possible, please supply the model of the platform)
11. What percentage of samples tested have ≥1% PD-L1 expression?
12. What percentage of samples tested have ≥50% PD-L1 expression?
13. What is the average turnaround time from sample receipt to report being issued?
14. Are there bottlenecks that prevent this turnaround time from being quicker?
15. Who pays for DLBCL testing?

Download response PDL1 testing. 070417

PET CT services – Alliance Medical.

For the purposes of the questions below, ‘Provider’ = Alliance Medical.
In respect of each of your Trust locations, please advise as follows. For ease of completion I have provided a table to populate with your answers:-
1. Has a services agreement between the Provider and your NHS Trust been executed covering all of the services to be provided by the Trust to the Provider and/or otherwise governing the terms of the Provider’s occupation or use of the site?
2. Has a final agreement been reached and executed between the Provider and the Trust for the provision of new PET CT scanning facilities, whether by way of construction on the acute Trust site or refurbishment of existing facilities?
3. Where the Provider plans to occupy facilities constructed or refurbished since contract commencement on 1 April 2015, what is the actual or proposed term of the lease/licence permitting that occupation?
4. Does the lease contain any break clause and if so, at what periods is it exercisable?
5. Is there any residual value payment associated with the expiry or earlier termination of such lease or licence?
6. On what date are services expected to commence from purpose built new facilities at each site (as envisaged by the press release for this contract)
7. Is implementation of the PET CT service at your Trust in line with your expectations (in terms of timing, responsibilities or otherwise) of the overarching contract entered into for PET CT Services by NHS England?

Download response PET CT services – Alliance Medical 180516

Pet Therapy

1) Has the Trust ever used any form of pet therapy or animal assisted therapy in your hospitals?

2) If your Trust has used such services how have they been provided to the Trust i.e. Voluntary or funded by the Trust and has this remained the same or changed between voluntary and funded?

3) What do you estimate the cost to be to the Trust of using animal assisted therapy by year for the last 5 years (if applicable?)

4) Who is responsible within the Trust for organising Pet Therapy Services?

5) What policies and procedures have been put in place as safeguards for using animals in hospitals?

6) What qualifications / certifications does the Trust expect therapy animals to hold to guarantee patient safety?

Download response Pet Therapy 060916

PET/CT scanner and ancillary facilities.

I write to request an up to date list of contractors, subcontractors, suppliers and consultants & their telephone numbers involved with the Single storey hospital building to house PET/CT scanner and ancillary facilities.

Maidstone Hospital, Hermitage Lane, Maidstone, Kent, ME16 9QQ

Download response PET/CT scanner and ancillary facilities 010816

Pharmacy department 150217

1. How many permanent staff are employed by the pharmacy department?
2. How many permanent vacancies are currently open/unfilled within the pharmacy department?
3. How many agency staff/locums are currently being used across the pharmacy department?
4. How many bank temps are being used across the pharmacy department?
5. During the 2015-2016 financial year, how much did the pharmacy department spend on temporary agency staff?
6. During the 2015-2016 financial year, how much did the pharmacy department spend on temporary bank staff?
7. During the 2015-2016 financial year, how much did the pharmacy department spend on permanent finders/introduction fees through recruitment agencies
8. Does the pharmacy department utilise frameworks for temporary staffing? If so, which framework is of choice?
9. Does the pharmacy department book agency staff direct with agencies or do all bookings run through a centralised temporary staffing team?
10. Does the pharmacy department work within a master vendor agreement or managed service agreement?
11. Which agencies does the pharmacy department use for temporary/locum staff?
12. Please provide me with the following contact names within the authority:
a) The name of the senior manager (Chief Pharmacist/Director of Pharmacy) with overall responsibility for the pharmacy department.
b) The name of the head of temporary staffing.

Download response Pharmacy department 150217

Pharmacy Management and staff structure. 010318

1. Copy of pharmacy management structure
2. Total WTE of pharmacists and pharmacy technicians
3. Total WTE consultant pharmacist posts, and their areas of speciality
4. Copy of Job Description for:
a. each Consultant Pharmacist post
b. Chief Pharmacist / Director of Pharmacy Name

Download response Pharmacy Management and staff structure. 010318

Pharmacy staffing structure

I would like to make a freedom of information request for the following information:-

– A detailed breakdown of current locum staff at each hospital by job title in the pharmacy department (for example At —— Hospital we have – Locum pharmacists, — Locum technicians and — Locum ATOs.)

– Management structure and contact names within the pharmacy department

Download response Pharmacy staffing structure 271115

Physiotherapy appointments. 31.01.17

1 How many physiotherapy appointments are made each Year with the Hospital/Trust?
a. How many of these are postponed/re-appointed for a later date
b. How many are cancelled
c. How many are DNA
2 How much is the Trust paid for each Physiotherapy appointment by the CCG (please indicate if there are different tariffs with different CCGs)
a. For the initial appointment
b. For the follow-up appointments
c. Is the Trust paid for cancellations?
3 How many referrals are from Acute Medicine (ED/Fracture/Ortho) to the Physiotherapy department are there per Year and how many from Primary Care.
4 Does the Trust work with any none NHS rehabilitation partners?
a. Please identify which speciality for rehabilitation
b. Please indicate the organisation
5 What is the mean and modal average waiting time (in days) for a physiotherapy appointment from initial referral from an NHS service (GP/Acute/other) to receipt on initial treatment at the physiotherapy department?
a. How are changes of appointment communicated?
6 For those attending a timed/scheduled/booked appointment at the physiotherapy department
a. how many are treated at that time stated on the appointment
b. For those not treated at the booked time, what is the average waiting time discrepancy from scheduled appointment to actual appointment
c. How long is the mean and modal average scheduled appointment time (in minutes)
i. How long is the actual mean and modal appointment (in minutes)
d. How many patients’ appointments re-scheduled after turning up at the booked time, but are unable to be seen due to delays
7 Does the Trust face any penalties for cancelations/re-scheduling appointments from Government/NHS/CCG?
8 What is the Trusts official stance on referrals to Private Physiotherapy services?
9 Does the Trust offer any private/paid for physiotherapy/rehabilitation service?

Download response Physiotherapy appointments. 31.01.17

Physiotherapy Services. 280917

VACANCIES
Request 1
a) Please confirm how many whole time equivalent physiotherapist and physiotherapy support worker vacancies were held in Maidstone and Tunbridge Wells NHS Trust as at 31 March 2017.
b) Please confirm how many of the posts in Request 1a had been vacant for 3 months or more as at 31 March 2017.

POSTS
Request 2:
Please confirm how many whole time equivalent (WTE) physiotherapists and physiotherapy support workers were employed by Maidstone and Tunbridge Wells NHS Trust on the 31 March 2017. (This should include any generic assistant or technical instructor posts that support physiotherapy service provision).

PATIENT DEMAND
Request 3:
Please confirm the number of new referrals (including patient self-referral) to physiotherapy services in Maidstone and Tunbridge Wells NHS Trust, in the following financial years:
• 1 April 2016 to end of 31 March 2017
• 1 April 2015 to end of 31 March 2016
• 1 April 2014 to end of 31 March 2015

SPENDING
Request 4:
Please confirm how much was spent on physiotherapy agency/locum/temp staff in Maidstone and Tunbridge Wells NHS Trust, in the following financial years:
• 1 April 2016 to end of 31 March 2017
• 1 April 2015 to end of 31 March 2016
• 1 April 2014 to end of 31 March 2015

PRACTICE BASED LEARNING
Request 5:
Please identify the clinical areas within your physiotherapy services that provide placements for physiotherapy undergraduates in the last financial year (1 April 2016 to end of 31 March 2017).

MUSCULOSKELETAL (MSK) PATHWAY
Request 6:
a) Please confirm/deny whether Maidstone and Tunbridge Wells NHS Trust provides MSK services that include first contact physiotherapists in General Practice
b) Please confirm/deny whether patients can self-refer to physiotherapy services within the MSK services provided by Maidstone and Tunbridge Wells NHS Trust

Download response Physiotherapy Services. 280917

Podiatry services 2013-2017. 200417

1. The services of how many podiatrists across all podiatry services were engaged by your trust in each of the following fiscal years 1) 2013-14; 2) 2014-15; 3) 2015-16; 4) Budgeted for 2016-17; all in (i) Working Time Equivalent and (ii) Headcount format

2. How many referrals were made from NHS services at your trust to private podiatric services in each of the following fiscal years 1) 2013-14; 2) 2014-15; 3) 2015-16; 4) Budgeted for 2016-17, and how much did these referrals cost the trust in each such year?

Download response Podiatry services 2013-2017. 200417

Policies and Procedures – Prescribed Drugs

I am writing to you to request the provision of several documents from the Trust approved document management database which relate to the main policies and procedures in place.

If at all possible, please could you provide the following documents (unique ID in brackets):

1. Critical Medicines where Timeliness of Administration is Crucial (RWF-OWP-APP299);
2. Critical Medicines Loading Doses (RWF-OWP-APP300);
3. Standard Operating Procedure for Prescribing, Preparing and Administering Injectable Medicines in Clinical Areas (RWF-OPPM-CSS2);
4. Standard Operating Procedures for the Management of Controlled Drugs in Operating Theatres (RWF-OPG-CSS4);
5. Standard Operating Procedures for the Management of Controlled Drugs in Wards and Departments (RWF-OPG-CSS5); AND
6. All of the above policies as in place on February and March 2014, if different from the above.

Download response Policies and Procedures – Prescribed Drugs 311215

Post CCT doctors in Radiology.130417

Please provide details of all the current filled training fellowship posts (or other similar training programmes for post CCT doctors) within your Radiology departments.
Please provide:
1. Start dates of current posts
2. End date of current posts
3. The sub-specialist interest under ophthalmology the training post is within (example: MSK, Breast Imaging, Paediatric Radiology…)

Download response Post CCT doctors in Radiology.130417

Provision of Physiotherapy services 031016

1. The number of patients on the waiting list for an appointment with a physiotherapist at the year-end 31st March in each year between 2006 and 2016.
2. The average waiting time for a physiotherapist appointment in each financial year from 2006 to 2016.
3. Annual expenditure on physiotherapy in the trust each year from 2006 to 2016.

Download response Provision of Physiotherapy services 031016

Radio Frequency Identification (RFID) technology. 111116

1. How many beds are in your trust?
2. How many Medical Devices are managed by your trust?
3. How many Clinical Technicians/Engineers are in your Trust?
4. Do you use RFID tracking technology, if yes, Please answer the below questions.
a. For what purpose do you use RFID? (i.e. Records, Patients, Medical Devices, Security etc.)
b. What were the initial setup costs of the supplier? (0-10k, 10-20k, etc.)
c. How many medical devices are tagged?
d. Do you use Passive or Active Tagging?
e. Approximately how long does it take to perform a ward audit using RFID?
f. What are the main medical device types tagged?
5. How long does it take your EBME department to perform a ward audit (for Non-RFID users)?

Download response Radio Frequency Identification (RFID) technology. 111116

Radiology. 210218

1. The name and email address of the Clinical Director responsible for Radiology
2. The name and email address of your Radiology Manager
3. The name and email address of your Imaging/Radiology Directorate Manager

Download response Radiology. 210218 

Radiopharmaceuticals. 270617

Pertains to four main radiopharmaceutical isotopes (radio-isotopes) used for PET-CT scanning:
18F-Fluorodeoxyglucose = FDG
18F-Choline = FEC for the diagnosis of prostate cancer
18F-Sodium Fluoride = NAF for the diagnosis of skeletal cancers
18F-Florbetaben = FBB for the diagnosis of Alzheimer’s
* includes academia and commercial

Question Set 1
Please provide information for the questions below
SUPPLIER INFORMATION
Who is your Radiopharmaceuticals supplier?*
Postcode of supplier
Annual order size (£/year)

Question Set 2
Please provide information for the questions below
CURRENT PURCHASED VOLUMES
18F-Fluorodeoxyglucose (FDG) (kg/month)
18F-Choline (FEC) (kg/month)
18F Florbetaben (FBB) (kg/month)
18F-Sodium Fluoride (NAF) (kg/month)
CURRENT AVERAGE PURCHASE PRICE
18F-Fluorodeoxyglucose (FDG) (kg/month)
18F-Choline (FEC) (kg/month)
18F Florbetaben (FBB) (kg/month)
18F-Sodium Fluoride (NAF) (kg/month)

Question Set 3
Please describe the procurement structure of your radiopharmaceuticals (ie, procurement buying-groups; tenders?)

Question Set 4
Please describe the tariff structure for radiopharmaceuticals (i.e., how do prices of radiopharmaceuticals change with the quantity bought?)

Question Set 5
When assessing the supply of FDG 18
What drives your choice of supplier? Please state your purchase criteria
When assessing the supply of FBB
What drives your choice of supplier? Please state your purchase criteria

Download response Radiopharmaceuticals. 270617

Ribavirin 200mg, 400mg and 600mg. 270617

I am writing to request hospital prescribing data for Ribavirin 200mg, 400mg and 600mg (Tablets and Capsules). The data is required for all generic and branded prescriptions and should have the below information:

Coverage period: January 1, 2015 to December 31, 2015
BNF Code
BNF Presentation Name
Net Ingredient Cost in £s.
Quantity Prescribed.

Download response Ribavirin 200mg, 400mg and 600mg. 270617

Rosuvastatin (Generic) and Crestor Tablets (April 2016 – March 2017).

I am writing to request details of the number of tablets prescribed for below products by your Trust. The period for which data is being requested is April 2016 – March 2017:
• Rosuvastatin Tablets 5mg
• Rosuvastatin Tablets 10mg
• Rosuvastatin Tablets 20mg
• Rosuvastatin Tablets 40mg
• Crestor Tablets 5mg
• Crestor Tablets 10mg
• Crestor Tablets 20mg
• Crestor Tablets 40mg

Download response Rosuvastatin (Generic) and Crestor Tablets (April 2016 – March 2017).

Scanners 150217

Question 1
How many of the following scanners do you operate in your Trust?
Question 2
For each scanner, could you please fill in the table below with the requested information?
Question 3
Have you used a mobile MRI or CT scanner in the last 12 months? If yes, approximately how many scans were undertaken on a mobile scanner in the last 12 months, and which provider was used?
Question 4
If so, what was the primary reason for using mobile services? (Please allocate an approximate % if multiple reasons)
Question 5
If a mobile scanner has been used in the last 12 months:
– What is the main reason why a new static scanner has not been installed to serve this volume? (Please allocate an approximate % if multiple reasons)
Question 6
Is your Trust planning on installing a new scanner, a new mobile scanner or adding third-party operated scanners, in the next 12 months? If so, is this as a replacement for a scanner already in your Trust?
Question 7
How much do you spend on outsourced radiology reporting, by hospital (or across Trust if not broken down at hospital level)?

Download response Scanners 150217

Secondary Care medicines. 310118

Please provide the medicine usage information according to Freedom of Information act for the below mentioned Anti Biotics during the past 5 years 2011/12, 2012/13, 2013/14, 2014/15, 2015/16.
It would be much appreciable if you can provide the pack size information of the usage if possible
1. *Cefuroxime powder for injection or infusion*
*250/750/1500 mg vials.*
2. *Ceftriaxone powder for injection or infusion 1gram and 2 gram vials.*
3. *Ceftazidime powder for injection or infusion*
*500/1000/2000 gram vials*
4. *Cefotaxime powder for injection or infusion*
5. *Meropenem powder for injection or infusion*
*500/1000 gram vials*
6. *Imipenem Cilastatin powder for injection or infusion*
*250/250 mg and 500/500 mg vials*
7. *Piperacillin Tazobactam powder for injection and infusion
4gram/500mg vials.*”

Download response Secondary Care medicines. 310118

Severe Asthma patients. 311017

1.) How many adult severe asthma patients have been seen via both in-patient visits and outpatient clinics in the last 3 months?
2.) How many adult severe asthma patients have you treated with a biologic in the last 3 months?
3.) Of these patients treated, can you provide which drugs they were treated with, as follows:
• Omalizumab (Xolair)
• Mepolizumab (Nucala)
• Resilizumab (Cinqaero)

Download response letter Severe Asthma patients. 311017

Sodium Hyaluronate eye drop.270218

1. How much did your organisation spend on Sodium Hyaluronate eye drop formulations between the period of 01/01/2017 to 31/12/2017?
2. Between the period 01/01/2017 to 31/12/2017, which brand(s) of Sodium Hyaluronate eye drop formulations did you use?
3. How many units of each brand did you use?

Download response Sodium Hyaluronate eye drop.270218

Speech therapy for patients with Parkinson’s Disease.

– How much of your budget in monetary and percentage terms is allocated to support for Parkinson’s?
– Do you provide speech therapy within your Parkinson’s services?
– If so, how much of your budget in monetary and percentage terms was allocated to speech therapy services in 2010, 2011, 2012, 2013, 2014, and 2015?
– How regularly do Parkinson’s patients have access to NHS funded speech therapy?
– How many Parkinson’s patients have you treated on average over the past five years?
– How many speech therapists do you provide funding for? Has this number increased or decreased in the past five years?

Download response Speech therapy for patients with Parkinson’s Disease 280416

Staff details and structure chart for Pharmacy department March 2016

Please provide me with:
1. The name of your Head/Director of Pharmacy (or Chief Pharmacist)
2. Structure chart of your pharmacy department
3. Total number of pharmacists, pharmacy technicians, pharmacy assistants and administrative staff in the dept.

Download response Staff details and structure chart for Pharmacy department March 2016 300316

Sterile Services 281116

Name of your Trust
Number of hospitals you provide sterile services to
Number of instruments processed each year?
Number of trays processed each year?
What is the sterilisation cost (in £’s) per instrument? Please provide breakdown if dependent upon tray size
Which specialty has the highest instrument sterilisation requirement?
Are your sterile services, on site or off site?
Are you sterile services in house or out sourced?
What is the isolated cost of sterilising loan trays/instruments in 2015?
If in house
total annual cost 2015 excluding staff
total annual cost 2015 including staff
Number of staff?
Total number of hours over-time paid 2015?
If off site
What is the distance to the off site?
What is the carriage cost incurred? Please provide breakdown if needed.
If outsourced
What is the total annual cost to fast track instrument trays?

Download response Sterile Services 281116

Sterilisation equipment

1. Please enter the name of your Hospital or Trust
2. Does your Trust sterilize your own surgical instruments and packs?
3. How many floor & pit mounted steam sterilizers are installed in your Trust?
4. How many tabletop steam sterilizers are installed in your Trust?
5. How many ethylene oxide sterilizers are installed in your Trust?
6. How many hydrogen peroxide plasma sterilizers are installed in your Trust?
7. Do you have any other types of sterilizers? If you do, could you please indicate the type and installation number?

Download response Sterilisation equipment 270616

Sterilisation unit for sterilisation of surgical instruments and implants November 2015

1. Is the current sterilisation unit for sterilisation of surgical instruments and implants used by the trust an in-house facility or do you currently pay a privately owned sterilisation unit to sterilise the trusts surgical equipment?

2. What is the cost to the trust for sterilisation per surgical tray?

3. Is this cost dependent on number of instruments per tray and what is the costing per banding for each quantity of instruments per tray?

Download response Sterilisation unit for sterilisation of surgical instruments and implants November 2015 201115

Sugammadex. 270218

• Do you buy a reversal drug in anaesthesia called Sugammadex.
• Can you advise quantities brought annually per year for the last 3 years.
• Can you advise of total spend annually per year for the last 3 years.

Download response Sugammadex. 270218 

TARGeted Intraoperative Radiotherapy

For Maidstone and Tunbridge Wells NHS Trust (and any previous iterations of it) the number of early breast cancer cases treated at the Trust with TARGeted Intraoperative Radiotherapy (also known as Intrabeam or TARGIT IORT) for each year from January 2000 to the date of this request. Please identify the number of cases in each year which were delivered as part of a clinical trial and the number which were delivered as treatment which was not part of a clinical trial.

For the Trust, the date at which the Trust or Clinical Commissioning Group purchased equipment able to deliver TARGeted Intraoperative Radiotherapy, the price paid for that equipment and the name of the organisation from whom it was purchased.

Download response TARGeted Intraoperative Radiotherapy 220216

Testing services for cancer indications and therapies.

Do you currently offer a companion diagnostic (stratified medicine) testing services for the following cancer indications and therapies? If so I would be grateful if you could please indicate which tests are offered, the charge per patient test (ideally a comment on what the overhead/kit breakdown of the test cost) and the number performed per year January-December (or month if easier – please specify in comments). The brand name of the test used or any information regarding commercial partnerships would also be appreciated to be included in the comments.

Test Types: IHC = Immunohistochemistry, FISH = Fluorescent In-Situ Hybridization, PCR = Polymerase Chain Reaction, Pyro= Pyrosequencing, NGS = Next Generation Sequencing. If the lab performs another test type or the test is linked to another oncological therapy not listed please check “Other” and include it in the comments section.

Download response Testing services for cancer indications and therapies 270616

The Patient Access Schemes Liaison Unit (PASLU). 011216

In order to assist the PASLU in finding new members, I would be extremely grateful if you could supply the contact details of your chief pharmacist or equivalent role within the trust so that the offer to join the NRG can be extended to them. More information regarding the PASLU and the NRG will then be sent to them directly.

Download response The Patient Access Schemes Liaison Unit (PASLU). 011216

The use of immunotherapy products

Please can you supply the total number of items purchased by product for immunotherapy in an allergy indication. E.g. GRAZAX 75,000 SQ-T oral lyophilisate. Please supply a full list of products used and the number of items for the last 12 months within your trust.

Download response The use of immunotherapy products 021215

Theranos’ Edison blood-testing machines 150916

I would like to know how much the trust has spent on Theranos’ Edison blood-testing machines since the beginning of 2012. I would also like to know if there were any planned investments on the products or any investigations into the results they produced.

Download response Theranos’ Edison blood-testing machines 150916

Total spend on sterilisation in 2014

What was the trusts total spend on sterilisation in 2014?

What was the trusts spend on sterilisation of Orthopaedic equipment in 2014?

How many instruments sets in 2014 had to be fast tracked, i.e. sterilized at a higher cost to be returned to theatres in a shorter time frame than usual?

How long is the current sterilization service contracted until?

How many trays in 2014 were returned to the account non-compliant? What were the reasons for the sterilised trays being classed as non-compliant?

Download response Total spend on sterilisation in 2014 130116

Trust imaging infrastructure.

Equipment type (CT or MRI):
Manufacturer:
Model:
Located in which hospital within Trust:
Acquisition year:
How it was financed (owned by Trust or leased via MES):
If MES which provider do you use:
What year will the equipment be replaced?
Is maintenance done in-house or by 3rd party provider?
If 3rd party provider which provider do you use?
What is the annual maintenance cost?
What are the operational hours of the equipment?

Download response Trust imaging infrastructure 180516

Urine cultures January to December 2015

• How many urine samples were tested for Culture and Sensitivity in the last full year that the Trust has records for
• How many of these samples showed signs of mixed growth

Download response Urine cultures January to December 2015 220216

Uveitis with a biologic treatment, including those on a Patient Access Scheme.

In your Trust please supply the number of patients currently treated for Uveitis with a biologic treatment, including those on a Patient Access Scheme.

Please state the number of Uveitis patients treated, and where possible by each biologic drug:
· Adalimumab
· Etanercept
· Infliximab
· Rituximab
· Other biologics

How many Psoriasis patients have been treated in the last 6 months with Fumaric acid esters (Fumaderm), If your trust can’t supply patients, please supply the number of packs of tabs

Download response Uveitis with a biologic treatment, including those on a Patient Access Scheme 270516

Vials/Implants for Wet Age Related Macular Degeneration (wAMD)

Within your organisation how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between September and December 2015?

Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Implants Lucentis (ranibizumab) Injections Ozurdex (Dexamethasone) Implants
Total Vials/Implants
Vials/Implants for Wet Age Related Macular Degeneration (wAMD)

Download response Vials/Implants for Wet Age Related Macular Degeneration (wAMD) 030216

Viscosupplementation. 210318

1. Does your organisation use/perform Viscosupplementation injections?
2. If so, how much did your organisation spend on Viscosupplementation injections between the period of 01/01/2017 to 31/12/2017?
3. If your organisation used Viscosupplementation between the period 01/01/2017 to 31/12/2017, which brand(s) Viscosupplement did you use?

Download response Viscosupplementation. 210318

Viscosupplementation Injections 2015 – 2017.

1) Does your organisation use/perform Viscosupplementation injections?

2) How much has your organisation spent in the financial year 2015/16 and 2016/17, on Viscosupplementation?

3) Which (brands) Viscosupplements have been use in the financial year 2016/17?

Download response Viscosupplementation Injections 2015 – 2017.

Viscosupplementation injections. 240717

1. Does your organisation use/perform Viscosupplementation injections?
2. If so, how much did your organisation spend on Viscosupplementation injections between the period of 01/01/2016 to 31/12/2016?
3. If your organisation used Viscosupplementation between the period 01/01/2016 to 31/12/2016, which brand(s) Viscosupplement did you use?

Download response Viscosupplementation injections. 240717

Vivomixx Sachets 2015. 300617

Can you please provide me with the usage statistics (number of sachets prescribed) of Vivomixx during the period January 2015 – December 2015.

Download response Vivomixx Sachets 2015. 300617

Walking frames. 090418

1. In the last 5 years, how many walking frames (including zimmer frames, wheeled walkers, rollators and pick-up walkers) and how many walking sticks have been issued to patients by your Trust? Please include separate numbers for each category of walking aid.
2. What was the total spend by your Trust on the above for each of the last 5 years? (If possible, please break this down by year and item type).
3. How many of the above have been returned to your Trust by patients over the last 5 years? (if possible, please break this down by year and item type).
4. Of those returned how many were deemed fit for re-use and how many were classed as unfit for re-issue?

Download response  Walking frames. 090418

X-ray equipment. 301117

1. Please can you provide the following information for each piece of mobile X-ray equipment within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

2. Please can you provide the following information for each X-ray room within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

Download response X-ray equipment. 301117

 

Emergency and Medical Services

Pain relief prescriptions 031016

For each of the questions, please can you provide answers for each of the financial years 2013/14, 2014/15 and 2015/16:

1. PARACETAMOL

a. Which suppliers did you buy paracetamol from?
b. How many packets of paracetamol did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of paracetamol did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for paracetamol?
e. How much did you spend on paracetamol in total?
f. How many prescriptions in total did you make for paracetamol?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for paracetamol?

2. IBRUPROFEN

a. Which suppliers did you buy ibuprofen from?
b. How many packets of ibuprofen did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of ibuprofen did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for ibuprofen?
e. How much did you spend on ibuprofen in total?
f. How many prescriptions in total did you make for ibuprofen?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for ibuprofen?

3. ASPIRIN

a. Which suppliers did you buy aspirin from?
b. How many packets of aspirin did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of aspirin did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for aspirin?
e. How much did you spend on aspirin in total?
f. How many prescriptions in total did you make for aspirin?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for aspirin?

4. CODEINE PHOSPHATE

a. Which suppliers did you buy codeine phosphate from?
b. How many packets of codeine phosphate did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of codeine phosphate did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for codeine phosphate?
e. How much did you spend on codeine phosphate in total?
f. How many prescriptions in total did you make for codeine phosphate?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for codeine phosphate?

Download response Pain relief prescriptions 031016

Abdominal aortic aneurysms. 160518

Are you able to provide me with a copy of the protocols the Trust use in terms of monitoring Abdominal Aortic Aneurysms (AAAs)?

Download response Abdominal aortic aneurysms. 160518

Accident and Emergency Quality Indicators.

The indicators published by HSCIC’s report include:
Left department before being seen for treatment (Data quality)
– Total number of attendances in A&E HES (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Attendances with an unknown attendance disposal category
– % of attendances with unknown attendance disposal categories
– % of attendances with an attendance disposal category of “Other”
Left department before being seen for treatment (Performance)
– Total number of attendances in A&E HES (excluding planned follow-up attendances, attendances where the attendance category was unknown, and attendances where the attendance disposal category was unknown)
– Number of attendances with an attendance disposal of “Left Department before being seen for treatment”
– Left department before being seen for treatment
Re-attendance (Data quality)
– Total number of applicable attendances for this indicator (1st A&E attendance, unplanned follow up attendance and unknown attendance)
– Attendances with unknown attendance category
– % of attendances with an unknown attendance category
Re-attendance (Performance)
– Total number of attendances in A&E HES (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Number of re-attendances within 7 days of a previous attendance at A&E
– Re-attendance rate
Time to initial assessment [emergency ambulance cases only] (Data quality)
– Total number of attendances in A&E HES that were brought in by ambulance (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Attendances with an unknown duration to initial assessment
– % of attendances with unknown duration to assessment times
Time to initial assessment [emergency ambulance cases only] (Performance; minutes)
– Median
– 95th Percentile
– Longest wait
Time to Treatment (Data quality)
– Total number of attendances in A&E HES (excluding planned follow-up attendances, attendances where the attendance category was unknown, and attendances where the attendance disposal category was: Left Before Treatment, Left Refusing Treatment, or Unknown)”
– Attendances with unknown duration to treatment
– % of attendances with unknown duration to treatment times
Time to Treatment (Performance; minutes)
– Median
– 95th Percentile
– Longest wait
Total Time in A&E (minutes) [Admitted patients only]
– Median
– 95th Percentile
– Longest wait
Total Time in A&E (minutes) [Non-admitted patients only]
– Median
– 95th Percentile
– Longest wait
Total Time in A&E (Data quality) [All patients]
– Total number of attendances in A&E HES (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Attendances with unknown duration to departure
– % of attendances with unknown duration to departure times
Total Time in A&E (Performance; minutes) [All patients]
– Median
– 95th Percentile
– Longest wait

Download response Accident and Emergency Quality Indicators 290616

Accidents in the home. 071217

1. A: How many people have died in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
1. B: How many children aged 0-18 have died in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
1. C: How many people aged 65+ have died in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
2. A: How many people have attended A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
2. B: How many children aged 0-18 have attended A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
2. C: How many people aged 65+ have attended A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
3. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
3. B: How many children aged 0-18 have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
3. C: How many people over 65 years have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
4. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to leisure activities?”
4. B: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in education settings?”
4. C: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident on the road?”
4. D: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident at work?”
5. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to a fall in the home?”
5. B: How many adults over 65 have attended A&E in the past year (Oct 2016 – Oct 2017) due to a fall in the home?”
5. C: How many people have died in the past year (Oct 2016 – Oct 2017) due to a fall in the home? ”
6. A: How many cases have attended A&E in the past year (Oct 2016 – Oct 2017) with suspected carbon monoxide poisoning?”
6. B: How many cases of carbon monoxide poisoning have been treated in A&E the past year (Oct 2016 – Oct 2017)?”
6. C: How many cases have been admitted from A&E in the past year (Oct 2016 – Oct 2017) for carbon monoxide poisoning treatment?”
6. D: How many people have died in the past year (Oct 2016 – Oct 2017) due to carbon monoxide poisoning?”
7. A: How many cases of asthma have been treated in A&E the past year (Oct 2016 – Oct 2017)?”
7. B: How many cases have been admitted from A&E in the past year (Oct 2016 – Oct 2017) for asthma? ”
7. C: How many people have died in the past year (Oct 2016 – Oct 2017) due to asthma?”
8. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an electrical accident in the home?”
9. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to a burn or scalding accident in the home?
10. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an injury caused while gardening?
10. B: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident with the lawn mower?
10. C: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an injury caused by a BBQ?

Download response Accidents in the home. 071217

Acopia and-or social admission or ICD 10 code z73. 250417

With regard to A&E statistics pertaining to presenting complaints can you please provide the number of times ‘acopia’ and/or ‘social admission’ or ICD 10 code z73 were recorded as causes for
a. Admission
b. Noted in the discharge summary
c. Recorded as a diagnosis for the periods of
January 2017- March 2017
2016
2015

Download response Acopia and-or social admission or ICD 10 code z73. 250417

Acute Myocardial Infarction (AMI).

Which test(s) does the Trust use to diagnose patients who present with suspected acute myocardial infarction (AMI)? Please give details of tests used – including the brand and name of the test(s).

What, if any, guidelines or protocols does the Trust follow to support the diagnosis of suspected AMI? Please give details.

Does your Trust use early rule-out protocols to diagnose AMI? If so, please give details.

What is the average waiting time for a diagnosis following a suspected AMI at the Trust?

What is the target turn-around-time for tests used in the diagnosis of AMI in the Trust? What percentage of tests are performed within this target turn-around-time?

How long has the Trust and/or hospitals within the Trust been using their current troponin test(s)?

Download response Acute Myocardial Infarction (AMI) 211215 (AMI)

Admissions and Discharge policies and Venous Thromboembolism (VTE) policy.

Under the Freedom of Information Act, please may you send me a copy of your Admissions Policy and Discharge Policy?

If held, please may you send me your policy on preventing and treating venous thromboembolism (VTE’s).

Download response Admissions and Discharge policies and Venous Thromboembolism (VTE) policy 010216

Admissions of patients over the age of 65. 020518

1. How many people in the following categories had a fall as their primary reason for emergency admission in 2011/2012, 2015/2016, 2016/2017?
People over 65:
People over 65 and with dementia:
2. How many people in the following categories had a urinary tract infection as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:
3. How many people in the following categories had delirium as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:
4. How many people in the following categories had dehydration or gastroenteritis as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:
5. How many people in the following categories had a chest infection or pneumonia as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:

Download response Admissions of patients over the age of 65. 020518

Admissions via A&E. 210218

1. How many patients visiting A&E each week who required admission were admitted within four hours? Please also provide the total number of patients attending A&E, for context.
2. What percentage of patients who required admission were admitted within four hours?
3. What was the average (mean) length of time between arrival and admission for patients who required admission each week?
4. How many patients who required admission were in A&E for more than 12 hours? Please note, I would like the number of patients who were in the department for more than 12 hours from the time they arrived, not those who waited more than 12 hours from decision to admit to admission.
5. Each week, what was the longest amount of time a patient spent in A&E between arrival and admission? I would like to know their age and sex.
6. I would appreciate it if you could provide the same information for the financial year 2016/17, 2015/16 and so on, back as far as records allow.

Download response Admissions via A&E. 210218

A&E admissions on 8 and 9 December 2016. 080517

How many admissions happened on 8 and 9 December and at what times and how many cubicles are available in A&E.

Download response A&E admissions on 8 and 9 December 2016. 080517 

A&E admissions for people in the last year of life. 270618

1. During the financial year 2016/2017 or last full year figures, what:
a. Was the total number of emergency admissions for people in the last year of life?
b. Was the total number of emergency bed days for people in the last year of life?
2. During the financial year 2016/2017 or last full year figures, what was the total number of people in the last year of life admitted from a care home setting as an emergency?

Download response  A&E admissions for people in the last year of life. 270618

A&E agency staff 2016. 290317

1. The amount spent on employing agency/temporary/locum doctors in A&E departments in each month in 2016.
2. The number of FTE roles covered by agency/temporary/locum doctors in each month in 2016
3. The total number of FTE doctors working in the A&E department in each month in 2016.

Download response A&E agency staff 2016. 290317

A&E attendances for assault in 2016. 091216

The data we require are as follows (for period 1st January 2016 and 31st December 2016) in an electronic format that allows us to read the data into a database. Many hospitals respond to our survey and provide data in the form we require. Preferably this format is in an excel file or comma separated text file.

We require the gender of the patient (M or F), the date that they attended due to assault (dd/mm/yyyy) and their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.

To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e. 2016.

Download response A&E attendances for assault in 2016. 091216

A&E attendances for assault in 2015.

The data we require are as follows (for period 1st January 2015 and 31st December 2015)

ED attendance date
Age or date of birth
Gender
Reason for ED attendance

We also require the total ED attendances for 2015.

Download response A&E attendances for assault in 2015 080216  

A&E beds and upfront charging. 250417

Accident and Emergency

1. As of April 2010, the total number of Accident and Emergency beds within the Trust (including predecessor Trusts)
2. As of March 2011, the total number of Accident and Emergency beds within the Trust (including predecessor Trusts)
3. As of April 2017, the total number of Accident and Emergency beds within the Trust
Please split the figures for questions 1-3 into overnight beds and day-only beds. This request includes beds that were temporarily unavailable.
4. Please list any Accident and Emergency wards or units that have been permanently closed since April 2010. Please state how many A&E beds they included at point of closure.
5. Please provide the business case or management report/review underpinning each closure listed in response to question 4
6. Please list any Accident and Emergency wards or units that have been permanently opened since April 2010. Please state how many A&E beds they include.

In this request, Accident and Emergency beds, wards and units are those whose primary usage is for Accident and Emergency cases.

Upfront charging of non-residents

7. What is the Trust’s policy on treating overseas patients who are eligible to be charged upfront for care but are not able or willing to pay upfront?
8. What is the Trust’s policy on upfront charging for overseas patients where it is not possible to establish the cost of care upfront?
9. What is the Trust’s policy towards clinical staff who refuse to enforce upfront payment?
10. What is the Trust’s policy on identifying which patients need to be asked for proof of residency in relation to upfront charging, and what form does that proof take?

Download response A&E beds and upfront charging. 250417

A&E by people suffering with mental health related issues 2012-2016. 091216

How many attendances have there been at A&E by people suffering with mental health related issues (for example, categories including, psychiatric conditions, social problems, self-harm) over the last five calendar years (2012/2013/2014/2015/ January 1st – September 30th 2016)?

Please give the breakdown for under 18s and over 18s attendances (and if possible a further breakdown of ages for under 18s).

If possible, for each year, please state how many people waited longer than the four hour waiting target?

If the trust is in charge of more than one hospital, please give separate information per hospital please.

Download response A&E by people suffering with mental health related issues 2012-2016. 091216

A&E repeat attendees. 071217

For each of the following financial years – how many patients turned up repeatedly in A&E 2015-16, 2016-17 and 2017-18 to date?

1. How many patients turned up more than 10 times within a year?
2. How many patients turned up 20 times within a year?
3. How many patients turned up 50 times within a year?
4. How many patients turned up more than 100 times within a year?
5. What was the most number of occasions that a patient turned up within a year?

Download response A&E repeat attendees. 071217

A&E statistics

1. How many minors/see & treat patients are seen in the A&E per day? If no statistics available please provide an approximate amount estimated by the Clinical Lead of the department.
2. How many haematology blood test requests are sent from the A&E?
3. How many patients arrive to the A&E by ambulance?
4. How many ENPs/ANPs does the A&E employ?
5. Is the A&E paid by the CCG per patient according to the national tariff for type 1 A&Es? Are there any modifications to the tariff?
6. How big is the activity with regards to particular HRG codes in minors area? For example how many patients with VB08Z code are seen annually? Please provide figures for all A&E HRG codes.

Download response A&E statistics 010816

A&E Urgent Care and Technology. 200917

1. TOTAL Number of Attenders to A&E for the year 2015/2016
a. Of these attenders – how may attended Majors?
b. Of these attenders – how many attended Minors?
c. Of these attenders – how many attended Children’s Paed A&E?
d. Of the TOTAL attenders, how may were conveyed by ambulance?
e. Of the TOTAL attenders, how many self-presented (made their own way to A&E)
f. Of the TOTAL attenders, how many were discharged with advice only/self-discharged without being seen (metrics can be added together)
g. How many 12 hour breaches did you have?
h. How many 4 hour breaches did you have?
i. What was the primary cause of the breaches?
2. TOTAL Number of Attenders to A&E for the year 2016/2017
a. Of these attenders – how may attended Majors?
b. Of these attenders – how many attended Minors?
c. Of these attenders – how many attended Children’s Paed A&E?
d. Of the TOTAL attenders, how may were conveyed by ambulance?
e. Of the TOTAL attenders, how many self-presented (made their own way to A&E)
f. Of the TOTAL attenders, how many were discharged with advice only/self-discharged without being seen (metrics can be added together)
g. How many 12 hour breaches did you have?
h. How many 4 hour breaches did you have?
i. What was the primary cause of the breaches? Was this reason different from 2015/16?
3. TOTAL Number of Attenders to A&E for year 2017/18 – to-date
4. Please describe how your patients are triaged, what is their typical journey? Is there a streaming model? If yes, how effective is it and who streams e.g. GP or Nurse?
5. What would you like to see implemented in your health economy to deter avoidable admissions? I.e. those who have attended A&E but could have been seen and treated in a walk-in centre/MIU, Pharmacy or GP etc.
6. Do you have Self Check-in Kiosks in your A&E area?
7. Do you have publicly available WiFi in your A&E waiting areas?
a. What is the bandwidth?
b. If you don’t have publicly available WiFi in your A&E waiting area, is there a plan to install this? If yes, when? Is it on trajectory for delivery and what is the planned bandwidth? Please comment
8. Do you think technology has a role to play in preventing avoidable admissions?
If yes, please comment on what the value of technology would be.

Download response A&E Urgent Care and Technology. 200917

A&E visits by postcode. 040118

You asked for a breakdown of the 10 most and 10 fewest A&E visits by postcode and hospital in 2017.

Download response A&E visits by postcode. 040118

A&E wait times. 270317

1. What was the date the live A&E wait time information went live on the trust website?
2. For the year before the live A&E wait time information was live on the trust website how many ambulance diverts were requested?
3. For the year before the live A&E wait time information was live on the trust website how many ambulance diverts were granted?
4. For the year after the live A&E wait time information was live on the trust website how many ambulance diverts were requested?
5. For the year after the live A&E wait time information was live on the trust website how many ambulance diverts were granted?
6. How many occasions has the hospital breached 12 hour trolley waiting times, in the last calendar year, for patients that require a inpatient bed.
7. What specialism (directorate/division) were patients who required a inpatient bed if they breached 12 hour trolley waiting times within the last year. Example medical/surgical/ maternity etc. To clarify 12 hour breach time refers specifically to 12 hour trolley wait decision to admit to admission.
8. How many outlying patients were placed in areas due to lack of available beds in the correct specialty/area for the year before the live A&E wait time information was live on the trust website. An example of a outlier is a patient requiring a medical bed being placed in another specialist area such as surgery due to no available medical beds.
9. How many outlying patients were placed in areas due to lack of available beds in the correct specialty/area for the year After the live A&E wait time information was live on the trust website. An example of a outlier is a patient requiring a medical bed being placed in another specialist area such as surgery due to no available medical beds.
10. What system is used to collate the information for the A&E live wait times?
11. How often is this updated on the trust website?

Download response A&E wait times. 270317

A&E waiting times 2013,2014 and 2015

1. How many patients have waited more than 12 hours in your A and E department in the last 3 years. Please break this down per month.
To be clear, this is since the patient arrived in A and E, not since decision to admit.

2. How many 12 hour decisions to admit patient did you report to NHS England in the last 3 years, please break this down per month.

This time frame is where you had to report a 12 hour breech to NHS England (it is typically taken after the patient has been in A and E more than 12 hours after decision to admit)

3. How many people came to A and E in the last 3 years, please break this down per month.
3a.Of these total number of patients, how many people were admitted to hospital for an inpatient stay – again please can you give me three years data, broken down per month.

4. Of those people that were admitted, in question 3 how many people breeched the 4 hour A and E target, per month for the last 3 years.

5. What was your percentage recorded rate of getting patients seen and out of the department in 4 hours, each month for the last 3 years? i.e. percentage of people who meet the 4 hour target.

Download response A&E waiting times 2013,2014 and 2015 160216

A&E waiting times. 301117

1) For all patients who are admitted from A&E, what is the average time from arrival in A&E to getting a bed on a ward? I would like this data from the period of September 2011 to September 2012 and the period of September 2016 to September 2017
(i) How many of these admitted patients went from arrival to a bed in under 4 hours?
(ii) How many went from arrival to a bed in under 12 hours?
(iii) How many went from arrival to a bed in over 12 hours?

Download response A&E waiting times. 301117

Agency spend for locum doctors in Acute Medicine. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Acute medicine over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend for locum doctors in Acute Medicine. 240317

Alcohol related illness in the under 14 year olds.

1. How many people under the age of 14 have been treated for alcohol related illness at your hospitals in 2014 and (as a separate figure) so far this year?

2. What was the youngest person treated for alcohol related illness in those periods (separate figures)?

3. How many people under the age of 14 have been treated for drug related illness at your hospitals in 2014 and (as a separate figure) so far this year?

4. What was the youngest person treated in those periods (separate figures)?

Download response Alcohol related illness in the under 14 years olds 311215

Aluminium Composite Material (ACM) cladding. 020818

Please can you tell me if any of your buildings are clad in Aluminium Composite Material, and if so how many?
If any buildings have ACM please can you tell me whether the trust will be removing the cladding and if you have estimated how much this will cost?

Download response Aluminium Composite Material (ACM) cladding. 020818

Alzheimer Disease 2012-2016

For the years between 2012 and 2016
1. How many people has your trust/hospital diagnosed with Alzheimer Disease for each of the years mentioned above? If possible could this be broken down by gender?
2. How many people are seen within 12 weeks of being referred by a GP?

Download response Alzheimer Disease 2012-2016 150317

Ambulatory ECG’s 2015-2016. 090217

1. Total number of Ambulatory ECG’s (aka Holter tests, R-Tests, etc) performed in 2015 and to date in 2016 calendar year.
2. If possible, please indicate how many were for ≤24-hour duration; 24-72 hour duration; ≥ 72 hour duration.
3. Please also indicate what current waiting time is for fitting of device and reporting results.

Download response Ambulatory ECG’s 2015-2016. 090217

Annual Departmental activity statistics 2011-2013. 030117

In your trust in each of the following years (in 2011, 2012 & 2013)
– Financial year 2011/2012 and financial year 2012/2013
– Or Calendar year 2011, Calendar year 2012 and Calendar year 2013
Annual departmental activity statistics for Obstetrics & Gynaecology Department for the following data:
Obstetrics (Maternity)
1- Annual total number of all types of deliveries
2- Annual total number Instrumental/operative vaginal deliveries
3- Annual total number of Caesarean sections
4- Annual total number of vaginal deliveries
5- Annual total number of Antenatal out-patients
6- Annual total number of maternity inpatients admitted to wards/hospital
Gynaecology:
7- Annual total number of gynaecological surgical procedures undertaken annually
8- Annual total number of Gynaecology out-patients
9- Annual total number of gynaecology inpatients admitted to wards/hospital
As a Trust in general:
10- Annual total number of theatre cases (surgical procedures), across all specialties
11- Annual total number of patients attended or booked in the outpatient clinics, across all specialties
12- Annual total number of patients admitted to the hospital wards, across all specialties

Download response Annual Departmental activity statistics 2011-2013. 030117

Annual suture usage. 040117

I require suture manufacturer codes with description and total boxes/pack ordered annually/per year. An excel sheet will be ideal.

Any year in the last three year will be suitable.

Download response Annual suture usage. 040117

Anticoagulation care Warfarin. 250917

1. Please confirm or deny whether your NHS Trust collects data on the number of patients diagnosed with atrial fibrillation who are treated with warfarin by i) gender and ii) age group.
a. If confirmed, please provide the number of i) male and ii) female patients
b. If confirmed, please provide the number of patients aged i) below 45 years old ii) 45-54 years old, iii) 55-64 years old, iv) 65-74 years old, v) 75-84 years old and vi) 85 years old and above
2. Please confirm or deny whether your NHS Trust collects data on the time in therapeutic range (TTR) of patients diagnosed with atrial fibrillation who are treated with warfarin.
a. If confirmed, please provide details of the number of patients with a TTR (calculated over a maintenance period of at least 6 months while excluding those initiated within the last 6 weeks, as per NICE Clinical Guideline 180 (CG180)) of i) 64.9-55 per cent, ii) 54.9-45 per cent, iii) 44.9-35 per cent and iv) 34.9 per cent and below.
3. Please confirm or deny whether your NHS Trust collects data on the International Normalised Ratio (INR) values of patients diagnosed with atrial fibrillation who are treated with warfarin.
a. If confirmed, please provide details of number of patients within the past six months recorded with i) two INR values higher than five, ii) one INR value higher than eight, or iii) two INR values less than 1.5.
4. Please confirm or deny whether your NHS Trust collects data on the frequency of blood tests for purposes of INR readings of patients diagnosed with atrial fibrillation.
a. If confirmed, please provide details of the average interval between blood tests for INR readings.
5. Please confirm or deny whether your NHS Trust collects data on the number of patients diagnosed with atrial fibrillation who are treated with warfarin and self-monitoring or self-managing their anticoagulation therapy.
a. If confirmed, please provide the number of patients diagnosed with atrial fibrillation who are treated with warfarin who are i) self-monitoring and receiving dosing instructions from a healthcare professional; and ii) self-managing their anticoagulation.
6. Please confirm or deny whether your NHS Trust has conducted a root cause analysis of adverse events related to anticoagulation treatment in atrial fibrillation patients.
a. If confirmed, please provide details of any root cause analysis of adverse events related to anticoagulation treatment in atrial fibrillation patients in the last 12 months.
7. Please confirm or deny whether your NHS Trust has written clinical protocols in place for reassessing patients diagnosed with atrial fibrillation who have poor warfarin anticoagulation control (as defined by NICE CG180) to determine why their TTR/INR are unstable.
a. If confirmed, please provide evidence of the protocol(s)
8. Please confirm or deny whether your NHS Trust has information, education and support tools available for patients diagnosed with atrial fibrillation to help them understand their treatment options and support adherence.
We supply BHF and Arrhythmia Alliance booklets to patients regarding AF and yellow warfarin booklets if they are put on warfarin. to patients
a. If confirmed, please provide evidence of the information, education and support tools that you use. see above

Download response Anticoagulation care Warfarin. 250917

Antiseptic preparations applied to the skin prior to a surgical procedure. 010518

Please would you tell me the number of units of the following products purchased by your hospital over the past 12 months:

Chlorhexidine 2% in IPA Biocide (Nex-Clorex 2%) Available in 200ml and 500ml bottles – Fannin UK Ltd

Chlorhexidine 2% in IPA Biocide Available in 200ml and 500ml bottles – Ecolab Ltd

Chlorhexidine 2% in IPA Licenced Medicine (ChloraPrep) Available in various sizes – Carefusion / BD

Red Staining Dye / Liquid Available in 12 x 12ml – Ecolab Ltd

Please would you tell me the pre-operative skin preparation (ie the name of the specific product) that you use for the following procedures? Please will you specify whether the manufacturer and whether the product is a biocide or a licensed medicine.

Procedure

• Abdominal hysterectomy –
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Breast surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Caesarean section
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Gastric surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Hip replacement
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Knee replacement
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Spinal surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?

Download response Antiseptic preparations applied to the skin prior to a surgical procedure. 010518

Assault attendances to Emergency Department 2017. 210218

We require the gender of the patient (M or F), the date that they attended due to assault (dd/mm/yyyy) and their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.

To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e. 2017.

Download response Assault attendances to Emergency Department 2017. 210218

AUS implant 2014-2017. 010617

I am trying to find out, for each of the last three years of available data, how many AUS’ were implanted by the Trust and how many were infected.

Download response AUS implant 2014-2017. 010617

Bariatric procedures 2013-2017. 260417

Please can you tell me the following information for the last three financial years and current numbers i.e.; 2016/17, 2015/16, 2014/15 and 2013/14
1) Number of bariatric procedures carried out
2) Cost of procedure (s)
3) Age of those who had a bariatric procedure
4) Weight of those who have had a bariatric procedure

Download response Bariatric procedures 2013-2017. 260417

Bariatric surgery 2013-2017. 260417

1) Can you please provide a breakdown of the number of people given bariatric surgery in each of the following years by the health board – 2013, 2014, 2015, 2016, so far 2017?
2) For each year, can you please provide the sexes and age groups (twenties, thirties, forties, etc.) of each person who had the surgery. Please provide the number of people under 21 for each year, with the exact age of each.
3) For each year, please provide the number of people with a medical condition, which meant they needed bariatric surgery, including those with none (can the data please be displayed so that their age groups are given also).
4) Please provide the number of people for each year with a BMI of 35 or less, and of 30 or less, again giving their medical condition and age group (or exact age for under-21s) for each.
5) Please provide a list of the criteria the health board has for offering people bariatric surgery, and if this has changed in the last five years, state when it changed and what it changed from and to.
6) If the health board’s target for the number of people undergoing bariatric surgery has changed in the last five years, please state what it changed from and to, and when this happened.

Download response Bariatric surgery 2013-2017. 260417

Blocked catheters and emergency admissions for 2012-2013, 2013-2014 and 2014-2015

1. The total number of emergency admissions in the Trust
2. The number of emergency admissions caused by a blocked catheter in the Trust
3. The number of emergency admissions caused by a urinary tract infections in the Trust
4. The estimated cost of (per day) of an emergency admission to hospital

Download response Blocked catheters and emergency admissions for 2012-2013, 2013-2014 and 2014-2015 270516

Blood pressure monitors

1. Total number of all types of blood pressure monitors in your institution (e.g. 1000 blood pressure monitors overall)
2. Can you please list all the types of blood pressure monitors and its quantities (e.g. NIBP – x20, SpO2 – x20), its brands (e.g. Omron – x20, Criticare – x20, Datascope – x20), and models (e.g. Criticare 506DXN – x10, Criticare 507DXN – x10, Datascope Accutorr + x20). We would like to ask you kindly if you can state this information in a separate spreadsheet document.
3. In which departments do you use blood pressure monitors? (e.g. 20 Omron in wards, 20 Criticare in ITU, 20 Datascope in outpatient surgery).
4. Types of devices acquired in period of 2014 – 2016 (e.g. 100 Omron monitors in 2014, 150 Criticare monitors in 2015.) if none please state when was the last purchase.
5. Minimum and maximum price of blood pressure monitors. If you can not provide this information, please give us an average price of a single blood pressure monitor
6. Please provide a full contract with supplier of blood pressure equipment
7. Which quality tests or quality standards a blood pressure device must pass in order for you to consider it as a good quality blood pressure monitor (e.g. CE Marked)
8. Can you please provide regulations and guidelines that your institution follow (we would like to know about national, local and your own guidelines + regulations (if it also possible can you please attach medical device management action card + medical equipment pre-registration form))
9. What creates extra costs for the usage of monitors on a yearly basis? Please break it down and relate the expenditure associated to it (e.g. cuffs = £2.000, hoses = £3.000, maintenance = £5.500)
10. Do you provide maintenance in-house or out?
11. How do you provide training to medical staff when a new blood pressure monitor is introduced in your hospital? (e.g. manual handbook, training sessions from suppliers)
12. How the supply chain is established in your organisation when you order new blood pressure monitors? (e.g. supplier delivers the products, currier or take out?)
13. Do you provide feedback to your suppliers? If “yes” how? (e.g. emailing, calling, submitting a form)
14. What is the average useful life of a single blood pressure monitor?

Download response Blood pressure monitors 090916

Bowel management with spinal injured patients. 301017

1. Does the Trust have a formal written policy for digital rectal examination/check, digital rectal stimulation and the digital removal of faeces (manual bowel evacuation) in spinal cord injured and other patients with neurogenic bowel dysfunction?
2. If the Trust does, please supply a copy of this document.
3. If the Trust does not, how is bowel care managed in the above patient groups who present with this care need?
4. Does the Trust employ a specialist continence nurse(s)?
5. If the Trust employs a specialist continence nurse(s) can they (a) undertake digital rectal checks, digital rectal stimulation and digital removal of faeces (manual bowel evacuation), otherwise known as ‘intimate digital bowel care procedures’ (b) provide instruction to other nurses to enable them to perform intimate digital bowel care procedures’?
6. If the Trust does not employ a specialist continence nurse, is there another health care professional who undertakes intimate digital bowel care procedures including manual bowel evacuation? If yes, who does this?
7. Does your Trust have a policy in place that will allow your staff to do trans-anal irrigation (TAI) of the bowel as a method of bowel care management for spinal cord injured patients? Do you train your staff to do TAI/ bowel irrigation?
8. Do you run bowel care courses for your staff that allows them to deliver the full range of bowel care required by spinal cord injured patients or others with a neurogenic bowel?
9. If yes, please provide details. If no, does the Trust have a policy which allows for the personal care assistants (PAs) of spinal cord injured patients to assist with this element of the patient’s care?

Download response Bowel management with spinal injured patients. 301017

C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

For the years 2014, 2015, and 2016 please details the following:

How many people and inpatients have been infected with and treated for a superbug.

List which superbug people were infected with.

In which hospital did they contract the infection?

How many of these people later died of the infection?

Download response C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

Carbapenemase-producing organisms. 181116

1. How many patients have been infected with carbapenemase-producing organisms in your trust?

2. How many patients with an infection from a carbapenemase-producing organism have died?

Download response Carbapenemase-producing organisms. 181116

Carbon Monoxide poisoning. 070817

1. How many cases have attended A&E with suspected carbon monoxide poisoning between 1st July 2016- 30th June 2017?
2. How many cases have been treated in A&E with suspected carbon monoxide poisoning between 1st July 2016- 30th June 2017?

Download response Carbon Monoxide poisoning. 070817

Cardiac equipment age and revenue 2014/2015.

Question 1
Hospital 1 (name)
No. operated No. leased / owned (If Applicable) number provided through a managed equipment provider) Year of manufacture (or installation, if yr of manufacture n/a)
Lab 1 Lab2 Lab3 Lab4 Lab5
Labs primarily serving PCI activity and coronary diagnostics
Labs primarily serving primary pacing & electrophysiology implantations, ablations and diagnostics
Labs primarily serving peripheral vascular angioplasty and diagnostics
All other
– of the above, labs within hybrid catheterisation lab / operating theatre

Question 2
Please provide the Trust’s revenue for the fiscal year 2014/15 from the HRGs below, broken down by source (NHS England or your local CCG) and by category: Coronary interventional cardiology, Pacing/Electrophysiology, Non-coronary catheter procedures, as follows:

Category Includes HRGs Trust’s Revenue 2014/15
From CCG From NHS England
Coronary interventional cardiology EA31Z Percutaneous Coronary Intervention (0-2 Stents)
EA36A Catheter 19 years and over
EA36B Catheter 18 years and under
EA49Z Percutaneous Coronary Interventions with 3 or more Stents, Rotablation, IVUS or Pressure Wire
Pacing/ Electrophysiology EA03Z Pace 1 – Single Chamber or Implantable Diagnostic Device
EA05Z Pace 2 – Dual Chamber
EA07Z Pace 3 – Biventricular and All Congenital Pacemaker Procedures – Resynchronisation Therapy
EA12Z Implantation of Cardioverter – Defibrillator only
EA27Z Percutaneous Standard EP or Ablation
EA29Z Percutaneous Complex Ablation (includes Atrial Fibrillation or Ventricular Tachycardia)
Non-coronary catheter procedures EA09Z Percutaneous Interventions: Percutaneous Transluminal ASD/VSD/PFO Closure and Valve Insertion
EA10Z Percutaneous Interventions: Balloon Valve Intermediate Interventions and Arterial Duct Closure
EA11Z Percutaneous Interventions: Other including Septostomy, Embolisations, Non-Coronary Stents and Energy Moderated Perforation
EA53Z Transcatheter Aortic Valve Implantation (TAVI)
EA35Z Other Percutaneous Interventions

Download response Cardiac equipment age and revenue 2014/2015 190416

Cardiac marker point of care tests. 251116

1. Please enter the name of your hospital or trust.
2. Does your trust use point-of-care testing for cardiac markers?
3. In what areas of the hospital is cardiac marker point-of-care testing used?
( ) ED
( ) Wards
( ) Intensive care
( ) Outpatient clinics
( ) Other (please specify)
4. For which cardiac markers does your trust use POCT?
( ) Troponin
( ) BNP
( ) D-dimer
( ) CK-MB
( ) Myoglobin
( ) Other (please specify)
5. For each POC cardiac marker test used in your trust, how many tests are performed every week?
Troponin –
BNP –
D-dimer –
CK-MB –
Myoglobin –
Other –
6. What is the average cost per test (excluding overheads) for each cardiac marker POCT?
Troponin –
BNP –
D-dimer –
Other –
7. How much is spent by your trust per year on cardiac marker point-of-care testing?
Total –
Troponin –
BNP –
D-dimer –
Other –

Download response Cardiac marker point of care tests. 251116

Cardiology. 220218

1. The name and email address of your Head of Cardiology
2. The name and email address of your Chief Cardiac technician / Head Cardiac technician or equivalent

Download response Cardiology. 220218

Cell saver machines. 070717

1. How many cell savers do you have within the Trust? Please provide a breakdown of cell savers per hospital if possible.
2. For which surgical procedures were cell savers used in the year 2015 – 2016, breakdown by number if possible?
3. How many consumables were purchased for cell savers during the year 2015 – 2016?
4. How much was spent on cell saver consumables for the year 2015 – 2016?

Download response Cell saver machines. 070717

Chemsex related admissions

1. The number of chemsex related admissions to hospital in each of the following periods:
– 2010/2011
– 2011/2012
– 2012/2013
– 2013/2014
– 2014/2015
2. The number of fatalities due to consumption of chemsex drugs (mephedrone, GHB, GBL, methamphetamine), in each of the following periods:
– 2010/2011
– 2011/2012
– 2012/2013
– 2013/2014
– 2014/2015
3. Number of emergency calls regarding a chemsex-related casualty /ies in each of the following periods:
– 2010/2011
– 2011/2012
– 2012/2013
– 2013/2014
– 2014/2015

Download response Chemsex related admissions 250716

Chronic pain service 031016

1. The definition of calculation used for new to follow up ratios for chronic pain referrals.
2. The data for new to follow up for chronic pain referrals for your trust for the years April 2010 to April 2015
3. Is the calculation used for new and follow-up in Chronic Pain a local or national definition?
4. Can you provide the wording of the definition used?
5. Does the New to follow up ratio calculation that is used by your organisation for Chronic Pain also apply to other specialties?
6. If no – please explain the differences in the calculations.

Download response Chronic pain service 031016

Community Neurology Specialist nurses Parkinson’s Disease. 060317

1) How many Community Neurology Specialist Nurses have been funded since April 2013 – please can the figures be broken down by year?
2) Who funded and provided the nurses each year?
3) Of these nursing positions, how many were solely dedicated to treating Parkinson’s Disease patients, broken down by financial year since April 2013?
4) And how many of the Community Neurology Specialist Nurses specialise in Parkinson’s Disease but treat other neurology patients, broken down by financial year since April 2013?
5) How many patients have been referred to specialist neurology nurses, broken down by financial year since April 2013?
6) Of these patients, how many have been referred because of having Parkinson’s Disease, broken down by financial year since April 2013?
7) What is the average waiting time for neurology patients to see a specialist neurology nurse, broken down by financial year since April 2013?
8) What is the average waiting time for Parkinson’s Disease patients to see a specialist neurology nurse, broken down by financial year since April 2013?
9) How much money has been spent by the provider(s) on specialist neurology nursing positions, broken down by financial year since April 2013?
10) How much money has been spent by the provider(s) on dedicated Parkinson’s Disease nursing positions, broken down by financial year since April 2013?
11) How many times have proposals been rejected to fund new Community Neurology Specialist Nurses, broken down by financial year since April 2013?
12) How many times have proposals been rejected to fund a dedicated Parkinson’s Disease nurse position, broken down by financial year since April 2013?

Download response Community Neurology Specialist nurses Parkinson’s Disease. 060317

Complex Regional Pain Care Syndrome (CRPS). 240317

What does your acute Complex Regional Pain Care Syndrome (CRPS) pathway look like for trauma and orthopaedic, rheumatology and hand acute services?

Download response Complex Regional Pain Care Syndrome (CRPS). 240317

Continuous renal replacement therapy (CRRT). 010217

1. How many machines do you have for continual renal replacement (CRRT) in the intensive care unit/critical care unit?
1. a. Can you split these by manufacturer and age of machine please?
2. Are you in a contract for your machines, if so when does the contract expire?
3. How many CRRT treatments were carried out in 2016 (or the latest 12 month period you have data for)?
4. How many bags of fluid did you use for CRRT in 2016 (or the latest 12 month period you have data for)?
5. Who is your current manufacturer of fluids for CRRT? And for Vascular access? (Double Lumen catheters)
6. Are you in a contract for fluids, if so, when does this expire and is it linked in with the machine contract?
7. What was your total spend on CRRT fluids in 2016 (or the latest 12 month period you have data for)?
8. What was your total spend on CRRT consumables (e.g. consumable sets for the machines) in 2016 (or the latest 12 month period you have data for)?
9. What is the typical renal dose you prescribe to the patients? (In ml/kg/h)
10. Are your units using Citrate Anticoagulation? If yes how frequent (in % vs. Heparin).

Download response Continuous renal replacement therapy (CRRT). 010217

Contract information for TNP and PAC.060317

Section 1
1) What are the Hospital names and locations that form part of the Trust? (Please provide details)
2) Which framework is utilized for purchasing such as SBS, NHS Supply Chain or other (please provide details of all that are used)
3) By which method is this procured? (Please state all that applies)
Section 2
1) What is the name of the manufacture used to provide Topical Negative Wound Therapy Treatment for each hospital location?
*Smith-Nephew
*KCI
*Talley
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) Is this equipment provided via Hire agreement, Purchase or other? (Please provide details)
4) Is the provision of this equipment contracted? Yes or No
5) If contracted is the service and maintenance of this equipment included as part of the contract? Yes or No
6) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
7) If 3rd party provider please state company name
8) Is the 3rd party service & maintenance contracted? Yes or No
9) If Yes what is the contract term? (Including any extension periods).
10) What is the expiry date of this contract?
The following questions are only applicable if the supply of Topical Negative Wound Therapy to the hospital trust is contracted.
1) As a result of the tender did you change provider? Yes or No (If Yes please provide name of previous supplier)
2) What date did your current contract start?
3) How long is the current contract? (Including any extension periods)
4) When does the current contract expire?
5) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
6) Please provide the financial value for the first 12 months of the current contract in place.
Section 3
1) What is the name of the manufacture used to provide pressure relief alternating dynamic surface air mattresses to the trust?
*Hill-Rom
*Smith-Nephew
*Talley
*Direct Healthcare
*Karomed
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) What is the total number of dynamic mattresses on-site?
4) Is this a managed service? Yes or No
5) Is the provision of dynamic surfaces contracted? Yes or No
6) If Yes is the service and maintenance of this equipment included as part of the contract? Yes or No
7) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
8) If 3rd party provider please state company name
9) Is this 3rd party service contracted? Yes or No
10) If Yes what is the contract term? (Including any extension periods).
11) What is the expiry date of this contract?
12) How is the decontamination of these products managed? In-house or 3rd party provider
13) If 3rd party provider please state company name
14) Is this 3rd party service contracted? Yes or No
15) If Yes what is the contract term? (Including any extension periods).
16) What is the expiry date of this contract
The following questions are only applicable if the supply of dynamic alternating air surface mattresses to the hospital trust is contracted.
1) Which method is used to tender the contract? (Please provide details)
2) What date did your current contract start?
3) What is the term of the contract? (including any extension periods)
4) When does the current contract expire?
5) Is the contract purchase, hire or other (please provide details)
6) If contracted, when did you last tender the contract?
7) As a result of the tender did you change provider? Yes or No (if Yes please provide previous supplier)
8) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
9) Please provide the financial value for the first 12 months of the current contract in place.
Section 4
1) What is the name of the manufacture used to supply profiling bed frames?
*Hill-Rom
*Sidhil
*Invacare
*Linet
*Huntleigh
*Other (please provide details)
2) By which method is this procured? (Please state all that applies)
3) Which products are used? (Please provide details)
4) What is the total number of hospital bed frames on-site?
5) Is the supply of bed frames contracted?
Yes or No?
The following questions are only applicable if the supply of profiling beds to the hospital trust is contracted.
1) What date did your current contract start?
2) How long is the current contract? (Including any extension periods)
3) When does the current contract expire?
4) When did you last tender the contract?
5) As a result of the tender did you change provider? Yes or No (if Yes please state previous supplier)
6) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
7) Please provide the financial value for the first 12 months of the current contract in place.

Download response Contract information for TNP and PAC.060317

Cost of flu treatment in A&E. 250117

a) How many people were admitted to Accident and Emergency with flu in each calendar year: 2010; 2011; 2012; 2013; 2014; 2015, and; 2016?

b) What is the total financial cost for people presenting with flu at Accident and Emergency in each calendar year in answer to Question A. Please provide this information broken down by calendar year, as follows: 2010; 2011; 2012; 2013; 2014; 2015, and 2016. This should include all costs incurred to treat the illness during the patients stay at the hospital, including all staff salaries and any other medical treatment costs.

Download response Cost of flu treatment in A&E. 250117

CRE infections. 181116

1. How many patients have been?
-colonised
-infected
With CRE infections for each of the past 10 years in your trust?
2. Does your trust have universal screening of patients for CRE when they are admitted, screening of patients with high risk factors or no formal screening policy?
3. How many patients were screened for CRE when they were admitted and deemed high risk for a CRE infection?
4. How many isolation rooms does your hospital have for isolating CRE patients?
5. How many isolation rooms have en suite bathrooms?
6. What is your policy if there is no side room available for isolating patients with CRE?

Download response CRE infections. 181116

Cryogenic freezing 061216

For the last five years, could you tell me how many, if any, patients have requested they are cryogenically frozen after death, in the hope they can be revived at a later date?

Download response Cryogenic freezing 061216

Dementia 2014-2015

1. The number of patients aged 65 and over who have fallen in hospital in 2014-15 or the last year for which statistics are available?
2. Number of patients aged 65 and over with a coding of dementia who have fallen in hospital in financial year 2014-15 or the last year for which statistics are available?
3. The number of patients aged 65 and over discharged between the hours of 2300 and 0600 in financial year 2014-15 or the last financial year for which statistics are available?
4. The number of patients aged 65 and over with a coding of dementia discharged between the hours of 2300 and 0600 in financial year 2014-15 or the last financial year for which statistics are available?
5. The number of delayed discharges and delayed transfers of care for patients aged 65 and over in financial year 2014-15 or the last financial year for which statistics are available?
6. The number of delayed discharges and delayed transfers of care for patients aged 65 and over with a coding of dementia in financial year 2014-15 or the last financial year for which statistics are available?
7. The number of delayed discharges and delayed transfers of care for patients aged 65 and over in financial year 2014-15 or the last financial year for which statistics are available by reason e.g. awaiting completion of assessment?
8. The number of delayed discharges and delayed transfers of care for patients aged 65 and over with a coding of dementia in financial year 2014-15 or the last financial year for which statistics are available by reason e.g. awaiting completion of assessment?
9. The number of patients aged 65 and over with a coding of dementia admitted from home in financial year 2014-15 or the last financial year for which statistics are available?
10. The number of patients aged 65 and over with a coding of dementia admitted from home and discharged to a care home in financial year 2014-15 or the last financial year for which statistics are available?
11. The average length of stay for patients aged 65 and over for the three financial years 2012-13, 2013-14 and 2014-15 or the last three financial years that figures are available?
12. The average length of stay for patients aged 65 and over with a coding of dementia for the three financial years 2012-13, 2013-14 and 2014-15 or the last three financial years that figures are available?
13. The number of hospital readmissions within 30 days for patients aged 65 and over in financial year 2014-15 or the last financial year for which statistics are available?
14. The number of hospital readmissions within 30 days for patients aged 65 and over with a coding of dementia in financial year 2014-15 or the last financial year for which statistics are available?
15. The number of current a) board-level staff b) clinical staff c) non-clinical staff?

Download response Dementia 2014-2015 010216

Dermatology Department

Does your dermatology department have nurses trained to draw bloods from outpatients in outpatient clinics?

Does your dermatology department have dermatologists trained to draw bloods from outpatients in outpatient clinics?

Does your dermatology department have access to tubes, syringes/needles in the department to draw bloods from outpatients in outpatient clinics and someone who collects or sends tubes to your bloods lab department etc?

Does your dermatology department draw either whole bloods, serum, plasma or draw only whole bloods but they put on the label that a whole blood-based test or serum-based test or plasma-based test is required to your bloods lab department etc? (by the way there are tubes with clot activator for serum after they are spun. There are tubes with clot inhibitor for plasma after they are spun)

Download response Dermatology Department 150416

Dermatology outpatient department.

Please tell me what are the clinics (ailment / ailment category clinics) for outpatients your dermatology department runs and what specific weekday they are run on.

Download response Dermatology outpatient department 270616

Dermatology Services

1. What is the composition of the multi-disciplinary team for dermatology in the Trust?
2. How many dermatology consultants work within the Trust?
3. How many speciality dermatology nurses work within the Trust (including dermatology clinical nurse specialists and dermatology nurse practitioners)?
4. Does the Trust have standards to support healthcare professionals to deliver psychodermatological care?
5. How many adult patients with Atopic Dermatitis (ICD-10-CM Diagnosis Code L20.9) have been referred for psychological support by the specialised dermatology multi-disciplinary team?
6. Does your Trust produce local guidelines to support the management of adult Atopic Dermatitis (L20.9)? (yes / no)
7. What is the ‘Friends and Family Test’ score for the Trust’s dermatology services?
8. What is the average time to treatment from referral for adults with Atopic Dermatitis (L20.9) in the Trust?
9. How many dermatology outpatient appointments occurred between 1st January and 31st December 2015 in your Trust for adult patients with diagnosed or suspected Atopic Dermatitis (L20.9) in each of the following categories:

a. first attendance – single professional
b. first attendance – multi-professional
c. follow up attendance – single professional
d. follow up attendance – multi-professional
10. If data on the number of dermatology outpatient appointments in your Trust for adult patients with diagnosed or suspected Atopic Dermatitis is not available for the period 1st January to 31st December 2016, please provide the most recent summary data available for each of the following categories:
a. first attendance – single professional
b. first attendance – multi-professional
c. follow up attendance – single professional
d. follow up attendance – multi-professional.
11. Please outline which of the following treatments are available to adult patients with Atopic Dermatitis (L20.9) in the Trust, according to the local formulary.
12. How many adult patients with Atopic Dermatitis (L20.9) in your Trust received prescriptions for the following treatments between 1st January and 31st December 2015?

Download response Dermatology Services 270616

Diabetes. 091117

1. The number of patients with Type 1 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
2. The number of patients with Type 2 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
3. The number of patients with Type 1 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
4. The number of patients with Type 2 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
5. The number of Diabetes Specialist Nurses that are employed in Maidstone and Tunbridge Wells NHS Trust as of the 1st October 2017. Please break down the response to this question by pay band e.g. band 6, band 7.
6. Is structured education for patients with Type 1 diabetes offered within Maidstone and Tunbridge Wells NHS Trust?
7. The number of patients with Type 1 diabetes that have received structured education within Maidstone and Tunbridge Wells NHS Trust between the period October 1st 2016 to October 1st 2017.

Download response Diabetes. 091117

Dinitrophenol (DNP)

1. For each of the past five financial years (2010/11 to 14/15) please list the number of patients who have attended accident and emergency after suffering ill effects from taking Dinitrophenol (DNP).

2. For each of the past five financial years please list the number of patients admitted to a ward after taking DNP.

3. For each of the past five years please list the number of patients who have died in hospital after taking DNP.

Download response Dinitrophenol (DNP) 150416

Dog bites or attacks 2013 – 2016. 100717

1. How many persons have been admitted to hospitals in your Trust for injuries caused by dog bites or attacks?
2. How many persons required inpatient treatment for injuries caused by dog bites or attacks?
3. How many persons required surgery for injuries caused by dog bites or attacks?
4. How many persons suffered fatal injuries for injuries caused by dog bites or attacks?
5. What the total cost of treating injuries caused by dog bites or attacks was to your trust?
Please provide information for the following calendar years:
2013
2014
2015
2016 to date

Download response Dog bites or attacks 2013 – 2016. 100717

Drug and alcohol admissions for homeless patients 2014-2016. 300317

1. How many homeless people (i.e. People with no fixed abode) have been admitted to hospitals within Maidstone and Tunbridge Wells NHS Trust for problems related to drugs? Could you please provide these figures for each of the last three calendar years?
2. How many homeless people (i.e. people with no fixed abode) have been admitted to hospitals within Maidstone and Tunbridge Wells NHS Trust for problems related to alcohol? Could you please provide these figures for each of the last three calendar years?

Download response Drug and alcohol admissions for homeless patients 2014-2016. 300317

Drug coated balloons 060317

1. How many Drug Coated Balloons were used by your Trust for Peripheral Vascular interventions in 2016?
2. What was the total spend by the Trust on Drug Coated Balloons for Peripheral Vascular interventions in 2016?
3. How many Drug Coated Balloons were used by your Trust for Arterio-venous (AV) percutaneous interventions in 2016?
4. What was the total spend by the Trust on Arterio-venous (AV) percutaneous interventions in 2016?
5. What was the total spend by the Trust on Drug coated balloons for Arterio-venous (AV) percutaneous interventions in 2016?

Download response Drug coated balloons 060317

Drug related A&E admissions. 210218

1. The number of A&E attendances where the word ‘cocaine’ appears in the free-text diagnosis field.
2. The number of A&E attendances where the word ‘ecstasy’ appears in the free-text diagnosis field.
3. The number of A&E attendances where the word ‘ketamine’ appears in the free-text diagnosis field.
4. The number of A&E attendances diagnosed as F14 under the ICD-10 classification system.
5. The number of A&E attendances diagnosed as F15 under the ICD-10 classification system.
6. The number of A&E attendances diagnosed as F16 under the ICD-10 classification system

Download response Drug related A&E admissions. 210218

Electrophysiology equipment. 300317

1. Does your Trust have an Electrophysiology Lab or perform Electrophysiology Procedures?
2. How many 3D Mapping Systems are installed in your Trust?
3. How many Electrophysiology Recording Systems are installed in your Trust?
On average, what is the lifespan of these EP Recording systems?
What brands are they?
Were there any EP Recording systems purchased in the last 12 months?
If yes, how many?
Were these to replace old machines or new purchases?
4. How many Intracardiac Echocardiography (ICE) Systems are installed in your Trust?
5. How many Radiofrequency (RF) Ablation Generators are installed in your Trust?
6. How many cardiac stimulators are installed in your Trust?
7. How many Remote Navigation Systems (from Stereotaxis) are installed in your Trust?

Download response Electrophysiology equipment. 300317

Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

1. For the last 4 quarters from January 2016 – December 2016, please provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
2. For the last 4 quarters from January 2016 – December 2016, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
3. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
4. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
5. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.

6. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2?

Download response Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

Emergency department closures 2010-2017. 240817

1. On how many occasions have your emergency departments been closed to new admissions during financial years 2010/2011, 2014/15, 2015/16 and 2016/17?

2. For each emergency department closure, please state the duration of and the reason for the closure.

3. For each emergency department closure, please also state the number of patients which were diverted elsewhere as a result of the department closing.

Download response Emergency department closures 2010-2017. 240817

Emergency Re-admissions 2012-2017. 200917

1. EMERGENCY READMISSIONS BROKEN DOWN BY DAY FOR THE LAST FIVE YEARS

2. REASONS RECORDED FOR EMERGENCY READMISSION

Download response Emergency Re-admissions 2012-2017. 200917

Emergency transfers from private hospitals.

I am writing to you under the Freedom of Information Act 2000 to request the following information from your hospital trusts.
How many patients arrived in A&E as an emergency transfer from Kent’s private hospitals, for the following financial years 2010-11, 2011-12, 2012-13, 2013-14, and 2014-15?

Would it be possible to list which private hospitals the patients were transferred from for each of the financial years above?

Would it be possible to list some of the conditions that the patients were admitted with?
I have identified the following list of private hospitals in Kent:
1. KIMS Maidstone
2. Nuffield Health Tunbridge Wells
3. Spire Tunbridge Wells
4. Spire Alexandra Walderslade
5. BMI Somerfield Maidstone
6. BMI Chaucer Canterbury
7. BMI Fawkham Manor
8. BMI Sloane Beckenham
9. BMI Chelsfield Park Orpington
10. Spencer Ashford
11. Spencer Margate
12. Benenden

Download response Emergency transfers from private hospitals 080116

Endoscopy services. 160518

I understand your trust uses external providers to deliver some aspects of your trusts Endoscopy service. Please kindly outline which suppliers you utilise and the total amount spent for Insourced or outsourced Endoscopy services during the months of November 2017 – March 2018.

Download response Endoscopy services. 160518

Enforced DNR. 300317

The number of patients who have been taken to the Royal Courts of Justice Court of Protection, to have a DNR placed upon their lives by your hospital. I would like to know if the patient had a Lasting Power of Attorney and the sex, age, ethnicity of the patients and the length of time each case took & outcomes of each case. From when the hospital opened to the present day.

Download response Enforced DNR. 300317

Escalation procedures for ITU/ICU/HDU.

This is FOI request, please tell me what happens if you get patients for ITU / ICU / HDU but they are full with other patients, what do you do?

Download response Escalation procedures for ITU/ICU/HDU 190416

Eye damage caused by lasers

The number of patients admitted for eye damage caused by lasers over the last three financial years. To clarify, this is from hand-held lasers, not complications from laser eye surgery.

2013-14

2014-15

2015-16

Download response Eye damage caused by lasers 060916

Genetic haemochromatosis 1 January 2015 to 31st December 2015 111116

For the period 1 January 2015 to 31st December 2015 (or the most recent full 12 month period if more recent data is available) :

A. The number of patients diagnosed with genetic haemochromatosis who have been provided with genetic testing for haemochromatosis and/or genetic counselling in relation to their condition.

B. The number of marriage or civil partners of patients diagnosed with genetic haemochromatosis who have been provided with genetic testing for haemochromatosis and/or genetic counselling in relation to their partners’ condition.

C. The number of siblings of patients diagnosed with genetic haemochromatosis who have been provided with genetic testing for haemochromatosis and/or genetic counselling in relation to their sibling’s condition.

D. A copy of your protocol or pathway applicable to the provision of genetic testing/counselling for families of patients diagnosed with genetic haemochromatosis.

Download response Genetic haemochromatosis 1 January 2015 to 31st December 2015 111116

GP’s in A&E. 110118

1. Is the Trust planning to use GPs within any of its emergency departments over the winter months?

2. Has the Trust recruited/is the Trust planning to recruit GPs to staff its emergency departments over the winter months? If so, how many will be/have been recruited? If so, please confirm (i) the cost of recruitment and (ii) the planned duration of the post(s).

3. If the Trust is planning to use GPs in A&E departments, how will they fit into the current system/how will they be used?

4. If the Trust is planning to use GPs in A&E departments, why is this necessary?

5. If the Trust is NOT planning to use GPs in A&E departments, will it be necessary to employ more consultants/nurses/locums for this coming winter? If so, why?

Download response GP’s in A&E. 110118

Haemochromatosis. 261016

A. the number of patients treated with Haemochromatosis in 2015 who are in maintenance phase of the treatment (*)
B. the number of patients treated with Haemochromatosis in 2015 who are in PRE-maintenance phase of the treatment (+)
C. a copy of the clinical protocol(s) used to treat haemochromatosis
D. a copy of the clinical protocol(s) for therapeutic venesection

(*) “Maintenance phase” relates to patients whose ferritin is <=50 ug/L
(+) “PRE-maintenance phase” relates to patients whose ferritin is in excess of 50 ug/L

Download response Haemochromatosis. 261016

Haemofiltration or continuous renal replacement therapy (CRRT). 020518

Please provide me with the following information relating to the provision of haemofiltration or continuous renal replacement therapy (CRRT) within the intensive care units (ICU’s) of your NHS Trust:
1. The name of your Trust.
2. The names of the hospitals within your Trust.
3. The ICU’s conducting haemofiltration / CRRT within your Trust.
4. The number of patients treated with CRRT per year within your Trust.
5. Current provider of CRRT services to your Trust.
6. The preferred CRRT modality.
7. The name of the Lead Clinician, in each hospital, responsible for CRRT services.
8. The name of the person in Procurement responsible for the CRRT contract in your Trust.
9. Date of the next tender for CRRT services.
10. A copy of the previous successful tender for CRRT services.

Download response Haemofiltration or continuous renal replacement therapy (CRRT). 020518

Heart failure (HF) specialist nurses. 221116

1. How many Heart Failure Specialist Nurses did the Trust employ from 30th June 2015 to 30th June 2016?
2. How many Heart Failure Specialist Nurses did the Trust employ from 30th June 2006 to 30th June 2007, and every year since (up until the period covered by question 1)?

Download response Heart failure (HF) specialist nurses. 221116

Histology Reporting. 240817

For the financial year 2016/17 please provide information relating to histology slides/ cases reported for patients of the trust.

1. How many histology slides and or cases (please state whether the number given is slides or cases or both) were reported by consultant histopathologists for patients treated by the trust. If exact numbers are not available, an estimate to within 5% is acceptable, but please state whether exact numbers or estimates are given. (Cytology should be excluded)

2.Of these slides/ cases how many were reported by: a.Consultants employed by the trust working in their normal NHS programmed activity sessions b.Consultants employed by the trust being paid for additional sessions c.Consultants employed by the trust being paid an amount per slide or case for activity outside their contracted programmed activities d.Consultants employed by other trusts, where the trust contracts with these consultants or their trust e.Backlogs Limited f.Unilabs g.Source Bioscience h.Cellular Pathology Services Limited i.Other private histology providers (please specify which)

3.How much was spent in 2016/17 with each of the following in relation to the reporting of histology slides/ cases a.Consultants employed by the trust being paid for additional sessions b.Consultants employed by the trust being paid an amount per slide or case for activity outside their contracted programmed activities c.Consultants employed by other trusts, where the trust contracts with these consultants or their trust d. Backlogs Limited e.Unilabs f.Source Bioscience g.Cellular Pathology Services Limited h. Other private histology providers (please specify which)

Download response Histology Reporting. 240817

HIV patients treated with antiretroviral therapy (ART). 170817

1. Within your Trust for HIV patients treated between August 2016 – May 2017’ and August 2016 – July 2017, the total numbers treated with antiretroviral therapy (ART)

2. For HIV patients treated between August 2016 – May 2017 and August 2016 – July 2017, the total numbers treated with the following drugs.

Download response HIV patients treated with antiretroviral therapy (ART). 170817 

Hysteroscopes and Resectoscopes. 250517

1. Please enter the number of hospitals under your Trust
2. Please enter the bed size for each of the hospitals in your Trust
3. Hysteroscopes
A. Rigid Hysteroscopes (non – video)
i. How many rigid hysteroscopes are installed per hospital in your trust?
ii. On average, what is the lifespan of these rigid hysteroscopes?
iii. How many of the installed rigid hysteroscopes were replaced last year / this year?
iv. Which manufacturer’s rigid hysteroscopes are used in the hospitals?
B. Flexible Fibre Hysteroscopes (non – video)
i. How many flexible fibre hysteroscopes are installed per hospital in your trust?
ii. On average, what is the lifespan of these flexible fibre hysteroscopes?
iii. How many of the installed flexible fibre hysteroscopes were replaced last year / this year?
iv. Which manufacturer’s flexible fibre hysteroscopes are used in the hospitals?
C. Flexible Video Hysteroscopes
i. How many flexible video hysteroscopes are installed per hospital in your trust?
ii. On average, what is the lifespan of these flexible video hysteroscopes?
iii. How many of the installed flexible video hysteroscopes were replaced last year / this year?
iv. Which manufacturer’s flexible video hysteroscopes are used in the hospitals?
4. Resectoscopes
A. Rigid Resectoscopes
i. How many rigid resectoscopes are installed per hospital in your trust?
ii. On average, what is the lifespan of these rigid resectoscopes?
iii. How many of the installed rigid resectoscopes were replaced last year / this year?
iv. Which manufacturer’s rigid resectoscopes are used in the hospitals?

Download response Hysteroscopes and Resectoscopes. 250517

Ingestion or inhalation of button batteries or foreign body. 200418

I would like to make a FOI request to access your trusts ‘ingestion/inhalation of button battery or foreign body’ clinical guideline.

Download response Ingestion or inhalation of button batteries or foreign body. 200418

Inguinal hernia. 050418

1. How many emergency admissions were recorded for T20 Primary repair of inguinal hernia in each of 2013 – 2014 – 2015 – 2016?

2. How many emergency admissions were recorded for T21 Repair of recurrent inguinal herniain each of 2013 – 2014 – 2015 – 2016?

Download response Inguinal hernia. 050418

Inpatient Haemorrhoid surgeries 01 January 2014- 31 December 2014.

1. Number of inpatient episodes of haemorrhoid surgeries done within the trust (broken down by hospital if there is more than one site) in the time period 1st January 2014 – 31st December 2014. If possible I would like the data broken down by types of procedure as set out below:
· Number of Haemorrhoidectomies (OPCS Code H51.1)
· Number of Stapled Haemorrhoidectomies (OPCS Code H51.3)
· Number of Rubber Band Ligation of Haemorrhoid (OPCS H52.4)
· Number of Haemorrhoidal Artery Ligations (OPCS Code L70.3) these may be identified by having the L70.3 code plus additional coding of Y53.2 and H53.8

2. Number of Outpatient Episodes for Rubber Band Ligation of Haemorrhoid (OPCS H524)

Download response Inpatient Haemorrhoid surgeries 01 January 2014- 31 December 2014 200416

Inpatient Laparoscopic Hernia Surgery Episodes during the period 1st January 2015 – 31st December 2015.

I would like to request data on the number of inpatient Laparoscopic Hernia Surgery Episodes done within your trust during the period 1st January 2015 – 31st December 2015. In particular I would like the results broken down by numbers of surgeries done for the following:

1. T20.2 Primary repair of inguinal hernia using prosthetic material (There is usually an additional code of Y75.1 OR Y75.2 assigned to indicate the surgery was done laparoscopically)
2. T21.2 Repair of recurrent inguinal hernia using prosthetic material (There is usually an additional code of Y75.1 OR Y75.2 assigned to indicate the surgery was done laparoscopically)
3. T24.2 Repair of umbilical hernia using prosthetic material (There is usually an additional code of Y75.1 OR Y75.2 assigned to indicate the surgery was done laparoscopically)
4. T25.2 Primary repair of incisional hernia using insert of prosthetic material (There is usually an additional code of Y75.1 OR Y75.2 assigned to indicate the surgery was done laparoscopically)
5. T26.2 Repair of recurrent incisional hernia using insert of prosthetic material (There is usually an additional code of Y75.1 OR Y75.2 assigned to indicate the surgery was done laparoscopically)
6. T27.2 Repair of ventral hernia using insert of prosthetic material (There is usually an additional code of Y75.1 OR Y75.2 assigned to indicate the surgery was done laparoscopically)

Download response Inpatient Laparoscopic Hernia Surgery Episodes during the period 1st January 2015 – 31st December 2015 040316

Insulin pumps 2015-2016. 080517

1. How many patients in your area with type 1 diabetes are currently using insulin pump therapy?
2. What percentage of your diabetes population were a) offered and b) received an insulin pump in 2015/2016
3. The total number of patients who were initiated on insulin pump therapy supplied by:
a) Animas
b) Cell-Novo
c) Medtronic
d) Omnipod
e) Roche
4. What was the total spend on insulin pumps and consumables in 2015/2016
5. What guidance, information and structured education do you provide on insulin pumps for
a. providers and
b. patients
6. What choice are providers/patients restricted to in terms of the insulin pumps offered/funded by Maidstone and Tunbridge Wells NHS Trust

Download response Insulin pumps 2015-2016. 080517

Intra-vitreal vials or implants September – December 2016.100217

1. Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between September and December 2016
Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

2. Does your trust record the time taken from referral of a patient for treatment to the time for an injection or implant to be complete?
If so what is the average waiting time for treatment with an injection of implant?

Download response Intra-vitreal vials or implants September – December 2016.100217

Laparoscopic procedures

Which of the following operations are performed at your trust?
1. Laparoscopic cholecystectomy
2. Inguinal hernia repair (open and/or laparoscopic)
3. Diagnostic laparoscopy

If so, can you please inform me as to whether your trust uses standardised/pre-printed consent forms for each procedure?

Download response Laparoscopic procedures 270616

Late night discharges 2010 – 2014

1. How many patients were discharged from Tunbridge Wells Hospital between the hours of 11pm and 6am each year for the last five years?
2. If possible, can you tell me how many of these discharged themselves, were discharged by the hospital and how many were technically discharged because they had died?
3. How many patients were discharged from Maidstone Hospital between the hours of 11pm and 6am each year for the last five years?
4. If possible, can you tell me how many of these discharged themselves, were discharged by the hospital and how many were technically discharged because they had died?

Download response Late night discharges 2010 – 2014 220515

Lipid clinics 2010-2016. 250717

1. Please confirm the total number of referrals to the Trust’s lipid clinic during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
2. Please confirm the total number of referrals to the Trust’s lipid clinics from (a) general practice and (b) secondary care during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
3. Please confirm the average waiting time between patient referral and appointment to the Trust’s lipid clinic during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
4. Please confirm the proportion of patients accessing the Trust’s lipid clinic that are meeting their lipid targets during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
5. Please confirm the proportion of high risk cardiovascular disease patients* accessing the Trust’s lipid clinic that are routinely offered a structured annual review during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
6. Please confirm or deny whether the Trust has in place an integrated care pathway or clinical management strategy for the management of high risk cardiovascular disease patients. If confirmed, please provide details.
7. Please state the budget allocated by the Trust to its lipid clinic during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.

Download response Lipid clinics 2010-2016. 250717

Malnutrition. 070318

1) The number of under 16’s who were admitted to hospital for the following:
– E40 , E41 , E42 , E43 , E44 , E45 to E46: Malnutrition
– T73.0: Effects of other deprivation – effects of hunger
– E54 : Ascorbic acid deficiency (Inc. scurvy)
– E55 : Rickets, active
– E50 : Vitamin A deficiency
– A15, A16, A17, A18, A19: Tuberculosis

In a) 2010 and b) 2017. I would ask that you include the any patients within these figures who may have other ailments alongside these that could have contributed to admission.
2) For a) 2010 and b) 2017 can you tell me how many were A & E admissions for the symptoms above (even in part) and how many were routine or non A&E admissions?

Download response Malnutrition. 070318

Maxillofacial surgery 2012 to 2015.

I am looking for information relating to any operations carried out that were concerned with Maxillofacial with particular emphasis on double jaw surgery, mandibular correction surgery.
I am looking for the info that relates to the years of January 2012 to December 2015 inclusive and that shows how many operations were conducted, how many were successful and how many were involved with complications such as stroke etc.

Download response Maxillofacial surgery 2012 to 2015 180516

Medical acronyms

Please tell me what these shorthand acronyms used by consultants in hospital mean:
1. R/V
2. PMOK SpR
3. VBG (could be UBG)
4. CVS – HS1 + 11 + 0, HR 84 bpm
5. O/e
6. SHx
7. <-BG
8. P/l – DIB
9. HPC
10. PMHx
11. LRTI
12. NKOA

Download response Medical acronyms 040116

Medical and surgical outliers 2013 – 2016.040117

In each of the financial years 2013-14, 2014-15 and 2015-16 (i.e. give figures for each year separately) please supply the following information:
1. How many patients were a) medical b) surgical outliers – i.e. in a bed in another department’s ward?
2. How many of these a) medical and b) surgical outliers were over the age of 65?
3. How many patients were moved between wards during their stay a) 3 times b) 4 times c) 5 times or more? In each category, how many patients were over the age of 65?
4. On how many occasions were patients moved between 8pm and 8am?
5. How many patients were “boarded” – i.e. taken to a ward where they waited until a permanent bed was ready?
6. What was the a) average b) maximum time that patients were “boarded” for?

Download response Medical and surgical outliers 2013 – 2016.040117

Mental Health attendances to A&E 2016-2017.270317

Between the 1st January 2016- 1st January 2017 how many people were seen in a mental health crisis or because of self-harm in accident and emergency?

Download response Mental Health attendances to A&E 2016-2017.270317

Mental Health patients in A&E 2011-2016.070317

1.) In 2015/2016 how many patients aged 19 and younger attended A&E for a mental health problem. (Drug related, psychiatric problems & self-harm).
2.) In 2015/2016 how many patients aged 19 and younger were admitted following a visit to A&E due to mental health. (Drug related, psychiatric problems & self-harm).
3.) In 2015/2016 how many patients 19 and younger arrived by ambulance for mental health problems?
4.) In 2015/2016 how long was the total length of stay in hospital for patients 19 and younger with a mental health problem. (Drug related, psychiatric problems & self-harm).
5.) 1.) 2.) 3.) and 4.) The same for
2011/2012
2012/2013
2013/2014
2014/2015

Download response Mental Health patients in A&E 2011-2016.070317

Mental Health related A&E attendances 2016. 070317

How many attendances have there been at A&E by people suffering with mental health related issues (for example, categories including, psychiatric conditions, social problems, self-harm) throughout 2016.

Please give me the total number of attendances of people suffering with mental health related issues, at A&E for 2016.

Please then give the breakdown for 18 and over, and under 18s and state how many people waited longer than the four hour waiting target.

If the trust is in charge of more than one hospital, please give separate information per hospital please.

Download response Mental Health related A&E attendances 2016. 070317

Missed outpatient appointments in 2014/2015 and 2015/2016.

1. one outpatient appointment (either first or subsequent attendance)
2. two outpatient appointments (either first or subsequent attendance)
3. three outpatient appointments (either first or subsequent attendance)
4. four outpatient appointments (either first or subsequent attendance)
5. five or more outpatient appointments (either first or subsequent attendance)
For each of the past two years, 2014/15 and 2015/16.

Download response Missed outpatient appointments in 2014/2015 and 2015/2016 180615

Modafinil. 250717

1. Name of the trust
2. Street, town, county and postcode of where the trust’s headquarters or main location/hospital is sited.
3. Number of hospital admissions across the Trust citing the drug ‘Modafinil’ at any point in patient notes for each year.
4. Number of hospital patients reporting illness where Modafinil was known to be related for each year.
5. Number of deaths in hospital relating to Modafinil if known.
6. Number of deaths where patient was known to be prescribed Modafinil
7. Known cases of Steven-Johnson Syndrome
8. Number of hospital patients where both Modafinil and Steven-Johnson Syndrome of SJS appear in the patient’s record.

Download response Modafinil. 250717

Modafinil and Steven-Johnson Syndrome. 251017

By accessing records of patients attending the trust or its hospitals or medical centres an diagnosed with Steven-Johnson Syndrome (or SJS) in the past financial year (2016-17), how many of records make any mention of Modafinil, whether a known prescription or assumed cause of the case.

Download response Modafinil and Steven-Johnson Syndrome. 251017

MRSA screening

Can you please let me know under FOI, whether your trust:

1. Has changed its MRSA screening after the 2014 PHE guidance called ‘implementation of modified admission MRSA screening guidance for NHS (2014).
2. If so, what was your screening regime?
3. If you restricted screening, have MRSA acquisitions (positive screen after 48 hours in hospital or after a negative screen) increased?
4. If so, but how much
5. Please tell me the number of MRSA bacteraemias for the years 2013/14, 2014/15 and 2015/16
6. If you restricted screening and if either MRSA acquisitions or MRSA bacteraemias increased, did you go back to universal screening?
7. If you moved to restricted screening and returned to universal screening, how long did you practice restricted screening.

Download response MRSA screening 060916

MS treatment Sept 2016 – Feb 2017. 240317

In your Trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months? Please use the latest 6 months of data that you can provide.
Please provide the number of patients by treatment for the following disease modifying drugs.
Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a (Plegridy)
Daclizumab (Zinbryta)
Others

Download response MS treatment Sept 2016 – Feb 2017. 240317

Multiple Sclerosis

I have a Freedom of Information request regarding Multiple Sclerosis – in your organisation, how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 12 months?

1. Please provide the number of patients by treatment for the following drugs:
Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a
Others

Download response Multiple Sclerosis 240915

Multiple Sclerosis 031016

In your trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months, latest 6 months that you can provide?
Please provide the number of patients by treatment for the following disease modifying drugs.
Aubagio (Teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (Glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (Fingolimod)
Lemtrada (Alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (Natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a (Plegridy)
Daclizumab (Zinbryta)
Others

Download response Multiple Sclerosis 031016

Multiple Sclerosis. 090218

In your Trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months, latest 6 months that you can provide?
Please provide the number of patients by treatment for the following disease modifying drugs.

Download response Multiple Sclerosis. 090218

Multiple sclerosis. 190618

In your trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months, latest 6 months that you can provide.

Download response Multiple sclerosis. 190618

Multiple Sclerosis. 210917

In your trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months, latest 6 months that you can provide?
Please provide the number of patients by treatment for the following disease modifying drugs.
Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a (Plegridy)
Daclizumab (Zinbryta)
Ocrevus (Ocrelizumab)
Others

Download response Multiple Sclerosis. 210917

Multiple Sclerosis and MRI

Number of patients with an annual review in the last 12 months and number of patients with an MRI in the last 12 months being treated with the following products:
· Tysabri
· Gilenya
· Interferon beta 1a
· Interferon beta 1b
· Copaxone
· Lemtrada
· Tecfidera
· Aubagio
· Plegridy
I would also like to request the following information on patient numbers:
· Number of new MS diagnoses
· Number of patients who have had a relapse in the above month
· Number of relapse events in the above month
I would like this information for the period March 2015 to February 2016, broken down by month

Download response Multiple Sclerosis and MRI 270516

Multiple Sclerosis December 2015 – May 2016.

In your trust how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 6 months, latest 6 months that you can provide?

Download response Multiple Sclerosis December 2015 – May 2016. 270616Download response Multiple Sclerosis December 2015 – May 2016. 270616strong>

Multiple Sclerosis treatment. 180517

In your trust how many patients with Multiple Sclerosis have been treated with
MS disease modifying drugs in the past 6 months, latest 6 months that you can provide.
Please provide the number of patients by treatment for the following disease modifying drugs.
Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a (Plegridy)
Daclizumab (Zinbryta)
Ocrevus (Ocrelizumab)
Others

Download response Multiple Sclerosis treatment. 180517

No Resus Orders (DNR) in 2011 – 2016. 200417

1. How many No Resus Orders were issued by your hospital in last 5 years?
2. How many of these patients survived and were thus discharged from your hospital in same above period?
3. Have you a pro forma No Resus Order checklist which you use to see whether patient should be given No Resus Order, please send me a copy?
4. What percentage of your SpR or Specialist Registrars are on the General Medical Council’s Specialist Register?

Download response No Resus Orders (DNR) in 2011 – 2016. 200417

Non-Oral Anti Coagulants (NOACs). 300518

1.) In your trust how many patients in the last 3* months have been treated for NVAF (Non-Valvular Atrial Fibrillation), with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
2.) How many patients in the last 3* months have been treated for DVT (Deep Vein Thrombosis), with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
Heparin
3.) How many patients in the last 3* months have been treated for PE (Pulmonary Embolism), with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
Heparin
4.) How many patients in the last 3* months have been treated for the prevention of recurrent DVT (Deep Vein Thrombosis) or prevention of recurrent PE (Pulmonary Embolism) with the drugs below:
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
Warfarin
*Latest 3 months that you have available

Download response Non-Oral Anti Coagulants (NOACs). 300518

Non-tuberculosis mycobacterium (NTM).130317

1. In the past 12 months how many patients have been diagnosed with non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)?
1a. Of these how many have been treated with an antibiotic?

2. Do you routinely screen for non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)?
2a. Do you run a NTM (Non-tuberculosis mycobacterium) clinic or service?
Please state any other trusts that share this service?
2b. If you do not have a NTM clinic, where do you refer suspected NTM patients?
2c. How many suspected NTM patients did the trust refer to other institutions in the last 12 months?

3. Which testing laboratory do you send your sputum samples for suspected NTM?
3a. Do have a shared care protocol for treating NTM?

4. Do you run a specific clinic for bronchiectasis patients?
4a. How many patients with bronchiectasis (J47/Q33.4) have you treated in the last 12 months?
4b. How many of these patients have also been diagnosed with non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)
4c. How many of these NTM diagnosed patients are treated long term [more than 12 months] with an antibiotic?
4d. How many of these NTM diagnosed patients are treated long term [more than 12 months] with inhaled or IV amikacin?

5. Do you run a specific clinic for chronic COPD patients?
5a. How many patients with chronic COPD (J44.0, J44.1, J44.8, J44.9) have you treated in the last 12 months?
5b. How many of these patients have also been diagnosed with non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)
5c. How many of these NTM diagnosed patients do you then treat with an antibiotic?
5d. How many of these NTM diagnosed patients do you then treat with inhaled or IV amikacin?

Download response Non-tuberculosis mycobacterium (NTM).130317

Number of injuries caused by e-cigarettes 2013 – 2016

I’m looking to receive details on how many patients have been admitted to hospital with injuries caused by e-cigarettes since 2013.

Can this please be broken down into separate figures for 2013, 2014, 2015 and 2016 so far?

If possible, could I also be provided with a brief description of the injuries suffered in each case?

Download response Number of injuries caused by e-cigarettes 2013 – 2016 180416

Number of patients hospitalised for self-harming in 2013-2016.

For the following financial years 2013-14, 2014-15 and 2015-16 up to March 2016
How many patients have been hospitalised for self-harm?
Can you please provide an age breakdown of the patients hospitalised for self-harming?
Can you please reveal the number of patients who were male and how many were female?

Download response Number of patients hospitalised for self-harming in 2013-2016 060616

Operations, operating theatres and intensive care beds. 170118

1) The total number of operations you performed in your operating theatres between 1/4/2017 and 30/9/2017 inclusive
2) The total number of high dependency / intensive care beds (level 2 or level 3) you had available to you on 30/9/2017
3) The total number of cases that went to a level 2 or level 3 post-operatively, either planned or unplanned
4) The total number of operations in any speciality where you cancelled the procedure on the day of surgery because of lack of availability of a level 2 or level 3 bed between 1/4/2017 and 30/9/2017

Download response Operations, operating theatres and intensive care beds. 170118

Orthotics tenders and budgets. 130317

With regards to your orthotics department, would it be possible to know the following information please:
Start/End date of current tender agreement for the provision of orthotics products and or service.
If at all possible, I would also be extremely grateful if you could provide any information relating to contract value and the categories of product/service covered.

Download response Orthotics tenders and budgets. 130317

Parkinson’s and self-administration of medication. 190717

Self-administration of medicines policies
1. Does your Trust have a self-administration of medicines policy for competent patients? Yes/ No
a. If yes, please provide a copy of this policy?
b. If yes, please outline whether this policy applies to all hospital sites and all wards, or specify the sites or wards to which it applies?
c. If no, are you planning to introduce this policy in 2017/18? Yes/ No

2. If you have a policy please provide details of the use of the self-administration of medicines policy? This includes:
a. How are your staff informed about this policy?
b. How is the implementation of this policy monitored across the hospitals in your Trust?

3. If you do not have a self-administration of medicines policy, why is this? [Please let us know of any barriers to introducing a policy in your Trust].

Carers visiting hours
4. Do you currently have a policy which allows carers to visit the person they care for outside of visiting hours? Yes/ No
a. If yes, please provide a copy of this policy.
b. If yes, please outline whether this policy applies to all hospital sites and all wards, or specify the sites or wards to which it applies..
c. If no, are you planning to introduce a policy in 2017/18? Yes/ No
d. If no, please outline any work that your Trust is undertaking with a view to enabling carers to visit the person they care for outside visiting hours?

5. If you have a policy, please provide details of the use of the policy to allow carers to visit outside of traditional visiting hours? This includes:
a. How are your staff informed about this policy?
b. How is the implementation of this policy monitored across the hospitals in your Trust?

6. If you do not have a policy which allows carers to visit the person they care for outside of visiting hours, why is this? [Please let us know of any barriers to introducing a policy in your Trust].

Download response Parkinson’s and self-administration of medication. 190717

Patients aged 18 and under who have undergone bariatric surgery in the last three years

1) How many patients aged 18 and under have undergone bariatric surgery in the last 3 years? Please break down how many per year.
2) How young was the youngest patient?
3) How many of those patients have also undergone surgery to remove excess skin as a result of that bariatric surgery? Please break down by year.

Download response Patients aged 18 and under who have undergone bariatric surgery in the last three years 170216

Patients attending A&E from Priory Hospital. 070318

– How many occasions did patients from the High Dependency Mental Health Unit, Priory Hospital Ticehurst [Ticehurst, East Sussex, TN5 7HU], who are under 18 years of age, receive treatment at the A&E department based at Tunbridge Wells hospital and / or any other A&E department run by the trust between 1st January 2017 to 31st December 2017.
– Please detail the reason for each visit.

Download response Patients attending A&E from Priory Hospital. 070318

Patients were admitted to the A&E Department on the 7th and 8th of January 2016

Please may you tell me how many patients were admitted to the A&E Department on the 7th and 8th of January 2016.

Of these patients, how many were admitted within 4 hours, between 4-12 hours and 12 hours or more.

Download response Patients were admitted to the A&E Department on the 7th and 8th of January 2016 010216

Patients who attended A&E due to mental health in each year covering the period financial year 2010-11 to 2014-15

1. How many patients attended A&E due to mental health in each year covering the period financial year 2010-11 to 2014-15? Please break down the statistics into the number per financial year.
2. What percentage of total A&E attendances did patients attending for mental health account for in each year? Again please cover the period financial year 2010-11 to 2014-15 and break down the statistics into the number per financial year
3. What was the average wait for patients attending A&E due to mental health to have an initial assessment in each year 2010-11 to 2014-15?
4. What was the average wait for patients attending A&E due to mental health to be assessed by a specialist in each year 2010-11 to 2014-15?
5. How many patients attending A&E due to mental health received inpatient treatment as a result of their visit to A&E? Please list stats for each year 2010-11 to 2014-15.
6. How many patients attending A&E for mental health were discharged without further treatment? Please list stats for each year 2010-11 to 2014-15.
7. Does your A&E have a psychiatric liaison service? If yes, when was this service established?
8. What proportion of total delayed transfers of care were related to mental health for each year between 2010-11 to 2014-15?
9. Please provide copies of any correspondence sent from your trust chief executive to NHS mental health trusts, CCGs, NHS England or the Department of Health regarding pressures on your services linked to mental health in 2013-14 or 2014-15.

Download response Patients who attended A&E due to mental health in each year covering the period financial year 2010-11 to 2014-15 050116

Plagiocephaly. 061217

How many cases of Plagiocephaly have you diagnosed and (or) treated in the last 5 years?

Download response Plagiocephaly. 061217

Poisoning incidents May 2015 to May 2016

Please can you give me a monthly break-down of the “finished admission episodes” involving poisoning with the following substances? I would like the data for each month from May last year to May this year.
T404 – Poisoning: Other synthetic narcotics
T406 – Poisoning: Other and unspecified narcotics
T409 – Poisoning: Other and unspecified psychodysleptics [hallucinogens]
T436 – Poisoning: Psychostimulants with abuse potential
T438 – Poisoning: Other psychotropic drugs, not elsewhere classified

Download response Poisoning incidents May 2015 to May 2016 280716

Primary Percutaneous Coronary Interventions.

1. On what date (month and year) did The Tunbridge Wells Hospital start to provide primary Percutaneous Coronary Interventions (PCI)?
2. If applicable, over what period did The Tunbridge Wells Hospital provide a primary Percutaneous Coronary Intervention weekday service (less than 24 hours a day, 7 days a week)? Please provide a date range (month, year to month, year)
Over this period, what hours did the weekday service operate?
3. If applicable, over what period did The Tunbridge Wells Hospital provide a primary Percutaneous Coronary Intervention service that operates 24 hours a day 7 days a week? Please provide a date range (month, year to month, year).
4. Does The Tunbridge Wells Hospital collaborate with another Trust to provide 24/7 primary Percutaneous Coronary Intervention coverage? If so, which Trusts are involved in this collaboration.

Download response Primary Percutaneous Coronary Interventions 290416

Red and black alerts for March 2015.

How many times in March 2015 were your trust hospitals under a red or black alert?

Please state which hospitals were affected and how long each hospital was affected.

Download response Red and black alerts for March 2015. 180516

Red and black alerts guidance and procedures.

1. Please provide the number of days each month, with the specific dates, that each A&E managed by your trust has been on green, amber, red or black alert for the last three years, up to the most recent possible date.

For clarification, if the most recent date is 02/05/16, please provide the data for the last 36 months.

Please present this in an excel file.

2. Please also provide the official definition, guidance, and procedures communicated to staff when a ‘black alert’ is announced, particularly guidance given to the flow coordinator or similar role.

Download response Red and black alerts guidance and procedures 180516

Removal of foreign objects. 061217

I would like a list of all procedures carried out on your premises by medical professionals to remove foreign objects from patients’ rectums / colons.

I define a “foreign object” as an object that is separate from the body, therefore not including natural growths or tumours.

I would like the list of each of these procedures to be accompanied with generic information of the procedure and the patient.

This should include date and time of procedure, gender of the patient and age of the patient.

Also accompanying each procedure, I would like generic information regarding the nature of the procedure.

This includes whether surgery under anaesthetic was required, and a brief summary naming the object(s) removed.

Download response Removal of foreign objects. 061217

Renal Multidisciplinary team (MDT)

1. Does your Trust employ one or more renal Multidisciplinary team (MDT)?
2. If yes, does this team include an Interventional Radiologist (IR)?
3. Does your Trust employ a Specialist to look into access problems with AV fistulas?

Download response Renal Multidisciplinary team (MDT) 270516

Respiratory admissions. 251017

1. If the Trust currently, or have previously, assigned additional hospital beds for respiratory admissions over winter months?
2. If the Trust has made any changes to its pathway for respiratory admissions in the last five years?
3. What percentage of patients with a primary diagnosis of COPD, admitted for an exacerbation of COPD, received specialist input in to their care within 24 hours of admission in each month of 2016 and each available month of 2017?
4. What percentage of patients with a primary diagnosis of COPD, admitted for an exacerbation of COPD, received a discharge bundle prior to discharge in each month of 2016 and each available month of 2017?

Download response Respiratory admissions. 251017

Respiratory illness and A&E. 240817

The total number of accident and emergency attendances in each month of the year 2016/17.

The total number of accident and emergency attendances in which respiratory illness was the cause of admission in each month of the year 2016/17.

The total number of accident and emergency attendances in 2016/17, 2015/2016, 2014/15, 2013/2014, 2012/13, and 2011/12.

The total number of accident and emergency attendances in which respiratory illness was the cause of admission in 2016/17, 2015/2016, 2014/15, 2013/2014, 2012/13, and 2011/12.

Download response Respiratory illness and A&E. 240817

Respiratory patients. 071217

1. Please provide monthly data on the number of respiratory patients admitted throughout each month of 2015/16. If available, the number in each diagnosis code from J00 – J99.
2. Please provide monthly data on the average length of stay of respiratory patients admitted throughout each month of 2015/16.
3. Please provide monthly data on the average mortality rates of respiratory patients admitted throughout each month of 2015/16.
4. How many patients with a primary diagnosis of respiratory come (a) via their GP; or (b) directly to the admission area; in each month of 2015/16?

Download response Respiratory patients. 071217

Resus trolley security seal, tag. 290118

1. What does the Trust use for securing the contents of resus trolleys? For example is a tamper evident seal used, or a lock and key? (If a seal is used, could you provide a brief description of the type used?)
2. How many of these seals/locking mechanisms are used by the Trust annually?
3. What is the Trust’s annual spend on these?
4. Where does the Trust order these from? (If they are procured through the NHS Supply Chain what is their product code?)
5. Who is responsible for ordering this product?

Download response Resus trolley security seal, tag. 290118 

Rota gaps in A&E. 220218

1) Please state the number of occasions in the last three financial years and the current financial year to 01.02.18 where a doctor shift in your accident and emergency departments was left unfilled.
2) Please state the number of complaints made by doctors at your accident and emergency departments due to having to fill rota shift absences in each of the last three financial years, and the current financial year to 01.02.18. Please provide a copy of the text of each complaint.
3) Please state the number of occasions that rota shift gaps in your accident and emergency departments have been filled by agency workers in each of the last three financial years and the current financial year to 01.02.18. Please state the cost of this to your trust in each of these years.
4) Please state the number of occasions that rota shift gaps in your accident and emergency departments have been filled by staff working additional shifts in each of the last three financial years and the current financial year to 01.02.18. Please state the cost of this to your trust in each of these years.

Download response Rota gaps in A&E. 220218

Self-harming. 260218

1. How many children aged under-18 were admitted to hospital through each of your accident and emergency departments between 1 April 2016 and 31 March 2017 due to self-harming?

2. Can you provide an age breakdown of admittance’s for this period?

Download response Self-harming. 260218

Self-harming in under 18 year olds.

1. How many children aged under 18 were admitted to each of your accident & emergency departments in the below years due to self-harming?
• 2015-16
• 2014-15
• 2013-14

2. Can you provide an age breakdown of admittances for each of these years?

3. Can you provide an injury breakdown for each of these years?

Download response Self-harming in under 18 year olds 060916

Serious Incidents recorded in the A&E departments 2014 to July 2016.

How many Serious Incidents (SI) were recorded in your A&E department in:
a. 2014
b. 2015
c. From 1/1/16- 25/7/16

Download response Serious Incidents recorded in the A&E departments 2014 to July 2016 050816

Severe asthma patients. 301117

1.) How many adult severe asthma patients have been seen in outpatient clinics in the last 3 months?
2.) How many adult severe asthma patients have you treated with a biologic in the last 3 months?
3.) How many adult severe asthma patients have you treated with:
Xolair (omalizumab)
Nucala (Mepolizumab)
Cinaero (Resilizumab)

Download response Severe asthma patients. 301117

Severe Asthma patients. 311017

1.) How many adult severe asthma patients have been seen via both in-patient visits and outpatient clinics in the last 3 months?
2.) How many adult severe asthma patients have you treated with a biologic in the last 3 months?
3.) Of these patients treated, can you provide which drugs they were treated with, as follows:
• Omalizumab (Xolair)
• Mepolizumab (Nucala)
• Resilizumab (Cinqaero)

Download response Severe Asthma patients. 311017

Snake bites – 2012-2016. 050517

The number of A&E attendances for snake bites for the following 5 calendar years, broken down into age groups -children and adults:

1. 1st Jan 2016 – 31 Dec 2016
2. 1st Jan 2015 – 31 Dec 2015
3. 1st Jan 2014 – 31 Dec 2014
4. 1st Jan 2013 – 31 Dec 2013
5. 1st Jan 2012 – 31 Dec 2012

Download response Snake bites – 2012-2016. 050517

Self-harm and suicidality in 14-25 year olds.

How many people aged 14-25 have presented to your services with self-harm and suicidality (ICD-10 term/code: ‘Intentional Self-Harm’ (X60-X84))? I would like the figures for the past 5 years (either calendar of financial).

Download response Self-harm and suicidality in 14-25 year olds 060916

Staff contacts within the Accident and Emergency Department. 080518

Please could you provide me with the name and email address of the person that holds the following responsibility within your Trust: Lead Nurse for Accident and Emergency; Clinical Service Manager for Accident and Emergency

Download response Staff contacts within the Accident and Emergency Department. 080518

Stoma Care nursing services. 241017

Information request 1 – The name of the incumbent Service Provider of the Stoma Care Nursing Services along with the date of the Contract Review?
Information request 2 – Stoma population per annum within your Trust?
Information request 3 – The number of patients who require scripts in continence and stoma per annum?
Information request 4 – Current number of stoma nursing staff on role at the Trust and their location?
Information request 5 – Has the stoma nursing services contract recently been extended and if so did this go to Tender?
Information request 6 – The appropriate E-Tender Portal website you use?

Download response Stoma Care nursing services. 241017

Stroke and COPD services. 190717

1. Please provide the waiting times for accessing any services confirmed in request one.

2. Please confirm/deny that patients can be a) re-referred into or b) self-refer back into any services confirmed in request one.

3. Please confirm the staffing make up of any services confirmed in request one.

Download response Stroke and COPD services. 190717

Substance abuse treatment. 070318

For each question I am seeking information for each of the following time periods:
i) 2013/14
ii) 2014/15
iii) 2015/16
iv) 2016/17
v) 2017/18 to date (most recent data available)
1. How many patients were identified as having a substance abuse/ reliance issue?
2. How many were offered residential rehabilitation (including those outsourced to private facilities)?
3. How much funding was granted to your CCG in order to cover substance rehabilitation treatments?

Download response Substance abuse treatment. 070318

Suicide and self-harm admissions. 090418

1. Could the trust please reveal the number of attempted suicide and self-harm admissions it has had since 2013. Please could this information be broken down into year and month of admission?
2. Could the information requested above please include the following details.
a. Age and gender of patient together. (Age can be broken down into groups if necessary to prevent identification, groups can be 0-12, 13-17, 18-30, 31-45, 45-60, 61+)

Download response Suicide and self-harm admissions. 090418

Suicide, self-inflicted deaths and attempted suicides.080318

Please could you give a breakdown of how many suicides, self-inflicted deaths and attempted suicides occurred among people under 18 with the ICD-10 code F12. – ‘mental and behavioural disorders due to use of cannabinoids’, during the 2016/17, 2015/2016, 2014/2015, 2013/2014, 2012/2013, 2011/2012, 2010/ 2011, 2009/ 2010, 2008/ 2009, 2007/ 2008, 2006/ 2007 periods?

Download response Suicide, self-inflicted deaths and attempted suicides.080318

Tender for the provision of Stoma Care Services Reference DN289588. 050418

Please provide the following information which refers to: Tender for the provision of Stoma Care Services Reference DN289588
Information request 1 – Please supply all documentation relating to all shortlisted suppliers for the above tender – to include scoring matrixes, evaluation material, criteria and weightings given along with panel member notes.

Information request 2 – Please supply all documentation relating to our specific bid for the above tender – to include scoring matrixes, evaluation material, criteria and weightings given along with panel member notes.

Download response Tender for the provision of Stoma Care Services Reference DN289588. 050418

Tourniquets. 121217

1) Does the trust use single use venous tourniquets, reusable tourniquets or both?
2) What is the annual spend/usage on each category of tourniquet?
3) How many reported incidences of tourniquets being inadvertently left on a patients arm have there been in the past 5 years?
4) What is the value if any, of any litigation costs associated with any such incidences?

Download response Tourniquets. 121217

Trampoline related injuries. 061217

The number of admissions to the Accident and Emergency Department for trampoline related injuries, during the following periods:

2011-2012
2012-2013
2013-2014
2014-2015
2015-2016
2016-2017 (to date)

If you have the information, please can you detail the kind of injury sustained e.g. Head injury or spinal injury.

Download response Trampoline related injuries. 061217

Treatment of haemorrhoids

Treatment of haemorrhoids
Surgical Procedures
Hospital Procedure Code
Milligan Morgan H51.1
Rubber Band Ligation H52.4
Stapled PPH (Procedure for Prolapsed Haemorrhoids H51.3
THD (Trans Haemorrhoidal Dearterialization) L70.8
HALO (Haemorrhoid Artery Ligation Operation) L70.3
Y53.2
Z37.8
Other (Please List):
Other (Please List):
Other (Please List):
Other (Please List):

Download response Treatment of haemorrhoids 311215

Treatments with specific products. 071217

Within your health trust how many patients are currently [within the past 3 months] being treated with the following agent and indication;
PRODUCTS:
MabThera IV (rituximab)
MabThera SC (rituximab)
Truxima (rituximab)
Rixathon (rituximab)
Gazyvaro (obinutuzumab)
Imbruvica (ibrutinib)
Zydelig (idelalisib)
Arzerra (ofatumumab)
Please can you state the number of patients for the above drugs for the following indications;
Follicular lymphoma [C82.0 to C82.9]
Diffuse Large B-cell Lymphoma [C83.3]
Chronic Lymphocytic Leukaemia [C91.1]
All other B-cell, haematological malignancies (all C82, C83, C85, C88.0, C88.4 codes not listed above]
Rheumatoid Arthritis [M5, M6]

How many Truxima patients were naive or new to biologic therapy?

Download response Treatments with specific products. 071217

Treatments with specific products. 150517

1. Within your trust how many patients have been treated with the following products in the past 3 months you have available;
MabThera IV (rituximab)
MabThera SC (rituximab)
Truxima (rituximab)
Gazyvaro (obinutuzumab)
Imbruvica (ibrutinib)
Zydelig (idelalisib)
Arzerra (ofatumumab)

2. Please can you state the number of patients for the above drugs for the following indications;
Follicular lymphoma [C82.0 to C82.9]
Diffuse Large B-cell Lymphoma [C83.3]
Chronic Lymphocytic Leukaemia [C91.1]
All other B-cell, haematological malignancies (all C82, C83, C85, C88.0, C88.4 codes not listed above]
Rheumatoid Arthritis [M5 and M6]

3. Does your trust code haematological malignancies against ICD10 codes?

Download response Treatments with specific products. 150517

Tunbridge Wells Hospital A&E. 070318

1. It is impossible to get your email address so I am writing.
2. I want to know under FOI the number of people at A&E on 13 January who were not registered with a GP.
3. Can you please tell me how you calculate the time in the department as only the arrival time is logged?

Download response Tunbridge Wells Hospital A&E. 070318

Urinary Flow Rate Tests. 081117

1. What is the charge made by the trust to CCGs for urinary flow rate test for prostate /hyperplasia and cancer patients?
a. If it is within a tariff code please indicate code and tariff
b. If outside tariff please indicate charge

Download response Urinary Flow Rate Tests. 081117

Urinary tract infections. 241017

1. The number of children attending A and E with upper and lower urinary tract infections also referred to as bladder infection, kidney infection, pyelonephritis and cystitis
2. The number of children admitted into hospital with upper and lower urinary tract infections also referred to as bladder infection, kidney infection, pyelonephritis and cystitis
3. The number of children diagnosed with urinary sepsis.
4. The number of deaths of children from sepsis as a result of a kidney or urinary tract infection, pyelonephritis or urinary sepsis.
In children 18 and under for the time period January 2012 until December 2016

Download response Urinary tract infections. 241017

Uscomm BP+. 270917

Please tell me if you have bought, stock it and use this product:

It is called Uscomm BP+, previously it was called Pulsecor.

It is used by cardiologists or doctors and consultants who have interest in heart related things.

Download response Uscomm BP+. 270917

Uveitis with a biologic treatment, including those on a Patient Access Scheme.

In your Trust please supply the number of patients currently treated for Uveitis with a biologic treatment, including those on a Patient Access Scheme.

Please state the number of Uveitis patients treated, and where possible by each biologic drug:
· Adalimumab
· Etanercept
· Infliximab
· Rituximab
· Other biologics

How many Psoriasis patients have been treated in the last 6 months with Fumaric acid esters (Fumaderm), If your trust can’t supply patients, please supply the number of packs of tabs

Download response Uveitis with a biologic treatment, including those on a Patient Access Scheme 270516

Variable Rate Intravenous infusion (VRIII) 301117

Q1. Do you use variable rate intravenous insulin infusion (VRIII) (formerly known as sliding scale) within your hospital yes/no
If yes continue questions if no end of request
Q2. Is the training you offer specific to VRIII or is it included in generic IV training
Q3. Is the VRIII training conducted by the diabetes team yes/no
Q4. If it is specific VRIII training conducted by the diabetes team is it mandatory for all staff who wish to use VRIII.

Download response Variable Rate Intravenous infusion (VRIII) 301117

 

Virtual clinics. 301117

1. Do you currently have a ‘virtual fracture clinic’ / ‘virtual triage clinic’ / alternative to a traditional face to face appointment?
2. If so what is it called and when did it start?
3. Name and contact details of lead orthopaedic consultant/ consultant in charge of fracture clinic?
4. Number of new patient referrals per annum to fracture clinic?
5. How much do you get paid per new patient “virtual” appointment?
6. What is your discharge percentage from the “virtual” appointment?
7. What software program do you use to run your virtual clinic? In-house or bought in?
8. If you don’t have any virtual clinic, have you been considering/planning for one?
9. Do all patients come to a generic fracture clinic? Or do A&E book into sub-speciality clinics e.g. acute knee, Paeds, hands etc.

Download response Virtual clinics. 301117

Wet Age Related Macular Degeneration (wAMD) between January and April 2017. 200617

Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between January and April 2017?

Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use.

Download response Wet Age Related Macular Degeneration (wAMD) between January and April 2017. 200617

Winter serious incidents. 160518

How many Serious Incidents (SI) were recorded in your A&E department in:

a. 1/11/2015 – 31/3/2016

b. 1/11/2016 – 31/3/2017

c. 1/11/2017 – 31/3/2018

Download response Winter serious incidents. 160518

Wound care formulary. 310118

Please note this response contains visual information:

1. Please supply me with your most up to date wound care formulary (please indicate if you do not work from a formulary)?
2. Who has operational responsibility for the formulary including the addition or deletion of products?
3. Please provide information on how compliance with your formulary is enforced?
4. Please provide information on how products are evaluated prior to being accepted onto the formulary? If this is part of a clinical evaluation or clinical trial, please provide the results.
5. Please provide information on who is responsible for the cost of wound care in your setting – is it CCG or Acute?
6. Please provide information if the wound care products are on prescription FP10?
7. Please provide a list of the wound care products that you are planning to keep on prescription FP10?
8. Please provide information if you are planning to take wound care products off prescription FP10?
9. Please provide a list of the wound care products that you are planning to take off prescription FP10?
10. Do you hold information about your patient demographic? If so, please provide information on what is your patient demographic and what are the most commonly treated wounds from your patient demographic
11. Please provide any information that you have relating to the average monthly usage of each product in the formulary?
12. Please provide information on the number of wound care products used that are not currently on the formulary?
13. Please provide any information on the monthly usage levels for non-formulary wound care products in the last twelve months?
14. How often do you review your wound care formulary and when was this last undertaken?
15. Please provide information about the procedure that you use of the information you assess when reviewing your formulary?
16. Please provide a list of the suppliers that are currently on your formulary?
17. Please provide figures for your total spend on wound care products in 2015 and 2016?
18. Please provide figures for your total spend on Compression bandages in 2015 and 2016?
19. Please provide figures for your total spend on Foam dressings in 2015 and 2016?
20. Please provide figures for your total spend on Anti-Microbial wound care products in 2015 and 2016?
21. Please provide figures for your total spend on Alginate (Silver) wound care products in 2015 and 2016?
22. Please provide figures for your total spend on Hydrocolloid wound care products in 2015 and 2016?
23. Please provide figures for your total spend on Wound contact products in 2015 and 2016?
24. Please provide figures for your total spend on Exudate Absorber (Super Absorber) Dressings products in 2015 and 2016?
25. Please provide figures for your total spend on Acute Wound Care products – Post Op Film Dressing Plus Pads, Steri-Strips, Stockinette and Semi Permeable Film Dressings in 2015 and 2016?
26. Please provide figures for your total spend on Skin Integrity wound products – Barrier Films and Barrier Creams in 2015 and 2016?
27. Please provide figures for your total spend on Vascular Access wound products – Semi Permeable Film Dressings and IV Dressings in 2015 and 2016?
28. Please provide figures for your total spend on hosiery products in 2015 and 2016?
29. Are you planning on collaborating with another healthcare entity to provide wound care services?
30. Please provide information on your current supply route – DHL, wholesaler or vendor direct?
31. Do you currently have a contract in place for supply of wound care products? If so when does it expire?
32. Please provide information on how many delivery points do you have for wound care deliveries?
33. Please provide information on how many community locations are holding stock of wound care and prescribing to the community?
34. Please provide information on what software platform do you use for ordering wound care products?
35. Do you have a wound care clinic in place for your local demographic and where do your referrals come from?

Download response Wound care formulary. 310118

 

Endoscopy

Endoscope repair and service contract 2015-2016.

1) Between 1st April 2015 and 31st March 2016, in monetary terms, how much did your Trust spend by individual hospital, on either repairing flexible endoscopes and/or spend on service contracts for the following equipment:
• Gastroscopes
• Colonoscopes
• Duodenoscopes
• Bronchoscopes
• Flexible cystoscopes

Download response Endoscope repair and service contract 2015-2016.

Endoscopy Procedures

1. Current waiting list time(s) for the below Endoscopy procedures in line with Joint Advisory Group (JAG) guidelines?
· OGD – Gastroscopy
· Flexible Sigmoidoscopy
· Colonoscopy
· EUS
· ERCP
2. Do you currently require assistance with a locum Consultant to help clear your current backlog / waiting list?
3. Number of Endoscopy sessions run weekly, and how many theatres available?
4. Do you operate over 5 days (Mon-Fri) or do you offer a full 7 day service?
5. The rate per session (or per hour) for Endoscopy waiting list initiative work that the Trust has paid to Consultant?
6. Please could you also tell me the sessional rate (or per hour) for Endoscopy waiting list initiative work paid to Locum Consultants between the same time period?
7. Please could you also tell me whether the hospital has ever used agencies to supply Endoscopy Consultants?
If so, which agencies have been used?

Download response Endoscopy Procedures 111115

Endoscopy systems 060317

1. Do you currently have endoscopy reporting software installed?
2. if the answer to Q1 is yes, who is the software provider?
3. If the answer to Q1, is yes, was the software installed under a fixed term contract or on an annual renewal basis?
4. if the software was installed under a fixed term contract,when does this contract expire?
5. If the answer to Q1 is no, are there any plans to install endoscopy reporting software?
6. if the answer to Q1 is no, is this because you do not provide endoscopy to patients?

Download response Endoscopy systems 060317

 

Estates & Facilities

Air handling units. (AHU). 081117

Would be possible to obtain by email the total number of air handling units in operating theatres in the hospitals managed by the trust and the age of the air handling units (as in how long they have been installed).

Download response Air handling units. (AHU). 081117

Air pollution cases

“I would be interested in seeing a report regarding any statics about how many people have suffered of any complications/ died due to air pollution or water pollution in the area in the last 2-3 years.”

Download response Air pollution cases 311215

Asbestos. 020518

1. Do any of your hospitals currently contain asbestos?
2. How many reported incidents of asbestos exposure have there been in any of your hospital buildings over the past five years (between January 2013 – December 2017).
3. How many claims have ever been made against your trust for asbestos related exposure/disease including but not exclusively for mesothelioma.
4. How many of these claims have been settled?
5. What is the amount of money that has been paid in settlement of these claims where your Trust did not go through NHS Resolution (formerly the NHS Litigation Authority)? Please include claims with and without your trust/board accepting responsibility and claims made through any other insurance schemes excluding the NHSLA/NHS Resolutions.

Download response Asbestos. 020518

Asbestos Contract 091216

Please can we make a freedom of information request to see a copy of the winning tender / contract for asbestos surveys within your NHS authority?

Download response Asbestos Contract 091216

 

Bariatric equipment. 220218

1. I wish to know how much your trust has spent on specialist equipment for bariatric patients (patients over 160kg) during the last three years?
2. Please give a breakdown of the type of specialist bariatric equipment used by the trust and the amounts spent, split between Rental Expenditure and Purchased Equipment?
a. If equipment used is on a Rental basis, please specify if this was under a contract basis or ad hoc?
b. If under contract, when is this due for renewal?
c. If known, who is the contract with?
3. How many bariatric beds does the Trust own?
4. How many bariatric patients have been admitted to your hospital/hospitals during the past 12 & 24 months for all procedures?

Download response Bariatric equipment. 220218

Bed stock. 120717

We require the number of beds at each hospital within your trust.

Download response Bed stock. 120717

Bed stock 2012 and 2017. 280217

1a How many beds did the Trust have for NHS services on 1 January 2012?
1b How many beds does the Trust have for NHS services on 1 January 2017?
2a How many beds did the Trust have for private patients on 1 January 2012?
2b How many beds does the Trust have for private patients on 1 January 2017?

Download response Bed stock 2012 and 2017. 280217

Bed stocks 2012 and 2017. 080217

1- How many beds did the trust have for NHS services in 2012?

2- How many beds does the trust have for NHS services in 2017?

3- How many beds did the trust have for private patients in 2012?

4- How many beds does the trust have for private patients in 2017?

Download response Bed stocks 2012 and 2017. 080217

Body worn cameras or video recording devices. 011217

The details of your use of body cameras in your organisation –

1. Does anyone (staff or contractors) in your organisation use/wear body cameras or body worn video recording devices while performing their duties?
If yes, please detail:
2. Who provides the body cameras and footage/evidence management used by your organisation?
3. How many staff members use body cameras and what capacities/teams do they work in? Are they staff or contractors (for e.g. outsourced security personnel) How many body cameras in all are currently owned and/or used by your organisation?
4. Were the cameras bought as a one off purchase and if so, how much did they cost your organisation?
5. If they are part of an ongoing contract – what is the current contract term (how long is it and when does it expire) and what is the value of said contract?
6. Where is the data recorded stored – on premises locally or on cloud?
7. Who is the point of contact for your body camera programme?

Download response Body worn cameras or video recording devices. 011217

C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

For the years 2014, 2015, and 2016 please details the following:

How many people and inpatients have been infected with and treated for a superbug.

List which superbug people were infected with.

In which hospital did they contract the infection?

How many of these people later died of the infection?

Download response C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

Catering 2015-2017. 250117

1. For the two past financial years (2015/16 and 2016/17 to date), please provide the following data, breaking it down month by month:
a. The number of inpatient main meals requested in the Trust
b. The number of inpatient main meals left untouched
c. The total cost of providing inpatient main meals
d. The cost of feeding one inpatient per day

2. Please name the catering companies and food suppliers used by the Trust in 2015/16 and 2016/17 to date

3. Please provide details of what changes, if any, the Trust has made or plans to make to inpatient catering and food procurement contracts with suppliers and/or catering companies in response to rising food commodity costs.

4. Please state:
a. Whether the Trust currently meets the following Government Buying Standards for food and catering services: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/418072/gbs-food-catering-march2015.pdf

b. Whether the Trust currently uses or has made plans to use the provisions in the Government Buying Standards that allow an authority to depart from mandated production and/or animal welfare standards to avoid a “significant increase in costs”. If so, please set out the date this decision what taken and the details of what was decided.

Download response Catering 2015-2017. 250117

Catering services 020317

1. Are the catering services provided at your trust managed ‘in house’ or outsourced to a third party provider? If the organisation has a fully managed contract please state.
2. Who is the supplier for this contract? Please can you provide me with the contract information for each individual supplier? [
3. What is the contract duration? Please also provide me with any extensions that maybe offered to the supplier.
4. What is the contract expiry date? Please at least provide me with the month and year.
5. When will this contract be reviewed? Please at least provide me with the month and year.
6. Can you please provide me with the total number of sites the contract covers? An estimate will also be acceptable.
7. What services are provided under this contract? A brief description will be acceptable.
8. Who is the main contact from within the organisation responsible for reviewing this contract? Can you please provide me with their full name, actual job title, contact number and direct email address?
9. Who is the manufacturer and supplier of the trusts patient meals?
10. Notes: If the contract information provided is going to be expiring within the next 3 months it would be helpful to know if you’re going to renew or are planning to go to tender for a new contract for this particular service.

Download response Catering services 020317

Catering services at Tunbridge Wells Hospital (TWH) and Maidstone Hospital (MGH). 190417

1. Whether your site offers bulk or plated service?
2. Do you use plastic or china cutlery and plates?
3. When it comes to your purchasing process in the catering sector, do you have a centralized system with a purchasing department or are the individual people allowed to make their orders themselves (up to a certain limit)?
4. Do you get your information about the products you need from your go-to manufacturer, your local dealer, your hospital’s purchasing department, the internet or a price list you own?
5. Are those who you get your information from the ones you also buy from or do you use a different authority for that?
6. Last but not least would it be possible to get the contact details of your catering manager (as in first and surname, phone number and email address)?

Download response Catering services at Tunbridge Wells Hospital (TWH) and Maidstone Hospital (MGH). 190417 

Cell saver machines. 070717

1. How many cell savers do you have within the Trust? Please provide a breakdown of cell savers per hospital if possible.
2. For which surgical procedures were cell savers used in the year 2015 – 2016, breakdown by number if possible?
3. How many consumables were purchased for cell savers during the year 2015 – 2016?
4. How much was spent on cell saver consumables for the year 2015 – 2016?

Download response Cell saver machines. 070717

Clinical Service Incidents 2015-2017. 250517

Please provide details of all clinical service incidents caused by estates and infrastructure failure at your hospital trust in 2015/16 and 2016/17 to date.

This is the definition of clinical service incidents: Incidents caused by estates and infrastructure failure which caused clinical services to be delayed, cancelled or otherwise interfered with owing to problems or failures related to the estates and infrastructure failure. Exclude failures relating to non-estates causes e.g. nursing availability, but include where external incidents which estates and infrastructures should have mitigated e.g. utility power failures where the Trusts backup power system failed to offset. An incident is considered to be a delay of at least 30 minutes to clinical services affecting at least 5 patients or equivalent. Both inpatient and outpatient service incidents should be included. Such incidents will include, but are not limited to: • Power and/or heating failures including overheating • Fires and false alarms (where caused by equipment faults or malfunction, deliberate/malicious causes should be excluded) • Water and/or sewage supply • Food production and/or delivery • Pest control

For each incident, please provide a summary of the incident and the impact on services. Please include what the problem was and how clinical services were affected, including details of how many patients were affected, what the service was and how long the service was delayed or whether it was cancelled.

Download response Clinical Service Incidents 2015-2017. 250517

Copy paper 041116

1. What was the latest price paid per ream (500 sheets) of standard white A4 copier paper (80 gsm or equivalent)?
2. If the answer to question 1. is not representative of a usual price paid, what is the average price paid per ream of copier paper during financial year 2015/16?
(Could you please specify whether VAT is included or not in the prices you give?)
3. How many reams of copy paper were purchased during the 2015/16 financial year?

Download response Copy paper 041116

Costa Coffee. 090617

Please can you supply me with information regarding all the Trust’s cost benefits (both financial and kind), commitments and agreements with Costa Coffee over the past 36 months at each of the Trust’s locations?

Download response Costa Coffee. 090617

Courier service contracts. 090418

1. The total value of the courier service contracts that were outsourced?
2. The name of your primary and any secondary Courier supplier
3. The value of your primary supplier contract, its expiry date and the services they provide (e.g. same day/next-day/overnight)
4. The value of your secondary supplier’s contract, its expiry date and the and services they provide (e.g. same day/next-day/overnight)
5. The total cost of the courier services that were managed in-house?
6. The number of staff employed in managing those contracts
7. The number of vehicles owned or leased to meet the in-house courier requirement
8. The name and email of the person responsible for the procurement/management of these services?

Download response Courier service contracts. 090418

Courier service contracts. 250417

Please send me details for the period 2016-17 on the following:

1. The total value of the courier service contracts that were outsourced?
2. The name of your primary and any secondary Courier supplier
a) The value of your primary supplier contract, its expiry date and the services they provide (e.g. ad hoc/same day/overnight/GP route)
b) The value of your secondary supplier’s contract, its expiry date and the and services they provide (e.g. ad hoc/same day/overnight/GP route)
3. The total cost of the courier services that were managed in-house?
a) The number of staff employed in managing those contracts
b) The number of vehicles owned or leased to meet the in-house courier requirement
4. The name and email of the person responsible for the procurement/management of these services

Download response Courier service contracts. 250417

CT scanner. 301117

Q1. Does your trust have a 64-slice (or above) CT scanner?
Q2. Does your trust perform Coronary CT angiography?
Q3. How many Coronary CT Angiography scans have you performed in the past financial year? (2016-2017)
Q4. Does your Trust have access to Coronary CT Angiography with non-invasive FFR analysis or HeartFlow technology?
Q5. If so how many CT FFR scans have been performed in total in the past financial year (2016-2017)?

Download response  CT scanner. 301117

Dangerous and/or illegal items confiscated by staff during 2013, 2014 and 2015

1. How many dangerous and/or illegal items have been confiscated by staff at hospitals across your trust over the last three years?

2. For each year, please provide a full breakdown of items.

Please send the information in calendar years (i.e. January-December, for 2013, 2014, and 2015).

This may include illegal drugs, and weapons/ potential weapons.

Download response Dangerous and/or illegal items confiscated by staff during 2013, 2014 and 2015 020316

Disposable cutlery and plates. 290118

United Kingdom-Maidstone: Disposable cutlery and plates
2015/S 021-033596
The details we require are:
• Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages*
• Contract values of each framework/contract (& any sub lots), year to date
• Start date & duration of framework
• Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
• Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
• Who is the senior officer (outside of procurement) responsible for this contract?

Download response Disposable cutlery and plates. 290118

Disposable drinking cups. 290118

How many disposable drinking cups has your trust purchased in each year for the last five years?

Download response Disposable drinking cups. 290118

Dyson products purchased in the last five years. 151216

How many Dyson products has your trust bought in the last five years?

What are these products and models?

A breakdown of how many items of each Dyson product was bought in the last five years, e.g. how many fans, vacuum cleaners, hand dryers etc.

How much money has been spent on all Dyson products for the last five years for your trust?

Please could I have a breakdown for how much has been spent on each type of product, e.g. vacuum cleaners, fans, hand dryers etc., for the last five years?

Download response Dyson products purchased in the last five years. 151216

Effective decontamination. 020817

For each of your hospitals separately, please could you provide me with?

1. How many bed days were lost in financial year 2016/17 whilst undertaking effective decontamination (Hydrogen Peroxide vaporising/fogging/UV): –
a) Following discharge/transfer of patient/s with known/suspected infections e.g. Cdiff/ Multi drug infections (i.e. proactive)
b) Following an outbreak of infection

2. a. Make and number of hydrogen peroxide vaporising fogging machines currently in use
b. Make and number of ultraviolet machines currently in use
c. Make and number of “other” (please state) types of decontamination machines currently in use

3 Is decontamination undertaken internally or through a managed service? If a managed service, please state which company.

4. If applicable, please specify the length of down time post room decontamination following hydrogen peroxide vaporising fogging for:
a. single side rooms
b. 4 bedded rooms.

Download response Effective decontamination. 020817

Electric Vehicle charging points.

1) Does your organisation already offer charging facilities (Electric Vehicle Charging Points EVCP) for electric vehicles and if so, how many charge points?
2) If there is currently no charging provision, what plans do you have to install EVCP and when?
3) Will the charge points be for fleet usage or public charging?
4) Within your organisation, which department is responsible for the selection and installation of EVCP?

Download response Electric Vehicle charging points 060916

Electrical Materials 2015-2016. 290317

1. Please state what your estimated annual spend is on electrical materials and associated products for the financial year 2015/2016. This might be against the agreement RM3747 – Building Materials and Associated Services, Lot 3 Electrical

2. Where possible please state the suppliers you have bought from and the spend against them.

3. Where possible please state the products bought and the price paid.

Download response Electrical Materials 2015-2016. 290317

Electronic invoices. 270317

1) Do you currently receive electronic invoices? Yes/No
2) If so, are these received in EDI format (not PDF)? Yes/No
3) If not, would you have a date when you could be ready to test/receive EDI Invoices?

Download response Electronic invoices. 270317

Emergency vehicle breakdowns.

1) How many instances of emergency vehicles (E.G police cars, fire engines, ambulances) needing roadside assistance were recorded between 2004-15? If the data doesn’t stretch back to 2004, please use the earliest you have.

2) In such cases, was the cost of recovery paid to a 3rd party? If so, what is the current call out charge?

Download response  Emergency vehicle breakdowns 180416

Energy efficiency 2015-2016. 250517

1. Who is the energy manager at the organisation? Please state the individual’s name and job title
2. For the financial year 2015/16 please provide the following:
a. Overall Energy Performance Certificate (EPC) rating
b. Total internal floor area (m2)
c. Of which, the total occupied floor area (m2)
d. Total energy consumed (kWh)
Please also provide the individual total figures for:
e. Electricity consumed
f. Gas consumed
g. Please state the annual lighting usage for the organisation
h. Total energy cost (£)
Please also provide the individual total costs for:
i. Electricity cost
j. Gas cost
k. Please state the annual lighting cost for the organisation

Download response Energy efficiency 2015-2016. 250517

Energy initiatives. 280717

1) Please state the organisation’s carbon reduction target

2) Lighting
a. Has the organisation updated any of its lighting to energy efficient LEDs?
b. What % of lighting assets have been upgraded?
c. How many bulbs, tubes etc. does this represent?
d. What date did these upgrades take place?
e. What was the total value of the initial investment?
f. How did you fund the investment? Please include the name of any third party finance providers.
g. What are the projected annual savings?
a. budgeted
b. Actual
h. Over how many years is this project expected to break even?
i. Does the organisation have further plans to upgrade lighting?
j. If so, has all the required funding been secured?
k. When is the project due to start?
l. Are there any further plans identified where funding has not yet been secured?
m. Who at the organisation is accountable for securing the funding and management of these projects (please provide name and job title)?

3) Other Energy-Saving Initiatives
What other efficiency projects have you engaged with? Please list all current and planned projects and provide the following information:
Project

4) Third Party Providers
Has the organisation engaged with any third party providers, either a company offering energy efficiency financing (Green Investment Bank, Salix Finance etc.) or through energy performance contracts (EPCs) with energy service providers, to fund the organisations energy efficiency initiatives? Please provide the following details for all arrangements, including any already listed in responses to previous questions:

Download response Energy initiatives. 280717

Energy Management. 070618

1. The supplier who provides the software to the organisation?
2. The cost associated with the software. Please provide me with the annual spend.
3. What is the brand of the software?
4. What is the duration of the contract?
5. When does this contract expire?
6. When does the organisation plan to review this contract?
7. Can you please provide me with the contract description of the services provided under the agreement with the supplier?
8. What is the organisation’s annual energy spend for the following:
a. Electricity
b. Gas
c. Water
9. What is the total number of meter points for Electricity for?
a. Non Half Hourly (NHH) meter points
b. Half Hourly (HH) meter points
10. What is the total number of Gas meter points?
11. What is the total number of Water meter points?
12. What is the total number of meter points for specialist gases and liquids?
13. Can you please provide me with the contact details of the key person responsible for this contract or around energy management?
14. Can you please send me the organisations’ energy management strategy/plan that covers 2018?

Download response  Energy Management. 070618

Energy Supplies. 060718

• The name of the Hospital’s Gas & Electricity supplier
• The name of the Hospital’s energy broker (if you have one)
• Annual Gas & Electricity consumption of the Hospital (kWH separate figures)
• Amount of Gas & Electricity supplies (no. of sites supplied and the cost of consumption in ££s)
• The renewal date of each energy contract

Download response Energy Supplies. 060718

Energy supplies. 140618

• The Trust’s total annual expenditure on a) gas and b) electricity for the two most recent years for which data is held

Download response Energy supplies. 140618

Energy supply. 070618

1. The name of your supplier for electricity and gas, for each year as far back as possible without incurring unreasonable cost or working time for you.
2. The unit rate and standing charge you are currently being charged by your energy supplier.
3. The cost of your energy bill for the past 12 months, for electricity and gas.

Download response Energy supply. 070618

Energy use

1. Could you please provide a contact name, telephone number and email address for the person who deals with Energy Management in your Trust.
2. Could you please provide a full list of all sites that your Trust operates, along with number of beds?

Download response Energy use 060916

Environmental and waste management. 040117

1. Who is the Trust’s waste manager and what are their contact details?
2. How much is spent on clinical waste per annum? (£)
3. How many tonnes of clinical waste are sent for alternative treatment (last financial year/12 months if possible)?
4. How many tonnes of clinical sharps waste are produced of per annum?
5. How many tonnes of offensive waste is produced per annum?
6. How many tonnes of waste is sent for landfill/waste to energy?
7. How many tonnes of waste is sent for recycling?
8. When does the domestic waste and recycling contract expire?
9. Who currently provides the domestic and recycling waste services?
10. Who currently provides the clinical waste services?
11. When does the clinical waste contract expire?
12. How much is spent on domestic waste per annum? (£)
13. How much is spent on recycling waste per annum?
14. How many tonnes of food waste is segregated and recycled per annum?
15. How much is spent on food waste recycling per annum? (£)
16. How much does the Trust spend on sharps containers per annum? (£)
17. Who currently supplies the sharps containers to the Trust?
18. Does the trust use e-learning for waste management?
19. Does the trust have its own procurement department?
20. Who is the infection control lead and what is their email address?
21. Who is the procurement lead and what is their email address?
22. Who is environmental lead and what is their email address?
23. Who is health and safety lead and what is their email address?
24. Who is the education lead and what is their email address?
25. Is the waste contract linked to a procurement framework?

Download response Environmental and waste management. 040117

Estates and Capital Projects Managers. 300317

Please can you provide the contact details, name, telephone number, email address, of the Head of Estates, Estates Managers and Capital Project Managers for your trust?

Download response Estates and Capital Projects Managers. 300317

Existing contracts relating to facilities management

Please can you provide me with the organisation’s existing contracts relating to facilities management for each of the categories below:
A. Property and Building Services Maintenance
B. Cleaning and Janitorial Services
C. Security Services- From building and car park security to prisoner escorting services
D. Catering Services
For each of the contract above can you please provide me with the organisation’s primary/main contracts that are above £1,000.00. If there isn’t
1. What is the type of contract please pick from one of the categories above? If the organisation has a fully managed contract please state “Managed”.
2. Who is the supplier for this contract? Please can you provide me with the contract information for each individual supplier?
3. What is the annual average spend? Please can you provide me with the contract information for each individual supplier?
4. What is the contract duration? Please also provide me with any extensions that maybe offered to the supplier.
5. What is the contract expiry date? Please at least provide me with the month and year.
6. When will this contract be reviewed? Please at least provide me with the month and year.
7. Can you please provide me with the total number of sites the contract covers? An estimate will also be acceptable.
8. What services are provided under this contract? A brief description will be acceptable
9. Who is the main contact from within the organisation responsible for reviewing this contract? Can you please provide me with their full name, actual job title, contact number and direct email address?
10. Notes: If the contract information provided is going to be expiring within the next 3 months it would be helpful to know if you’re going to renew or are planning to go to tender for a new contract for this particular service.

Download response Existing contracts relating to facilities management 280815

Fax machines. 040118

1. Do you have an electronic fax management system (a fax server)?
2. How many manual fax machines do you have? Please answer this as of 1 April 2017 and as of 1 April 2010?
3. What is the annual maintenance cost of the fax machines within your Trust or associated sites? Please answer this as of 1 April 2017 and as of 1 April 2010?
4. How old is your oldest manual fax machine currently in use? What date was it purchased?

Download response Fax machines. 040118

Fire Risk Assessment. 180817

I would be grateful if you could send me the most recent fire risk assessment for your trust.

Download response Fire Risk Assessment. 180817

Fire safety. 070417

I would like to make the following request under the FoI Act

1. In the last five years, has your organisation been served with any enforcement notices relating to fire safety? If so, please give details.
2. Please direct me to your latest fire safety risk assessment (or attach if not online). When was this last updated? What has been done in response to any areas of concern in the assessment?
3. Have you assessed backlog maintenance related to fire safety? If so, what is needed and have you estimated the cost of doing these and do you have any plans to carry out this work and when? Please direct me to the most recent board papers and/or send me any report related to this backlog.

Download response Fire safety. 070417

Gamma cameras in the Trust Nuclear Medicine Department.080318

• The number of Gamma Cameras in your Nuclear Medicine Department together with the make, model and date of installation.
• The anticipated date of replacement of the above
• Gamma Camera purchase outcome data for gamma cameras in the past 5 years
• Name and email address of Nuclear Medicine Consultants
• Name and email address of Nuclear Medicine physicist and chief technologist

Download response Gamma cameras in the Trust Nuclear Medicine Department.080318

Gender neutral toilets. 070717

Please can you tell me if you have any gender neutral toilets in your hospital? If so how many?

Download response Gender neutral toilets. 070717

Gluten-free products

1. How many coeliacs in your trust currently receive free gluten-free products on prescription?

2. Could you indicate which of the following products your trust prescribes, and if applicable the total cost per product to your trust (including admin, procurement, VAT and delivery costs)

3. How much does your trust spend annually on prescribing gluten-free food products for coeliac sufferers, including procurement, admin costs and delivery?

Download response Gluten-free products 060916

Goods and services (2013/14) (2014/15) and (2015/16) 011216

In each of the last three financial years (2013/14) (2014/15) and (2015/16) please state how much your organisation has paid for goods and services from each of the following companies
* ACADEMY OF FABULOUS STUFF COMMUNITY INTEREST COMPANY (10189968)
* LINDUM LOFTS & EXTENSIONS LIMITED (06083403)
* HEALTH MANAGERS NETWORK LIMITED (08234437)
* WOUND SPECIALIST LIMITED (08188747)
* CARBON HEALTH NETWORK LIMITED (06887536)
* UK HEALTHGATEWAY LIMITED (06319587)
* GRASMERE MANAGEMENT COMPANY LIMITED (05685001)

Please provide me with copies of each invoice (accepting that personal details will have to be redacted) so that I can see how much was paid and a description of what it was paid for.

Download response Goods and services (2013/14) (2014/15) and (2015/16) 

Hand sanitizer dispensers. 070318

1. Is there a contract in place in your trust with a third party (such as Carillion or Serco) to replenish hand sanitizer dispensers in your hospital?
2. If so, how much is your trust billed for each such replenishment?
3. If not, how much does it cost the trust to replenish such a dispenser?

Download response Hand sanitizer dispensers. 070318

Healthcare waste management and procurement. 070417

Please could you provide the following information relating to the amount, cost, methods and reporting of the disposal and treatment of municipal, healthcare and clinical waste?
The questions below relate to bagged waste only, including the following:
• Municipal waste, residual (not segregated for recycling);
• Municipal waste, recyclable (segregated by single type or as a comingled recyclable stream);
• Offensive waste;
• Infectious waste streams, orange and yellow categories (not sharps).
1. Please indicate the total amount of waste (in weight) produced by your organisation:
Municipal, residual (black bags)
Municipal, recycling
Offensive (tiger stripes)
Infectious (orange), suitable for alternative treatment
Infectious (yellow), requiring incineration
2. The associated costs for collection and treatment/disposal of these wastes:
Municipal, residual (black bags)
Municipal, recycling
Offensive (tiger stripes)
Infectious (orange), suitable for alternative treatment
Infectious (yellow), requiring incineration
3. Do you currently compact offensive waste? Yes/No
If No – do you have plans to implement compaction in the next financial year?
4. How often does your organisation report on the management of waste (including cost) at Board level?
Annually/quarterly/monthly/never
5. Do you currently employ any nurses specifically to support the procurement of consumables/supplies/equipment in your organisation (for example a specialist procurement nurse)?
Yes/No
(if yes how many full time equivalents do you employ?)

Download response Healthcare waste management and procurement. 070417

Hermitage Lane traffic impact. 081117

1) Have you any figures and statistics relating to the impacts observed by members of your staff and HR department for impacts on staff and employment?

2) Do you record changes in appointment cancellations and rearrangements that may relate to the impacts of the frequent stationary traffic conditions we face on Hermitage Lane?

Download response Hermitage Lane traffic impact. 081117

Hospital closures due to drainage or sewer systems since 2012. 091216

1. Since 1 January 2012, on how many separate occasions have any hospital wards, operating theatres or other clinical hospital premises in the trust have had to be closed temporarily because of issues with the hospital’s drainage or sewer systems?

2. What percentage of hospital wards operated by the trust have been temporarily closed since 1 January 2012 as a result of issues with the hospital’s drainage or sewer systems?

3. Since 1 January 2012, on how many separate occasions have any hospital wards, operating theatres or other clinical hospital premises in the trust have had to be closed permanently because of issues with the hospital’s drainage or sewer systems?

4. What percentage of hospital wards operated by the trust have been permanently closed since 1 January 2012 as a result of issues with the hospital’s drainage or sewer systems?

Download response Hospital closures due to drainage or sewer systems since 2012. 091216

Hospital food. 070417

Under the terms of the Freedom of Information Act 2000 I would like answers to the following 5 questions:
1. For the most recent two financial years (14/15) and (15/16) please state what the cost of providing food to patients was at your trust per patient per day?
For example: 14/15 – £3.80, 15/16 – £4.20
2. If you have a figure please state what percentage of food in the most recent financial year (15/16) was returned untouched by patients?
3. If you have an outside caterer that is responsible for supplying food to the Trust, please state the name of the company and how much it was paid by the Trust in (15/16)?
4. In the 2016 calendar year please state how many complaints you logged relating to the provision of on-site food and give brief details of the nature of those complaints.
5. What is the trust’s policy on healthy eating?

Download response Hospital food. 070417

Hospital food. 220118

Please could you tell me the cost of feeding one inpatient per day (patient meal day). I would like the average daily cost for all meals and beverages fed to one inpatient per day.

This figure SHOULD NOT include additional costs like staffing. I would just like the figure for how much is spent daily, per patient on all food and drink only.

This is not the average cost for a single meal but for all meals and beverages cooked for the patients in one day.

Where possible please supply the latest possible data 2016/17 and 2015/16.

Download response Hospital food. 220118

Hospital food costs and wastage. 250517

1. Could you tell me the cost of feeding one inpatient per day (patient meal day) calculated in the same way it is done for the ERIC data?

http://hefs.hscic.gov.uk/ERIC.asp

I would like the average daily cost for the provision of all meals and beverages fed to one inpatient per day. The cost should include all pay and non-pay, including provisions, ward issues, disposables, equipment and its maintenance. This is not the average cost for a single meal but for all meals and beverages delivered to the patients in one day. Please supply the latest possible data 2016/17.
2. Could you tell me the number of wasted meal servings using the same calculation methods used in the ERIC reporting system. Although this figure is no longer included in the ERIC reporting I would still like to see latest figures. Please supply up to date figures including 2017. For plated meal systems, this is the number (calculated over the full menu cycle or 7 days where no menu cycle is used), of unserved in-patient meals remaining at the end of the meals service period expressed as a percentage of the total number of meals provided and available at the commencement of the meal service period.

Download response Hospital food costs and wastage. 250517

Hospital meal wastage. 200418

1. Can you please tell me the number of hospital meals thrown away every day and the cost of doing so?
2. Please provide these figures for 2013, 2014, 2015, 2016 and 2017 if the figures are available?
3. Please can you tell me how much each meal costs, per day, per patient, for each of the years stated in question 2?
4. If possible, can you please provide the main reasons why the food isn’t consumed and is thrown away?

Download response Hospital meal wastage. 200418

Hospital Nutrition. 070318

1. The cost of providing food to patients at your trust for the years 2015/16 and 2016/17. Please can this data be expressed in terms of the average cost per patient per day? It can be either per financial year or calendar year, whichever way your system records it – but please make clear which one you are providing in your response.
2. The number of complaints received about food at your trust received in 2017 (financial year or calendar year as applicable) and any details you have regarding the nature of those complaints (food temperature, menu variety, presentation etc.)
3. The percentage of food returned untouched in 2017 (financial year or calendar year as applicable) and what happens to the uneaten food.
4. How many of the 5 food standards required by the standard NHS Contract is your trust currently meeting? The standards I refer to are listed in detail here https://www.gov.uk/government/news/new-rules-to-serve-up-better-food-for-nhs-patients-and-staff
5. Do you cook fresh food on site for patients?
6. Does your trust ask for feedback from patients regarding their experiences of hospital food?

Download response Hospital Nutrition. 070318

Hospital parking 2013-2017. 060617

1. How much money was generated by your hospital trust through parking charges in the hospital car parks during 2013-14, 2014-15, 2015-16 and 2016-17?
2. How many parking fines were issued for parking infringements in your car parks during the years stated above?
3. How many parking fines were written off during the years stated above?

Download response Hospital parking 2013-2017. 060617

Hospital privacy curtains. 100118

1. What is the policy regarding the changing of a hospital privacy curtain in each NHS Hospital? How often are they changed on average per year? Is there any variation based on high or low risk areas/departments? For example: “Curtains are changed every 3, 4 or 6 months, or if visibly soiled or after a terminal clean, A&E curtains are changed more frequently at every two months. “
2. Is the policy referenced in Q1 applied to all curtain types; Linen, disposable, disposable antimicrobial. Please specify any variation of policy based on curtain type.
3. What type (Linen, disposable, disposable antimicrobial) of privacy curtain is used, who is the producer/manufacturer? If multiple curtain products are present please list these.
4. Does an external company provide curtain services to the trust (supply of curtains, curtains changing, fitting, laundering)? If so, please state the company name, services provided, and curtain contract end/review date.
5. What is the annual cost to each hospital for linen and laundry services for the privacy curtains? If disposable curtains are used, what is total annual spend for these, for approximately how many curtains?
6. How many privacy curtains are in use in each hospital within the trust? Please state compared to the number of beds for each hospital.
7. What proportion of curtain spend per year is through the NHS supply chain? Please state values in GBP.

Download response Hospital privacy curtains. 100118

Installed bases. 091117

I kindly ask you to provide details for the following types of installed bases within the Trust.

Ophthalmic Operating Microscopes
Ophthalmic Biometry Diagnostic Equipment
Phacoemulsification Equipment
Eximer Lasers
Femtosecond Laser
Femto Cataract Equipment
OCT Scanners
Visual Field Screeners / Perimeters
Ophthalmic Retinal Cameras
Ophthalmic Therapeutic Lasers
Slitlamps

In the detail, please include the location, date of installation, manufacturer and model type of the installed bases.

Download response  Installed bases. 091117

ISO 9001 Quality Management. 020817

Does your EBME department have ISO 9001 quality management system registration?
If so which extension 2008 or 2015?
When did you achieve this?

Download response ISO 9001 Quality Management. 020817

Items logged as missing or stolen 2013-2015.

1. How many items/money has your trust logged as stolen or missing from your premises over the last three years?

Please provide the figures broken down by the following calendar years (Jan-Dec): i)2013 ii)2014 iii)2015

2. Please provide each incident in a list form including: year, item stolen, and estimated value of the item/money (if held), and whether the missing/stolen item had belonged to member of staff, a patient/visitor, or was hospital money/property.

Download response Items logged as missing or stolen 2013-2015 060416

Legionella contract 2016

Who is responsible for this contract? Can you please provide me with their name, job title, contact number and email address?
Is this contract completed by a contractor, or is the work undertaken in-house
What is the name of the incumbent supplier (if applicable?)
When did the current contract commence
What services do they provide (i.e. temp monitoring, sampling, RA, IAQ etc.?)
When does the existing contract expire, and where will this be advertised
What is the approx. number of sites the contract covers?
What is the annual average spend (excluding VAT)

Download response Legionella contract 2016 280716

Management of Medical Devices.

Please could you provide me with the name, job title and email address of the current director or board member with overall responsibility for the management of medical devices as required by the MHRA policy, Managing Medical Devices April 2014.

Download response Management of Medical Devices 090916

Manned security guarding

Please can you email me with the following information?
1. Do you have contract in place for manned security guarding?
2. If so, when was it awarded and renewal date?
3. Does it or any other contract have a specific provision for 1:1 care, bed watch (specialling) services?
4. How much did the trust spend on 1:1 care (bed watch or specialling) within the last 12 months?
5. Can you please provide the name and contact details for the procurement officer in charge of any such contract.

Download response Manned security guarding 010216

Medical Devices. 270618

I’m trying to find out some information on the numbers and types of specific medical devices used across the Trust.
Volumetric Pumps
Syringe Pumps
TCI Pumps
PCA Pumps
Epidural Pumps
MRI Compatible Pumps
Please note:
– Where numerous purchases have been made over the years, please provide the date of the largest/ most significant purchase.

Download response Medical Devices. 270618

Medical devices cyber security. 301117

1. Please State how many networked diagnostic medical imaging devices, e.g. CT, ultrasound, etc. are used by the Trust? Please include all DICOM endpoints that have a local image store when calculating this. I.e. include diagnostic workstations as well as scanners.
2. How many of these devices are full drive encrypted or have their image store encrypted or do not have a local image store?
3. Please state how many of these devices have operating system and application patches applied and the frequency. Below table should be used
4. Please state number of devices connected to the trust network in below table.
5. How many of these devices have anti-virus or other anti-malware software that is updated, when new definitions/updates are available?
6. The next question relates to dataflows. For the definition of this question a dataflow can be viewed as either a DICOM send or a DICOM Query Retrieve. So for example if a capture device can send a study to a workstation and the same workstation is allowed to Query and Retrieve a study from the same capture device this would be counted as 1. Please complete table with number of data flows.
7. Do you have policy and procedure for secure removal of patient data on loan, lease, trial or end of service devices that includes medical devices?
8. Do you have a Legacy I.T. Hardware & Software Security Policy?

Download response Medical devices cyber security. 301117

Medical Devices Manager details. 080517

Under the Freedom of Information Act please could you give me the name and email address of the person within your Trust that holds the following job title:

Medical Devices Manager

Download response Medical Devices Manager details. 080517

Mobility related products. 110917

Formally request a breakdown of your suppliers of mobility-related products (wheelchairs, hoists etc.), including names, goods/services supplied and funds paid out to each supplier.

Download response Mobility related products. 110917

NHS Soft Facilities Management Contracts. 270618

1. Please state the full name of your Trust
2. Please state which Soft FM service lines (if any) are outsourced such as:
§ Patient Catering
§ Retail Catering
§ Cleaning
§ Ward Hostess
§ Portering
§ Security
§ Car parking
§ Reception
§ Helpdesk
§ Waste management
§ Ancillary services such as Pest Control, Window Cleaning, Hygiene Services, Grounds maintenance, linen and laundry
§ Other – please specify
3. Please state the site names where those services take place
4. Please state which company (s) holds which Soft FM service lines
5. Please state the core contract start date and end date of your current Soft FM services.

6. Please state whether there are any provisions for contract extensions (including how many years and the extension terms). If yes, please state if the contract extension been awarded
7. Please state the annual total value of each service line for the year 2017/18?
8. At the end of the contract term, does the Trust intend to go to market to outsource the services again?
9. If not, what options will the Trust consider (such as reverting to an in house service delivery or establishing a wholly owned subsidiary of the Trust?)
10. If no Soft FM services are currently outsourced, is the Trust likely to consider outsourcing during the next 5 years?

Download response NHS Soft Facilities Management Contracts. 270618

NHS Spend on all Bariatric Equipment Rental/Lease in the past 3 years?

1) Could you please tell me your trusts NHS Spend on all Bariatric Equipment Rental/Lease in the past 3 years?

2) Could you please tell me your trusts NHS Spend on capital purchasing of Bariatric Equipment in the past 3 years?

3) What is your current contractual status if any, if so, who is this with, what is the term of the contract including renewal date? If not under contract, how is this service provided, for example, is this simply on an Ad Hoc basis?

Download response NHS Spend on all Bariatric Equipment Rental/Lease in the past 3 years 050216

Non-emergency patient transfers service. 200417

• Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages*
• Contract values of each framework/contract (& any sub lots), year to date
• Start date & duration of framework
• Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
• Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
• If no contract/ framework in place confirmation that these services are conducted in-house
• Who is the senior officer (outside of procurement) responsible for this contract or service provision?

Download response Non-emergency patient transfers service. 200417

Non-emergency patient transport services. 071216

1. Following the appointment of NEPTS provider G4S to provide all non-emergency patient transport services in Kent from 1st July 2016 and the appointment of Coperforma to provide all non-emergency patient transport services in Sussex from 1st April 2016, can you confirm if MTW Trust have engaged any services, other than from G4S, to transport/convey patients.
2. If the answer to 1 is affirmative, please list the names of the supplying companies.
3. Was the work commissioned in Q1, work that should have been completed by G4S.
4. If the answer to 3 is affirmative, have MTW Trust re-charged G4S.
5. How were the companies in question 2 selected, was this by tender. If not by tender what process was used?
6. How are the companies in question 2 market tested for price, quality delivery and qualifications of staff.
7. How much, in value, have MTW Trust been invoiced for additional Patient Transport Services in July, August, September and October 2016.
8. What process is in place to measure quality standards for any patient transport journeys undertaken by the incumbent NEPTS provider?
9. Can all categories of such quality standards applied be listed and identified?
10. How is activity data reported and what process is in place to ensure accuracy in all activity data collected.
11. What methods are used to ensure NHS information governance protocols/ policy are complied with in relation to P.I.D?

Download response Non-emergency patient transport services. 071216

Non-emergency patient transport services (NEPTS). 070417

1. Do you outsource your NEPTS work to private sector?
2. If you do outsource, when is your initial contract term due and can you tell me the maximum term granted for these contracts?
3. What is the annual value of your NEPTS contract?
4. Do you have plans to join with any other Trusts as part of your procurement?

Download response Non-emergency patient transport services (NEPTS). 070417

Non-emergency Patient Transport Services (NEPTS). 120717

1. Who is your current and previous NEPTS operator (spanning the last 3 years or existing contract- whichever is longer?
2. What is the current contract (s) end date (s) and are there any provision for extensions?
3. Who or which body would the procurement of your future contract be made by?
4. Please provide the name, address, email and telephone number of the person responsible for the commissioning of services and the same for the person responsible for reviewing contract performance.
5. Please provide the current Service Speciation’s in place across the contract (s).
6. How is your current contract operated (in lots or as a whole)? What are the different budgets for these?
7. What is your forecast spend in the following years (please break this down by service: scheduled patient journeys excl. renal, renal patient journeys, high dependency, secure and staff (if this is not available then please provide the total spend)
a. 2017/18?
b. 2018/19?
c. 2019/20?
8. Please provide KPI and Penalties measure in place across this contract and the most recent performance review of the same.
9. Please provide the current Patient Transport Eligibility policy and what are your provisions for revision to this?
10. What is your policy on transporting Escorts? Do you currently make payment provisions for this?

Download response Non-emergency Patient Transport Services (NEPTS). 120717

Number of assaults. 141217

For the year 2016-17, please tell me:

1. The total number of assaults (Guidance on this is attached)
2. The number of these assaults that your organisation reported to the police
3. The number of criminal sanctions obtained resulting from this police report (or otherwise)
4. The number of civil and recorded administrative sanctions obtained resulting from this report (or otherwise)
5. The number of assaults where the medical condition of the assailant was deemed to be a contributing factor in the assault

Download response Number of assaults. 141217

Outbreaks of resistant organisms 2012-2016. 280217

In the last five years, please list each outbreak the trust has declared due to the following organisms:
– Vancomycin-resistant enterococci
– Methicillin-Resistant Staphylococcus aureus (MRSA)
– Extended-spectrum β-lactamase (ESBLs) producing Gram-negative bacteria
-Carbapenem resistant enterobacteriaceae
-Carbapenemase producing organism
-Drug resistant Acinetobacter
-Drug resistant pseudomonas

For each case please specify
-The organism causing the outbreak (eg for carbapenemase producing organisms specify Klebsiella pneumoniae carbapenemase)
-Date the outbreak was declared and date it was declared over
-Number of confirmed cases and number of probable cases
-Description of control measures, eg whether wards were closed, patients put in isolation rooms, hydrogen peroxide vapour used to clean rooms etc. For ward closures please give details of ward type and size (eg 30-bed renal ward)
-Whether the outbreak was reported to Public Health England, and if so, the date it was reported
-Date audit report, outbreak investigation, infection control committee report (or equivalent report) was published
-Number of bed days lost
-Number of patient deaths

Download response Outbreaks of resistant organisms 2012-2016. 280217

Outsourcing of cleaning services 2010-2015

We have identified through Patient Environment di Action Teams (PEAT) and Patient-led assessments of the care environment (PLACE) surveys that the hospital MAIDSTONE GENERAL HOSPITAL was assessed on the following dates: 20-Jan-11, 09-Feb-12, 26-Apr-13, 23-Apr-14, and 29-Apr-15. We would like to ask, under the Freedom of Information Act 2000:

1. Are the dates recorded correctly, if not could you please provide us the correct ones.
2. Whether the cleaning service, during that period, was contracted-out to an outside contractor or was delivered in house.
3. The annual amount of money spent for the cleaning service.
4. The name(s) of the company(s) which provided theses services, if contracted-out.
5. The number of staff employed, annually, for the cleaning service.
6. The complete text of all communications between all cleaning-service provider(s)), both if they were outside contractors or internal ones, and the hospital trust management within six weeks of the above listed assessment dates.

Download response Outsourcing of cleaning services 2010-2015 270516

Packed lunches for patients. 020617

(1) Does the Trust provide a packed lunch/dinner to patients discharged before/during mealtimes?
(2) If yes, please give an example of the contents of the meal
3i) Are the meals provided under a PFI arrangement? If so, is this a separate contract, or linked to a wider catering/other contract?
(4) Please give the value of the contract to provide packed lunches for the last year figures are available. If part of a wider contract, please estimate the proportion of the contract which covers packed lunches.
(5) How many packed lunch/dinner meals were provided during the year 2015/16?
(6) Please calculate an average cost for providing each meal.

Download response Packed lunches for patients. 020617

Paint brands. 190118

1. What paint do you currently buy or specify? Including Brands if possible please.
2. Do you allow each hospital in your trust to decide themselves or is it a trust based decision?
3. What influences your decision when buying paint? Price, Historical, Specific Colours, Service?
4. How do you procure your paint? If framework, which one? 1 (or more) of 13 NHS Frameworks nationally.
5. Where do you buy paint from? Prices if possible please
6. Do you have your own labour? If so how may painters? Or do you use an FM company? Which one
7. How much paint do you buy or specify in contract value in a year?
8. Who is your FM company, main or sub-contractors?

Download response Paint brands. 190118

Paper procurement. 240717

Question 1:
How many reams of paper, of the following types, did your organisation procure during the 2016/17 financial year*?

Question 2:
Does your Procurement Department stipulate that paper procured within the organisation should be purchased from the NHS Supply Chain Core Stationary List?

Download response Paper procurement. 240717

Patient Safety Case from Pembury PFI Hospital Project. 300317

We would like to receive a copy of the Patient Safety Cases developed for the Pembury PFI project as referenced in the “New Hospital at Pembury – Summary Report” Issued by the NHS National Patient Safety Agency.

Download response Patient Safety Case from Pembury PFI Hospital Project. 300317

Patients who have been physically restrained.

Context
I am seeking information about people who have been physically restrained while patients in your trust.
Request
I would like to request the following information for your trust for each of the last five years:
1. How many patients have been physically restrained by hospital security staff
a. Please list a breakdown of the reasons why
2. How many patients with a learning disability have been physically restrained by hospital security staff
a. Please list a breakdown of the reasons why
3. How many times have the police been called because of the behaviour of a patient
a. Please list a breakdown of the reasons why
b. Please outline what action was taken by the police
4. How many times have the police been called because of the behaviour of a patient with a learning disability
a. Please list a breakdown of the reasons why
b. Please outline what action was taken by the police

Download response Patients who have been physically restrained 210316

Personal service companies 090916

Please provide, in an excel spreadsheet, the following information about payments made by the Trust to Personal Service Companies over the past five financial years (2011/12 to 2015/16). Please indicate:

1. The date of the payment;
2. The name of the Personal Service Company that payment was made to;
3. The size (£) of the payment;
4. The “Expense Area” and “Expense Type” of the payment.

Download response Personal service companies 090916

Pest control 2014-2016 071216

1. How many times did your hospital trust have to call out pest control between the financial years 2014/15 and 2015/16?
2. Please further detail each specific incident as far as possible? (For example: what type of pest was seen: rat; cockroaches; ants’ nest etc and where was it spotted: staff locker room; electrical cupboard; kitchen; ward)
3. Please describe any proofing/housekeeping/hygiene recommendations – and/or precautions to be observed by trust staff – given by pest control contractors to help eliminate causes of infestation.
4. Please provide an up-to-date copy of your hospital’s pest control policy if you have one.

Download response Pest control 2014-2016 071216

Pest control services. 210218

How many times in each of the last five years it has engaged the services of a pest control company;

For each occasion, please state: (i) the type of pest reported; (ii) the location of the pest (please be as specific as possible e.g. cardiology ward/ITU/operating theatre/mortuary); (iii) the cost of the call out

Download response Pest control services. 210218

Pest infestations 2011-2016

1. How many incidents of pest infestations have occurred on Trust property in each of the years 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16? (If no figures are available for 2015/16 please provide data for five years from 2010/11).
1. a. Please give details of the type of pest e.g. rats, cockroaches, flies for those infestations.
1. b. Please give details of the types of wards where pest infestations have been found.
c. Please give details of how they were dealt with if possible.
2. How many wards or buildings have been closed as a result of pest infestations in each of the years 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16 ? (If no figures are available for 2015/16 please provide data for five years from 2010/11).
3. Does the Trust have an in-house pest control unit?
4. How often does the Trust carry out pest control risk assessments or inspections?
5. How much money has the Trust spent on pest control in each of the years 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16? (If no figures are available for 2015/16 please provide data for five years from 2010/11).

Download response Pest infestations 2011-2016 270616

PFI contract for Maidstone and Tunbridge Wells NHS Trust.

a) the total actual and projected nominal cash costs of this PFI contract, including all projected adjustments for inflation (reflecting the basis on which the unitary charge is indexed to inflation, as agreed in the contract), along with start date and completion date;
b) for each year of the contract, the total actual and projected nominal cash costs of this PFI contract, including all projected adjustments for inflation (reflecting the basis on which the unitary charge is indexed to inflation, as agreed in each contract);
c) for each year of the contract, the non-service element of the total actual and projected nominal cash cost of each PFI contract, estimated as above;
d) the pre-tax nominal Project Internal Rate of Return and the pre-tax nominal Equity Internal Rate of Return, as calculated at the start of the contract, and as projected by the relevant SPV as of today.

Download response PFI contract for Maidstone and Tunbridge Wells NHS Trust 180516

PFI – fines and deductions 281216

Sheet 1 Postcodes
Treasury records – Yellow – because the name of individual PFI projects can sometimes change I have asked you to provide in addition to the name, the Unique HMT ID number that identifies a PFI scheme on the HM Treasury spreadsheet so that I can be sure that I am identifying each scheme correctly.
Postal Address – Green – Could you please provide the postal address for each of the PFI projects listed. Where there are multiple addresses, please could you list each in turn and separate each with a forward slash.

Sheet 2 Fines & Deductions
Each of the PFI projects held by the authority may have incurred financial penalties for poor performance. Could you please record the details of each individual fine or deduction, since the first date of operations, in the second page of the spreadsheet.

Deduction information – Green – Could you please give a short narrative summary of the reason for the deduction, select the type of deduction incurred and note whether this was disputed by the contractor.
Date Information – Blue – Could you please record the date on which the deduction was first made then go on to note over how long the deduction was applied.
Financial Information – Orange – Please record the amount that the authority tried to deduct from the contractor, and where the deduction was disputed and the full sum not awarded the final settlement of the dispute.

Download response PFI – fines and deductions 281216

PFI PPP Safety Audit. 140617

Please answer the following for each PFI/PPP schemes in your health trust treating each scheme as a separate request.
Please provide all documents showing how your organisation has responded to the findings contained in the report on Edinburgh Schools Construction by John Cole: including, but not limited to memos, emails, minutes, reports.
I would like to understand the expertise and resource committed by your organisation to the management and oversight of PFI schemes from procurement through to ongoing contract operation. Please provide documents relating to the PFI Team(s) allocated to each project its makeup and structure of the team during each project phase. This may comprise terms of reference, organisation chart, post titles and role profiles.
Provide the deed of appointment for the Independent Certifier and any other documents setting out the scope of that role. Please confirm the level of indemnity insurance and liability period.
Please confirm whether your organisation employed a member of the Institute of Clerk of Works or an inspector of similar standing and assigned them to each construction site. If someone in this role was employed please confirm their level of qualification, the salary associated with this role and how much time was allocated to per project/site.
Please provide a list of all enforcement or improvement notices served; investigations carried out and reports commissioned into fire safety (include dates and specify who commissioned or issued these) Please provide copies of all items listed.
Provide details of all attempts to make deductions relating to structural defects for each project. Confirm the amount, what it was for, and when the deduction was made.

Download response PFI PPP Safety Audit. 140617

Physical attacks on staff 2015-2016.

1. I would like to gain accurate figures on reported physical assaults against staff in and around the hospital and the type of assault committed please for 2015 / 16

2. Further I would like to gain contact details for:

LSMS
Security Manager
Health & Safety Manager

Download response Physical attacks on staff 2015-2016 060416

Pieces of mail 091216

1) On average, how many pieces of mail does the Trust send on an annual basis?
i. 250,000-500,000
ii. 500,000-750,000
iii. 750,001- 1,000,000
iv. 1,000,001 – 1,250,000
v. 1,250,001 – 1,500,000
vi. Greater than 1,500,000
2) Within your Trust do you use:
a. Franking Machines (Y).
i . If yes, how many franking machines do you have?
ii. If yes, who supplies your franking machines?
• Pitney Bowes
• Neopost
• Other – please specify
b. PPI Envelopes (envelopes with pre-printed indices) (N)
i. If yes, do you have an envelope machine(s) to automate folding and enveloping documents?
ii. If yes, who supplies your envelope machine(s)?
• Pitney Bowes
• Neopost
• Other – please specify
3) For the majority of your postal communication do you use:
a. Internal mail Room
b. External Mail Supplier
i. If yes, please provide the name of External Mail Supplier
c. External Hybrid Mail Supplier
i. If yes, please provide the name of External Hybrid Mail Supplier
4) Does your Hybrid supplier provide you with any of the following mail services?
i. Offsite printing
ii. Posting letters
iii. Other
5) Which supplier(s) do you use to pick up your post?
i. Royal Mail
ii. Whistl
iii. UKMail
iv. Other (please specify)
6) Which procurement frameworks does your Trust use/belong to?
7) How long is left on the current mailing contract?
8) Please supply the name of the person(s) responsible for Transformation projects in your trust and the department they work in if available?

Download response Pieces of mail 091216

Planned refurbishment works and maintenance 2017/18 040117

1. Planned Refurbishment Works & Maintenance budget for 2017/2018

2. Details of all planned refurbishment and maintenance projects for 2017/2018

3. The job title of the person responsible for the above projects e.g Head of Estates

4. The name of the person responsible for the above projects

Download response Planned refurbishment works and maintenance 2017/18 040117

Planned refurbishment works and maintenance 2017-18 040117

1. Planned Refurbishment Works & Maintenance budget for 2017/2018

2. Details of all planned refurbishment and maintenance projects for 2017/2018

3. The job title of the person responsible for the above projects e.g Head of Estates

4. The name of the person responsible for the above projects

Download response Planned refurbishment works and maintenance 2017-18 040117

Police attendances in 2015

1. In 2015, how many times were police called to hospital premises within the Trust? This question should be referred to Kent Police.

2. If possible, could you break this down into how many visits by police were related to acts by a) patients b) visitors c) staff d) other (please specify if possible)

3. If possible, for incidents involving acts by patients, please state how many related to patients with dementia.

Download response Police attendances in 2015 230516

Postage. 150517

1. How many 2nd Class letters does your Trust send out each year from your Maidstone and your Tunbridge Wells sites?
2. What franking charge are you paying for 2nd Class?
3. What is the name and email address of your Facilities Manager who is responsible for the Post Rooms and outbound mail at each of the two sites?

Download response Postage. 150517

Potholes. 070618

Could you please provide the following information relating to potholes across your estate?
1. Please detail the annual cost to your Trust of a) damage directly caused by potholes and b) repairing potholes, in each financial year since 2010.
2. Please detail how many potholes there are across your estate in total at the current time.
3. How many potholes have been reported on your estate each year since 2010?
4. What is the diameter of the largest pothole currently on your estate? Please also provide details of the size of the largest pothole which has existed on your estate since 2010.
5. Please outline how many occasions there have been when you wished to repair a pothole, but due to funding shortages the pothole was not repaired or the repair was delayed.

Download response Potholes. 070618

Print room and mail services 151216

Print room and commercial print
1. Does the Trust have one or more onsite print rooms/Medical Illustration Departments?
2. If the Trust has an onsite print room/Medical Illustration department, is it managed in house or outsourced?
3. If it is managed in house, who provides the service?
4. If it is being outsourced, who provides the service, when did the contract start and what is the contract term
5. How many staff work in the print room/Medical Illustration Department?
6. Who is the main supplier(s) of the Trusts higher volume commercial print (leaflets, medical forms, posters, letterhead, etc.), when did the contract start and what is the contract term
7. What was the spend on commercial print during 2015/16

Mail services
1. Does the Trust manage its own incoming mail or is this service outsourced
2. If outsourced, who is the current provider, when did the contract start and what is the contract term
3. Is any of the incoming mail scanned or is it physically transported across the Trust
4. If the service is provided in house how many staff are involved in:
a. Distributing incoming mail
b. Collecting outgoing mail
5. What is the volume of outgoing mail sent by the Trust?
6. Does the Trust have any centralised services for printing and sending mail
7. Does the Trust have any hybrid mail services for sending appointment letters or other correspondence?
8. If yes, who is the hybrid mail provider, when did this contract start and what is the contract term
9. Does the Trust have any software products for sending appointment letters electronically or SMS reminders to patients
10 If so, what software products are used, when where these installed and what is the contract term for support

print-room-and-mail-services-151216

Printing, mail room and stationary 031016

1. The number of people currently employed by the trust?
2. Who supplies you printer/copier/scanners across the trust?
3: What make and model and how many of each of printers/copiers/scanners do you have in your main print room and also across the trust?
4. How long are the print services contracts for?
5. What print management software’s do you use across the trust?
6. What scanning software’s do you use across the trust?
7. Is it just this site that you do the printing for or is it other sites too?
8. How much do you spend on printing services across the trust?
9. What is the overall cost of the managed print service contract?
10. What document management software’s/systems do you use across the trust?
11. What IT provider do you use?
12. How long is the print room contract and when is the current print room contract due to end?
13. Do you have an in house design department?
14. Do you have a in-house mail room?
15. Is the mail room contract outsourced or run by the trust?
16. What is the average/estimated monthly amount of the following?
A: Letters coming in to the post room?
B: Letters going out of the post room?
C: Parcels coming in to the post room?
D: Parcels going out of the post room?
17. Is there any plans to scan and archive all the old patients files?
18. If yes to question 17 what is the estimated amount of files?
19. What is the overall yearly spend on stationary across the trust
20. Also could you include the name, title, contact number, and email address for the people responsible for managing the print estate in the trust?
21. Also could you include the name, title, contact number, and email address for the people responsible for managing the post room estate in the trust?

Download response Printing, mail room and stationary 031016

Private Finance Initiative contracts.240217

Please provide information for each PFI hospital or unit within the trust.
1. Any performance adjustments deducted from the yearly unitary charge in respect of each hospital. Please include deductions planned but not yet made and those sought but in dispute.
2. Any other deductions/payments made under the PFI contract regarding defects including, but not limited to, those made by the Trust and the special purpose vehicle/project company.
3. The number of disputes concerning defects/deductions, resolved or otherwise, and whether they went to mediation, adjudication or court.
4. The sections/clauses of the PFI contract pertaining to deductions made in respect to defects, how much they can be and in which circumstances they can be made.
5. The sections/clauses regarding termination of the contract and the powers the trust has in this situation.

Download response Private Finance Initiative contracts.240217

Private patient taxi services 2015-2016 040117

Could you provide me with the total annual cost of private patient taxi services, excluding voluntary car services and patient transport services, e.g. ambulances for 2015/16 (the data that was previously gathered and published as part of ERIC returns: http://hefs.hscic.gov.uk/ERIC.asp)

Download response Private patient taxi services 2015-2016 040117

Recycling of medical aids. 140317

This request concerns the recycling of medical aids by your hospital trust.
1) Please confirm whether your trust recycles medical aids (such as crutches, wheelchairs etc.) for reuse by other patients.
2) Is yes, please provide information on the number of medical aids that were recycled in the 2016 calendar year, broken down by the type of medical aid recycled.
3)
a) Please provide a copy of your trust’s current guidance on recycling medical aids.
b) Please also provide a copy of your trust’s guidance on the recycling of medical aids returned to your trust from other NHS authorities.
c) If you do not have an exact ‘copy’ of this guidance, can you please provide a description of the policies requested in 3a) and 3b)
4) If you do not currently recycle medical aids, please provide a copy of your trust’s guidance on why you do not recycle medical aids, or the minutes of the meeting at which it was decided that your trust would not recycle medical aids. 5) If you do not currently recycle medical aids, please provide all information held concerning current or future trials of this policy within your trust.

Download response Recycling of medical aids. 140317

Repairs on medical instruments 170117

– What is your annual volume and spend on repairs for the following Medical Instruments?
– What is your annual volume and spend on repairs with 3rd party repair companies (who were not the original manufacturer of the instrument)?
– How many Stryker Power tools do you have in your inventory?
– How many Flexible Endoscopes do you have in your inventory? 165
– How many of these scopes were manufactured by the following:

Download response Repairs on medical instruments 170117. 080617

Repairs and servicing of alternating mattress systems 2016. 020817

Please complete the green cells in the below document. If this service is provided by a contractor, please ask for this information from the company. This is for the last full 12 months record, or the last calendar year.

Download response Repairs and servicing of alternating mattress systems 2016. 020817

Restraint of patients 070317

1) How many times were security staff called to restrain patients at your organisation?
(i) Between April 2015 to March 2016
(ii) Between April 2016 to the end Jan 2017
2) If recorded, please detail the condition of the patients who were restrained and/or reason the patient needed to be restrained
3) How many of the patients who needed to be restrained in total had dementia?
4) Does your organisation employ an Admiral nurse (dementia specialist nurse) or other dementia lead nurse [please specify]?
5) Is your organisation signed up to John’s Campaign?

Download response Restraint of patients 070317

Risk Assessment Policy and Procedure

1. Your organisation’s current Risk Assessment Policy (or nearest equivalent,
e.g. Risk Management Policy and Guidance).

2. Your organisation’s current Risk Assessment Procedures (or nearest equivalent,
e.g. Risk Management Procedures).

Download response Risk Assessment Policy and Procedure 280716

Rough sleepers within the Hospital sites. 260418

Please can you tell me if the trust has found rough sleepers sleeping in any of its A&E departments or other areas of hospitals at any point over the last five years?
If so, please tell me how many rough sleepers and on how many occasions for each year over the last five years.
Download response Rough sleepers within the Hospital sites. 260418

Safety Assessments. 210917

1. Has your organisation complied with the NHS Improvement letter of 24 June 2017, and follow up communications, requiring you to have an inspection of all inpatient areas carried out by your local fire and rescue service?

2. Have you carried out your own checks or worked with independent investigators to assess safety since the Grenfell Tower fire on 14 June?

3. Please attach all and any reports etc prepared as a result of inspections whether by the fire service or others. If precise locations are sensitive, please consider whether any concerns can be addressed by redacting the location details

4. What are you doing to mitigate any risks which have been identified? When will any work identified in the reports be completed?

Download response Safety Assessments. 210917

Security. 140317

i) Who provides security at each of your hospital sites? Where security is supplied by multiple providers please breakdown this provision.
ii) How many complaints have been made to the trust in regards to hospital security guards in 2016?
iii) For each complaint, please give a short description of the details (where available) and identify which security provider the security officer was employed by.
iv)The number of times security guards have been used to restrain patients from January 2016 to the latest available figures? And the departments where the restraint took place?
v) Does the trust use security personnel to restrain patients with mental health problems or patients with dementia?

Download response Security. 140317

Security Seals. 100118

• I would like to know if the trust currently uses any security seals or tamper evident tags, (besides any used for clinical waste) and what each product is used for within the trust.
• I would also like to know the annual quantity purchased (as well as the annual cost to the Trust if possible)?
• Where does the trust purchase these products from? i.e. is it direct from a supplier or from the NHS Supply Chain?
• If these items are purchased through the Supply Chain what are the catalogue codes of each item?
• Who is responsible for purchasing these products?

Download response Security Seals. 100118

Security staff. 210218

1) Please could you provide figures for the total amount spent by the trust on security staff in the current financial year and in each of the previous 4 financial years?

2) Please could you tell me how many (if any) security staff you currently employ (directly or via an outside supplier), broken down by hospital site, at the present point in time and in the previous 4 financial years (I would be content with an overall figure rather than a breakdown for previous financial years)

3) Please could you tell me how many injuries were sustained by staff as a result of being assaulted while at work over each of the past 5 financial years?

Download response Security staff. 210218

 

Service Contracts between June 2015 – May 2016 031016

1) Who is your current provider for the following services (between June 2015 – May 2016):
Service Supplier
Boilers/Heating Systems
Air Conditioning / Refrigeration
Ventilation/Air Handling
2) How were they procured?
Examples: Framework, OJEU Tender, Direct Appointment, Mini Competition, Tender/Quote in line with the Trust SFI’s
2a) If a framework please advise which one?
3) Please provide us a copy of your Trusts Standing Financial Instructions (SFI’s)
4) Have you scheduled the re-procurement of these contracts? If so, when?

Download response Service Contracts between June 2015 – May 2016 031016

Soft surface coverings. 040917

For the purposes of this FOI, we define soft surfaces as fabric coverings on chairs, sofas, or any other fabric covered item. If unsure of our definition, please seek clarification before replying to the questions below.

1. Please state the different soft surface cleaning products (such as fabric sprays) in use across the trust in the last year. If possible please split this across each hospital in the trust. What is the total cost of each of these products for the most recent financial year.
2. For the above list please state the number of units purchased for each product. Please also state the unit volume of each product e.g. 100mL, 1L, 5L etc. Where possible, please state if the product requires dilution or is ready to use, and if the product comes in a spray bottle.
3. Please provide details of the product name and company, total contract value and expiration date of any contract relating to the previous questions.
4. What proportion of your hard surface cleaning spend was through the NHS supply chain in the last financial year?
5. Please provide details of the soft surface cleaning protocols for different patient environments, and the products used. For example the cleaning protocols for a standard clean, cleaning protocols after a contact precaution patient and other scenarios.
6. Please provide details of the deep clean protocol, including the soft surface cleaning products or technologies utilised.
7. Are there any additional soft surface disinfection technologies used within the hospital not mentioned in previous answers?
8. Have any fabric sprays been used or trialed as a method of disinfecting soft surfaces? Please state the IPC’s position on such a trial.

Download response Soft surface coverings. 040917

Special Purpose Vehicles (SPVs). 160617

1. Does the trust have a Special Purpose Vehicle (SPV)?
If so, please provide the following details for all SPVs held by the trust
a. Registered name
b. Date incorporated
c. What was the agreed function/purpose of the SPV?
d. Who owns shared capital? (Please list all entities and the % of capital held by each)
e. How much VAT was recovered during 2015/16 from the use of the SPV?
f. What was the SPVs Income Surplus for 2015/16?
g. Has the SPV been disclosed to HMRC?
2. Is the trust considering the establishment of an SPV?
If so, please provide the following details for all planned SPVs
a. What are the proposed functions/purpose of the SPV?
b. How much VAT is expected to be recovered from the use of an SPV?

Download response Special Purpose Vehicles (SPVs). 160617

Sterile services and decontamination units. 290617

1. How many theatres does your hospital have?
2. How is the Sterile Services and Decontamination Unit in your hospital organised?
o Own Decontamination Unit
o Own Decontamination Unit that also provides for other hospitals
o Supplied by a Decontamination Unit from a different hospital
o Contracted out
3. From which manufacturer do you get your instruments?
o Getinge
o MMM
o Belimed
o BHT
o Steris
o Dawned
o Peacocks
o Medisafe
o Others:
4. What kind of transporting system do you use at your hospital?
o Open carts
o Closed carts
o Cart in cart system (e.g. Känguruh-System)
o Others:
5. What size are the containers you use?
o ISO
o DIN
o SPRI
o Others:
6. How many containers are processed (cleaned, sterilized, etc.) in your hospital per year?
7. When it comes to your purchasing process in the decontamination sector, do you have a centralized system with a purchasing department or are the individual people allowed to make their orders themselves (up to a certain limit)?
o Centralized system
o Decentralized system
8. Where do you get the information about the products you need from?
o Manufacturer
o Dealer
o Purchasing department
o Internet
o Price list
o NHS Supplier List
o Others:
9. From whom do you buy your products in the end?
o Manufacturer
o Dealer
o Others:
10. Who is the decision maker when it comes Decontamination and Sterile Services issues (as in buying new products, etc.)?
o Sterile Services Manager
o Theatre Manager
o Head of Procurement
o Other:
11. Is it possible to get the contact details for this person (as in first and surname, phone number and E-Mail address)?

Download response Sterile services and decontamination units. 290617

Surveillance equipment. 090418

1. How many fixed (static) surveillance cameras are functional on the trust’s premises?
a) How many are focused outside buildings (for instance in grounds or car parks)?
b) How many are focused inside buildings?
2. How many moving surveillance cameras (those that zoom in, pan and tilt) are functional on the trust’s premises?
a) How many are focused outside buildings (for instance in grounds or car parks)?
b) How many are focused inside buildings?
3. Do you have any covert (hidden) cameras on your premises? If yes, please say:
a) How many are focused outside buildings (for instance in grounds or car parks)?
b) How many are focused inside buildings?
4. Do security officers employed by the trust use body worn video cameras? If yes, please say:
a) How many body worn cameras are in use by security guards on your premises?
b) When these are turned on
5. How much has the trust spent on surveillance equipment, in total? Please break this down by:
a) Fixed surveillance cameras
b) Moving surveillance cameras
c) Body worn video cameras
6. What is the make, model and manufacturer of the devices used by the trust?
a) Fixed surveillance cameras
b) Moving surveillance cameras
c) Body worn video cameras
7. Where is the footage from the devices stored? Please break this down by:
a) Fixed surveillance cameras
b) Moving surveillance cameras
c) Body worn video cameras
8. How long is the footage from the devices held? Please break this down for:
a) Fixed surveillance cameras
b) Moving surveillance cameras
c) Body worn video cameras
9. How many times has footage from devices been used in a successful or unsuccessful prosecution? Please break this down by device:
a) Fixed surveillance cameras
b) Moving surveillance cameras
c) Body worn video camera
10. Does your trust comply with the Surveillance Camera Commissioner’s code of conduct? (https://www.gov.uk/government/publications/surveillance-camera-code-of-practice)

Download response Surveillance equipment. 090418

Taxis and courier services.090418

1) Please state the amount your authority spent on taxis and courier services in each of the following financial years:
This should include both taxis and private hire vehicles.
i) 2012/13
ii) 2013/14
iii) 2014/15
iv) 2015/16
v) 2016/17
vi) 2017/18 to 15.01.18
2) Please provide a breakdown of the amount spent on taxis and courier services by department (for example, pathology, accident and emergency, etc.)
Please provide information for each of the following financial years:
i) 2012/13
ii) 2013/14
iii) 2014/15
iv) 2015/16
v) 2016/17
vi) 2017/18 to 15.01.18
3) Please provide a breakdown of the amount spent on taxis and courier services by reason for spend (for example, staff transport, transport of test results or samples etc.)
Please provide information for each of the following financial years:
i) 2012/13
ii) 2013/14
iii) 2014/15
iv) 2015/16
v) 2016/17
vi) 2017/18 to 15.01.18

Download response Taxis and courier services.090418

The amount of out of date medicines and equipment discarded by the Trust

Please detail the following for each of the hospitals in your trust, stating which hospital the details relate to:
1) In the calendar year 2015,
a. please state how much medicine was discarded by the hospital due to being passed its expiry date? (please say what the medicine was and how much was thrown away (defined by weight))
b. Please state the cost of this discarded medicine.
c. Please state how much equipment was discarded by the hospital due to being passed its expiry date (please say what the equipment was, including but not limited to items such as bandages or needles, and how many of each item were thrown away)
d. Please state the cost of this discarded equipment.
2.
a – d) Same for 2014.
3.
a – d) Same for 2013

Download response The amount of out of date medicines and equipment discarded by the Trust 150416

The number of times security guards were called to deal with patients with dementia in 2015

1. In 2015, how many times were security guards called to deal with patients with dementia?

2. If possible, please state the reason in each case.

3. If possible, please state what extra equipment was used such as handcuffs or restraints.

Download response The number of times security guards were called to deal with patients with dementia in 2015 130416

Utilities. 020518

1. The name, job title and contact email of the individual who manages the contracts for your gas, electricity, and water.
2. The name, job title and contact email of the individual who manages the budgets for your gas, electricity, and water contracts.
3. The value of your typical annual gas, electricity, and water expenditure.
4. The number of electricity, gas, and water meters in your estate.
5. Details of Existing Utility Management Systems
6. The number of properties in your building portfolio.

Download response Utilities. 020518

Utilities information. 190417

1. Contracts/Agreements relating to the supply of Gas which may include the following:
• Natural Gas Supply
• Gas Heating / Boiler Maintenance
• Installation of Gas Central Heating Systems
2. Contracts/Agreements relating to the supply of Electricity which may include the following:
• Street Lighting
• Electricity Supply (Half Hourly)
• Electricity Supply (Non Half Hourly)
• Corporate Electricity Supply
3. Contracts/Agreements relating to the supply of Water which may include the following:
a. Supply of Water
b. Waste Water
Contract Information- For each of the types of the contract that I am requesting please can you send me the following information. Please remember if there is more than one provider can you please split the contract information up for each individual provider?
1. Unique Contract Key: Please can you provide me with a unique reference quote that relates to each contract.
2. Current Provider: If there is more than one provider please split the contract information individually.
3. Annual Average Spend: Please can you send me the average spends over the last three years. Approximate spend is also acceptable.
4. Contract Duration: Duration of the contract/agreement and can you please include any extension periods that could be executed
5. Contract Commence Date: The date the contract/agreement commenced
6. Contract Expiry Date: The date the contract/agreement expired
7. Contract Description: A brief description of the contract of what support/service in involved
8. Responsible Officer: Who within the organisation is responsible for this contract? Please can you send me the full names, actual job title, internal contact number and the officers direct email address?

Download response Utilities information. 190417

Vehicle leasing and maintenance contracts – June 2016

Can you split the supplier contracts for annual spend, dates, contract description (number of vehicles, make and model of vehicles)

Download response Vehicle leasing and maintenance contracts – June 2016 060616

Vehicle provision 2016-2017 200117

1. The number of vehicles provided to all grades of Administrative or Management staff by your Trust.
2. The annual cost of this provision for the most recently available financial year.
3. Confirmation that this provision registered with HMRC as a ‘Benefit in Kind’.

Download response Vehicle provision 2016-2017 200117

Vending machines and outlets 070317

1) Do you have vending machines selling chocolate or sweets in portions larger than 250g per item?
2) Do you have any fast food chains in your trust, such as Burger King, Costa Coffee, Starbucks, pizza chains, Subway, Pret or Greggs? Please list.
3) If YES, will these chains meet the NHS England health eating targets set for March 2017?
4) If they will not meet the healthy eating targets, please explain how they have failed to meet them, including details.
5) What action will be taken after March 2017 on food outlets that fail to comply?

Download response Vending machines and outlets 070317

Walking frames. 090418

1. In the last 5 years, how many walking frames (including zimmer frames, wheeled walkers, rollators and pick-up walkers) and how many walking sticks have been issued to patients by your Trust? Please include separate numbers for each category of walking aid.
2. What was the total spend by your Trust on the above for each of the last 5 years? (If possible, please break this down by year and item type).
3. How many of the above have been returned to your Trust by patients over the last 5 years? (if possible, please break this down by year and item type).
4. Of those returned how many were deemed fit for re-use and how many were classed as unfit for re-issue?

Download response Walking frames. 090418

Washer-disinfectors. 290617

1. How many washer-disinfectors are installed in your premises?

2. In which departments are these washer-infectors installed?

3. Do these washer-disinfectors disinfect thermally or by chemical use or both?

4. Do these washer-disinfectors produce records for inspection purposes?

5. Are these washer-disinfectors maintained and serviced by your own staff or by outside sub-contractors?

6. Have you any plans to purchase/install any new washer-disinfectors within the next 12 months, and if so can you specify how many and an approximate date of purchase?

7. What purchasing mechanism is preferred for washer disinfectors? i.e.: outright purchase or rental/lease arrangement?

**If you were to purchase a new washer-disinfector would it be from NHS Supply Chain or direct from the supplier?
8. Can you provide the names and contact details of the following personnel?

Estates Manager or Director.
Facilities Manager
Laboratory Manager
Purchasing or Procurement Manager.

Download response Washer-disinfectors. 290617

Water hygiene. 150317

This request relates specifically to water hygiene and the measures taken to prevent infection from waterborne pathogens.
Can you please advise the number of point-of-use filters used per annum by the Trust to prevent waterborne bacteria exiting the water system?
Ideally a breakdown giving the number of filters used in 2014, 2015 and 2016. However if only approximate annual usage figures are available then this will be adequate for our purposes.

Download response Water hygiene. 150317

X-ray equipment. 301117

1. Please can you provide the following information for each piece of mobile X-ray equipment within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

2. Please can you provide the following information for each X-ray room within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

Download response X-ray equipment. 301117

 

Finance

2016-2017 Budget. 140617

Under the FOI Act please can you let me know your organisations budget for?
2016
2017
This is the total operating budget for your organisation across all departments etc.

Download response 2016-2017 Budget. 140617

Accounting and budgeting software. 090418

1.) What financial accounting software do you use?
2.) Who supplies this software (name of vendor or supplier)?
3.) What was the original date of purchase or contact start date for this product (please provide the exact date if possible)?
4.) When is the contact renewal or expiry date for this product?
5.) If relevant, what is the cost of annual support and maintenance (last financial year April 2016- March 2017)?
6.) What is the name of your budgeting and forecasting system?
7.) Does your budgeting and forecasting system add on to your FMS (financial management system) or is it a standalone system?
8.) When was your budgeting and forecasting system purchased (please provide the exact date if possible)?
9.) What is the cost of annual support and maintenance for your budgeting and forecasting system?
10.) Do you currently use an online procurement or EMarketplace system, if so which system do you use?

Download response Accounting and budgeting software. 090418

Acquascience. 070318

Please supply the following information, has your hospital trust have had dealings or contacts with a company call Acquascience who might have been under contact to Leica, for the supply and removal of the following during the past 2 years and the approximate quantities removed.”

Supply Removal and safe disposal

• Xylene
• IDA / IMS 99%
• IDA / IMS 95%
• IDA / IMS 70%
• Methanol
• Neutral Buffered Formalin 10%
• Formaldehyde 37% – 40%
• Formal Saline 10%
• Deionised Water
• Formic Acid
• Acid Alcohol • Xylene
• IDA / IMS (all %)
• Methanol
• Tissue Fixative (NBF / FS)
• Formic Acid
• Alcohol Stains
• Aqueous Stains
• Paraffin Wax
• Used Histology Pots
• Other Plastic Containers

Download response Acquascience. 070318

Administration costs 2008-2017. 200417

1. What are the administration costs for each year since 2008, or since the establishment of the Trust, of:
a. The Trust as a whole.
b. Each of the Hospitals within your Trust.
2. Please identify each of the organisations within your Trust (ie. Hospitals, Community based NHS and private providers) that have a business, corporate or related department.
3. The total operating budget for each year since 2008, or since the establishment of the Trust, of:
a. The Trust as a whole.
b. Each of the Hospitals within your Trust.

Download response Administration costs 2008-2017. 200417

Agency Locum Doctor spend for 2015-2016.

• The total amount you spend on Agency Locum Doctors for the financial year 15/16 (April – March)
• For the above information to be broken down by grade and specialty (example provided below)

Download response Agency Locum Doctor spend for 2015-2016 270616

Agency locum doctors and consultants spend for 2015-2016.

Please can you let us know what the Trust as a whole (including hospitals that are run by you) spent on employing agency locum Doctors and Consultants last year.

Download response Agency locum doctors and consultants spend for 2015-2016 010716

Agency locum spend 2015-2016.

Please could you send me the agency locum spend for the trust for the last financial year. I would like the spend for doctors only.

Please include the agency spend in each specialty breaking it down into the different grades (SHO, Middle Grade, Consultant).

Please could you also provide the spend on introductory fees for doctors for each specialty based on Doctors taken onto NHS contracts.

Download response Agency locum spend 2015-2016 050816

Agency nurse expenditure for 2015-2016.

• The total amount you spend on Agency Nurses for the financial year 15/16 (April – March)
• For the above information to be broken down by banding and specialty (example provided below)

Download response Agency nurse expenditure for 2015-2016 010716

Ahmedia Ltd 011216

1. Costs claimed by Ahmedia Ltd for NHS England staff unable to attend their Health Care Strategy Forum for the financial year 2015/16?

Download response letter Ahmedia Ltd 011216

Annual Report and Accounts production. 151217

1. How much it cost to commission, design and produce your Annual Report and Accounts in each of the following years: 2013, 2014, 2015, 2016 and 2017.
2. How much it cost to print your Annual Report and Accounts in each of the following years: 2013, 2014, 2015, 2016 and 2017.
3. How much it cost to distribute your Annual Report and Accounts in each of the following years: 2013, 2014, 2015, 2016 and 2017.

Download response Annual Report and Accounts production. 151217

Annual Report and Business Plan 16/17.

Please provide the following information:
1. Most current Annual Report
2. Most current organisation Business Plan

Download response Annual Report and Business Plan 16/17 060916

Bereavement Services. 260318

1. Are the Bereavement Services at this Trust run by the trust or an external party?
a. If it’s an external party, who are they?
2. Who is the primary contact for bereavement services at the Trust?
a. What is their correspondence address, email and phone number?
b. Is this their sole responsibility or do they have other job roles?
3. Is there a Bereavement Office at the Trust’s Hospital(s)?
a. Where are the Bereavement Offices located?
4. Is the Bereavement Office always open (24/7), a 9-5 service or by appointment only?
a. If it is not a 24/7 open office, is there a cover for this service out of hours?
5. Are the Bereavement Services only utilised within the Trust, or do they also cover community work (under agreement with other Trusts/CCGs)?
6. Does your Trust present Bereavement Books to the bereaved?
a. Are these produced in-house?
b. Are these produced by an external agency under contract (such as RNS publications)?
7. If under contract;
a. how long is the contract term;
b. when does it end;
c. are there additional benefits in the contract beyond the literature (ie, a cash rebate, other products);
d. does the literature provided contain advertisements;
e. who can sign the contract?

Download response Bereavement Services. 260318

Biopsy and coaxial needles. 160518

1 – References: size (length, diameter) and type (manual, semi-automated, automated) of the different biopsy needles used;
2 – Quantities of biopsy needles annually purchased for every reference;
3 – References: size (length, diameter) of the different coaxial needles used;
4 – Quantities of coaxial needles annually purchased for every reference;
5 – Quantities provided by each needle manufacturer;
6 – Prices for every different needle, both biopsy and coaxial

Download response Biopsy and coaxial needles. 160518

Budget information. 160617

1) The trust’s total annual budget.
2) The annual cost to the trust of any spending associated with using buildings owned by, leased from or built by private providers – including interest payments.
3) The maintenance and any other associated costs the Trust has paid (during the last three years) to private providers for these buildings. And the expected associated costs for the current financial year.
4) The total value of any contracts the trust holds with private providing services and any commercially viable details of these.

Download response Budget information. 160617

Business Intelligence. 190618

1. Which Bi tool does your trust predominantly use?
2. What’s the secondary predominantly used?
3. What’s the tertiary predominantly used?
4. How much did your Trust spend on a BI tool in last three financial years? (£)
5. What tool does your Trust use for benchmarking?
6. How much did your Trust spend on a benchmarking tool in last three financial years?
7. How many employees were there in your BI team?
8. Please breakdown the BI staff by their job (such as analyst, architect, developer etc.)
9. What tool does your Trust use to save data?

Download response Business Intelligence. 190618

Capped expenditure process. 240717

Under the Freedom of Information Act I wish to request the following information:

• Any official documents your organisation/s hold relating to the Capped Expenditure Programme/Process (CAP) – should include board documents, draft guidelines for process, consultation documents, timelines, memos etc.
• Any correspondence between senior leaders in the area/senior member of staff charged with responsibility for the CAP and NHS leaders at NHS England or NHS Improvement
• Please provide a copy of your ‘final return’ detailing your plans for delivering CEP savings locally – provided to NHS England by the original deadline of 5th May.

Download response Capped expenditure process. 240717

Catalogue and P2P system. 200418

1. Do you currently have a Catalogue system at the Trust?
2. Which supplier do you use for your Catalogue system?
3. How long have you had this system in place? 2016
4. Are you under contract for your current catalogue system?
5. What is the annual spend on this catalogue system?
6. What is your % catalogue compliance?
7. Which P2P system do you use?
8. How long have you had this system in place?
9. Are you under contract for your P2P system?
10. What is the annual spend on this P2P system?
11. Which Inventory Management system do you use?

Download response Catalogue and P2P system. 200418

Charitable donations. 270418

1. What was the hospital’s total income from charitable donations/funding in the 2017/18 tax year, the 2016/17 tax year and the 2015/16 tax year? For each tax year, please state where the charitable donations/funding came from (e.g. hospital league of friends, charities, etc). And for each tax year, please state what percentage of the hospital’s total revenue came from charitable donations/funding.
2. For the 2017/18 tax year, please provide the breakdown of charitable donations/funding for each of the hospital’s departments (some examples of departments are listed underneath my questions) If time still allows, please specify what the charitable donations/funding paid for, e.g. liver FibroScan machine
3. For the 2016/17 tax year, please provide the breakdown of charitable donations/funding for each of the hospital’s departments If time still allows, please specify what the charitable donations/funding paid for, e.g. liver FibroScan machine
4. For the 2015/16 tax year, please provide the breakdown of charitable donations/funding for each of the hospital’s departments If time still allows, please specify what the charitable donations/funding paid for, e.g. liver FibroScan machine

Download response Charitable donations. 270418

Clinical waste bag seals.080318

• I would like to know what the trust currently uses to seal clinical waste bags and the annual quantity purchased (as well as the annual cost to the Trust if possible)?
• I would also like to know where the trust purchases these products from, i.e. is it direct from a supplier or from the NHS Supply Chain?
• Who is responsible for purchasing this product?
• How does the trust provide an audit trail for their clinical waste?

Download response Clinical waste bag seals.080318

Compromise agreements January 2011 and December 2015

Please advise in relation to the 5 years between January 2011 and December 2015 inclusive:
1) How many compromise agreements has the Trust entered into with staff or former staff? Please include all COT3 agreements in this figure.
2) How many of these compromise agreements require staff members not to disclose the existence of the compromise agreement itself?
3) How many of these compromise agreements contain non-disparagement clauses that require staff members not to criticise the employees of the Trust?
4) How many of these compromise agreements were entered into by the Trust with staff who had previously made public interest disclosures, (whether or not these were raised by formally invoking the Trust’s whistleblowing policy)?
5) If staff who have entered into a compromise agreement with the Trust were to voice concerns about reprisal by the Trust for whistleblowing, would the Trust consider this to be an actionable breach of non-disparagement clauses, or would it consider the raising of such concerns to be qualifying disclosures under PIDA?

Download response Compromise agreements January 2011 and December 2015 270616

Contract information for TNP and PAC.060317

Section 1
1) What are the Hospital names and locations that form part of the Trust? (Please provide details)
2) Which framework is utilized for purchasing such as SBS, NHS Supply Chain or other (please provide details of all that are used)
3) By which method is this procured? (Please state all that applies)
Section 2
1) What is the name of the manufacture used to provide Topical Negative Wound Therapy Treatment for each hospital location?
*Smith-Nephew
*KCI
*Talley
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) Is this equipment provided via Hire agreement, Purchase or other? (Please provide details)
4) Is the provision of this equipment contracted? Yes or No
5) If contracted is the service and maintenance of this equipment included as part of the contract? Yes or No
6) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
7) If 3rd party provider please state company name
8) Is the 3rd party service & maintenance contracted? Yes or No
9) If Yes what is the contract term? (Including any extension periods).
10) What is the expiry date of this contract?
The following questions are only applicable if the supply of Topical Negative Wound Therapy to the hospital trust is contracted.
1) As a result of the tender did you change provider? Yes or No (If Yes please provide name of previous supplier)
2) What date did your current contract start?
3) How long is the current contract? (Including any extension periods)
4) When does the current contract expire?
5) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
6) Please provide the financial value for the first 12 months of the current contract in place.
Section 3
1) What is the name of the manufacture used to provide pressure relief alternating dynamic surface air mattresses to the trust?
*Hill-Rom
*Smith-Nephew
*Talley
*Direct Healthcare
*Karomed
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) What is the total number of dynamic mattresses on-site?
4) Is this a managed service? Yes or No
5) Is the provision of dynamic surfaces contracted? Yes or No
6) If Yes is the service and maintenance of this equipment included as part of the contract? Yes or No
7) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
8) If 3rd party provider please state company name
9) Is this 3rd party service contracted? Yes or No
10) If Yes what is the contract term? (Including any extension periods).
11) What is the expiry date of this contract?
12) How is the decontamination of these products managed? In-house or 3rd party provider
13) If 3rd party provider please state company name
14) Is this 3rd party service contracted? Yes or No
15) If Yes what is the contract term? (Including any extension periods).
16) What is the expiry date of this contract
The following questions are only applicable if the supply of dynamic alternating air surface mattresses to the hospital trust is contracted.
1) Which method is used to tender the contract? (Please provide details)
2) What date did your current contract start?
3) What is the term of the contract? (including any extension periods)
4) When does the current contract expire?
5) Is the contract purchase, hire or other (please provide details)
6) If contracted, when did you last tender the contract?
7) As a result of the tender did you change provider? Yes or No (if Yes please provide previous supplier)
8) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
9) Please provide the financial value for the first 12 months of the current contract in place.
Section 4
1) What is the name of the manufacture used to supply profiling bed frames?
*Hill-Rom
*Sidhil
*Invacare
*Linet
*Huntleigh
*Other (please provide details)
2) By which method is this procured? (Please state all that applies)
3) Which products are used? (Please provide details)
4) What is the total number of hospital bed frames on-site?
5) Is the supply of bed frames contracted?
Yes or No?
The following questions are only applicable if the supply of profiling beds to the hospital trust is contracted.
1) What date did your current contract start?
2) How long is the current contract? (Including any extension periods)
3) When does the current contract expire?
4) When did you last tender the contract?
5) As a result of the tender did you change provider? Yes or No (if Yes please state previous supplier)
6) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
7) Please provide the financial value for the first 12 months of the current contract in place.

Download response Contract information for TNP and PAC.060317

Contract Register. 140618

I want to submit a request for some information from the Trust in relation to their contract’s register.
The contract register should display all the Trust existing/live contracts this includes medical and non-medical. I would like the register to display the following columns:
1. Contract Reference
2. Contract Title
3. Supplier Name
4. Spend (Total or Annual)
5. Contract Duration
6. Contract Extensions
7. Contract Dates
8. Contract Description
9. Contact Owner (Full contact details if possible.)
10. CPV codes/ProClass
11. Framework or Tender Reference
IMPORTANT
You may forward me a Weblink to a portal to download the contract register, please make sure all of the Trust’s contract are provided.

Contract Data/API Contact Details
12. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? Name, Job Title, Telephone, Email Address

Download response Contract Register. 140618

Cost of flu treatment in A&E. 250117

a) How many people were admitted to Accident and Emergency with flu in each calendar year: 2010; 2011; 2012; 2013; 2014; 2015, and; 2016?

b) What is the total financial cost for people presenting with flu at Accident and Emergency in each calendar year in answer to Question A. Please provide this information broken down by calendar year, as follows: 2010; 2011; 2012; 2013; 2014; 2015, and 2016. This should include all costs incurred to treat the illness during the patients stay at the hospital, including all staff salaries and any other medical treatment costs.

Download response Cost of flu treatment in A&E. 250117

Data visualisation tools. 050718

1. Please could you provide me with a list of dashboards* the organisation uses and how many users per dashboards there are?
2. Please could you provide the monthly agency spend for Business Intelligence for the financial year 2017/2018?
1. April 2017 –
2. May 2017 –
3. June 2017 –
4. July 2017 –
5. August 2017 –
6. September 2017 –
7. October 2017 –
8. November 2017 –
9. December 2017 –
10. January 2018 –
11. February 2018 –
12. March 2018 –

Download response Data visualisation tools. 050718

Debt collection services. 241017

1. How much money has your trust spent on debt-collection services over the last three financial years?
Please provide this information broken down by financial year for 2014-15, 2015-16, and 2016-17.

2. For the same three financial years, please state how much money was collected by these debt-collection services?
Please break down by the same years as above.

3. At the end of the financial year, what was the largest outstanding debt owed by a single patient? (to clarify, this question refers only to individuals, not companies). Please provide the sum, and state whether the patient was a British patient who had undergone private treatment, or a patient from overseas. Please state what services treatment they received.

Download response Debt collection services. 241017

Debt collection services. 241017

1. How much money has your trust spent on debt-collection services over the last three financial years?
Please provide this information broken down by financial year for 2014-15, 2015-16, and 2016-17.

2. For the same three financial years, please state how much money was collected by these debt-collection services?
Please break down by the same years as above.

3. At the end of the financial year, what was the largest outstanding debt owed by a single patient? (to clarify, this question refers only to individuals, not companies). Please provide the sum, and state whether the patient was a British patient who had undergone private treatment, or a patient from overseas. Please state what services treatment they received.

Download response Debt collection services. 241017

Disposable cutlery and plates. 290118

United Kingdom-Maidstone: Disposable cutlery and plates
2015/S 021-033596
The details we require are:
• Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages*
• Contract values of each framework/contract (& any sub lots), year to date
• Start date & duration of framework
• Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
• Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
• Who is the senior officer (outside of procurement) responsible for this contract?

Download response Disposable cutlery and plates. 290118

Disposable drinking cups. 290118

How many disposable drinking cups has your trust purchased in each year for the last five years?

Download response Disposable drinking cups. 290118

Dressings and bandages. 020518

Can you please provide your organisation’s total spend for either the last calendar year (2017) or last full financial year with NHS Supplies in respect of Dressings and Bandages. This is either direct spend by yourselves or as part of any contract, you let for these services.

Download response Dressings and bandages. 020518

Drug spend 2014-15 and 2015-16. 081117

a) Total drug spend for financial years 2014-15, and 2015-16
b) Total Off-tariff drug spend for financial years 2014-15, and 2015-16
c) Total Homecare drug spend for financial years 2014-15, and 2015-16

Download response Drug spend 2014-15 and 2015-16. 081117

Dyson products purchased in the last five years. 151216

How many Dyson products has your trust bought in the last five years?

What are these products and models?

A breakdown of how many items of each Dyson product was bought in the last five years, e.g. how many fans, vacuum cleaners, hand dryers etc.

How much money has been spent on all Dyson products for the last five years for your trust?

Please could I have a breakdown for how much has been spent on each type of product, e.g. vacuum cleaners, fans, hand dryers etc., for the last five years?

Download response Dyson products purchased in the last five years. 151216

Electronic invoices. 270317

1) Do you currently receive electronic invoices? Yes/No
2) If so, are these received in EDI format (not PDF)? Yes/No
3) If not, would you have a date when you could be ready to test/receive EDI Invoices?

Download response Electronic invoices. 270317

eProcurement system. 200417

Where different and distinct systems are in use at separate Trust sites, please disclose this. Where this is the case, please answer the following sections in a site-specific format.
Where any/all of the procurement functions are outsourced to another party/parties (e.g. a private company or a distinct NHS body) please disclose the structure of this relationship.
1. Does the Trust have/have use of an eProcurement system(s)?
If so, please name the provider(s).
2. What is the length (in years) of the contract(s) in place with such provider(s)?
3. What is the end/renewal date (dd/mm/yyyy) of the contract(s)?
4. What Finance/E.R.P (enterprise resource planning) system does the Trust use?
5. How many members of staff work in the procurement/purchasing department(s) at the Trust?
6. How many members of staff across the Trust have permission/access to raise requisitions and purchase orders through the eProcurement system(s) in place? (estimate)

The following section of this FOI request concerns the capability of any/all eProcurement systems being used by the Trust.
1. Does the system(s) in place cover the sourcing (auctioning/tendering) of goods/services used by the Trust?
2. Does the system(s) in place cover the management of contracts with chosen suppliers?
3. Does the system(s) in place cover the enablement of electronic catalogues to allow buyers within the Trust to purchase goods/services sourced by the Trust?
4. Does the system(s) in place cover the payment to suppliers for goods/services sourced by the Trust? This includes the management of electronic Purchase Orders, Goods Receipts and Invoices.
5. Does the system(s) in place cover the management of supplier relationships and performance?
6. Does the system(s) in place have the capability to analyse current and/or historical procurement spend by the Trust?
7. Does the system(s) in place have the capability to report and demonstrate data relating to procurement spend by the Trust?
8. Does the system(s) in place have the capability to integrate with the Finance/E.R.P (enterprise resource planning) system?
9. Are updates (free or paid) offered for the incumbent system(s), either on a regular or irregular basis?
10. Are there any formalised projects or initiatives currently underway to review/upgrade current procurement practices within the Trust? If yes, please provide details.

Download response eProcurement system. 200417

Estates and Capital Projects Managers. 300317

Please can you provide the contact details, name, telephone number, email address, of the Head of Estates, Estates Managers and Capital Project Managers for your trust?

Download response Estates and Capital Projects Managers. 300317

Finance and human resources IT systems. 221217

Human Resources
1. The name of the business system your Human recourses department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no
10. The name and email address of your Director of Human Resources?
Finance
1. The name of the business system your Finance department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no
10. The name and email address of your Director of Finance?

Payroll
1. The name of the business system your Payroll department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no

Download response Finance and human resources IT systems. 221217

Financial Accounts 2015-2016

I am requesting an electronic copy of your 2015/16 financial accounts.

Download response Financial Accounts 2015-2016 280716

Financial position 2014 to 2017

1. The trust’s reported financial position (its surplus or deficit)
For the year to March 31, 2014
For the year to March 31, 2015
For the year to March 31, 2016
For the current 2016/17 year to July 31
2. The trust’s planned surplus or deficit
For the year to March 31, 2014
For the year to March 31, 2015
For the year to March 31, 2016
For the current 2016/17 year

Download response 060916

Financial position of the Trust 2014-2016.

Please provide information on the financial position, for 2014/15 and 2015/16 for i) the trust/CCG ii) all NHS hospitals within the trust and iii) the mental health trusts. Please set out the gross assets and liabilities in each case and whether the Trust was in surplus or deficit and the level thereof.

Download response Financial position of the Trust 2014-2016 180516

Financial services

Could you please send me contract information relating to Banking Services, Audit Services and Card Processing Services? If you do not understand what each of these mean please see below:
· Banking Services- contract information relating to the organisation banking services.
· Audit Services (Financial) – contract relating to internal and external audit services.
· Accountancy – Contracts relating to TAX advisory services.
· Card Processing Services / Merchant services- a wide range of payment processing options. Most automatically associate merchant services with debit and credit card processing.
Can you please provide me with the following contract information for each of the contract category specified above?
1. Contract Category: Please see select from the categories provided; Banking Services; Financial Audit Services; Card Processing Services
2. Existing Supplier Name for each contract
3. Contract Description: Please do not just state two to three words can you please provide me detail information about this contract and please state if upgrade, maintenance and support is included. Please also include the modules included within the contract.
4. Annual Average Spend for each contract
5. Contract Duration: What is the duration of the contract please include any available extensions within the contract.
6. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
7. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
8. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provided, please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY
9. Contact Details: I require the full contact details of the person within the organisation responsible for this particular contract.
10. Notes: Please provide me with any further information with regards to this contract this could include any contract extension available as well as information on renewals or plans for future tenders.

Download response Financial services 060916

Financial Services. 230817

• Banking Services- contract information relating to the organisation banking services.
• Audit Services (Financial) – contract relating to internal and external audit services.
• Accountancy – Contracts relating to TAX advisory services.
• Card Processing Services This is a contract the organisation may have that relates to the use debit/credit cards used by staff to make payments to suppliers. This also includes procurement cards.
• Merchant services This is a contract where by people make payments to the organisation via a machine or terminal. This also includes machines that have chip and pin and contact less
1. Contract Category: Please see select from the categories provided; Banking Services; Financial Audit Services; Card Processing Services
2. Existing Supplier Name for each contract
3. Contract Description: Please do not just state two to three words can you please provide me detail information about this contract and please state if upgrade, maintenance and support is included. Please also include the modules included within the contract.
4. Annual Average Spend for each contract
5. Contract Duration: What is the duration of the contract please include any available extensions within the contract.
6. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
7. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
8. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provided, please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY
9. Contact Details: I require the full contact details of the person within the organisation responsible for this particular contract.
10. Notes: Please provide me with any further information with regards to this contract this could include any contract extension available as well as information on renewals or plans for future tenders.

Download response Financial Services. 230817

Financial services – June 2016

1) What is the accounting software that the Trust uses?
2) Who is the Trust’s service provider (in-house or 3rd party provider)?
a. If outsourced to a 3rd party provider, what is the name of the service provider you use?
b. If outsourced to a 3rd party provider, how long did the transition to the service provider take?
c. If outsourced to a 3rd party provider, was the transition fee paid prior to the service start date and what was the transition price paid?
d. If outsourced to a 3rd party provider, what is the value of the service contract per annum?
e. If outsourced to a 3rd party provider, when did the contract start and when is the contract due to expire?
f. If outsourced to a 3rd party provider, is the Trust’s intention to re-procure these services through a Trust run OJEU procurement exercise when the current contract expires?
i. If not, what is the route through which you will contract these services?
g. If the Trust provide these services in-house, does the Trust intend to investigate outsourcing these services in the next 12 months
3) What is the volume of Accounts Payable invoices processed per annum by the Trust?
4) What is the volume of Accounts Receivable invoices processed per annum by the Trust?

Download response Financial services – June 2016 060616

Gain share agreements

Are there any “gain share” agreements in place between you the provider and a CCG?
Please state “Yes” or “No”
If “Yes”, then please provide the following details:
1. Disease areas CCG included in the “gain share” agreement
2. Names of any specific drugs involved
3. How will savings be apportioned between you the provider and the CCG

Download response Gain share agreements 280716

Gainshare Agreements

1. Are there any Gainshare agreements in place between you the provider and a CCG?
If “No” – end.
If “Yes”, then please provide the following details:
Disease Area
CCG included in the Gainshare agreement
Names of any specific drugs involved
How will savings be apportioned between you and the CCG?
2. Who (what position) within the Trust is responsible for the agreement?
3. How and in what form are the savings from any Gainshare given to the CCG?
By Gainshare agreement I mean one where the benefits associated with more efficient us of medicines not reimbursed through national prices is shared between the provider and the clinical commissioning group party to the agreement.

Download response Gainshare Agreements 111115

Goods and services (2013/14) (2014/15) and (2015/16) 011216

In each of the last three financial years (2013/14) (2014/15) and (2015/16) please state how much your organisation has paid for goods and services from each of the following companies
* ACADEMY OF FABULOUS STUFF COMMUNITY INTEREST COMPANY (10189968)
* LINDUM LOFTS & EXTENSIONS LIMITED (06083403)
* HEALTH MANAGERS NETWORK LIMITED (08234437)
* WOUND SPECIALIST LIMITED (08188747)
* CARBON HEALTH NETWORK LIMITED (06887536)
* UK HEALTHGATEWAY LIMITED (06319587)
* GRASMERE MANAGEMENT COMPANY LIMITED (05685001)

Please provide me with copies of each invoice (accepting that personal details will have to be redacted) so that I can see how much was paid and a description of what it was paid for.

Download response Goods and services (2013/14) (2014/15) and (2015/16) 

Haemostat product usage. 040118

Name of haemostat PRODUCT MPC (Manufacturers product code) Pack/Unit size Quantity of packs used in 12 months from 1/4/16 to 31/3/17

Download response Haemostat product usage. 040118

HCR Services. 100118

1) Does the Trust have an agreement to use HCR Services either under contract, via a purchase/supply order or some other agreement?
a. If yes, please would you answer the following questions?
i. Is this under contract?
ii. When did it start?
iii. When does it end?
iv. Is the Trust paid additional monies by HCR Services above the amounts to be recovered?
b. Is this via some other agreement?
i. What kind of Agreement?
ii. When did it start?
iii. When does it end?
iv. Is the Trust paid additional monies by HCR Services above the amounts to be recovered?
2) In relation to the HCR Services, what is required from the emergency department(s)?
a. To collect data on attendees who have suffered a 3rd party accident and send on to HCR services (with appropriate permission)?
i. If yes, how is the permission obtained?
b. To pass every patient a leaflet on HCR Services?
c. To only pass patients who have suffered a 3rd Party Accident a leaflet on HCR Services?
3) In relation to the HCR Services and the above, is there a requirement for this service to be operated elsewhere within the hospitals (Wards, Ambulatory, Outpatients?)
4) If possible please enclose a scan/copy of any literature that would be passed to a patient.
5) In brief please explain how HCR services improve the revenue to be recovered via the NHS Injury cost recovery scheme? (What else do they do that would not be done otherwise?)

Download response HCR Services. 100118

Label supplies. 310717

1. Who currently supplies you with labels?
2. Who is currently the contact to deal with label supplies?
3. How much do you currently spend on labels annually?

Download response Label supplies. 310717

Legal spend in Government

1. How much did your organisation spend on legal fees in the financial year 2015?
2. Do you have a panel of preferred legal providers? If yes, what year was this panel appointed?

Download response Legal spend in Government 270616

Locum-agency spend. 300518

1) The total amount the trust spent on agency/locum doctors for the following years: 2012/13, 2013/14, 2014/15, 2015/16, 2016/17 – breaking this information down by speciality and grade.
2) What is the highest hourly/shift rate paid to an agency or locum doctor at any point in the following years: 2012/13, 2013/14, 2014/15, 2015/16, 2016/17 – please include job title and date.

Download response Locum-agency spend. 300518

Lord Carter Review. 060217

1. The overall savings estimate that has been sent to the trust by Lord Carter, as part of his review of NHS efficiency. Please note, I am not asking for the agreed/confirmed savings figure, I’m asking for the initial figure that was presented to the trust by Lord Carter and his team.
2. The overall savings estimate as a proportion of the trust’s turnover.
3. The ‘pack’ that has been sent to the trust, outlining the areas where savings could potentially be made.

Download response Lord Carter Review. 060217

Lord Carter Review. 160617

I need the report on savings estimates sent to hospital trusts as part of Lord Carter’s review. I believe that many acute trusts have received these estimates. Please can you share this report?

Download response Lord Carter Review. 160617

Losses and special payments 2014-2015

In your financial accounts for the financial year 2014/15 did you have a section for “losses and special payments?
1. If so how much money was accounted for in the 2014/2015 financial year as being “losses and special payments”? (Please note l am aware that the loss may have occurred many years earlier but I am interested in items which were accounted for in the last financial year, irrespective or when the loss took place.)
Please detail the three largest single amounts within this total, giving a cost for each loss and a detailed description of the claim and the reason for the loss.
2. What was the total paid on claims for property lost by patients and how much related to (i) Dentures, (ii) Spectacles, (iii) jewellery and (iv) hearing aids?

Download response Losses and special payments 2014-2015 080216

Losses and special payments 140217

In your financial accounts for the financial year 2015/16 did you have a section for “losses and special payments?

1. If so how much money was accounted for in the 2015/2016 financial year as being “losses and special payments”? (Please note l am aware that the loss may have occurred many years earlier but I am interested in items which were accounted for in the last financial year, irrespective or when the loss took place.)

Please detail the three largest single amounts within this total, giving a cost for each loss and a detailed description of the claim and the reason for the loss.

Download response Losses and special payments 140217

Medical locum agencies. 070417

1. A list of all agencies the trust uses for temporary workers (Med Locums).

2. A breakdown of monetary spend per agency for the last 12 months.

Download response Medical locum agencies. 070417

Medical locum spend 2016. 130417

I would like to request the Trusts Medical Agency Locum Spend for the year 2016.

Can you please break these figures down accordingly?
1. Agency Locum spend for A&E Doctors in 2016
2. Agency Locum spend for General and Acute medicine Doctors in 2016
3. Agency Locum spend for Radiology Doctors in 2016
4. Agency Locum spend for Paediatric Doctors in 2016
5. Agency Locum spend for Obs and Gynae Doctors in 2016
6. Total Medical Agency Locum Spend in 2016

Please also break them down into the grade accordingly (SHO, Middle and Consultant).

Download response Medical locum spend 2016. 130417

NHS settlement agreements

1. For each of the last five financial years (11/12 – 15/16) what was the total number of employees who signed settlement agreements when they left your Trust? Please note I would like an annual breakdown for each year as opposed to one figure covering the five-year period.
2. For each of the last five financial years how much was paid to departing employees as part of the settlement agreements? Again, I am looking for annual breakdowns of the data.
The annual breakdown should include the following three elements;
A – The statutory amount the employee received (ie the sum to which they were legally entitled for redundancy).
B – The amount paid in special severance payments.
C The overall total of statutory and special severance payments for each of the last five financial years.
3 (A). For each of the past five financial years, how many of the settlement agreements signed with departing employees contained confidentiality clauses?
(B) Of the total number of confidentiality clauses issued during each financial year, how many came from Category 1 as defined above? Category 2? Category 3? Other?

4. For each of the last five financial years, how many departing NHS staff who signed a settlement agreement received an agreed reference as part of the agreement?
5. For each of the past five financial years, how many of the settlement agreements signed with departing employees were referred to the Treasury/Department for Health to be signed off?

Download response NHS settlement agreements 280716

NHS suppliers. 100118

Please can you send me a list of all suppliers you purchase goods or services from and the annual value you bought from them in your last financial year?

Download response NHS suppliers. 100118

Non-medical contracts register

Can you please provide me the full version of your contracts register (Excel) that lists all the contracts the organisation has around non-medical equipment?

Please do not send me a simple contract’s register that only list contract dates and supplier names as I require department, categories and contract owner.

We are currently conducting this research within your region and have also contacted similar organisations to obtain the same information.
Please if possible, can you include?

1. Existing Supplier
2. Annual Spend
3. Contract Brief
4. Contract Dates
5. Department
6. Product Categories – The more the better.
7. Contract Owner including job title and email address
8. If possible can you also provide me with the contact details of the person responsible for uploading and publishing the contract’s register?

Download response Non-medical contracts register 090916

Orthopaedic suppliers – July, August, September 2015

This would relate to the purchase of Orthopaedic products for the latest year (and previous years if possible).

Specifically, I’m interested in products related to primary Hips and Knees procedures. This would include:

Hip Replacement:
– Primary cemented/cementless Femoral implants
– Metal/Ceramic/Bipolar/Unipolar Modular Heads
– Standard/Crosslinked polyethylene Acetabular cups
– Standard/Crosslinked/Ceramic/Metal modular Acetabular inserts

Knee Replacement:
– CR/PS Cemented/Cementlenss Femur Primary Bicondylar
– FB/MB Primary CR/CS/PS Articular Surfaces
– FB/MB Primary Cemented/Cementless Tibial Components
– Cemented/Cementless Tibial Components

I’ve attached an example of the data format I would find useful, which lists :
– The Supplier
– Order Quantity
– Unit Price or Order Value (both are listed)
– Item Description
– Order Date

Download response Orthopaedic suppliers – July, August, September 2015 160216

Paper procurement. 240717

Question 1:
How many reams of paper, of the following types, did your organisation procure during the 2016/17 financial year*?

Question 2:
Does your Procurement Department stipulate that paper procured within the organisation should be purchased from the NHS Supply Chain Core Stationary List?

Download response Paper procurement. 240717

Patient communication by letter

Please provide details of the system or process which is currently used by the Trust to communicate with patients by letter, and the organisation or individuals responsible for implementing and maintaining this service.
o Does the Trust use the services of an external provider for patient and non-patient letters?
o Please provide details of the Trust’s current Letter printing service supplier/system
o Please confirm if you use Hybrid mail and what type?
Hybrid? Yes No
Bulk and Desktop? Yes No
Bulk only? Yes No
o What are the Trust’s annual costs for the printing and postage of patient letters?
o Please provide monthly volumes and values for the number of patient letters sent?
Does the Trust use an external printing service for either patient or non-patient letters?
If it does:
 When was this service implemented and the specialties included?
 Please provide specific details of any aims or targets which were established at the outset and whether these have been achieved?
 Please give an indication of the costs associated with the service, including initial implementation costs and support costs?
 How many NHS staff are responsible for the implementing and supporting of this service and what is their role within the Trust?
 Please provide details of your current letter supplier:
o Supplier name
o Date contract began and contract end date
o Contract review date
o Cost of contract to date and annual spend
o Cost of set up
o Cost of support
o Fulfilment
o Postage – First class? Second class?
• Please provide details of the process which was followed to procure an external print service?
• Please provide details of the channels used to publish the notification of procurement, for an external print service?
If no external letter supplier/service is used:
• What are the Trust’s costs for the service and support of printing?
• Have you previously considered using outsourced letter printing services, and if so, please provide details of why you chose not to.

Does the Trust use the services of an external provider for patient and non-patient letters?

Please provide details of the Trust’s current Letter printing service supplier/system

Please confirm if you use Hybrid mail and what type?

What are the Trust’s annual costs for the printing and postage of patient letters?

Please provide monthly volumes and values for the number of patient letters sent?
Does the Trust use an external printing service for either patient or non-patient letters?
If it does:
When was this service implemented and the specialties included?

Please provide specific details of any aims or targets which were established at the outset and whether these have been achieved?

Please give an indication of the costs associated with the service, including initial implementation costs and support costs?
How many NHS staff are responsible for the implementing and supporting of this service and what is their role within the Trust?

Please provide details of your current letter supplier:

Please provide details of the process which was followed to procure an external print service?

Please provide details of the channels used to publish the notification of procurement, for an external print service?

Download response Patient communication by letter 020316

Payments to consultancy firms 2014-2017. 290118

1. Please provide a list of all the occasions in which private consultancy firms have been used/paid by the Trust/CCG during the last three financial years, including this year to date (2014-15, 2015-16 and 2016-17). Please break this information down by date of project/contract, cost to the Trust/CCG and the name of the firm. Please also provide an explanation of the reasons/purpose for the use of the consultancy firm.
2. Please provide any details for any contracts/projects agreed with private consultancy firms for the financial year ahead broken down by the same details as above.

Download response Payments to consultancy firms 2014-2017. 290118

Penalties and fines 2014-2015.

1) Name of a) your trust b) the hospitals in your trust
2) Does the hospital trust have a Major A&E Unit?
3) We would like to request the income retained by the commissioner (the CCG) as a result of funds withheld or ‘defunded’ from your Trust under the application of the 30% marginal emergency tariff in the following financial year of 2014/15?
4) How much money has the Trust been fined or had withdrawn/withheld for not meeting the percentage target for referral to treatment time of 18 weeks for patients in the following financial year of 2014/15?
5) How much money has the Trust been fined or had withdrawn/withheld for not meeting the percentage target for A&E waiting time (4 hours) in the following financial year of 2014/15?
6) How much money has the Trust been fined or had withdrawn/withheld for emergency readmissions of patients within 30 days of discharge in the following financial year of 2014/15?

Download response Penalties and fines 2014-2015 181115

Personal service companies 090916

Please provide, in an excel spreadsheet, the following information about payments made by the Trust to Personal Service Companies over the past five financial years (2011/12 to 2015/16). Please indicate:

1. The date of the payment;
2. The name of the Personal Service Company that payment was made to;
3. The size (£) of the payment;
4. The “Expense Area” and “Expense Type” of the payment.

Download response Personal service companies 090916

PFI contract for Maidstone and Tunbridge Wells NHS Trust.

a) the total actual and projected nominal cash costs of this PFI contract, including all projected adjustments for inflation (reflecting the basis on which the unitary charge is indexed to inflation, as agreed in the contract), along with start date and completion date;
b) for each year of the contract, the total actual and projected nominal cash costs of this PFI contract, including all projected adjustments for inflation (reflecting the basis on which the unitary charge is indexed to inflation, as agreed in each contract);
c) for each year of the contract, the non-service element of the total actual and projected nominal cash cost of each PFI contract, estimated as above;
d) the pre-tax nominal Project Internal Rate of Return and the pre-tax nominal Equity Internal Rate of Return, as calculated at the start of the contract, and as projected by the relevant SPV as of today.

Download response PFI contract for Maidstone and Tunbridge Wells NHS Trust 180516

PFI – fines and deductions 281216

Sheet 1 Postcodes
Treasury records – Yellow – because the name of individual PFI projects can sometimes change I have asked you to provide in addition to the name, the Unique HMT ID number that identifies a PFI scheme on the HM Treasury spreadsheet so that I can be sure that I am identifying each scheme correctly.
Postal Address – Green – Could you please provide the postal address for each of the PFI projects listed. Where there are multiple addresses, please could you list each in turn and separate each with a forward slash.

Sheet 2 Fines & Deductions
Each of the PFI projects held by the authority may have incurred financial penalties for poor performance. Could you please record the details of each individual fine or deduction, since the first date of operations, in the second page of the spreadsheet.

Deduction information – Green – Could you please give a short narrative summary of the reason for the deduction, select the type of deduction incurred and note whether this was disputed by the contractor.
Date Information – Blue – Could you please record the date on which the deduction was first made then go on to note over how long the deduction was applied.
Financial Information – Orange – Please record the amount that the authority tried to deduct from the contractor, and where the deduction was disputed and the full sum not awarded the final settlement of the dispute.

Download response PFI – fines and deductions 281216

Private Finance Initiative contracts.240217

Please provide information for each PFI hospital or unit within the trust.
1. Any performance adjustments deducted from the yearly unitary charge in respect of each hospital. Please include deductions planned but not yet made and those sought but in dispute.
2. Any other deductions/payments made under the PFI contract regarding defects including, but not limited to, those made by the Trust and the special purpose vehicle/project company.
3. The number of disputes concerning defects/deductions, resolved or otherwise, and whether they went to mediation, adjudication or court.
4. The sections/clauses of the PFI contract pertaining to deductions made in respect to defects, how much they can be and in which circumstances they can be made.
5. The sections/clauses regarding termination of the contract and the powers the trust has in this situation.

Download response Private Finance Initiative contracts.240217

Procurement of consumable supplies. 040717

Please provide me with the contact email address for the person in charge of procurement of consumable supplies.

Download response Procurement of consumable supplies. 040717

Procurement Department. 110917

Can I please request the following details?

• Organisational structure for the Procurement Department.

Can you please confirm the name and email address of the Director/Head of Procurement.

Could you also confirm which of these managers/leads in the Procurement Department are interims and their contact details?

Download response Procurement Department. 110917

Public Health funerals 140217

1. Has the Trust conducted any Public Health Act funerals since 01/01/16 to the present (up to and including the date of your response)?
2. If the answer to this question is yes, please disclose for each:
a) The full name of the deceased
b) The date of birth of the deceased
c) The date of death of the deceased
d) The last known address of the deceased
e) Whether details of the estate have been/will be or are likely to be referred to the Government Legal Department, if known.
3. Have there been any similar FOI requests to this (within the time period outlined in question 1)?
4. Within the time period outlined in question 1, has the Trust ever used a genealogist, family researcher, ‘heir hunter’ or similar company to try to locate the next of kin of a deceased person for whom the Trust has taken responsibility for conducting a public health funeral? If so, which research company has been used?

Download response Public Health funerals 140217

Public Health Funerals 2016-2017. 100517

1. How many of these funerals did you arrange in the last financial year?

2. Would you list all funerals with the following details for each: the date, whether the body was buried or cremated, whether a funeral service was held, the total cost (including all disbursements such as crematorium fees and burial plots. And excluding any offset of monies recovered from the estates of the deceased), and the funeral director used. I do not require any personal information such as name or date of birth of the deceased.

3. How were the funerals providers found – on a case-by-case basis or part of a tendered contract?

4. If part of a tendered contract, when did the contract begin and when is it scheduled to be renewed?

Download response Public Health Funerals 2016-2017. 100517

Public sector financial efficiency.

1) Does the organisation use an external provider for VAT advisory services? If so please state the name of the organisation used? (E.g. Ernst Young, Berthold Bauer, Liaison, CRS, KPMG etc.)?
2) Please state the contract start and end date.
3) Please confirm the total value of VAT recovered by the provider in 2015/16
a. Please state the total value of under-claims recovered
b. Please state the total value of over-claims recovered
4) Please state the total amount spent by the organisation for these services in 2015/16
5) Did the organisation use an external provider to re-review VAT recovered in the last financial year (15/16)?
a. If so please state the name of the company used
6) Please state the total amount of additional VAT recovered by the provider in 2015/16
7) Please state the total amount spent by the organisation for these services
8) Please state the total number of Accounts Payable invoices processed by the organisation in the last financial year (15/16)
9) Please state the total value of Accounts Payable invoices in the last financial year (15/16)
10) In the last five years, please state the name(s) of all external organisation(s) used to review AP and identify and recover erroneous payments, and the period(s) reviewed by each.
11) Please state the total value of moneys recovered by each provider in the period(s) reviewed.
12) Please state the total amount paid to any external parties for this review work.

Download response Public sector financial efficiency 060916

Recruitment Advertising expenditure from 1 January to 31 December 2016. 070817

Please provide us with an exact figure of the Trust’s total Recruitment Advertising expenditure from 1 January to 31 December 2016.

Download response Recruitment Advertising expenditure from 1 January to 31 December 2016. 070817

Respiratory circuits. 020518

Please kindly confirm how many of the following respiratory circuits were used in the 17/18 financial year by Maidstone and Tunbridge Wells NHS Trust:

Manufacturer: Resmed
Product Name: Slimline CPAP Tubing
Product Description: Slimline CPAP Tubing 15mm
Manufacturer Code: 36810

Download response Respiratory circuits. 020518